data_2aj0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2aj0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.5 pttt . . . . . 0 N--CA 1.444 -0.754 0 N-CA-C 105.946 -1.872 . . . . 4.64 105.946 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.5 m -151.9 154.76 36.75 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 105.888 -1.893 . . . . 1.65 105.888 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.25 137.99 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 O-C-N 124.428 1.08 . . . . 1.84 109.851 169.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -116.49 151.21 36.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.517 -1.661 . . . . 3.19 106.517 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 -87.86 131.94 34.38 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 107.67 -1.233 . . . . 6.77 107.67 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.87 147.7 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 119.677 1.126 . . . . 2.03 109.963 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -141.21 151.76 44.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.007 -0.738 . . . . 2.84 109.007 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.68 -79.78 0.37 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.253 1.406 . . . . 1.92 110.941 174.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.2 pp -73.38 150.93 41.42 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 122.348 -0.501 . . . . 4.05 110.629 -171.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 p -144.51 63.81 1.31 Allowed 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.762 0.825 . . . . 3.25 110.793 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.8 t -155.49 123.77 5.88 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.861 -0.525 . . . . 2.47 111.653 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m -48.43 -41.06 28.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.349 1.46 . . . . 3.02 112.222 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -61.27 -42.44 98.63 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.481 -0.762 . . . . 3.34 110.681 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.8 m -67.83 -40.6 83.75 Favored 'General case' 0 C--O 1.231 0.124 0 O-C-N 121.355 -0.841 . . . . 2.65 110.248 176.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.33 -46.22 72.84 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 122.2 -0.313 . . . . 1.89 110.326 171.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.91 -43.92 97.88 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.767 0.827 . . . . 2.19 110.987 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -54.19 -51.62 63.81 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.745 -0.597 . . . . 4.33 109.599 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.26 -60.51 3.3 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.293 0.637 . . . . 3.78 112.508 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -38.57 72.48 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.383 0.992 . . . . 2.91 110.57 -173.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -64.68 -46.38 82.67 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.643 0.377 . . . . 3.44 110.894 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -52.44 -41.91 63.69 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 122.052 -0.405 . . . . 1.58 110.604 173.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 51.5 t -62.68 -55.12 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.971 -0.455 . . . . 1.84 110.106 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.7 mttt -48.47 -37.74 18.16 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.772 1.027 . . . . 2.59 113.772 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -54.0 -34.72 60.64 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.805 0.729 . . . . 3.3 112.717 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.9 mt -70.0 129.72 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.66 -0.867 . . . . 2.32 108.66 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -71.06 -11.11 60.78 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.906 -1.121 . . . . 2.58 113.472 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.24 -21.95 61.68 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.873 0.749 . . . . 1.55 112.397 -177.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -111.65 152.67 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 O-C-N 121.365 -1.08 . . . . 1.76 109.143 -175.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.8 m -106.72 -56.51 2.18 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.208 1.403 . . . . 1.88 107.848 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -125.49 161.33 27.36 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.374 0.607 . . . . 2.36 112.323 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.16 139.91 20.78 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.729 -1.212 . . . . 1.92 107.729 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.0 mt -133.01 106.38 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 106.065 -1.828 . . . . 2.37 106.065 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.2 m -120.76 118.59 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 122.79 0.436 . . . . 3.21 109.937 -162.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 . . . . . 0 CA--C 1.528 0.106 0 O-C-N 122.425 -0.172 . . . . 3.12 110.778 -167.757 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.1 m . . . . . 0 CA--C 1.534 0.357 0 CA-C-O 120.48 0.181 . . . . 2.65 111.135 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -158.64 165.59 34.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.61 -0.681 . . . . 4.33 109.933 -158.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.1 tt -129.38 104.8 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 126.084 1.754 . . . . 4.15 108.171 -174.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.7 m -84.81 139.5 31.88 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.673 -0.862 . . . . 1.79 108.673 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.2 t -134.35 138.63 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 104.556 -2.387 . . . . 2.3 104.556 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.3 m -147.91 133.8 19.09 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.111 -1.07 . . . . 1.86 108.111 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.79 -92.68 0.14 Allowed Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 107.398 -2.281 . . . . 0.72 107.398 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -165.88 51.97 0.09 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.996 1.718 . . . . 2.26 109.489 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.52 166.59 29.73 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 120.657 -1.277 . . . . 1.61 111.591 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.0 m -119.67 165.44 14.48 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.424 1.49 . . . . 1.27 111.155 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -46.88 -46.86 8.23 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 CA-C-O 117.214 -1.374 . . . . 3.98 110.725 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -29.87 -50.69 0.12 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.16 1.784 . . . . 3.46 114.052 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -65.02 -48.37 74.13 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 122.38 1.086 . . . . 2.51 110.827 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.6 t -61.34 -32.79 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.058 1.743 . . . . 1.84 110.93 174.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -60.45 -53.75 53.81 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 126.696 1.998 . . . . 3.27 107.176 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.59 -56.44 13.53 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.434 -0.803 . . . . 4.32 109.571 176.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.21 -51.48 25.15 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.247 0.619 . . . . 1.53 110.81 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.68 -16.06 28.76 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 124.297 0.951 . . . . 0.4 113.197 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.65 -21.67 1.69 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.481 1.14 . . . . 1.62 112.293 169.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -54.07 -35.99 62.65 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.001 1.273 . . . . 3.15 112.705 173.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -121.29 -7.59 9.28 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.651 1.18 . . . . 2.5 112.528 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 71.85 53.86 0.2 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.515 1.526 . . . . 0.99 111.09 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.75 164.42 25.26 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.225 -0.922 . . . . 2.49 111.181 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.66 112.56 18.58 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.162 -1.792 . . . . 4.55 106.162 172.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 mt -113.58 143.51 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 106.735 -1.58 . . . . 1.88 106.735 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.9 mt -128.14 122.66 22.23 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 106.64 -1.615 . . . . 2.53 106.64 -173.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.53 111.76 2.19 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.665 1.577 . . . . 0.83 108.028 169.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 121.377 0.608 . . . . 4.4 110.71 169.529 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? . . . . . 0 C--O 1.233 0.216 0 N-CA-C 109.231 -0.655 . . . . 5.28 109.231 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.8 m -148.36 154.27 39.73 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 107.668 -1.234 . . . . 1.53 107.668 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 p -135.6 142.24 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 123.616 0.573 . . . . 1.63 110.438 169.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -127.52 147.15 50.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.602 1.161 . . . . 3.03 107.905 -169.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -89.0 128.5 35.71 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.372 -0.973 . . . . 4.55 108.372 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.29 149.23 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.095 -1.076 . . . . 1.9 108.095 169.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -143.47 148.95 36.85 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.423 -0.584 . . . . 2.62 109.423 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.51 -58.37 0.62 Allowed Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.146 0.879 . . . . 1.55 111.586 166.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.86 172.08 8.27 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.309 0.643 . . . . 3.54 112.157 -176.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.2 t -163.8 77.63 0.39 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.692 0.397 . . . . 3.99 109.962 171.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.9 t -168.11 126.91 1.21 Allowed 'General case' 0 C--N 1.342 0.266 0 O-C-N 121.969 -0.457 . . . . 2.56 111.427 172.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.4 m -49.91 -42.09 47.44 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.475 1.11 . . . . 2.12 112.233 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -53.76 -40.92 66.62 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.648 -0.657 . . . . 4.63 111.451 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.44 -47.08 83.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.381 -0.6 . . . . 2.46 109.381 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.15 -42.81 77.56 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.802 0.441 . . . . 1.74 111.098 175.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.81 -49.39 73.08 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.401 0.62 . . . . 1.81 109.87 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.471 ' HZ2' ' CD ' ' A' ' 61' ' ' GLU . 31.8 ttpt -53.83 -48.41 69.94 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.415 -0.587 . . . . 5.32 109.415 175.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -53.94 -65.33 0.59 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.723 0.809 . . . . 4.18 111.899 176.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.94 -40.69 70.2 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.976 0.807 . . . . 2.87 110.828 -171.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -61.81 -48.87 78.67 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 110.201 -0.296 . . . . 4.4 110.201 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -57.36 -41.17 79.59 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.986 -0.446 . . . . 2.4 110.473 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -64.41 -46.02 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 O-C-N 121.809 -0.557 . . . . 1.74 110.782 175.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -57.06 -33.95 67.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.913 0.885 . . . . 2.79 112.054 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.25 -21.54 65.26 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.932 0.716 . . . . 2.65 112.932 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.5 mm -77.8 106.71 8.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 O-C-N 120.739 -1.226 . . . . 3.65 110.748 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -65.95 85.19 0.08 Allowed 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 125.71 1.604 . . . . 2.57 108.653 163.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.47 -40.37 0.08 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.459 -1.056 . . . . 1.98 110.459 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.9 p -97.14 156.65 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 108.347 -0.982 . . . . 1.97 108.347 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 55.0 m -105.4 -54.9 2.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.171 1.388 . . . . 1.61 107.69 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -126.29 134.9 51.01 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 109.552 -0.536 . . . . 2.42 109.552 170.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.11 126.27 40.82 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.972 -1.122 . . . . 1.87 107.972 170.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.0 mm -111.22 101.91 13.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.237 -1.394 . . . . 3.44 107.237 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.03 145.88 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 116.618 -0.265 . . . . 3.08 110.553 -175.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 107.429 -1.323 . . . . 2.85 107.429 173.031 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 111.942 0.349 . . . . 2.98 111.942 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.92 171.1 20.02 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.639 0.775 . . . . 5.02 110.063 -165.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.81 113.99 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 108.48 -0.934 . . . . 2.07 108.48 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 m -91.2 143.33 26.78 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 123.983 0.913 . . . . 1.58 109.976 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.18 133.75 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.842 2.057 . . . . 1.81 106.761 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.8 m -143.05 124.34 14.62 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 106.96 -1.496 . . . . 1.76 106.96 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.12 -93.07 0.11 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 118.663 -1.732 . . . . 0.69 109.172 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -166.66 53.76 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.454 1.102 . . . . 2.34 109.931 166.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.51 172.93 15.23 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.022 -1.048 . . . . 2.18 110.643 176.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.0 m -117.14 162.83 17.2 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.678 1.591 . . . . 1.14 111.154 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 tp -52.27 -32.17 15.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.719 0 CA-C-O 117.525 -1.226 . . . . 2.85 112.973 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -34.93 -47.22 0.34 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.387 1.075 . . . . 4.83 112.103 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -57.46 -51.66 68.55 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.405 1.098 . . . . 2.21 111.465 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.11 -42.18 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.681 1.592 . . . . 1.59 110.902 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -63.22 -43.77 97.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.84 0.856 . . . . 4.02 108.836 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -52.11 -54.88 25.03 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.813 -0.613 . . . . 4.07 109.62 171.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.41 -54.15 15.08 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.926 0.784 . . . . 1.7 110.162 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.96 -15.99 15.93 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 125.395 1.474 . . . . 0.33 114.442 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.0 -26.01 2.3 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.424 1.112 . . . . 1.89 111.534 167.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -51.03 -41.77 60.05 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.111 0.869 . . . . 3.52 112.857 173.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.471 ' CD ' ' HZ2' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -115.35 -3.67 12.43 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.164 0.986 . . . . 4.3 111.216 179.142 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 73.85 49.83 0.12 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.846 1.659 . . . . 1.07 110.835 175.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -74.47 166.81 22.89 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.641 -0.662 . . . . 2.52 111.311 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.62 122.5 33.27 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.652 -1.61 . . . . 5.13 106.652 171.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 mt -122.98 108.2 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.363 0.665 . . . . 1.87 110.079 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 91.7 mt -94.12 130.79 33.17 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.436 0.694 . . . . 2.39 109.315 -172.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.01 91.8 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.387 2.058 . . . . 0.64 109.008 168.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.252 0 C-N-CA 123.409 0.684 . . . . 4.42 109.987 168.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 109.306 -0.628 . . . . 5.99 109.306 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.5 m -149.08 146.25 27.63 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 106.212 -1.773 . . . . 2.16 106.212 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.15 140.16 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 124.226 0.954 . . . . 1.71 110.847 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -128.67 148.86 50.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.774 1.23 . . . . 3.38 107.92 -172.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -88.02 122.73 31.95 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.815 -0.809 . . . . 5.22 108.815 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 p -109.81 140.05 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 124.386 1.074 . . . . 1.84 108.332 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -138.82 157.59 45.79 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.878 -1.156 . . . . 2.74 107.878 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 120.97 -77.37 0.32 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.925 1.25 . . . . 1.66 110.614 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.3 177.63 7.11 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.549 0.69 . . . . 3.72 111.486 -175.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.6 t -161.59 -43.91 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.994 0.918 . . . . 4.65 110.401 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.3 t -50.97 126.23 15.65 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.351 1.06 . . . . 2.81 113.301 -168.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 m -45.32 -44.64 11.73 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.237 1.815 . . . . 2.62 112.914 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -54.37 -48.12 71.85 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.63 0.729 . . . . 3.92 111.016 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.06 -43.18 88.17 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 123.474 0.71 . . . . 2.22 109.367 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.55 -49.31 70.64 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.335 0.254 . . . . 2.11 110.958 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.37 -52.95 63.45 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.523 1.129 . . . . 1.96 109.651 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -48.94 -49.5 39.99 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.888 -0.412 . . . . 3.27 109.888 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.8 -64.18 0.96 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 112.69 0.626 . . . . 3.76 112.69 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -55.82 -44.58 78.04 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.83 0.741 . . . . 3.03 109.552 -172.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -57.03 -53.02 62.82 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.874 -0.417 . . . . 5.41 109.874 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -48.16 -48.65 34.24 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.303 -0.628 . . . . 1.52 109.303 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.6 t -60.99 -47.0 95.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 117.915 0.325 . . . . 1.65 110.789 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -36.52 63.87 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.017 0.527 . . . . 3.43 111.765 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -70.84 -9.91 58.53 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 119.109 0.868 . . . . 1.98 113.161 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.1 mm -83.72 128.91 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 120.539 1.518 . . . . 3.8 109.812 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.44 -28.83 61.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.412 1.485 . . . . 2.44 113.411 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.54 -16.03 64.8 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 123.983 0.801 . . . . 1.76 113.685 -174.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.8 p -118.8 153.47 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.928 1.291 . . . . 2.16 109.232 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 93.0 m -93.95 -51.1 5.02 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.723 -0.843 . . . . 1.59 108.723 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -135.47 160.23 39.13 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.057 0.456 . . . . 2.64 110.517 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -154.08 140.33 18.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.078 -1.082 . . . . 1.74 108.078 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.6 mt -127.59 118.98 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 105.73 -1.952 . . . . 2.16 105.73 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 m -105.56 133.76 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.767 -0.827 . . . . 3.09 108.767 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 m120 . . . . . 0 CA--C 1.523 -0.089 0 N-CA-C 108.286 -1.005 . . . . 3.58 108.286 167.528 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 m . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 108.435 -0.95 . . . . 2.8 108.435 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.52 174.82 14.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.911 0.778 . . . . 5.03 111.522 -174.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.4 118.98 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.168 1.787 . . . . 1.97 107.764 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.8 m -97.03 138.11 35.07 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.61 1.164 . . . . 1.56 109.58 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.0 t -118.24 143.66 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 127.871 2.468 . . . . 1.96 105.823 171.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.1 m -146.32 88.25 1.78 Allowed 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 125.111 1.364 . . . . 1.85 107.547 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.37 -113.12 0.27 Allowed Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 108.638 -1.785 . . . . 0.9 108.638 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -155.94 48.45 0.5 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.932 -0.766 . . . . 2.99 108.932 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -155.61 177.68 11.11 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.792 -0.567 . . . . 2.39 110.234 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.4 m -114.27 169.81 8.75 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.235 1.414 . . . . 1.27 111.274 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.6 tp -53.92 -33.07 23.17 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 CA-C-O 117.685 -1.15 . . . . 2.66 111.728 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -35.37 -48.59 0.48 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.538 1.063 . . . . 3.73 112.48 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -61.13 -50.27 73.88 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.301 0.572 . . . . 3.21 112.287 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.6 t -58.34 -44.91 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 125.127 1.371 . . . . 1.68 110.536 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -67.27 -41.84 84.84 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.111 0.964 . . . . 3.53 110.112 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -54.42 -51.57 64.5 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.062 -0.718 . . . . 3.91 109.062 171.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.05 -48.36 44.01 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.005 -0.434 . . . . 1.48 110.785 170.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.93 -9.79 16.03 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.064 1.316 . . . . 0.37 114.795 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.58 -21.63 10.92 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.232 1.516 . . . . 1.66 112.122 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -56.69 -33.28 66.29 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.414 1.006 . . . . 3.35 112.854 172.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.06 -12.31 9.13 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.862 1.265 . . . . 2.51 112.683 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 72.26 62.29 0.13 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.571 1.148 . . . . 0.82 110.369 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.3 174.21 11.48 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.489 -0.757 . . . . 2.26 110.458 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.22 68.34 1.3 Allowed 'General case' 0 C--N 1.34 0.162 0 N-CA-C 106.935 -1.505 . . . . 5.71 106.935 -169.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.8 mt -84.82 107.18 15.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 113.922 -1.49 . . . . 1.62 110.138 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.4 mt -92.7 129.19 41.14 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 108.98 -0.748 . . . . 2.34 108.98 -172.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.07 100.9 0.66 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.397 2.065 . . . . 0.73 109.797 172.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 . . . . . 0 CA--C 1.533 0.308 0 C-N-CA 122.609 0.364 . . . . 3.31 111.293 169.328 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 107.31 -1.367 . . . . 5.51 107.31 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.0 m -151.55 156.12 39.87 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.315 -1.365 . . . . 2.1 107.315 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.01 139.81 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 O-C-N 124.593 1.183 . . . . 1.73 111.545 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -127.43 143.22 51.24 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.713 1.605 . . . . 3.62 107.691 -163.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.33 140.73 31.41 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 118.876 0.762 . . . . 4.26 109.279 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.89 137.33 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 123.822 0.849 . . . . 2.05 109.106 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -140.77 152.11 44.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.03 1.332 . . . . 2.72 107.74 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.02 -56.68 0.73 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 125.225 1.393 . . . . 1.44 110.409 164.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.72 157.71 17.21 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.103 0.561 . . . . 3.39 111.456 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 t -161.55 73.56 0.44 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.319 -0.622 . . . . 3.4 109.319 174.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -169.39 134.05 1.43 Allowed 'General case' 0 C--N 1.338 0.099 0 O-C-N 121.62 -0.675 . . . . 3.1 110.734 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 m -59.84 -43.07 94.79 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.313 0.645 . . . . 2.32 111.147 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -58.44 -48.59 80.22 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.791 -0.568 . . . . 2.9 110.17 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.0 m -57.32 -48.05 79.98 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.625 -0.509 . . . . 2.2 109.625 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.46 -50.41 65.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.736 0.414 . . . . 2.06 111.007 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.31 -52.34 66.02 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.154 0.981 . . . . 1.73 109.64 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -54.93 -44.65 74.45 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 119.881 -0.727 . . . . 4.75 110.669 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.36 -63.24 1.21 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.12 0.568 . . . . 3.63 110.131 177.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.86 -40.01 87.17 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.835 0.35 . . . . 2.58 110.612 -171.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -49.52 72.92 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.896 0.878 . . . . 3.87 109.647 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -51.64 -48.44 63.34 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.14 0.576 . . . . 2.35 109.587 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.6 t -60.15 -48.38 88.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 O-C-N 122.179 -0.326 . . . . 1.72 110.628 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -55.04 -34.78 63.83 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.594 -0.691 . . . . 3.01 112.539 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -70.9 -8.79 55.39 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.47 0.915 . . . . 2.12 113.47 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.5 mm -70.86 140.19 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 120.282 1.401 . . . . 3.52 109.768 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -89.74 139.96 30.05 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 125.373 1.469 . . . . 2.73 109.172 171.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.34 -46.54 1.16 Allowed Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.327 1.442 . . . . 2.77 110.601 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.3 p -64.33 158.54 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 122.386 -0.479 . . . . 2.11 110.062 174.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.8 m -108.34 -60.2 1.76 Allowed 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 107.996 -1.113 . . . . 2.56 107.996 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -127.78 161.8 28.13 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.659 0.614 . . . . 2.21 112.659 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.65 141.58 21.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.431 -0.951 . . . . 2.0 108.431 166.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.8 mt -127.96 104.57 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 106.433 -1.692 . . . . 2.39 106.433 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.44 122.1 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.704 -1.221 . . . . 2.94 107.704 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 . . . . . 0 CA--C 1.52 -0.176 0 N-CA-C 105.9 -1.889 . . . . 3.14 105.9 175.374 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 119.356 -0.354 . . . . 3.32 111.582 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt -162.45 153.96 18.14 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.03 1.332 . . . . 4.82 111.269 -165.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.64 117.9 52.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.712 1.205 . . . . 1.8 109.23 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.4 m -91.3 141.17 29.07 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 124.599 1.16 . . . . 1.66 109.338 173.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 t -122.23 145.83 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.439 -1.689 . . . . 1.84 106.439 166.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.2 m -145.89 138.67 25.75 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.265 -1.383 . . . . 1.57 107.265 175.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.94 -91.98 0.18 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 108.224 -1.95 . . . . 0.85 108.224 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -170.75 58.34 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.276 1.83 . . . . 2.2 109.737 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.73 162.44 41.26 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.165 -0.96 . . . . 1.49 111.4 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 61.8 m -109.76 168.01 9.73 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.43 1.892 . . . . 1.15 110.09 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.7 tp -52.06 -35.53 18.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 CA-C-O 117.083 -1.437 . . . . 2.51 111.736 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -28.37 -52.67 0.09 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.53 1.532 . . . . 3.2 112.661 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -61.85 -46.01 91.32 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.789 0.804 . . . . 2.17 111.484 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.1 t -70.15 -37.45 71.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.157 1.383 . . . . 1.65 110.913 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -48.6 80.86 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.525 1.53 . . . . 3.3 108.452 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -51.07 -47.94 61.71 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.75 0.42 . . . . 4.8 110.752 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.64 -51.18 71.02 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.424 0.556 . . . . 1.99 110.771 173.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.84 -26.23 25.3 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 126.54 2.019 . . . . 0.7 112.308 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -44.31 -31.77 1.12 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.276 1.038 . . . . 1.9 112.469 170.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -53.72 -32.37 51.76 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.681 1.128 . . . . 3.49 113.63 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.49 0.56 6.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.177 1.391 . . . . 2.6 112.168 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 60.21 57.17 3.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.508 1.523 . . . . 1.55 111.896 177.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.83 160.65 20.16 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 121.46 -0.775 . . . . 2.58 112.118 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 72.43 0.82 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.998 -1.112 . . . . 4.39 107.998 -169.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -82.23 119.7 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.189 -0.671 . . . . 1.94 109.189 -175.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.9 mm -98.3 112.28 61.78 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 125.0 1.32 . . . . 2.71 108.7 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -73.44 83.14 1.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.017 1.811 . . . . 1.72 110.488 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 . . . . . 0 N--CA 1.447 -0.582 0 C-N-CA 125.522 1.529 . . . . 3.2 110.62 173.386 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 107.787 -1.19 . . . . 5.58 107.787 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.7 m -146.74 154.66 41.66 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.032 -1.47 . . . . 1.86 107.032 172.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.02 142.69 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 O-C-N 123.999 0.812 . . . . 1.88 110.151 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -127.67 140.45 52.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.732 -1.581 . . . . 3.16 106.732 -172.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.3 ttt-85 -84.62 126.34 33.26 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.735 -1.209 . . . . 6.41 107.735 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 p -111.39 146.4 16.41 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 107.356 -1.35 . . . . 1.67 107.356 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.02 171.96 14.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.335 0.397 . . . . 2.31 111.546 -176.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.26 56.77 21.77 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.379 -0.828 . . . . 2.26 112.418 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 pp -163.07 166.47 23.54 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.602 1.561 . . . . 3.8 107.854 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.3 p -174.76 66.11 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.091 0.557 . . . . 3.21 109.951 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.6 t -156.71 124.63 5.54 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.334 0.515 . . . . 3.38 111.436 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -58.29 -43.9 88.26 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.007 0.923 . . . . 2.21 111.727 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -57.42 -44.83 84.94 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.748 0.704 . . . . 2.62 110.533 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.6 m -61.27 -45.94 92.44 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.943 -0.391 . . . . 2.11 109.943 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.22 -47.02 72.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.717 0.407 . . . . 1.72 110.954 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.68 -51.3 69.0 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.533 1.133 . . . . 1.78 109.469 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -52.9 -45.17 67.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.883 -0.599 . . . . 3.73 109.603 174.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.59 -63.39 1.21 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.184 -0.436 . . . . 4.0 110.846 176.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -60.51 -38.02 83.01 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.314 0.961 . . . . 2.35 111.527 -172.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.3 ttt85 -61.3 -49.62 76.28 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.122 -0.325 . . . . 4.86 110.122 175.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -51.42 -50.58 59.41 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.266 -0.642 . . . . 1.72 109.266 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.4 t -56.83 -50.11 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 O-C-N 121.972 -0.455 . . . . 1.71 110.982 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -53.19 -34.69 58.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.449 1.099 . . . . 2.62 112.01 175.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -68.69 -16.55 63.86 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.178 0.899 . . . . 2.19 113.397 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.2 mt -77.28 111.21 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 120.036 1.289 . . . . 2.47 109.865 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -50.49 -31.39 15.22 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.187 2.195 . . . . 2.89 113.448 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.16 -25.05 74.68 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.286 0.946 . . . . 1.55 113.629 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -96.64 162.82 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 119.027 1.414 . . . . 2.15 110.723 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.1 m -110.43 -56.71 2.31 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.763 -1.199 . . . . 1.96 107.763 171.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -137.19 164.7 27.87 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.82 -0.437 . . . . 2.13 109.82 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -154.72 137.31 15.14 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.828 -1.175 . . . . 1.89 107.828 172.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.4 mm -112.6 101.55 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.035 -1.098 . . . . 3.15 108.035 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.69 120.87 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 108.681 -0.859 . . . . 3.73 108.681 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 107.901 -1.148 . . . . 2.77 107.901 171.599 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 CA--C 1.533 0.312 0 CA-C-O 119.789 -0.148 . . . . 2.89 110.676 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -161.51 164.68 29.46 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.986 0.914 . . . . 4.93 110.056 -164.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.66 112.4 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.097 1.359 . . . . 1.93 108.089 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.7 m -88.25 147.7 24.7 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 123.746 0.819 . . . . 1.59 109.735 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.9 t -132.61 137.29 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 127.586 2.355 . . . . 2.3 105.729 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.3 m -145.89 101.17 3.51 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.798 -1.186 . . . . 1.74 107.798 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 178.77 -102.38 0.17 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 118.11 -1.995 . . . . 0.6 110.023 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -163.03 44.8 0.12 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.44 1.496 . . . . 2.44 108.278 172.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.03 169.62 17.31 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.329 1.052 . . . . 1.73 109.965 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.0 m -131.44 169.95 15.34 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.672 1.189 . . . . 1.43 110.066 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 tp -61.19 -30.59 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-O 117.363 -1.303 . . . . 2.64 112.727 -174.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -37.32 -52.76 1.1 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.892 1.223 . . . . 3.7 111.928 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -59.47 -46.77 87.82 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.742 0.645 . . . . 3.8 112.742 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.8 t -63.06 -42.72 97.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 123.694 0.797 . . . . 1.7 110.206 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.85 -52.75 64.09 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 127.154 2.182 . . . . 3.07 108.729 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -51.19 -52.36 45.07 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.622 -0.51 . . . . 3.59 109.622 173.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.43 74.8 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.803 -0.561 . . . . 1.7 110.721 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.0 -6.41 12.52 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.48 1.99 . . . . 0.5 113.867 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.37 -24.75 1.33 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.017 1.408 . . . . 1.9 112.071 171.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -54.52 -36.29 64.09 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.479 0.918 . . . . 3.52 113.479 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -121.92 -5.87 9.03 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.095 0.861 . . . . 2.35 113.088 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 68.55 58.0 0.42 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.24 1.016 . . . . 0.96 110.845 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.27 168.77 18.65 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.36 -0.838 . . . . 2.17 111.236 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.92 68.25 1.51 Allowed 'General case' 0 C--N 1.343 0.322 0 CA-C-O 122.239 1.019 . . . . 5.19 110.061 -170.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.4 mt -81.82 139.61 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.49 -0.777 . . . . 1.67 110.288 -172.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.5 mt -129.25 133.42 25.13 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.224 1.009 . . . . 2.51 109.942 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.59 87.6 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.408 2.739 . . . . 0.89 111.592 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 N--CA 1.44 -0.973 0 C-N-CA 124.337 1.055 . . . . 3.18 109.268 169.776 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 108.155 -1.054 . . . . 4.33 108.155 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.0 m -150.55 140.59 22.03 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.077 -1.453 . . . . 2.28 107.077 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 p -127.47 140.92 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 124.195 0.934 . . . . 1.98 110.32 171.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -128.97 155.89 44.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.321 -1.363 . . . . 3.74 107.321 -174.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.0 ttt-85 -88.99 122.08 31.99 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.295 -0.859 . . . . 5.95 109.1 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.5 p -113.09 140.15 34.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 124.521 1.129 . . . . 1.82 108.033 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -153.28 164.81 37.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.853 -1.536 . . . . 3.47 106.853 -172.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.69 -54.6 0.54 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.467 1.032 . . . . 1.54 112.105 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.31 172.28 1.16 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.708 1.203 . . . . 3.81 113.142 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -168.44 67.62 0.07 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.723 -0.656 . . . . 3.43 111.498 170.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.1 t -160.03 133.69 7.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.817 1.19 . . . . 2.73 113.366 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 m -56.16 -49.88 72.73 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.342 1.457 . . . . 2.22 112.065 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -51.62 -45.14 63.14 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.661 0.744 . . . . 2.97 110.515 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.0 m -68.04 -37.9 81.87 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.001 -0.545 . . . . 1.84 110.567 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.42 -48.65 65.61 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.279 0.49 . . . . 1.93 110.605 170.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.48 -50.81 72.09 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.831 0.824 . . . . 1.76 109.193 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -53.67 -43.56 68.98 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.854 -0.612 . . . . 3.34 110.799 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -65.77 -60.65 2.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.643 0.377 . . . . 3.94 111.199 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.422 ' OE1' ' NZ ' ' A' ' 26' ' ' LYS . 1.8 pp20? -56.55 -41.42 76.81 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 118.818 0.736 . . . . 2.9 110.614 -175.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -60.01 -53.49 57.19 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 119.185 -0.436 . . . . 3.84 110.352 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -50.59 -46.73 58.06 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 118.672 0.669 . . . . 1.67 110.015 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.9 t -59.77 -49.15 84.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 109.713 -0.477 . . . . 1.88 109.713 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.422 ' NZ ' ' OE1' ' A' ' 22' ' ' GLU . 22.9 mttt -55.32 -36.36 66.15 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.547 -0.721 . . . . 2.46 112.643 175.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -72.35 -6.99 47.18 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.425 0.898 . . . . 1.89 113.425 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.3 141.92 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 120.46 1.482 . . . . 2.86 109.274 171.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -88.7 128.45 35.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.46 -1.311 . . . . 3.67 107.46 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.14 -39.26 2.95 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.264 0.935 . . . . 2.72 112.097 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 p -64.71 159.38 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 121.578 -0.954 . . . . 1.98 110.615 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.2 m -115.25 -61.86 1.68 Allowed 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.333 1.053 . . . . 1.93 108.208 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -122.44 154.21 38.08 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.288 0.367 . . . . 2.54 111.338 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.9 137.89 19.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.867 -0.52 . . . . 1.58 110.101 169.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.4 mt -128.59 91.02 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 106.766 -1.568 . . . . 2.75 106.766 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.99 103.39 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.742 -0.836 . . . . 3.76 108.742 -176.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 . . . . . 0 C--O 1.231 0.086 0 N-CA-C 106.316 -1.735 . . . . 2.8 106.316 174.893 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 119.855 -0.117 . . . . 2.76 111.19 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 169.77 24.04 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.459 0.704 . . . . 6.8 110.944 -172.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.33 117.35 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 124.588 1.155 . . . . 1.91 108.141 176.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.7 m -97.07 134.67 40.12 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 123.545 0.738 . . . . 1.66 109.571 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.34 145.33 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 126.305 1.842 . . . . 2.24 106.673 168.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.6 m -146.81 136.72 23.29 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 106.625 -1.62 . . . . 1.62 106.625 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.05 -90.23 0.17 Allowed Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 109.343 -1.503 . . . . 0.74 109.343 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -173.17 55.72 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.321 1.448 . . . . 2.54 110.178 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.35 160.14 43.92 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.692 -1.255 . . . . 1.59 110.79 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.9 m -111.57 167.01 10.66 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.713 1.605 . . . . 1.3 110.315 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.3 tp -56.43 -30.2 30.45 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 CA-C-O 117.763 -1.113 . . . . 2.74 113.191 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -33.06 -53.8 0.37 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.615 1.166 . . . . 3.34 112.224 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -63.52 -47.73 80.48 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.655 0.74 . . . . 2.38 111.685 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.34 -45.36 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.008 0.923 . . . . 1.69 110.078 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.87 -51.63 69.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.663 1.985 . . . . 2.66 109.108 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -53.56 -44.33 69.19 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.597 0.359 . . . . 3.8 110.477 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.03 -54.99 40.74 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.16 0.505 . . . . 1.7 110.47 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.96 -17.19 9.05 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 126.957 2.218 . . . . 0.39 114.088 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -38.86 -35.79 0.23 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.944 0.872 . . . . 1.54 111.921 162.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -54.54 -31.52 56.55 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.723 1.008 . . . . 3.39 113.723 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -122.35 4.24 9.7 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.954 1.301 . . . . 2.46 111.921 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 58.69 53.98 5.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.694 1.198 . . . . 1.18 110.629 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -68.95 159.79 32.04 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.851 -0.531 . . . . 2.76 111.535 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.37 67.05 1.38 Allowed 'General case' 0 C--N 1.343 0.301 0 CA-C-O 121.42 0.628 . . . . 4.47 109.608 -172.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -81.56 140.28 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.069 -0.514 . . . . 1.64 109.888 -172.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 85.5 mt -127.66 132.35 24.29 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.164 0.986 . . . . 2.38 108.942 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.99 105.03 1.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.124 2.549 . . . . 0.88 110.033 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 123.674 0.79 . . . . 3.36 111.001 177.812 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.155 0 N-CA-C 110.811 -0.07 . . . . 5.2 110.811 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.9 m -155.35 162.12 40.9 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.592 -1.262 . . . . 1.59 107.592 174.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.54 148.94 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 O-C-N 123.453 0.471 . . . . 1.68 111.531 164.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -135.56 143.49 45.7 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.069 1.348 . . . . 3.36 107.954 -170.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -91.57 126.93 36.83 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.576 0.625 . . . . 5.33 110.132 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.32 154.43 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 C-N-CA 123.929 0.892 . . . . 1.99 109.213 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -147.15 158.23 43.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.783 -0.821 . . . . 2.71 108.783 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.62 -56.82 0.68 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 125.16 1.362 . . . . 1.6 111.06 164.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.98 173.72 4.32 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.9 0.88 . . . . 3.48 112.483 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.3 p -162.82 63.01 0.2 Allowed 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.882 -0.511 . . . . 3.47 110.193 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.3 t -155.52 118.49 4.31 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.241 0.473 . . . . 2.09 111.709 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.1 t -52.87 -38.95 62.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.375 0.67 . . . . 3.6 111.354 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -56.23 -39.28 72.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.642 -0.661 . . . . 3.75 110.707 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.5 m -70.53 -39.9 73.78 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.786 -0.572 . . . . 2.2 110.373 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.05 -43.77 74.1 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.787 0.722 . . . . 1.86 110.764 171.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.74 -49.58 74.47 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.709 0.404 . . . . 1.67 110.344 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.4 tptt -49.76 -48.11 50.48 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.146 0.579 . . . . 3.73 109.668 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -56.08 -64.05 0.98 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.443 1.097 . . . . 4.09 111.148 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -56.33 -38.2 71.02 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.129 1.331 . . . . 2.64 111.85 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -63.61 -51.05 66.95 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.348 0.659 . . . . 3.5 111.38 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -53.96 -44.33 70.66 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.629 -0.669 . . . . 1.53 110.27 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.8 t -61.54 -48.14 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 122.777 0.431 . . . . 1.8 110.274 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -54.01 -34.92 61.2 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.801 0.84 . . . . 2.75 112.825 175.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -62.31 -23.95 67.03 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.763 0.711 . . . . 3.04 112.355 174.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.9 mt -70.81 131.69 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 O-C-N 120.963 -1.086 . . . . 2.38 108.777 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -75.75 -28.2 58.38 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.21 1.004 . . . . 3.01 112.722 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.74 -29.36 72.7 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.827 0.727 . . . . 1.58 113.013 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 p -89.59 166.95 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 118.633 1.217 . . . . 1.81 109.356 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.0 m -124.02 -61.25 1.38 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.825 -1.176 . . . . 1.84 107.825 173.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -129.17 111.12 12.6 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.195 -0.668 . . . . 2.68 109.195 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.22 131.96 49.85 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.147 -1.057 . . . . 1.75 108.147 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.7 mm -109.54 97.91 6.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.035 -1.839 . . . . 2.94 106.035 176.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -97.9 136.29 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 109.241 -0.651 . . . . 3.29 109.241 -175.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 . . . . . 0 N--CA 1.456 -0.141 0 N-CA-C 108.736 -0.838 . . . . 2.66 108.736 171.398 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.0 m . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 109.871 -0.418 . . . . 2.96 109.871 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -157.91 178.12 10.58 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.515 -0.741 . . . . 4.82 110.93 -167.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.4 111.94 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 125.466 1.506 . . . . 1.64 108.318 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.0 m -90.17 141.78 28.36 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 123.675 0.79 . . . . 1.98 109.168 171.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 69.2 t -120.95 130.15 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 127.115 2.166 . . . . 2.03 105.249 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.7 m -133.78 142.26 47.82 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 106.781 -1.563 . . . . 1.75 106.781 163.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.93 -102.54 0.23 Allowed Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 104.18 -3.568 . . . . 0.61 104.18 175.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -160.05 45.67 0.23 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.581 0.752 . . . . 3.1 110.983 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.07 176.21 9.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.003 0.921 . . . . 1.88 111.12 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.4 m -126.03 166.64 16.6 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.934 1.694 . . . . 1.47 110.757 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.52 -39.97 14.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-O 117.016 -1.469 . . . . 3.69 111.402 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -29.58 -53.5 0.14 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.419 1.488 . . . . 3.05 113.195 -177.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -66.03 -44.5 84.49 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.358 0.599 . . . . 2.21 112.282 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 t -58.4 -36.62 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.517 1.127 . . . . 1.63 110.895 171.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.35 -55.45 33.42 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 107.988 -1.116 . . . . 2.77 107.988 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.1 tp60 -52.31 -44.86 65.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.466 1.106 . . . . 4.66 110.509 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.4 -55.46 34.76 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.625 0.77 . . . . 1.83 111.049 171.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.2 -15.84 39.12 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 125.636 1.588 . . . . 0.33 113.41 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.96 -25.25 0.19 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.167 -0.92 . . . . 1.8 112.699 165.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -51.38 -40.32 58.98 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.914 1.234 . . . . 3.15 112.901 172.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -111.04 -13.07 14.13 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.31 1.044 . . . . 2.92 111.81 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 76.32 49.01 0.07 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.367 1.467 . . . . 0.88 110.095 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.32 159.83 28.47 Favored 'General case' 0 N--CA 1.462 0.142 0 O-C-N 121.648 -0.657 . . . . 2.51 111.804 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.02 112.71 17.49 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 106.477 -1.675 . . . . 5.28 106.477 174.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.56 130.86 71.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.528 -0.915 . . . . 1.88 108.528 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 49.0 mm -108.4 126.9 28.54 Favored Pre-proline 0 N--CA 1.452 -0.345 0 C-N-CA 125.07 1.348 . . . . 2.93 108.593 -174.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.67 97.69 0.73 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.641 2.227 . . . . 0.66 109.08 171.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 . . . . . 0 CA--C 1.537 0.471 0 C-N-CA 120.17 -0.612 . . . . 3.67 110.092 173.087 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 pttp . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 109.974 -0.38 . . . . 4.03 109.974 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.2 m -148.28 150.07 32.99 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.367 -1.345 . . . . 1.49 107.367 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.82 140.18 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 O-C-N 123.901 0.751 . . . . 1.63 111.542 169.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -122.95 148.68 45.2 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.41 -1.7 . . . . 3.29 106.41 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.89 150.55 26.43 Favored 'General case' 0 N--CA 1.461 0.122 0 N-CA-C 108.31 -0.996 . . . . 7.64 108.31 173.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.67 146.78 23.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.478 0.711 . . . . 1.77 109.413 170.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.4 167.07 22.92 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.005 1.322 . . . . 2.42 107.923 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 120.44 -75.63 0.32 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.691 1.139 . . . . 1.65 111.156 173.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 pp -68.8 157.41 36.49 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-N 117.088 0.444 . . . . 3.87 109.855 -177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 p -146.83 62.15 1.2 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.29 0.636 . . . . 3.39 110.176 -176.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 t -160.03 123.08 3.48 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.715 0.635 . . . . 2.38 112.715 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.7 m -48.66 -45.0 38.2 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.672 1.189 . . . . 2.79 111.908 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -57.3 -36.65 71.33 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.755 -0.59 . . . . 3.18 111.24 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.5 m -70.15 -41.0 74.44 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 122.055 -0.403 . . . . 2.29 110.034 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.81 -47.74 73.66 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.01 0.368 . . . . 2.13 110.117 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.92 -52.34 65.88 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.756 0.822 . . . . 1.94 110.823 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -50.31 -52.3 37.89 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.105 0.962 . . . . 2.79 109.793 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -52.19 -62.1 1.85 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 118.571 -0.728 . . . . 4.07 111.571 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.55 -40.62 79.3 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.262 0.937 . . . . 2.66 110.975 -173.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.2 mtt180 -52.71 -56.01 18.57 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.774 0.716 . . . . 4.74 110.468 171.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -51.57 -43.38 62.42 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.355 0.597 . . . . 2.37 110.252 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.4 t -61.95 -50.08 81.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 C-N-CA 123.254 0.622 . . . . 1.77 111.141 175.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -57.75 -27.86 63.41 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.008 1.323 . . . . 3.2 112.318 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -68.36 -22.55 64.66 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.845 0.748 . . . . 2.21 112.825 171.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.7 mt -69.33 132.69 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.624 1.102 . . . . 2.49 108.13 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -74.32 -32.62 62.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.652 0.781 . . . . 2.76 112.446 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.15 -36.54 90.9 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.063 0.839 . . . . 1.55 112.435 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 p -86.31 159.1 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 O-C-N 121.115 -1.226 . . . . 1.86 109.937 -176.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -117.93 -57.34 2.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.858 1.263 . . . . 1.58 108.15 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -127.87 144.97 51.08 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.048 -0.661 . . . . 2.28 111.315 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.64 131.57 31.72 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.87 -0.789 . . . . 1.74 108.87 171.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mp -114.88 78.99 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 107.746 -1.205 . . . . 2.98 107.746 -173.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 m -84.08 136.51 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 115.636 -0.711 . . . . 3.15 110.821 -167.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 105.995 -1.854 . . . . 2.86 105.995 179.097 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 120.619 0.247 . . . . 2.65 111.271 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.59 172.51 18.43 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 112.831 0.678 . . . . 7.38 112.831 -161.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.31 112.43 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 106.776 -1.565 . . . . 1.65 106.776 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.8 m -92.78 135.94 33.67 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.221 -1.029 . . . . 1.68 108.221 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.53 142.31 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.237 1.815 . . . . 1.96 106.789 173.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.3 m -147.44 136.95 22.71 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 106.983 -1.488 . . . . 1.69 106.983 176.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.76 -94.75 0.16 Allowed Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 106.12 -2.792 . . . . 0.57 106.12 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -165.11 56.33 0.12 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.223 1.809 . . . . 2.5 108.984 173.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.09 170.6 15.64 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.072 -1.017 . . . . 1.73 110.945 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.2 m -129.62 160.66 32.62 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.387 1.475 . . . . 1.32 110.319 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 tp -53.41 -33.71 21.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 CA-C-O 117.299 -1.334 . . . . 2.73 113.059 -172.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -35.07 -48.15 0.41 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.826 1.194 . . . . 5.17 112.089 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -62.38 -49.74 74.33 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.169 0.985 . . . . 2.42 111.223 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.22 -38.52 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.884 1.274 . . . . 1.59 110.581 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -67.41 -46.64 72.61 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.833 1.653 . . . . 2.96 108.329 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -51.87 -52.6 48.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.798 0.439 . . . . 4.35 109.93 172.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.85 -51.31 52.63 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.508 0.595 . . . . 1.75 110.872 170.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.54 -13.9 18.9 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 125.373 1.464 . . . . 0.32 113.911 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.68 -25.92 1.36 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.751 1.275 . . . . 1.72 111.813 168.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -51.81 -31.43 27.33 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.478 1.036 . . . . 3.45 113.322 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -133.98 -6.25 2.74 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.802 1.038 . . . . 2.72 113.802 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 74.03 60.02 0.08 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.354 1.462 . . . . 0.82 111.106 173.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.98 161.86 25.23 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.701 -0.625 . . . . 2.69 110.466 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.67 72.31 1.33 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 107.508 -1.293 . . . . 5.33 107.508 -170.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 mt -82.24 135.49 24.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.2 -1.363 . . . . 1.85 109.247 -172.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 38.8 mm -124.89 127.41 25.12 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 123.629 0.771 . . . . 3.5 110.268 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.23 103.3 1.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.912 2.408 . . . . 0.65 110.108 174.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 N--CA 1.44 -0.94 0 C-N-CA 125.812 1.645 . . . . 4.82 110.5 170.985 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.178 0 N-CA-C 109.996 -0.372 . . . . 4.63 109.996 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.8 m -155.58 162.02 40.73 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.551 -0.907 . . . . 1.61 108.551 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.62 142.47 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 O-C-N 123.535 0.522 . . . . 1.81 110.962 165.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -126.88 154.57 44.25 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.217 1.407 . . . . 3.22 108.665 -171.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -92.02 114.63 27.23 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 118.574 -0.726 . . . . 4.72 109.209 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 p -100.63 137.08 29.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.797 0.839 . . . . 1.76 109.025 174.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.64 156.4 46.86 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.322 -0.992 . . . . 2.4 108.322 171.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 133.2 -74.71 0.43 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.386 -1.485 . . . . 1.39 109.386 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.64 171.14 9.88 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.007 0.743 . . . . 3.6 113.007 -174.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.3 m -158.22 83.08 0.85 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.263 1.425 . . . . 4.38 109.649 175.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.4 t -158.25 137.6 11.75 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.055 0.843 . . . . 2.61 112.158 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.3 m -61.19 -47.05 87.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.03 0.932 . . . . 2.49 111.305 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -60.15 -40.35 89.54 Favored 'General case' 0 C--O 1.233 0.196 0 O-C-N 121.164 -0.96 . . . . 2.8 110.265 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.1 m -60.77 -44.72 96.4 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.019 -0.426 . . . . 1.86 109.999 173.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.78 -46.72 71.11 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.404 0.282 . . . . 1.91 110.493 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.14 -50.55 72.45 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.952 0.501 . . . . 1.77 109.915 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.22 -50.07 40.07 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.235 0.614 . . . . 3.31 109.996 174.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -64.2 -57.58 9.08 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.081 0.552 . . . . 3.89 110.513 -173.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -59.05 -41.13 87.14 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.866 -0.733 . . . . 2.13 110.142 -176.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -61.87 -50.01 73.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.994 -0.527 . . . . 4.58 109.897 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -48.22 -50.58 28.89 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.614 -0.513 . . . . 2.27 109.614 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.7 t -57.74 -52.15 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 110.395 -0.224 . . . . 1.64 110.395 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -49.35 -39.74 32.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.503 1.121 . . . . 3.39 111.605 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -67.49 -19.96 65.4 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.872 0.693 . . . . 2.08 112.872 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.9 mt -76.12 122.22 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 119.857 1.208 . . . . 2.5 109.552 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -66.52 -18.67 65.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.745 1.218 . . . . 2.67 113.648 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.45 -34.2 68.17 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 123.51 0.576 . . . . 1.65 111.978 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.92 -173.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 O-C-N 121.799 -0.824 . . . . 2.07 110.542 -172.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.0 m -132.93 -62.0 0.82 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.834 -1.172 . . . . 1.85 107.834 170.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -120.64 164.48 16.45 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.076 0.465 . . . . 4.14 111.982 175.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.25 136.56 10.9 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.987 -1.006 . . . . 1.73 109.898 168.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mp -119.78 101.36 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 O-C-N 124.686 1.241 . . . . 2.99 107.812 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.5 p -84.96 137.16 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.588 0.755 . . . . 3.59 109.792 175.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 . . . . . 0 N--CA 1.465 0.283 0 CA-C-N 118.838 0.745 . . . . 2.9 109.747 165.752 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 119.444 -0.312 . . . . 2.69 110.174 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -158.51 165.8 33.7 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.619 0.768 . . . . 4.02 111.103 -173.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.45 119.11 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.63 1.172 . . . . 2.01 109.848 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.7 m -94.13 145.79 24.44 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.558 1.143 . . . . 1.89 111.098 175.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.41 ' C ' ' HG1' ' A' ' 46' ' ' THR . 90.0 t -131.75 134.22 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 127.557 2.343 . . . . 2.28 105.871 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.41 ' HG1' ' C ' ' A' ' 45' ' ' VAL . 82.1 m -145.71 75.46 1.43 Allowed 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 120.707 -1.245 . . . . 2.29 108.461 -173.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -157.92 -117.31 0.51 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 108.065 -2.014 . . . . 1.28 108.065 173.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.02 59.08 1.3 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.769 1.227 . . . . 4.31 108.185 177.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.73 162.02 41.07 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.686 -0.634 . . . . 1.5 110.063 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.9 m -110.92 161.43 15.85 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.343 1.457 . . . . 1.78 110.339 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.1 tp -51.21 -36.52 16.79 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 117.732 -1.128 . . . . 2.92 113.154 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -35.52 -47.37 0.45 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.685 1.194 . . . . 4.31 113.393 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -67.49 -39.73 85.21 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.361 -0.837 . . . . 2.35 111.659 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.7 t -68.05 -44.01 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.202 1.001 . . . . 1.56 109.524 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -53.37 -48.65 68.4 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.107 2.163 . . . . 2.8 109.163 174.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -52.9 -52.22 58.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.637 0.775 . . . . 4.14 110.605 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.29 -49.23 70.1 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.098 0.863 . . . . 1.74 110.666 172.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.78 -13.6 4.54 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.131 1.348 . . . . 0.46 113.957 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.69 -32.75 1.06 Allowed 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.545 1.173 . . . . 1.68 111.565 165.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -49.18 -37.01 21.1 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.656 0.984 . . . . 3.2 113.656 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -125.43 12.09 8.08 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.217 1.007 . . . . 2.84 111.127 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 60.77 47.91 7.52 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.805 1.242 . . . . 1.2 110.467 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 mp -65.15 153.04 42.06 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.524 -0.307 . . . . 3.62 110.764 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.65 108.65 11.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.612 -1.996 . . . . 4.59 105.612 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mt -112.55 126.29 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.481 -0.933 . . . . 1.87 108.481 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 mp -104.56 131.16 22.11 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 108.133 -1.062 . . . . 2.53 108.133 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.33 105.02 0.81 Allowed 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.783 1.656 . . . . 0.78 107.875 165.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 121.288 0.566 . . . . 4.41 111.195 171.619 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 108.799 -0.815 . . . . 4.65 108.799 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.0 m -149.48 154.41 38.76 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 107.804 -1.184 . . . . 1.55 107.804 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.34 140.07 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 O-C-N 124.431 1.082 . . . . 1.8 109.905 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -129.41 136.93 50.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.23 -1.396 . . . . 3.32 107.23 -167.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -84.56 133.11 34.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 118.189 -0.91 . . . . 5.53 109.384 -174.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -120.54 145.53 26.8 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 C-N-CA 124.63 1.172 . . . . 1.83 109.842 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -139.42 150.76 45.63 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.899 -1.519 . . . . 2.4 106.899 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.76 -71.11 0.42 Allowed Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.471 1.034 . . . . 1.41 110.729 168.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.98 165.92 8.24 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.265 1.026 . . . . 3.17 112.106 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.2 p -161.62 64.91 0.26 Allowed 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.875 -0.516 . . . . 3.33 110.055 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.6 t -159.34 134.59 8.3 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 110.047 -0.353 . . . . 2.75 110.047 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.7 p -53.34 -48.13 68.75 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.12 0.968 . . . . 3.18 109.89 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -43.4 -51.11 6.67 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.302 1.041 . . . . 3.03 111.772 173.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.4 m -64.06 -45.63 87.94 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 109.988 -0.375 . . . . 2.18 109.988 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -46.97 73.22 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.567 0.222 . . . . 1.56 111.401 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.45 -48.98 78.65 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.326 1.05 . . . . 1.86 109.86 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -53.77 -48.19 69.99 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.724 -0.473 . . . . 5.41 109.724 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.76 -59.81 4.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.695 0.798 . . . . 3.64 111.573 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -56.88 -41.22 77.64 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 119.347 -0.941 . . . . 2.73 109.961 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -60.04 -48.43 81.76 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 119.275 -0.393 . . . . 3.81 110.165 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -49.06 -51.77 29.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.072 0.397 . . . . 1.71 110.001 172.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.2 t -59.11 -48.04 88.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 O-C-N 122.027 -0.421 . . . . 1.55 110.76 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -54.47 -37.06 64.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.739 1.215 . . . . 2.33 112.086 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -65.31 -18.54 65.39 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.895 0.77 . . . . 2.09 112.963 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.1 mt -76.88 115.92 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 119.79 1.177 . . . . 2.32 109.538 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -77.68 60.76 2.26 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.595 1.958 . . . . 3.92 110.097 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -154.15 -36.72 0.03 OUTLIER Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.205 1.859 . . . . 1.79 111.965 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.94 172.31 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 121.46 -1.024 . . . . 2.11 109.124 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.2 m -121.58 -60.71 1.59 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.682 1.193 . . . . 2.02 108.032 171.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -122.89 134.33 54.38 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 109.887 -0.412 . . . . 2.1 109.887 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.19 126.09 42.21 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.149 -1.056 . . . . 1.56 108.149 171.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.19 95.07 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 105.408 -2.071 . . . . 3.38 105.408 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -91.79 141.38 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 120.398 -0.521 . . . . 3.17 109.856 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 . . . . . 0 CA--C 1.529 0.161 0 N-CA-C 107.951 -1.129 . . . . 2.54 107.951 168.894 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.9 m . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 111.823 0.305 . . . . 3.65 111.823 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.457 ' NZ ' ' OE1' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -158.27 167.75 28.92 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.36 1.064 . . . . 4.8 109.98 -173.476 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.67 119.48 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 125.544 1.537 . . . . 1.85 108.386 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.1 m -96.83 144.76 26.49 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 118.313 0.506 . . . . 1.72 110.099 172.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.27 138.84 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 127.116 2.166 . . . . 2.0 106.87 174.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.4 m -145.47 134.47 22.61 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.536 -1.653 . . . . 2.28 106.536 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.55 -94.98 0.16 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 107.348 -2.301 . . . . 0.64 107.348 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -164.3 50.07 0.12 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.337 1.455 . . . . 2.57 109.349 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.14 173.71 11.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.897 0.879 . . . . 1.87 110.414 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.0 m -137.89 169.73 17.29 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.071 1.348 . . . . 1.71 111.039 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -50.46 -40.61 18.82 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 CA-C-O 117.222 -1.37 . . . . 3.86 110.694 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -34.63 -49.8 0.43 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.681 1.582 . . . . 5.51 113.773 -176.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -68.77 -45.39 71.5 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.441 0.639 . . . . 2.61 112.035 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.9 t -57.32 -33.84 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.271 1.028 . . . . 1.69 110.593 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -59.98 -57.29 13.48 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.667 1.587 . . . . 3.07 106.863 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -53.84 -47.34 71.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.868 -1.06 . . . . 3.85 110.01 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.62 -52.2 49.57 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.848 -0.532 . . . . 1.48 111.191 171.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.52 -9.7 26.17 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.64 1.114 . . . . 0.34 112.643 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.34 -23.68 3.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 119.151 1.476 . . . . 1.69 111.478 169.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -52.11 -32.11 33.78 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.277 0.944 . . . . 3.31 112.76 172.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -136.96 10.48 3.07 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.819 0.848 . . . . 2.76 112.682 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 57.33 65.75 1.3 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.855 1.262 . . . . 1.63 111.655 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.19 -166.53 0.73 Allowed 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.848 -0.533 . . . . 2.3 110.959 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.53 62.65 0.61 Allowed 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 120.49 -1.381 . . . . 5.43 107.5 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 mt -79.86 137.8 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.359 -1.291 . . . . 1.8 109.299 -173.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.9 mt -127.19 136.28 28.65 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 124.194 0.997 . . . . 2.65 109.599 -174.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.18 83.67 0.35 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.979 2.453 . . . . 0.82 110.968 172.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.457 ' OE1' ' NZ ' ' A' ' 42' ' ' LYS . 5.1 tt0 . . . . . 0 CA--C 1.542 0.671 0 C-N-CA 126.526 1.931 . . . . 3.52 109.969 167.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 107.361 -1.348 . . . . 5.33 107.361 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.7 m -155.1 151.97 28.95 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.372 -1.344 . . . . 2.06 107.372 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -119.3 141.12 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 O-C-N 124.448 1.092 . . . . 1.9 110.535 162.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -122.32 152.86 39.67 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.914 1.685 . . . . 3.08 106.746 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -94.26 134.71 36.45 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.41 1.005 . . . . 4.57 110.704 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 p -112.58 135.85 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 O-C-N 124.322 1.014 . . . . 1.63 109.71 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -135.82 172.08 13.52 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.147 0.43 . . . . 2.98 110.593 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.41 -47.43 2.6 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.43 1.491 . . . . 1.62 112.129 176.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.49 167.28 2.66 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.475 0.71 . . . . 3.44 112.863 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.5 t -165.99 64.19 0.11 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.869 0.468 . . . . 3.68 111.125 172.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.8 t -156.85 134.68 10.94 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 120.949 -1.094 . . . . 2.19 110.582 171.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 91.4 m -68.18 -44.92 74.82 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 122.114 -0.367 . . . . 3.08 110.918 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -56.19 -40.52 74.11 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.141 -0.974 . . . . 3.06 110.803 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.0 m -55.82 -32.98 64.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.037 0.535 . . . . 2.13 111.364 174.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.96 95.21 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 122.843 0.457 . . . . 1.71 109.839 176.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.37 -45.34 91.59 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.635 0.731 . . . . 1.71 109.078 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.2 tmtp? -52.1 -46.63 65.35 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.749 -0.659 . . . . 3.9 109.325 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.416 ' CZ ' HG12 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -61.97 -58.21 8.75 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 119.007 -0.52 . . . . 3.83 112.325 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -54.27 -47.94 71.77 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.873 -0.788 . . . . 2.6 108.873 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 ttt-85 -63.03 -50.61 70.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.704 -0.48 . . . . 5.66 109.704 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -49.34 -47.77 47.09 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 117.904 0.32 . . . . 1.66 110.265 175.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.5 t -62.51 -49.4 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 122.088 -0.383 . . . . 1.89 110.102 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -50.95 -35.66 34.68 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.9 0.88 . . . . 3.43 112.162 173.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -70.36 -12.76 61.8 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.322 0.86 . . . . 2.87 113.322 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.3 mt -78.54 131.51 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 120.199 1.363 . . . . 2.54 109.791 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -86.3 20.77 2.26 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.638 1.975 . . . . 3.55 112.494 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.62 -12.87 4.87 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.845 1.212 . . . . 1.48 112.54 -178.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -115.67 157.17 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 C-N-CA 125.332 1.453 . . . . 1.91 107.433 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.9 m -109.32 -60.08 1.81 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.708 1.203 . . . . 1.97 108.454 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -117.27 148.62 41.51 Favored 'General case' 0 N--CA 1.462 0.125 0 O-C-N 123.207 0.317 . . . . 2.94 110.589 175.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.58 129.68 12.68 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.71 -0.478 . . . . 1.83 109.71 172.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.3 mt -130.19 102.49 7.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 107.269 -1.382 . . . . 2.52 107.269 -174.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 p -88.94 144.73 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 122.938 0.495 . . . . 3.18 110.81 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 . . . . . 0 CA--C 1.536 0.418 0 C-N-CA 125.076 1.351 . . . . 2.85 108.465 176.735 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.441 -0.888 0 N-CA-C 106.148 -1.797 . . . . 5.71 106.148 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -153.63 140.29 18.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.678 -0.489 . . . . 6.87 109.678 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.89 114.78 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.263 1.025 . . . . 2.01 108.627 174.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.1 m -87.58 133.09 33.86 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 123.811 0.845 . . . . 1.6 109.034 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.4 t -121.91 140.52 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 126.657 1.983 . . . . 1.8 105.797 171.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.9 m -147.98 135.3 20.54 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.535 -1.283 . . . . 1.9 107.535 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.03 -96.46 0.16 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 106.509 -2.636 . . . . 0.63 106.509 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.4 49.24 0.26 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.611 1.164 . . . . 4.12 109.411 169.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.17 174.32 11.7 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.843 0.857 . . . . 1.96 111.131 177.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -125.05 170.57 11.04 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.926 1.691 . . . . 1.58 111.557 -174.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.4 tp -52.47 -37.61 24.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-O 117.513 -1.232 . . . . 2.8 112.269 -177.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -31.7 -52.47 0.24 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.019 1.328 . . . . 4.31 112.365 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -58.98 -50.75 72.89 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.584 1.183 . . . . 2.25 111.675 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.416 HG12 ' CZ ' ' A' ' 21' ' ' PHE . 65.1 t -61.89 -44.77 99.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.935 1.694 . . . . 1.79 110.433 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -63.29 -45.08 93.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.531 1.532 . . . . 3.55 109.495 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -51.58 -51.04 58.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.235 -0.654 . . . . 4.22 109.235 172.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.3 -48.97 67.92 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.912 -0.492 . . . . 1.77 110.682 173.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.02 -9.22 7.01 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.873 1.702 . . . . 0.37 113.96 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.53 -29.18 1.67 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.497 1.148 . . . . 1.58 111.49 166.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -51.69 -35.56 43.21 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.344 0.974 . . . . 3.38 113.555 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -121.61 4.73 10.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.41 1.084 . . . . 2.47 111.472 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 59.24 52.51 6.0 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.631 1.172 . . . . 1.07 110.054 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.22 158.03 29.91 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.575 -0.284 . . . . 3.54 110.481 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.75 119.2 25.24 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.747 -1.205 . . . . 4.89 107.747 167.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.0 mt -120.54 139.36 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.171 1.388 . . . . 1.77 107.97 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mp -128.28 133.31 25.01 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 108.358 -0.978 . . . . 2.78 108.358 -176.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.53 112.53 3.06 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.337 2.025 . . . . 0.84 108.87 170.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 . . . . . 0 CA--C 1.532 0.285 0 C-N-CA 123.657 0.783 . . . . 3.24 111.27 172.341 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 107.639 -1.245 . . . . 5.68 107.639 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.7 m -150.15 156.53 41.78 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.579 -1.267 . . . . 1.55 107.579 174.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 p -137.21 139.65 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 123.761 0.663 . . . . 1.7 110.326 168.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -125.18 145.84 49.78 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.011 1.325 . . . . 3.76 108.156 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.18 125.18 32.63 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 118.307 -0.854 . . . . 4.61 109.484 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 p -115.92 132.59 64.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 C-N-CA 123.34 0.656 . . . . 1.81 110.132 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -135.09 166.85 22.12 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.38 1.472 . . . . 3.09 108.661 -175.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.23 -50.84 0.98 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.908 1.242 . . . . 1.31 111.407 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.04 161.48 4.03 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.735 1.214 . . . . 4.41 113.417 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.1 p -172.45 51.03 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.746 0.647 . . . . 3.75 112.746 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -160.86 143.0 12.46 Favored 'General case' 0 C--N 1.346 0.426 0 O-C-N 120.76 -1.212 . . . . 3.06 113.656 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.8 m -63.32 -49.32 74.41 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.074 0.95 . . . . 2.46 111.661 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -55.05 -40.49 70.34 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.571 -0.706 . . . . 4.46 110.674 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.0 m -64.56 -43.26 94.49 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 122.136 -0.352 . . . . 2.18 110.771 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.99 -48.58 64.36 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.009 0.368 . . . . 2.2 110.173 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.53 -51.49 69.23 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.715 0.806 . . . . 2.08 110.332 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -49.9 -44.98 50.39 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.872 0.469 . . . . 3.44 109.978 175.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.65 -58.49 6.16 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.22 -0.895 . . . . 3.84 111.536 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -51.98 -45.19 64.36 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.55 1.068 . . . . 3.53 108.91 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -61.61 -59.06 5.77 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.344 0.658 . . . . 6.62 111.082 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -49.67 -48.11 49.68 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.016 -0.735 . . . . 1.62 109.016 -178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.5 t -60.76 -48.24 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 122.994 0.518 . . . . 1.85 110.546 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -56.07 -36.06 67.67 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.663 1.185 . . . . 3.49 111.992 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.14 -9.71 58.53 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.255 0.835 . . . . 2.38 113.255 175.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.1 mm -78.69 110.52 14.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 120.039 1.291 . . . . 3.45 110.587 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.61 85.7 0.07 Allowed 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.166 1.786 . . . . 3.44 108.584 165.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.38 -42.1 0.12 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 109.865 -1.294 . . . . 1.89 109.865 -177.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -97.92 151.29 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 108.642 -0.873 . . . . 2.03 108.642 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.3 m -106.28 -55.95 2.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.943 1.297 . . . . 1.67 108.09 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -121.44 125.44 46.9 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.948 -0.76 . . . . 3.36 108.948 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.82 136.89 47.85 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.292 -1.003 . . . . 1.9 108.292 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.8 mt -129.39 110.84 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.871 -1.159 . . . . 2.15 107.871 -176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.6 p -95.24 111.48 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 118.413 0.551 . . . . 3.19 111.37 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 C--N 1.341 0.228 0 N-CA-C 106.953 -1.499 . . . . 3.36 106.953 167.266 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 110.258 -0.275 . . . . 2.74 110.258 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -157.79 155.73 30.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.812 -0.555 . . . . 4.23 110.731 -163.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.28 117.46 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 125.69 1.596 . . . . 1.93 108.367 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.3 m -89.18 144.63 25.97 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.727 0.811 . . . . 1.82 109.921 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.96 132.43 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 127.163 2.185 . . . . 1.95 106.617 175.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.9 m -143.27 132.41 23.11 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.996 -1.483 . . . . 2.47 106.996 173.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.9 -90.07 0.12 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.982 -1.647 . . . . 0.76 108.982 177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -165.41 54.65 0.11 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.72 1.608 . . . . 2.88 109.208 167.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.88 174.68 10.36 Favored 'General case' 0 C--N 1.34 0.172 0 O-C-N 121.032 -1.042 . . . . 1.79 112.175 -176.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.1 m -134.61 166.35 23.11 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.454 1.501 . . . . 1.64 110.518 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -48.1 -44.5 12.12 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.877 0 CA-C-O 117.199 -1.381 . . . . 4.1 111.098 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -31.7 -47.93 0.14 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.054 1.741 . . . . 3.69 114.113 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -66.73 -46.51 75.22 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.671 0.748 . . . . 2.76 111.32 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.1 -31.47 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.993 1.317 . . . . 1.74 111.161 172.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -60.24 -55.5 33.03 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.253 1.421 . . . . 3.19 107.274 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.06 -48.06 76.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.374 -0.83 . . . . 4.88 110.3 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.04 -51.1 44.95 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.414 0.552 . . . . 1.82 110.793 172.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.18 -10.7 29.07 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.112 -0.826 . . . . 0.3 113.533 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.04 -30.18 4.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.857 1.328 . . . . 2.05 112.24 172.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -57.57 -28.18 63.35 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.464 1.029 . . . . 3.66 113.213 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -128.38 -5.75 5.36 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.131 0.973 . . . . 3.09 112.471 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 63.22 61.39 1.08 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.715 1.206 . . . . 1.34 111.018 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -82.19 169.37 16.68 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 121.891 -0.506 . . . . 2.18 110.495 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.05 70.8 1.42 Allowed 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.114 -1.069 . . . . 5.2 108.114 -170.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.0 mt -79.96 135.41 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 108.678 -0.86 . . . . 1.77 108.678 -173.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.26 135.62 23.2 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 124.37 1.068 . . . . 2.5 108.291 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.33 100.46 0.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 121.847 1.698 . . . . 0.97 109.324 170.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 108.687 -0.857 . . . . 3.96 108.687 172.33 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 105.659 -1.978 . . . . 6.0 105.659 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 88.9 m -153.5 156.07 37.42 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 106.301 -1.741 . . . . 1.65 106.301 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -132.69 145.99 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 O-C-N 123.992 0.807 . . . . 1.67 110.919 168.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -131.06 146.68 52.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.401 -1.703 . . . . 3.21 106.401 -172.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -85.17 128.15 34.55 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.816 -0.809 . . . . 6.04 108.816 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -112.31 135.26 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.91 -1.515 . . . . 1.67 106.91 174.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -142.59 154.74 44.69 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 104.964 -2.236 . . . . 3.05 104.964 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.52 -81.81 0.35 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.398 0.999 . . . . 1.6 110.999 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.31 163.06 23.19 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.304 0.552 . . . . 3.91 110.929 -174.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.2 t -149.26 79.21 1.4 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.197 0.599 . . . . 4.0 110.721 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.3 t -160.53 146.65 15.18 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.087 0.858 . . . . 2.34 112.387 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -68.39 -46.35 70.26 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.391 1.476 . . . . 2.63 111.996 -177.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -55.02 -43.52 73.76 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.426 -0.796 . . . . 3.03 110.424 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.3 m -56.96 -45.25 82.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.624 -0.716 . . . . 1.84 110.512 173.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.12 -49.89 72.63 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 122.941 0.497 . . . . 2.13 110.268 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.07 -46.42 68.58 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.235 0.54 . . . . 1.89 110.267 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -61.52 -46.11 91.35 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.446 -0.343 . . . . 4.54 110.849 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.21 -64.81 0.72 Allowed 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.848 0.859 . . . . 4.2 110.706 175.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -39.63 83.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.981 0.81 . . . . 2.42 111.086 -172.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -53.04 62.76 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.139 0.576 . . . . 3.65 110.393 172.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -53.33 -46.5 69.51 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.431 -0.581 . . . . 1.63 109.431 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.5 t -59.22 -51.25 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 122.678 0.391 . . . . 1.76 110.324 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.5 mttt -50.64 -38.43 46.18 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.036 0.935 . . . . 3.04 112.414 173.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.63 -12.53 54.08 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.488 0.921 . . . . 3.01 113.488 175.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.2 mt -86.29 113.47 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 120.319 1.418 . . . . 2.37 110.1 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -53.4 -25.16 14.59 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.833 1.653 . . . . 3.36 114.006 176.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.67 -31.13 65.43 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.886 0.755 . . . . 1.6 112.466 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.27 -172.99 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 121.278 -1.131 . . . . 2.01 109.99 -171.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.1 m -140.71 -57.97 0.52 Allowed 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 120.769 -1.207 . . . . 2.06 108.811 171.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -128.53 157.95 39.77 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 119.954 -0.698 . . . . 2.67 111.36 171.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -154.84 149.55 26.53 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.239 -0.652 . . . . 1.81 109.239 172.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.9 mt -130.32 131.07 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 107.047 -1.464 . . . . 2.84 107.047 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 p -118.61 110.04 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 124.389 1.076 . . . . 3.48 109.703 -175.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 107.619 -1.252 . . . . 2.45 107.619 171.73 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 112.493 0.553 . . . . 2.69 112.493 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -157.94 160.02 37.14 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.793 -0.567 . . . . 4.44 110.891 -158.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.26 115.7 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.145 -1.428 . . . . 1.99 107.145 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 79.6 m -90.84 141.76 28.48 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.322 1.449 . . . . 1.66 108.722 174.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.1 t -129.63 140.85 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 104.58 -2.378 . . . . 2.26 104.58 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.4 m -147.26 133.35 19.3 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 107.185 -1.413 . . . . 1.85 107.185 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.7 -96.26 0.16 Allowed Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 106.836 -2.505 . . . . 0.65 106.836 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -163.8 57.53 0.17 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.585 1.954 . . . . 3.31 108.475 172.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.71 168.12 25.32 Favored 'General case' 0 C--N 1.341 0.219 0 O-C-N 120.9 -1.125 . . . . 1.55 111.588 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -126.29 165.67 18.55 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.278 1.431 . . . . 1.95 111.696 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.7 tp -55.64 -28.93 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 117.352 -1.308 . . . . 2.87 113.321 -172.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -35.6 -51.03 0.63 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.78 1.173 . . . . 3.37 111.469 173.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -69.13 -41.46 77.34 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.289 0.566 . . . . 2.39 111.776 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.2 t -65.24 -38.42 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 O-C-N 121.624 -0.672 . . . . 1.77 110.22 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -61.38 -53.85 51.33 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 127.611 2.364 . . . . 3.35 107.97 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -49.03 -42.36 37.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.15 0.58 . . . . 4.52 111.135 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.77 -47.6 68.72 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.167 0.508 . . . . 1.9 110.849 174.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.27 -15.99 12.93 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 126.928 2.204 . . . . 0.33 113.117 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -40.5 -29.32 0.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.303 1.051 . . . . 1.79 112.465 163.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -50.23 -36.16 29.84 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.9 1.074 . . . . 3.11 113.9 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -126.16 -4.73 6.77 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.472 1.509 . . . . 2.39 112.47 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 73.03 57.46 0.11 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.092 1.357 . . . . 1.33 110.85 173.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.11 168.29 19.84 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.186 -0.946 . . . . 2.33 111.204 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.09 64.55 1.59 Allowed 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.492 -1.299 . . . . 5.78 107.492 -171.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.74 130.78 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 113.501 -1.681 . . . . 1.91 109.098 -174.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.8 mt -122.62 131.13 24.41 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 108.388 -0.967 . . . . 2.04 108.388 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.41 106.88 1.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.203 1.935 . . . . 0.85 109.128 169.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 CA--C 1.536 0.405 0 C-N-CA 123.858 0.863 . . . . 3.41 109.881 172.617 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 108.005 -1.109 . . . . 5.4 108.005 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.2 m -153.35 159.03 42.37 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 106.422 -1.696 . . . . 1.67 106.422 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 p -136.66 148.33 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 O-C-N 124.111 0.882 . . . . 1.72 110.778 173.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -133.27 141.8 48.19 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 106.729 -1.582 . . . . 3.42 106.729 -171.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.1 mtt85 -83.14 137.26 34.14 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.455 1.025 . . . . 5.34 108.416 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 p -121.78 140.65 45.11 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 124.093 0.957 . . . . 1.85 110.112 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -140.33 155.03 46.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.998 -1.482 . . . . 2.86 106.998 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.17 -81.68 0.35 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.811 1.196 . . . . 1.42 110.598 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.64 161.23 29.29 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.957 0.379 . . . . 3.87 110.522 -175.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 t -153.52 90.78 1.43 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.315 -0.624 . . . . 4.36 109.315 170.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.9 t -165.36 127.83 2.13 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.4 0.68 . . . . 2.23 110.077 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 m -50.32 -45.38 54.76 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.258 1.023 . . . . 2.28 111.743 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -59.34 -39.78 84.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.891 -0.506 . . . . 3.34 111.227 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.4 m -65.95 -46.29 78.67 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.686 -0.487 . . . . 2.09 109.686 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.58 -49.07 71.24 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.742 0.246 . . . . 1.87 110.417 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.87 67.59 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.57 0.748 . . . . 1.96 110.556 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.0 tttp -57.17 -46.93 82.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.135 -0.484 . . . . 3.76 110.349 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -49.61 -63.29 1.15 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 118.643 -0.694 . . . . 4.07 111.108 171.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -57.97 -39.75 78.92 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 119.099 0.863 . . . . 2.61 111.321 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -58.11 -51.06 71.28 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.698 -0.482 . . . . 3.55 109.698 173.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -53.5 -43.14 68.04 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.11 0.414 . . . . 2.69 110.223 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.68 -52.18 64.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 122.808 0.443 . . . . 1.55 111.28 174.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -53.84 -35.36 61.38 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.366 1.066 . . . . 2.98 111.515 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -72.53 10.26 0.87 Allowed 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 114.128 1.159 . . . . 2.75 114.128 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.0 mt -105.42 112.83 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.276 1.43 . . . . 2.24 110.714 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -52.59 -36.15 55.54 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 127.887 2.475 . . . . 3.62 113.758 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.2 -30.17 75.08 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.474 -0.785 . . . . 1.66 112.002 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.05 172.3 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 O-C-N 121.627 -0.925 . . . . 2.01 109.252 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.6 m -126.34 -59.83 1.29 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.466 -1.309 . . . . 1.87 107.466 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -122.58 164.2 18.59 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-O 121.351 0.596 . . . . 3.5 112.404 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.48 135.73 12.12 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.986 -0.746 . . . . 1.74 108.986 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.7 mm -118.82 102.39 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 105.389 -2.078 . . . . 3.13 105.389 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.51 118.93 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.651 -0.87 . . . . 3.04 108.651 -172.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 . . . . . 0 C--N 1.338 0.1 0 N-CA-C 108.857 -0.794 . . . . 2.66 108.857 -176.387 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 m . . . . . 0 CA--C 1.534 0.33 0 CA-C-O 120.648 0.261 . . . . 3.26 110.968 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.05 167.29 30.88 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.833 0.853 . . . . 4.74 109.885 -173.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.47 114.27 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 126.348 1.859 . . . . 2.09 107.541 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.1 m -91.55 136.26 33.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.37 -0.974 . . . . 1.61 108.37 171.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 t -119.96 147.93 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 126.584 1.954 . . . . 2.05 106.791 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.9 m -146.27 138.29 25.01 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.447 -1.316 . . . . 1.57 107.447 175.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.11 -91.84 0.15 Allowed Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 108.047 -2.021 . . . . 0.61 108.047 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -167.11 50.31 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.937 1.695 . . . . 2.31 109.196 173.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.12 178.05 8.87 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.968 -1.083 . . . . 1.88 110.821 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.2 m -138.21 171.37 14.5 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.21 1.404 . . . . 2.04 110.951 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -46.43 -47.41 6.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-O 116.68 -1.628 . . . . 3.93 110.875 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -33.18 -47.74 0.2 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 121.104 1.774 . . . . 3.86 114.155 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -70.16 -44.39 68.91 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.252 -0.905 . . . . 2.07 112.291 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.7 t -58.47 -27.83 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.139 1.376 . . . . 1.78 111.547 169.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.29 -52.23 29.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.876 1.67 . . . . 2.99 106.747 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -54.15 -45.67 72.06 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.808 0.843 . . . . 4.13 110.403 174.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.8 -57.65 10.13 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.408 0.549 . . . . 1.46 110.658 169.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.11 -16.18 25.11 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 125.407 1.479 . . . . 0.34 113.713 -174.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -42.7 -29.47 0.3 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.18 -0.914 . . . . 1.61 112.544 166.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -52.97 -35.26 58.73 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.836 1.198 . . . . 3.17 113.411 175.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.8 -1.55 9.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.682 1.193 . . . . 2.48 112.264 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 65.06 55.6 1.11 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.732 1.213 . . . . 0.9 110.519 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.05 171.66 11.49 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.156 -0.965 . . . . 2.28 110.955 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.57 64.3 1.52 Allowed 'General case' 0 C--N 1.341 0.218 0 N-CA-C 107.731 -1.211 . . . . 5.6 107.731 -175.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mt -80.7 139.47 18.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 113.982 -1.463 . . . . 1.9 108.429 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.5 mt -128.0 133.25 24.93 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.436 1.094 . . . . 2.42 108.116 -174.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -64.52 109.0 1.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.323 2.016 . . . . 0.78 109.621 172.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 109.725 -0.472 . . . . 4.54 109.725 172.804 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.114 0.483 . . . . 4.61 109.77 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -150.25 148.4 28.84 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 105.838 -1.912 . . . . 1.69 105.838 170.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.67 147.64 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 124.204 0.94 . . . . 1.73 110.284 169.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -133.0 145.09 50.55 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.082 -1.451 . . . . 3.58 107.082 -173.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 50.8 mtm-85 -87.68 124.89 34.03 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 109.037 -0.727 . . . . 6.2 109.037 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 p -109.74 152.91 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.056 0 N-CA-C 108.638 -0.875 . . . . 1.65 108.638 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -147.37 166.81 26.02 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.284 -1.376 . . . . 2.35 107.284 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.6 -68.34 0.28 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.236 0.922 . . . . 1.61 112.14 171.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 pp -73.41 157.94 35.94 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 117.833 0.817 . . . . 3.95 110.347 -175.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.0 m -152.25 69.9 0.9 Allowed 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.92 0.488 . . . . 4.09 110.199 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.2 t -157.86 121.87 4.15 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.045 0.538 . . . . 2.21 110.775 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 m -47.18 -44.26 21.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.205 1.402 . . . . 2.18 111.947 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -53.52 -43.92 68.7 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.888 0.475 . . . . 3.02 110.787 178.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.1 m -70.43 -39.73 74.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.386 -0.34 . . . . 1.99 110.369 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.01 -44.64 78.86 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.681 0.673 . . . . 1.62 110.766 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.39 -49.12 72.85 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.345 0.658 . . . . 1.87 110.683 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -49.53 -49.38 46.27 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.494 0.717 . . . . 3.43 109.227 173.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -56.93 -63.43 1.21 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 118.449 -0.786 . . . . 4.12 111.646 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -40.17 74.76 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 119.173 -1.011 . . . . 2.47 110.671 -172.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -59.32 -51.71 68.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.216 0.207 . . . . 3.43 111.232 174.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -52.24 -45.77 65.46 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.76 -0.588 . . . . 1.71 110.702 175.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.0 t -65.51 -45.33 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.095 0.558 . . . . 1.82 110.399 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -54.03 -38.44 65.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.293 1.037 . . . . 2.99 110.867 173.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -70.33 -0.61 8.45 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.864 1.061 . . . . 2.99 113.864 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.9 mm -85.6 134.08 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 120.837 1.653 . . . . 3.47 110.287 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -74.74 124.7 27.25 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.839 1.656 . . . . 4.11 109.316 167.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.91 -39.86 1.95 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.578 1.085 . . . . 2.17 110.955 171.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.03 159.08 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 O-C-N 121.871 -0.782 . . . . 1.75 109.311 173.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.7 m -116.17 -55.68 2.38 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.871 1.668 . . . . 2.14 107.856 177.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -127.23 147.29 50.22 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.416 0.447 . . . . 2.89 110.554 170.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.79 140.53 40.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.719 -1.215 . . . . 1.85 107.719 166.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.6 mt -125.25 109.92 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 N-CA-C 106.451 -1.685 . . . . 2.4 106.451 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.78 129.96 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 123.106 0.253 . . . . 3.02 110.788 -171.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 107.034 -1.469 . . . . 2.89 107.034 169.191 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 111.659 0.244 . . . . 2.73 111.659 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.409 ' HZ2' ' CD ' ' A' ' 68' ' ' GLU . 0.6 OUTLIER -160.34 168.54 25.03 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.692 -0.63 . . . . 4.73 111.669 -163.18 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.08 113.99 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.773 -1.195 . . . . 1.66 107.773 -176.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.8 m -91.88 141.58 28.49 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.49 1.116 . . . . 1.61 109.066 174.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.8 t -129.34 138.38 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 104.744 -2.317 . . . . 2.11 104.744 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.2 m -147.61 132.46 18.03 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 106.391 -1.707 . . . . 1.55 106.391 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.87 -95.82 0.17 Allowed Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 106.651 -2.579 . . . . 0.66 106.651 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.63 63.59 0.11 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.086 1.754 . . . . 3.81 108.53 174.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.22 164.69 36.84 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.075 -1.016 . . . . 1.51 110.629 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.0 m -118.26 162.61 17.98 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 125.939 1.696 . . . . 1.77 110.65 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 tp -54.02 -31.84 21.83 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 CA-C-O 117.466 -1.254 . . . . 2.71 112.632 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -32.17 -48.57 0.17 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.89 1.276 . . . . 5.06 111.953 175.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -59.83 -52.5 65.18 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.92 0.867 . . . . 2.34 111.465 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.06 -42.41 96.52 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 C-N-CA 125.44 1.496 . . . . 1.82 110.699 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -61.99 -48.96 78.01 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.049 1.34 . . . . 2.93 108.644 178.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -56.12 -51.59 67.39 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.162 0.585 . . . . 4.46 110.35 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.51 -52.98 19.83 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.654 0.661 . . . . 1.4 110.835 168.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.46 -18.4 29.67 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 125.382 1.468 . . . . 0.32 113.414 -177.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.23 -22.77 1.11 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.543 1.171 . . . . 1.72 112.335 170.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -55.49 -32.11 62.58 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 120.167 1.348 . . . . 3.18 112.894 172.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.91 -25.21 6.83 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.127 1.371 . . . . 2.57 111.657 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 83.48 60.41 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.674 2.39 . . . . 0.74 111.363 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.16 165.72 22.16 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.119 -0.988 . . . . 2.63 111.73 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.04 111.72 17.82 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.966 -1.494 . . . . 5.83 106.966 175.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.08 127.6 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 108.845 -0.798 . . . . 1.63 108.845 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.9 mm -111.64 125.3 30.63 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.027 1.331 . . . . 2.73 108.796 -172.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.14 92.24 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.04 2.493 . . . . 0.76 110.032 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.409 ' CD ' ' HZ2' ' A' ' 42' ' ' LYS . 22.8 pt-20 . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 121.531 0.681 . . . . 3.91 111.002 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.6 pttt . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 108.117 -1.068 . . . . 4.54 108.117 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.9 m -147.46 150.64 34.99 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 108.234 -1.025 . . . . 1.54 108.234 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -135.36 132.88 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 124.337 1.023 . . . . 1.77 111.114 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -115.57 153.65 30.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.772 1.629 . . . . 3.33 108.012 -169.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -92.89 112.72 24.78 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.484 -0.932 . . . . 5.08 108.484 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.9 p -96.18 144.03 11.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.572 1.149 . . . . 1.62 109.055 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -141.93 163.39 33.02 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.541 -0.541 . . . . 2.96 109.541 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.4 -70.26 0.24 Allowed Glycine 0 CA--C 1.528 0.906 0 C-N-CA 126.013 1.768 . . . . 1.55 111.024 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.94 173.3 8.99 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.388 0.884 . . . . 3.89 113.388 -170.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.1 p -167.06 82.63 0.23 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.846 0.859 . . . . 3.38 109.716 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.01 133.03 4.39 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.763 0.711 . . . . 3.13 112.422 176.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.4 m -54.59 -46.72 73.81 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.573 1.149 . . . . 2.26 111.71 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -59.42 -36.59 76.16 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.985 0.898 . . . . 3.93 111.142 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.9 m -69.79 -45.37 68.12 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 108.822 -0.807 . . . . 2.57 108.822 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.56 -43.85 68.82 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 122.759 0.424 . . . . 1.69 110.419 174.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.68 -55.21 37.83 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.471 0.708 . . . . 1.65 109.515 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -54.88 -41.09 70.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.53 -0.304 . . . . 3.74 111.037 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.427 ' CZ ' HG12 ' A' ' 54' ' ' VAL . 2.2 t80 -64.6 -60.16 3.45 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 119.403 -0.332 . . . . 3.7 111.096 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.31 -40.93 75.15 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 118.429 0.559 . . . . 2.52 109.781 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -57.97 -54.53 45.86 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.059 0.943 . . . . 3.2 109.352 175.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -49.67 -51.71 36.19 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.422 0.556 . . . . 1.95 109.851 176.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.5 t -55.5 -52.65 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 110.26 -0.274 . . . . 1.66 110.26 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -51.05 -39.24 55.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.194 1.398 . . . . 2.72 112.383 174.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -71.88 -14.17 61.87 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.057 0.762 . . . . 2.07 113.057 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mt -77.55 131.47 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 120.531 1.514 . . . . 2.39 108.761 171.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -77.22 -9.5 58.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.447 1.099 . . . . 2.44 113.75 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.91 -30.91 45.56 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.768 0.699 . . . . 1.55 112.09 -178.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.1 p -97.36 158.67 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 121.377 -1.072 . . . . 1.94 109.42 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.0 m -106.08 -55.0 2.39 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.677 -1.231 . . . . 1.84 107.677 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -129.32 154.62 46.69 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.758 -0.46 . . . . 2.92 109.758 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.72 143.9 23.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.892 -0.781 . . . . 1.66 108.892 173.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.5 mt -127.5 105.77 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.313 -1.366 . . . . 2.47 107.313 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.57 125.95 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.507 -0.923 . . . . 3.68 108.507 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.0 m120 . . . . . 0 N--CA 1.465 0.296 0 CA-C-N 119.408 1.004 . . . . 3.47 109.94 169.32 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 m . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.898 -0.408 . . . . 2.77 109.898 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.77 167.85 28.38 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 122.948 0.499 . . . . 4.29 110.637 -170.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.52 120.39 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.632 1.173 . . . . 1.81 108.892 174.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.7 m -98.09 145.29 26.7 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.408 1.083 . . . . 1.61 111.177 177.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.75 140.55 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 127.563 2.345 . . . . 1.9 107.551 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.1 m -148.5 89.66 1.72 Allowed 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 124.971 1.309 . . . . 1.81 108.486 -177.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.89 -106.98 0.19 Allowed Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 108.51 -1.836 . . . . 0.87 108.51 175.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -151.92 62.77 0.85 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.706 1.202 . . . . 3.61 108.114 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.15 162.61 36.65 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.121 0.969 . . . . 1.8 110.071 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -119.5 162.14 19.39 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.884 1.673 . . . . 1.82 109.043 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.0 tp -52.67 -33.51 18.5 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 CA-C-O 117.231 -1.366 . . . . 2.55 112.012 -176.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.3 mm-40 -28.7 -53.41 0.11 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.67 1.588 . . . . 3.16 112.802 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -69.09 -41.87 76.92 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.574 0.702 . . . . 2.39 111.708 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.427 HG12 ' CZ ' ' A' ' 21' ' ' PHE . 33.9 t -66.99 -38.04 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.278 1.031 . . . . 1.72 110.272 178.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -60.98 -49.76 76.14 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.229 1.812 . . . . 2.85 108.512 174.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -52.53 -51.62 58.73 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.83 0.452 . . . . 4.44 110.142 175.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.5 -48.61 62.85 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.627 0.649 . . . . 1.45 111.188 170.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.32 -9.64 6.42 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.918 -0.935 . . . . 0.35 114.036 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.91 -25.66 0.83 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 119.176 1.488 . . . . 1.7 112.682 170.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -53.73 -36.35 62.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.81 1.186 . . . . 3.47 113.235 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -121.0 -5.93 9.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.217 1.007 . . . . 2.61 112.894 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 67.46 50.57 0.92 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.75 1.22 . . . . 0.86 110.417 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -72.35 168.01 19.28 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.532 -0.73 . . . . 2.67 112.158 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.07 124.49 40.73 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.195 -1.78 . . . . 5.14 106.195 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.0 mt -130.85 134.49 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.708 1.203 . . . . 1.75 107.913 -175.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.6 mt -113.98 121.79 36.07 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.756 1.222 . . . . 2.73 108.169 -172.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -77.37 70.73 6.68 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 124.227 3.284 . . . . 1.41 109.5 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 . . . . . 0 N--CA 1.441 -0.913 0 C-N-CA 126.057 1.743 . . . . 6.96 112.913 -167.927 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 30.8 pttt . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 108.059 -1.089 . . . . 4.57 108.059 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.1 m -150.2 147.19 27.4 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 107.766 -1.198 . . . . 1.64 107.766 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -123.02 143.84 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 124.947 1.404 . . . . 1.57 110.318 171.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -129.8 153.42 48.26 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.023 -1.843 . . . . 3.21 106.023 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -95.42 147.95 22.98 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.583 0.629 . . . . 4.59 110.156 173.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.34 121.7 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 123.045 0.538 . . . . 2.09 110.684 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.04 -173.45 2.31 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.069 0.548 . . . . 2.81 111.449 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.43 -46.94 3.34 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.666 1.603 . . . . 1.34 113.427 170.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 pp -50.13 156.8 0.74 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.874 1.269 . . . . 4.34 113.495 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 t -167.55 51.21 0.06 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.88 0.472 . . . . 3.56 111.221 173.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.1 t -159.16 117.74 2.9 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 120.807 -1.183 . . . . 2.2 112.854 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 m -53.04 -41.96 65.26 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.191 0.996 . . . . 2.55 112.212 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -57.25 -39.74 76.2 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.67 0.747 . . . . 3.15 109.982 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.0 m -69.39 -43.83 72.7 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.866 -0.606 . . . . 1.99 109.947 175.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.28 -48.57 45.9 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.062 0.545 . . . . 1.91 110.84 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.27 -48.86 80.04 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.573 -0.739 . . . . 1.51 109.879 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -58.51 -38.42 77.66 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.022 -0.535 . . . . 3.96 110.532 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -58.07 -60.52 3.62 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.45 0.7 . . . . 4.05 109.758 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -55.8 -45.04 78.35 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.278 0.49 . . . . 2.47 110.029 -175.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -64.06 -47.26 80.84 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.022 -0.535 . . . . 3.26 109.808 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -52.46 -46.39 66.47 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.918 -0.401 . . . . 1.97 109.918 173.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.4 t -60.33 -50.16 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 118.314 0.507 . . . . 1.74 109.727 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -51.63 -34.83 39.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.899 0.88 . . . . 2.29 112.996 173.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -67.26 -22.81 65.65 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.875 0.761 . . . . 3.03 112.533 176.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.1 mt -70.74 133.18 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.596 1.089 . . . . 2.69 109.213 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -77.66 -17.35 57.8 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.557 1.143 . . . . 2.94 113.093 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.48 -11.44 80.15 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.379 0.99 . . . . 1.62 113.768 -176.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.3 p -115.06 153.18 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 118.59 1.195 . . . . 1.67 108.949 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.8 m -103.1 -51.56 3.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.23 -1.026 . . . . 1.74 108.23 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -132.38 161.08 34.51 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.837 0.351 . . . . 2.1 110.278 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.77 138.05 16.6 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.874 -1.158 . . . . 1.64 107.874 174.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 22.0 mm -126.55 102.81 10.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 106.839 -1.541 . . . . 3.35 106.839 -177.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.2 p -98.42 144.38 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 122.507 0.323 . . . . 3.27 110.658 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.0 m120 . . . . . 0 C--O 1.235 0.295 0 N-CA-C 108.803 -0.814 . . . . 4.16 108.803 173.423 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.444 -0.725 0 N-CA-C 108.32 -0.993 . . . . 5.81 108.32 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -145.69 142.54 29.1 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.044 1.293 . . . . 6.63 112.407 -170.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.78 119.33 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.105 1.362 . . . . 1.92 110.151 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 m -98.56 139.96 33.5 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.941 1.296 . . . . 1.57 110.225 172.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.5 t -122.29 140.66 45.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 127.806 2.442 . . . . 1.95 105.576 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.5 m -147.22 85.72 1.61 Allowed 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.134 -0.979 . . . . 1.87 108.424 -173.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.88 -106.87 0.19 Allowed Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 109.43 -1.468 . . . . 0.94 109.43 176.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -152.21 54.87 0.81 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.733 0.813 . . . . 2.14 108.958 170.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.77 163.6 33.55 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.425 -0.797 . . . . 1.79 110.497 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.5 m -109.57 161.42 15.37 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.337 1.455 . . . . 1.66 110.136 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.0 tp -50.74 -31.63 9.96 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 CA-C-O 117.314 -1.327 . . . . 2.71 113.321 -178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -29.86 -50.04 0.11 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.07 1.348 . . . . 5.15 112.475 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -63.93 -45.49 89.02 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 122.025 0.917 . . . . 2.37 111.604 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.0 t -69.57 -30.73 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.507 1.123 . . . . 1.65 110.48 178.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -61.7 -50.06 73.97 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.046 -1.094 . . . . 3.19 108.046 172.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -51.97 -50.87 60.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.837 0.455 . . . . 3.68 110.617 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.14 -52.24 36.78 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.856 -0.527 . . . . 1.8 111.13 170.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.07 -22.31 35.09 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 126.002 1.763 . . . . 0.57 112.952 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.38 -31.49 4.08 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.733 1.266 . . . . 1.86 112.368 171.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.57 -36.32 55.72 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.314 0.961 . . . . 3.51 113.113 175.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -130.35 4.62 4.75 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.255 1.022 . . . . 3.08 112.122 -173.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 61.82 54.75 2.8 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.597 1.559 . . . . 1.04 112.884 171.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -80.17 -176.96 5.84 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.344 -0.542 . . . . 2.18 110.801 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.87 87.72 1.86 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.328 -1.73 . . . . 5.04 106.328 -176.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 mt -89.0 132.31 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.858 1.263 . . . . 2.37 109.9 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.7 mp -129.17 136.54 29.32 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.539 1.136 . . . . 2.71 109.025 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -72.51 64.93 3.76 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.812 3.008 . . . . 1.03 110.847 174.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 . . . . . 0 N--CA 1.453 -0.297 0 C-N-CA 123.24 0.616 . . . . 6.4 109.928 170.992 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.8 pttt . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.226 0.536 . . . . 5.11 109.699 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.0 m -146.84 143.72 28.78 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.44 -0.948 . . . . 1.92 108.44 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -116.34 134.44 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 124.869 1.356 . . . . 2.04 110.505 168.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -116.13 163.26 16.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.791 1.636 . . . . 3.5 106.593 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -106.21 131.41 53.49 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 118.619 -0.705 . . . . 4.61 110.39 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 p -116.87 142.64 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.366 -0.976 . . . . 1.53 108.366 -174.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -142.93 166.64 24.09 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.756 0.707 . . . . 2.9 109.885 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.25 66.0 3.0 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.464 1.507 . . . . 3.12 112.379 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.16 167.96 16.84 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.774 1.63 . . . . 3.71 109.712 175.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 m -64.41 -82.66 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.302 0.482 . . . . 7.54 112.302 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -172.71 -167.52 0.44 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.372 -0.83 . . . . 4.61 109.911 -175.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.7 t -47.95 -36.72 12.98 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.417 1.487 . . . . 3.57 112.969 -176.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -52.49 -50.93 61.76 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.929 0.871 . . . . 4.47 110.385 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.5 m -71.89 -32.66 67.63 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.871 -0.604 . . . . 1.82 110.909 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.71 -46.86 74.26 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 118.581 0.628 . . . . 1.64 110.044 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -49.99 75.43 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.495 -0.775 . . . . 1.56 109.085 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -53.65 -41.86 67.22 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.415 -0.357 . . . . 3.07 110.686 175.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -63.76 -57.39 10.08 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.362 0.665 . . . . 4.2 110.549 179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -55.16 -45.3 75.71 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.61 0.641 . . . . 2.53 109.609 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -60.82 -52.15 66.29 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.407 0.683 . . . . 4.47 109.462 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -48.78 -49.87 36.71 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 123.335 0.654 . . . . 2.91 109.961 176.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.8 t -61.65 -50.76 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 120.392 -0.523 . . . . 1.7 109.938 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -50.31 -33.92 21.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.187 0.995 . . . . 2.31 113.113 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -69.91 -22.39 63.21 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.459 0.704 . . . . 2.74 112.614 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.9 mt -76.97 138.95 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.674 1.124 . . . . 2.16 109.18 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -82.47 -21.12 35.7 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.33 1.052 . . . . 2.36 113.402 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.86 -31.11 72.52 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 123.845 0.736 . . . . 1.69 112.503 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -95.01 -178.95 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 124.846 1.258 . . . . 1.77 109.222 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.9 m -141.83 -57.95 0.47 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.372 1.069 . . . . 1.91 109.062 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.79 148.91 35.72 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-O 121.169 0.509 . . . . 2.56 110.228 172.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.11 124.0 11.3 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.729 -1.211 . . . . 2.21 107.729 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.0 mt -128.49 98.95 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 107.653 -1.24 . . . . 2.34 107.653 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 p -96.4 138.22 22.24 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 C-N-CA 122.85 0.46 . . . . 3.36 110.541 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 . . . . . 0 C--O 1.232 0.176 0 N-CA-C 107.952 -1.129 . . . . 3.17 107.952 166.486 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.5 m . . . . . 0 N--CA 1.44 -0.926 0 N-CA-C 107.019 -1.475 . . . . 5.37 107.019 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -152.35 140.84 20.69 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.611 0.641 . . . . 5.56 111.547 -176.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.9 106.91 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.226 1.411 . . . . 1.7 109.18 -177.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.2 m -84.39 134.12 34.49 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.67 1.188 . . . . 1.91 109.718 174.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.02 138.94 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.294 1.838 . . . . 1.87 106.67 171.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.5 m -148.71 136.58 20.74 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.045 -1.465 . . . . 2.04 107.045 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.74 -94.38 0.15 Allowed Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 106.188 -2.765 . . . . 0.64 106.188 173.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -159.97 49.16 0.29 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.27 0.628 . . . . 2.37 110.383 169.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.6 172.91 12.56 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.516 -0.74 . . . . 1.55 112.035 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.8 m -127.29 164.93 20.67 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.785 1.634 . . . . 1.56 111.316 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 tp -53.75 -28.54 16.66 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-O 117.846 -1.073 . . . . 2.78 113.228 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -32.48 -51.09 0.26 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.542 1.137 . . . . 3.11 111.831 171.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -68.91 -41.76 77.77 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.416 0.627 . . . . 2.5 111.601 -177.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 37.1 t -67.1 -37.13 78.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 123.691 0.796 . . . . 1.69 110.224 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -57.32 -54.5 46.05 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.496 1.518 . . . . 3.16 108.05 173.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.82 -53.68 49.07 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 110.081 -0.34 . . . . 3.86 110.081 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.46 -47.96 62.94 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.159 0.504 . . . . 1.66 111.161 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.23 -18.34 4.74 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 126.348 1.927 . . . . 0.5 113.208 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.97 -24.26 0.58 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.555 1.678 . . . . 1.74 112.837 171.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -53.96 -34.39 59.6 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.88 1.218 . . . . 3.66 113.35 172.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -120.84 -19.38 7.33 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.316 1.446 . . . . 2.67 112.394 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 73.71 55.45 0.1 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.415 1.886 . . . . 1.04 110.856 -177.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.26 166.42 23.49 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.279 -0.888 . . . . 2.56 111.079 -176.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.51 120.06 34.77 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.568 -1.271 . . . . 5.01 107.568 169.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.45 140.28 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 125.001 1.321 . . . . 2.01 108.049 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.77 131.93 24.1 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.288 1.035 . . . . 2.78 108.602 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.08 97.35 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.567 2.178 . . . . 0.76 108.998 170.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 . . . . . 0 N--CA 1.451 -0.408 0 C-N-CA 123.758 0.823 . . . . 3.32 111.107 176.433 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.7 pttt . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 108.425 -0.954 . . . . 5.19 108.425 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.0 m -156.15 154.18 30.45 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 107.75 -1.204 . . . . 1.67 107.75 -173.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -129.36 143.15 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 124.499 1.125 . . . . 1.57 110.931 170.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -128.22 147.86 50.6 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.169 1.388 . . . . 3.11 107.574 -175.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -88.75 132.77 34.47 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.623 0.647 . . . . 7.13 109.392 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 p -109.62 148.95 12.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.9 1.28 . . . . 1.82 107.792 172.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.27 160.82 42.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.784 -0.821 . . . . 2.69 108.784 168.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.15 34.53 5.86 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.116 0.865 . . . . 1.99 113.785 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.96 171.5 20.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.362 1.081 . . . . 3.03 109.814 169.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.1 t -171.08 60.24 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.849 0.86 . . . . 3.99 110.404 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -142.58 121.69 12.93 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.503 0.592 . . . . 2.29 110.854 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m -51.57 -50.14 60.69 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.328 1.051 . . . . 2.37 111.321 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -54.11 -44.4 71.23 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.978 -0.451 . . . . 3.28 110.803 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.1 m -64.92 -46.67 80.68 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.942 -0.392 . . . . 1.93 109.942 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.87 74.73 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.918 0.487 . . . . 1.77 111.195 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.04 -49.18 66.03 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.587 0.755 . . . . 2.13 110.185 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -52.32 -47.84 65.77 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.642 -0.503 . . . . 3.43 109.642 173.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.17 -57.53 10.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.104 0.562 . . . . 3.55 110.93 174.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -56.63 -44.57 81.38 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.722 0.692 . . . . 2.39 110.089 -174.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -59.87 -53.86 52.97 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 108.834 -0.802 . . . . 6.71 108.834 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -44.94 -49.16 11.26 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.401 1.08 . . . . 2.69 110.342 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.5 t -60.39 -52.21 64.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 110.298 -0.26 . . . . 1.63 110.298 175.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -53.18 -31.88 45.03 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.277 0.843 . . . . 2.27 113.277 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -70.33 -15.42 62.87 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.388 0.994 . . . . 2.28 113.094 175.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.5 mt -71.99 115.92 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-O 122.474 1.13 . . . . 2.36 109.445 178.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.08 95.12 0.16 Allowed 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.76 1.624 . . . . 2.61 108.941 171.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.84 -36.74 0.72 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.227 -0.749 . . . . 2.31 111.227 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.2 p -79.67 155.25 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 121.677 -0.896 . . . . 2.16 109.757 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.2 m -109.44 -58.55 2.02 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.529 1.132 . . . . 2.02 108.133 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -123.74 157.74 33.29 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.206 0.527 . . . . 2.94 111.343 173.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.43 134.99 20.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.97 -1.493 . . . . 1.78 106.97 167.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.8 mt -124.85 102.61 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 104.541 -2.392 . . . . 2.57 104.541 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.0 m -117.14 133.05 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 110.328 -0.249 . . . . 3.45 110.328 -167.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 . . . . . 0 C--O 1.227 -0.116 0 N-CA-C 109.358 -0.608 . . . . 2.88 109.358 176.755 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.0 m . . . . . 0 C--O 1.235 0.311 0 CA-C-O 118.338 -0.839 . . . . 2.74 109.479 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -156.32 165.91 34.97 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.961 0.8 . . . . 4.66 112.199 -170.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.2 115.89 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 126.663 1.985 . . . . 2.04 107.706 -178.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.9 m -97.1 137.45 36.14 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.974 0.909 . . . . 1.62 109.026 173.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.18 143.98 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 126.564 1.946 . . . . 2.18 106.325 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 m -146.1 130.74 17.9 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 106.669 -1.604 . . . . 1.54 106.669 178.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 147.23 -101.52 0.23 Allowed Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 105.888 -2.885 . . . . 0.56 105.888 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -163.57 56.94 0.17 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.719 1.608 . . . . 2.29 109.069 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.09 164.21 31.31 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.155 0.982 . . . . 1.81 109.16 173.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.3 m -131.26 163.38 27.92 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.662 1.185 . . . . 1.48 111.211 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -45.83 -48.73 4.86 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.859 0 CA-C-O 117.19 -1.386 . . . . 3.88 111.178 -174.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -30.97 -50.91 0.15 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.296 1.438 . . . . 3.38 113.318 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -66.15 -44.66 83.49 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 122.027 0.917 . . . . 3.5 110.67 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.5 t -65.89 -33.37 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.815 1.246 . . . . 1.64 110.63 174.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.85 -55.35 36.02 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.951 -1.5 . . . . 4.0 106.951 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -51.55 -45.74 63.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.901 -1.045 . . . . 4.0 110.837 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.88 -53.95 52.12 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.706 0.685 . . . . 1.73 111.138 171.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.85 -20.51 19.36 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 125.179 1.371 . . . . 0.3 112.703 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.81 -22.48 0.31 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.418 1.109 . . . . 1.6 113.156 168.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -53.76 -31.66 49.41 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.223 1.374 . . . . 3.21 112.825 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -128.62 -10.85 5.02 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.463 1.505 . . . . 2.93 112.593 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 74.59 60.57 0.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.631 1.973 . . . . 0.89 111.507 172.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -84.35 -179.05 7.1 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.469 -0.769 . . . . 2.23 112.429 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.22 110.22 8.25 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 105.872 -1.899 . . . . 5.1 105.872 176.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.12 135.65 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.908 -1.145 . . . . 1.76 107.908 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.22 137.15 29.39 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.818 1.247 . . . . 1.99 108.967 -169.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.77 89.82 0.63 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.193 2.595 . . . . 1.18 111.184 174.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 . . . . . 0 CA--C 1.54 0.573 0 C-N-CA 126.579 1.951 . . . . 3.7 111.156 171.887 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.8 pttt . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 121.326 0.584 . . . . 5.11 109.697 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.1 m -147.11 143.65 28.45 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.471 -0.937 . . . . 1.92 108.471 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -116.37 134.64 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 O-C-N 124.899 1.374 . . . . 2.04 110.454 168.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -116.41 163.12 16.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.522 -1.659 . . . . 3.48 106.522 -177.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -106.55 131.06 54.15 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 118.644 -0.693 . . . . 4.62 110.323 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 p -117.12 142.63 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 108.354 -0.98 . . . . 1.55 108.354 -173.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -143.34 166.84 23.63 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.752 0.706 . . . . 2.91 109.648 176.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.73 64.77 3.81 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.421 1.486 . . . . 3.12 112.339 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.64 167.55 17.03 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.799 1.639 . . . . 3.71 109.748 175.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.4 m -64.88 -82.35 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.254 0.464 . . . . 7.52 112.254 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -172.46 -167.67 0.47 Allowed 'General case' 0 C--N 1.344 0.333 0 O-C-N 121.323 -0.861 . . . . 4.6 110.06 -175.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.0 t -48.28 -36.55 14.32 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.339 1.456 . . . . 3.57 113.021 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -52.63 -50.73 62.56 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.949 0.88 . . . . 4.45 110.349 176.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.7 m -71.81 -33.07 68.23 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.744 -0.662 . . . . 1.83 110.823 176.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.56 -47.1 73.64 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 118.46 0.573 . . . . 1.64 110.035 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.46 -50.09 74.97 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.571 -0.741 . . . . 1.56 109.072 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -53.53 -41.68 66.64 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.44 -0.345 . . . . 3.08 110.758 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -63.84 -57.22 10.53 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.478 0.711 . . . . 4.2 110.561 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -55.25 -45.16 76.06 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 118.61 0.641 . . . . 2.53 109.674 -177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -60.7 -52.29 65.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.307 0.643 . . . . 4.47 109.378 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -48.75 -49.88 36.3 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.351 0.661 . . . . 2.92 109.908 176.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.0 t -61.71 -50.88 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 120.499 -0.48 . . . . 1.7 109.912 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 55.4 mttt -50.61 -33.43 22.13 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.128 0.971 . . . . 2.31 113.214 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -69.97 -22.3 63.16 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.498 0.719 . . . . 2.71 112.582 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.9 mt -77.25 139.29 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 119.64 1.109 . . . . 2.15 109.232 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -82.83 -21.1 34.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.283 1.033 . . . . 2.37 113.419 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.97 -31.23 72.36 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.9 0.762 . . . . 1.69 112.359 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -94.41 -177.61 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.855 1.262 . . . . 1.78 109.104 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.2 m -143.91 -57.47 0.39 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.04 -1.037 . . . . 1.95 109.092 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -113.97 149.25 35.58 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-O 121.236 0.541 . . . . 2.59 110.251 171.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.4 124.51 11.43 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.791 -1.188 . . . . 2.2 107.791 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.91 99.13 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 107.692 -1.225 . . . . 2.34 107.692 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 p -96.07 138.67 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 C-N-CA 122.807 0.443 . . . . 3.39 110.429 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 . . . . . 0 C--O 1.233 0.19 0 N-CA-C 107.945 -1.131 . . . . 3.13 107.945 166.016 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.5 m . . . . . 0 N--CA 1.442 -0.87 0 N-CA-C 106.983 -1.488 . . . . 5.38 106.983 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -151.87 141.18 21.45 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.7 0.682 . . . . 5.53 111.719 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.07 107.08 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.294 1.438 . . . . 1.7 109.186 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.8 m -84.38 134.1 34.49 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.686 1.195 . . . . 1.88 109.73 173.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -122.74 139.15 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.199 1.8 . . . . 1.86 106.679 171.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.1 m -148.81 136.87 20.85 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 107.031 -1.47 . . . . 2.04 107.031 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.89 -94.62 0.15 Allowed Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 106.261 -2.736 . . . . 0.64 106.261 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -159.86 49.22 0.29 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.325 0.65 . . . . 2.43 110.381 169.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.6 173.07 12.37 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.503 -0.748 . . . . 1.55 112.022 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.1 m -127.7 164.73 21.45 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.709 1.603 . . . . 1.55 111.358 -174.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 tp -53.71 -28.71 16.72 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 CA-C-O 117.809 -1.091 . . . . 2.77 113.231 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -32.73 -50.92 0.28 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.391 1.076 . . . . 3.12 111.825 171.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -68.89 -41.44 78.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.385 0.612 . . . . 2.49 111.652 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.0 t -67.44 -37.15 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.662 0.785 . . . . 1.69 110.111 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -57.41 -54.42 47.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.596 1.558 . . . . 3.15 107.944 173.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.63 -53.73 47.65 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 110.101 -0.333 . . . . 3.86 110.101 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.63 -47.95 63.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.132 0.491 . . . . 1.67 111.132 173.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.27 -18.44 4.89 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 126.336 1.922 . . . . 0.5 113.245 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.73 -24.52 0.58 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.468 1.634 . . . . 1.74 112.878 171.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -54.01 -34.33 59.59 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.893 1.224 . . . . 3.66 113.315 172.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -120.35 -19.73 7.51 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.195 1.398 . . . . 2.66 112.339 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 74.13 55.24 0.09 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.494 1.918 . . . . 1.02 110.729 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.95 166.09 23.98 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.261 -0.899 . . . . 2.56 111.082 -176.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.98 121.16 38.34 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.523 -1.288 . . . . 4.98 107.523 169.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.33 140.6 44.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 125.007 1.323 . . . . 2.03 108.029 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.12 131.74 23.99 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.356 1.062 . . . . 2.8 108.525 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.28 97.82 0.79 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.537 2.158 . . . . 0.76 108.829 170.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 . . . . . 0 N--CA 1.45 -0.441 0 C-N-CA 123.532 0.733 . . . . 3.35 111.028 177.105 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.412 ' H3 ' ' CD ' ' A' ' 3' ' ' GLU . 26.2 mtt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 109.492 -0.559 . . . . 9.79 109.492 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.7 -53.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.766 1.226 . . . . 7.57 109.1 -175.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.412 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 1.1 mp0 49.03 44.84 22.91 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.447 1.499 . . . . 4.6 111.511 166.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -136.48 143.79 44.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 127.634 2.374 . . . . 4.64 105.946 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.5 m -151.9 154.76 36.75 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 105.888 -1.893 . . . . 1.65 105.888 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.25 137.99 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 O-C-N 124.428 1.08 . . . . 1.84 109.851 169.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -116.49 151.21 36.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.517 -1.661 . . . . 3.19 106.517 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 -87.86 131.94 34.38 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 107.67 -1.233 . . . . 6.77 107.67 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.87 147.7 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 119.677 1.126 . . . . 2.03 109.963 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -141.21 151.76 44.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.007 -0.738 . . . . 2.84 109.007 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.68 -79.78 0.37 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.253 1.406 . . . . 1.92 110.941 174.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.2 pp -73.38 150.93 41.42 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 122.348 -0.501 . . . . 4.05 110.629 -171.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 p -144.51 63.81 1.31 Allowed 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.762 0.825 . . . . 3.25 110.793 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.8 t -155.49 123.77 5.88 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.861 -0.525 . . . . 2.47 111.653 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m -48.43 -41.06 28.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.349 1.46 . . . . 3.02 112.222 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -61.27 -42.44 98.63 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.481 -0.762 . . . . 3.34 110.681 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.8 m -67.83 -40.6 83.75 Favored 'General case' 0 C--O 1.231 0.124 0 O-C-N 121.355 -0.841 . . . . 2.65 110.248 176.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.33 -46.22 72.84 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 122.2 -0.313 . . . . 1.89 110.326 171.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.91 -43.92 97.88 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.767 0.827 . . . . 2.19 110.987 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -54.19 -51.62 63.81 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.745 -0.597 . . . . 4.33 109.599 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.26 -60.51 3.3 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.293 0.637 . . . . 3.78 112.508 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -38.57 72.48 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.383 0.992 . . . . 2.91 110.57 -173.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -64.68 -46.38 82.67 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.643 0.377 . . . . 3.44 110.894 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -52.44 -41.91 63.69 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 122.052 -0.405 . . . . 1.58 110.604 173.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 51.5 t -62.68 -55.12 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.971 -0.455 . . . . 1.84 110.106 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.7 mttt -48.47 -37.74 18.16 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.772 1.027 . . . . 2.59 113.772 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -54.0 -34.72 60.64 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.805 0.729 . . . . 3.3 112.717 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.9 mt -70.0 129.72 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.66 -0.867 . . . . 2.32 108.66 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -71.06 -11.11 60.78 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.906 -1.121 . . . . 2.58 113.472 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.24 -21.95 61.68 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.873 0.749 . . . . 1.55 112.397 -177.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -111.65 152.67 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 O-C-N 121.365 -1.08 . . . . 1.76 109.143 -175.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.8 m -106.72 -56.51 2.18 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.208 1.403 . . . . 1.88 107.848 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -125.49 161.33 27.36 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.374 0.607 . . . . 2.36 112.323 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.16 139.91 20.78 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.729 -1.212 . . . . 1.92 107.729 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.0 mt -133.01 106.38 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 106.065 -1.828 . . . . 2.37 106.065 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.2 m -120.76 118.59 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 122.79 0.436 . . . . 3.21 109.937 -162.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -99.13 -49.34 4.53 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 122.425 -0.172 . . . . 3.12 110.778 -167.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 58.46 -162.77 0.22 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.443 0.697 . . . . 3.76 112.094 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.12 -69.91 2.65 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 110.084 -1.206 . . . . 3.06 110.084 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.2 61.57 0.1 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.312 -1.736 . . . . 3.06 106.312 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.1 m -155.06 -125.03 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 O-C-N 122.052 -0.405 . . . . 2.65 111.135 -171.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -158.64 165.59 34.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.61 -0.681 . . . . 4.33 109.933 -158.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.1 tt -129.38 104.8 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 126.084 1.754 . . . . 4.15 108.171 -174.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.7 m -84.81 139.5 31.88 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.673 -0.862 . . . . 1.79 108.673 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.2 t -134.35 138.63 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 104.556 -2.387 . . . . 2.3 104.556 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.3 m -147.91 133.8 19.09 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.111 -1.07 . . . . 1.86 108.111 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.79 -92.68 0.14 Allowed Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 107.398 -2.281 . . . . 0.72 107.398 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -165.88 51.97 0.09 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.996 1.718 . . . . 2.26 109.489 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.52 166.59 29.73 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 120.657 -1.277 . . . . 1.61 111.591 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.0 m -119.67 165.44 14.48 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.424 1.49 . . . . 1.27 111.155 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -46.88 -46.86 8.23 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 CA-C-O 117.214 -1.374 . . . . 3.98 110.725 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -29.87 -50.69 0.12 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.16 1.784 . . . . 3.46 114.052 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -65.02 -48.37 74.13 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 122.38 1.086 . . . . 2.51 110.827 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.6 t -61.34 -32.79 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.058 1.743 . . . . 1.84 110.93 174.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -60.45 -53.75 53.81 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 126.696 1.998 . . . . 3.27 107.176 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.59 -56.44 13.53 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.434 -0.803 . . . . 4.32 109.571 176.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.21 -51.48 25.15 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.247 0.619 . . . . 1.53 110.81 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.68 -16.06 28.76 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 124.297 0.951 . . . . 0.4 113.197 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.65 -21.67 1.69 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.481 1.14 . . . . 1.62 112.293 169.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -54.07 -35.99 62.65 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.001 1.273 . . . . 3.15 112.705 173.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -121.29 -7.59 9.28 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.651 1.18 . . . . 2.5 112.528 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 71.85 53.86 0.2 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.515 1.526 . . . . 0.99 111.09 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.75 164.42 25.26 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.225 -0.922 . . . . 2.49 111.181 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.66 112.56 18.58 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.162 -1.792 . . . . 4.55 106.162 172.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 mt -113.58 143.51 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 106.735 -1.58 . . . . 1.88 106.735 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.9 mt -128.14 122.66 22.23 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 106.64 -1.615 . . . . 2.53 106.64 -173.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.53 111.76 2.19 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.665 1.577 . . . . 0.83 108.028 169.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -54.27 147.11 13.91 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.377 0.608 . . . . 4.4 110.71 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.9 tptp -152.46 136.77 16.65 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.321 -1.733 . . . . 4.97 106.321 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -140.04 98.02 3.36 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.081 -1.822 . . . . 7.84 106.081 164.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.37 0 C-N-CA 129.078 2.951 . . . . 9.51 104.652 -179.294 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.6 mtt . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 109.286 -0.635 . . . . 10.02 109.286 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.02 160.96 40.48 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.153 -1.425 . . . . 6.91 107.153 174.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -142.77 37.39 1.45 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.256 1.023 . . . . 6.67 110.908 -168.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -126.13 135.48 51.73 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.787 1.635 . . . . 5.28 109.231 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.8 m -148.36 154.27 39.73 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 107.668 -1.234 . . . . 1.53 107.668 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 p -135.6 142.24 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 123.616 0.573 . . . . 1.63 110.438 169.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -127.52 147.15 50.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.602 1.161 . . . . 3.03 107.905 -169.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -89.0 128.5 35.71 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.372 -0.973 . . . . 4.55 108.372 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.29 149.23 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.095 -1.076 . . . . 1.9 108.095 169.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -143.47 148.95 36.85 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.423 -0.584 . . . . 2.62 109.423 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.51 -58.37 0.62 Allowed Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.146 0.879 . . . . 1.55 111.586 166.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.86 172.08 8.27 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.309 0.643 . . . . 3.54 112.157 -176.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.2 t -163.8 77.63 0.39 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.692 0.397 . . . . 3.99 109.962 171.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.9 t -168.11 126.91 1.21 Allowed 'General case' 0 C--N 1.342 0.266 0 O-C-N 121.969 -0.457 . . . . 2.56 111.427 172.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.4 m -49.91 -42.09 47.44 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.475 1.11 . . . . 2.12 112.233 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -53.76 -40.92 66.62 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.648 -0.657 . . . . 4.63 111.451 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.44 -47.08 83.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.381 -0.6 . . . . 2.46 109.381 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.15 -42.81 77.56 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.802 0.441 . . . . 1.74 111.098 175.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.81 -49.39 73.08 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.401 0.62 . . . . 1.81 109.87 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.471 ' HZ2' ' CD ' ' A' ' 61' ' ' GLU . 31.8 ttpt -53.83 -48.41 69.94 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.415 -0.587 . . . . 5.32 109.415 175.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -53.94 -65.33 0.59 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.723 0.809 . . . . 4.18 111.899 176.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.94 -40.69 70.2 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.976 0.807 . . . . 2.87 110.828 -171.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -61.81 -48.87 78.67 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 110.201 -0.296 . . . . 4.4 110.201 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -57.36 -41.17 79.59 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.986 -0.446 . . . . 2.4 110.473 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -64.41 -46.02 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 O-C-N 121.809 -0.557 . . . . 1.74 110.782 175.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -57.06 -33.95 67.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.913 0.885 . . . . 2.79 112.054 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.25 -21.54 65.26 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.932 0.716 . . . . 2.65 112.932 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.5 mm -77.8 106.71 8.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 O-C-N 120.739 -1.226 . . . . 3.65 110.748 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -65.95 85.19 0.08 Allowed 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 125.71 1.604 . . . . 2.57 108.653 163.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.47 -40.37 0.08 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.459 -1.056 . . . . 1.98 110.459 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.9 p -97.14 156.65 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 108.347 -0.982 . . . . 1.97 108.347 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 55.0 m -105.4 -54.9 2.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.171 1.388 . . . . 1.61 107.69 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -126.29 134.9 51.01 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 109.552 -0.536 . . . . 2.42 109.552 170.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.11 126.27 40.82 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.972 -1.122 . . . . 1.87 107.972 170.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.0 mm -111.22 101.91 13.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.237 -1.394 . . . . 3.44 107.237 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.03 145.88 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 116.618 -0.265 . . . . 3.08 110.553 -175.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -140.2 51.89 1.68 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.429 -1.323 . . . . 2.85 107.429 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -60.36 123.2 16.57 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.566 0.746 . . . . 4.13 109.186 174.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.19 -60.47 0.38 Allowed Glycine 0 C--O 1.225 -0.455 0 N-CA-C 109.061 -1.616 . . . . 2.76 109.061 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.4 56.04 0.18 Allowed 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.874 -1.158 . . . . 2.86 107.874 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.63 -113.51 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.913 -0.492 . . . . 2.98 111.942 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.92 171.1 20.02 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.639 0.775 . . . . 5.02 110.063 -165.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.81 113.99 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 108.48 -0.934 . . . . 2.07 108.48 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 m -91.2 143.33 26.78 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 123.983 0.913 . . . . 1.58 109.976 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.18 133.75 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.842 2.057 . . . . 1.81 106.761 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.8 m -143.05 124.34 14.62 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 106.96 -1.496 . . . . 1.76 106.96 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.12 -93.07 0.11 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 118.663 -1.732 . . . . 0.69 109.172 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -166.66 53.76 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.454 1.102 . . . . 2.34 109.931 166.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.51 172.93 15.23 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.022 -1.048 . . . . 2.18 110.643 176.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.0 m -117.14 162.83 17.2 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.678 1.591 . . . . 1.14 111.154 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 tp -52.27 -32.17 15.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.719 0 CA-C-O 117.525 -1.226 . . . . 2.85 112.973 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -34.93 -47.22 0.34 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.387 1.075 . . . . 4.83 112.103 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -57.46 -51.66 68.55 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.405 1.098 . . . . 2.21 111.465 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.11 -42.18 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.681 1.592 . . . . 1.59 110.902 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -63.22 -43.77 97.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.84 0.856 . . . . 4.02 108.836 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -52.11 -54.88 25.03 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.813 -0.613 . . . . 4.07 109.62 171.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.41 -54.15 15.08 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.926 0.784 . . . . 1.7 110.162 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.96 -15.99 15.93 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 125.395 1.474 . . . . 0.33 114.442 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.0 -26.01 2.3 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.424 1.112 . . . . 1.89 111.534 167.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -51.03 -41.77 60.05 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.111 0.869 . . . . 3.52 112.857 173.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.471 ' CD ' ' HZ2' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -115.35 -3.67 12.43 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.164 0.986 . . . . 4.3 111.216 179.142 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 73.85 49.83 0.12 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.846 1.659 . . . . 1.07 110.835 175.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -74.47 166.81 22.89 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.641 -0.662 . . . . 2.52 111.311 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.62 122.5 33.27 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.652 -1.61 . . . . 5.13 106.652 171.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 mt -122.98 108.2 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.363 0.665 . . . . 1.87 110.079 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 91.7 mt -94.12 130.79 33.17 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.436 0.694 . . . . 2.39 109.315 -172.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.01 91.8 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.387 2.058 . . . . 0.64 109.008 168.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.48 154.11 1.39 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.409 0.684 . . . . 4.42 109.987 168.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.86 130.8 16.2 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.877 -0.786 . . . . 7.86 108.877 -176.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -59.19 146.68 38.17 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.529 0.68 . . . . 7.8 110.892 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 N-CA-C 105.773 -1.936 . . . . 9.4 105.773 -176.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 mtt . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 107.735 -1.209 . . . . 10.05 107.735 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.97 155.92 3.19 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.536 -1.653 . . . . 5.74 106.536 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -160.35 170.79 20.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.247 1.419 . . . . 5.0 108.461 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.41 160.65 20.56 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.306 -0.628 . . . . 5.99 109.306 171.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.5 m -149.08 146.25 27.63 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 106.212 -1.773 . . . . 2.16 106.212 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.15 140.16 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 124.226 0.954 . . . . 1.71 110.847 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -128.67 148.86 50.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.774 1.23 . . . . 3.38 107.92 -172.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -88.02 122.73 31.95 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.815 -0.809 . . . . 5.22 108.815 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 p -109.81 140.05 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 124.386 1.074 . . . . 1.84 108.332 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -138.82 157.59 45.79 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.878 -1.156 . . . . 2.74 107.878 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 120.97 -77.37 0.32 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.925 1.25 . . . . 1.66 110.614 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.3 177.63 7.11 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.549 0.69 . . . . 3.72 111.486 -175.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.6 t -161.59 -43.91 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.994 0.918 . . . . 4.65 110.401 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.3 t -50.97 126.23 15.65 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.351 1.06 . . . . 2.81 113.301 -168.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 m -45.32 -44.64 11.73 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.237 1.815 . . . . 2.62 112.914 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -54.37 -48.12 71.85 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.63 0.729 . . . . 3.92 111.016 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.06 -43.18 88.17 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 123.474 0.71 . . . . 2.22 109.367 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.55 -49.31 70.64 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.335 0.254 . . . . 2.11 110.958 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.37 -52.95 63.45 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.523 1.129 . . . . 1.96 109.651 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -48.94 -49.5 39.99 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.888 -0.412 . . . . 3.27 109.888 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.8 -64.18 0.96 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 112.69 0.626 . . . . 3.76 112.69 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -55.82 -44.58 78.04 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.83 0.741 . . . . 3.03 109.552 -172.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -57.03 -53.02 62.82 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.874 -0.417 . . . . 5.41 109.874 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -48.16 -48.65 34.24 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.303 -0.628 . . . . 1.52 109.303 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.6 t -60.99 -47.0 95.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 117.915 0.325 . . . . 1.65 110.789 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -36.52 63.87 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.017 0.527 . . . . 3.43 111.765 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -70.84 -9.91 58.53 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 119.109 0.868 . . . . 1.98 113.161 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.1 mm -83.72 128.91 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 120.539 1.518 . . . . 3.8 109.812 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.44 -28.83 61.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.412 1.485 . . . . 2.44 113.411 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.54 -16.03 64.8 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 123.983 0.801 . . . . 1.76 113.685 -174.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.8 p -118.8 153.47 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.928 1.291 . . . . 2.16 109.232 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 93.0 m -93.95 -51.1 5.02 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.723 -0.843 . . . . 1.59 108.723 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -135.47 160.23 39.13 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.057 0.456 . . . . 2.64 110.517 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -154.08 140.33 18.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.078 -1.082 . . . . 1.74 108.078 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.6 mt -127.59 118.98 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 105.73 -1.952 . . . . 2.16 105.73 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 m -105.56 133.76 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.767 -0.827 . . . . 3.09 108.767 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -90.89 -59.05 2.27 Favored 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 108.286 -1.005 . . . . 3.58 108.286 167.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 56.97 -168.77 0.11 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.03 0.932 . . . . 4.05 111.15 -165.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.92 38.01 94.72 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.537 -0.625 . . . . 2.65 111.537 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 76.84 69.23 0.06 Allowed 'General case' 0 C--N 1.338 0.094 0 C-N-CA 126.735 2.014 . . . . 3.37 109.152 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 m -157.42 -120.48 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.387 1.075 . . . . 2.8 108.435 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.52 174.82 14.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.911 0.778 . . . . 5.03 111.522 -174.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.4 118.98 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.168 1.787 . . . . 1.97 107.764 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.8 m -97.03 138.11 35.07 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.61 1.164 . . . . 1.56 109.58 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.0 t -118.24 143.66 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 127.871 2.468 . . . . 1.96 105.823 171.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.1 m -146.32 88.25 1.78 Allowed 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 125.111 1.364 . . . . 1.85 107.547 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.37 -113.12 0.27 Allowed Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 108.638 -1.785 . . . . 0.9 108.638 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -155.94 48.45 0.5 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.932 -0.766 . . . . 2.99 108.932 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -155.61 177.68 11.11 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.792 -0.567 . . . . 2.39 110.234 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.4 m -114.27 169.81 8.75 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.235 1.414 . . . . 1.27 111.274 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.6 tp -53.92 -33.07 23.17 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 CA-C-O 117.685 -1.15 . . . . 2.66 111.728 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -35.37 -48.59 0.48 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.538 1.063 . . . . 3.73 112.48 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -61.13 -50.27 73.88 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.301 0.572 . . . . 3.21 112.287 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.6 t -58.34 -44.91 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 125.127 1.371 . . . . 1.68 110.536 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -67.27 -41.84 84.84 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.111 0.964 . . . . 3.53 110.112 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -54.42 -51.57 64.5 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.062 -0.718 . . . . 3.91 109.062 171.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.05 -48.36 44.01 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.005 -0.434 . . . . 1.48 110.785 170.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.93 -9.79 16.03 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.064 1.316 . . . . 0.37 114.795 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.58 -21.63 10.92 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.232 1.516 . . . . 1.66 112.122 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -56.69 -33.28 66.29 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.414 1.006 . . . . 3.35 112.854 172.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.06 -12.31 9.13 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.862 1.265 . . . . 2.51 112.683 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 72.26 62.29 0.13 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.571 1.148 . . . . 0.82 110.369 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.3 174.21 11.48 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.489 -0.757 . . . . 2.26 110.458 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.22 68.34 1.3 Allowed 'General case' 0 C--N 1.34 0.162 0 N-CA-C 106.935 -1.505 . . . . 5.71 106.935 -169.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.8 mt -84.82 107.18 15.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 113.922 -1.49 . . . . 1.62 110.138 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.4 mt -92.7 129.19 41.14 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 108.98 -0.748 . . . . 2.34 108.98 -172.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.07 100.9 0.66 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.397 2.065 . . . . 0.73 109.797 172.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -46.87 -49.97 19.4 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.609 0.364 . . . . 3.31 111.293 169.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.83 83.17 0.16 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.684 0.794 . . . . 5.74 109.455 175.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 82.23 -175.69 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.691 2.396 . . . . 7.73 108.943 -169.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.26 0 CA-C-O 115.816 -2.04 . . . . 10.07 105.991 -174.371 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.0 mtt . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 117.565 -1.207 . . . . 10.43 110.295 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -34.47 -68.13 0.12 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.104 1.362 . . . . 6.27 112.675 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.45 141.78 9.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.859 -1.163 . . . . 6.44 107.859 163.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.37 119.0 3.35 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.997 2.119 . . . . 5.51 107.31 174.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.0 m -151.55 156.12 39.87 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.315 -1.365 . . . . 2.1 107.315 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.01 139.81 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 O-C-N 124.593 1.183 . . . . 1.73 111.545 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -127.43 143.22 51.24 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.713 1.605 . . . . 3.62 107.691 -163.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.33 140.73 31.41 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 118.876 0.762 . . . . 4.26 109.279 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.89 137.33 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 123.822 0.849 . . . . 2.05 109.106 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -140.77 152.11 44.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.03 1.332 . . . . 2.72 107.74 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.02 -56.68 0.73 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 125.225 1.393 . . . . 1.44 110.409 164.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.72 157.71 17.21 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.103 0.561 . . . . 3.39 111.456 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 t -161.55 73.56 0.44 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.319 -0.622 . . . . 3.4 109.319 174.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -169.39 134.05 1.43 Allowed 'General case' 0 C--N 1.338 0.099 0 O-C-N 121.62 -0.675 . . . . 3.1 110.734 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 m -59.84 -43.07 94.79 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.313 0.645 . . . . 2.32 111.147 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -58.44 -48.59 80.22 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.791 -0.568 . . . . 2.9 110.17 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.0 m -57.32 -48.05 79.98 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.625 -0.509 . . . . 2.2 109.625 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.46 -50.41 65.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.736 0.414 . . . . 2.06 111.007 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.31 -52.34 66.02 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.154 0.981 . . . . 1.73 109.64 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -54.93 -44.65 74.45 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 119.881 -0.727 . . . . 4.75 110.669 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.36 -63.24 1.21 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.12 0.568 . . . . 3.63 110.131 177.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.86 -40.01 87.17 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.835 0.35 . . . . 2.58 110.612 -171.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -49.52 72.92 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.896 0.878 . . . . 3.87 109.647 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -51.64 -48.44 63.34 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.14 0.576 . . . . 2.35 109.587 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.6 t -60.15 -48.38 88.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 O-C-N 122.179 -0.326 . . . . 1.72 110.628 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -55.04 -34.78 63.83 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.594 -0.691 . . . . 3.01 112.539 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -70.9 -8.79 55.39 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.47 0.915 . . . . 2.12 113.47 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.5 mm -70.86 140.19 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 120.282 1.401 . . . . 3.52 109.768 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -89.74 139.96 30.05 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 125.373 1.469 . . . . 2.73 109.172 171.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.34 -46.54 1.16 Allowed Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.327 1.442 . . . . 2.77 110.601 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.3 p -64.33 158.54 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 122.386 -0.479 . . . . 2.11 110.062 174.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.8 m -108.34 -60.2 1.76 Allowed 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 107.996 -1.113 . . . . 2.56 107.996 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -127.78 161.8 28.13 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.659 0.614 . . . . 2.21 112.659 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.65 141.58 21.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.431 -0.951 . . . . 2.0 108.431 166.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.8 mt -127.96 104.57 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 106.433 -1.692 . . . . 2.39 106.433 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.44 122.1 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.704 -1.221 . . . . 2.94 107.704 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -122.11 102.63 8.27 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 105.9 -1.889 . . . . 3.14 105.9 175.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -100.51 -161.47 0.87 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.092 0.557 . . . . 4.02 110.992 -174.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.02 -61.47 4.34 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.825 -1.31 . . . . 2.4 109.825 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.35 61.9 0.22 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.961 0.905 . . . . 3.32 108.701 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.4 m -155.58 -129.21 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.836 -0.54 . . . . 3.32 111.582 -175.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt -162.45 153.96 18.14 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.03 1.332 . . . . 4.82 111.269 -165.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.64 117.9 52.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.712 1.205 . . . . 1.8 109.23 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.4 m -91.3 141.17 29.07 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 124.599 1.16 . . . . 1.66 109.338 173.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 t -122.23 145.83 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.439 -1.689 . . . . 1.84 106.439 166.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.2 m -145.89 138.67 25.75 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.265 -1.383 . . . . 1.57 107.265 175.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.94 -91.98 0.18 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 108.224 -1.95 . . . . 0.85 108.224 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -170.75 58.34 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.276 1.83 . . . . 2.2 109.737 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.73 162.44 41.26 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.165 -0.96 . . . . 1.49 111.4 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 61.8 m -109.76 168.01 9.73 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.43 1.892 . . . . 1.15 110.09 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.7 tp -52.06 -35.53 18.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 CA-C-O 117.083 -1.437 . . . . 2.51 111.736 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -28.37 -52.67 0.09 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.53 1.532 . . . . 3.2 112.661 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -61.85 -46.01 91.32 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.789 0.804 . . . . 2.17 111.484 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.1 t -70.15 -37.45 71.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.157 1.383 . . . . 1.65 110.913 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -48.6 80.86 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.525 1.53 . . . . 3.3 108.452 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -51.07 -47.94 61.71 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.75 0.42 . . . . 4.8 110.752 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.64 -51.18 71.02 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.424 0.556 . . . . 1.99 110.771 173.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.84 -26.23 25.3 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 126.54 2.019 . . . . 0.7 112.308 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -44.31 -31.77 1.12 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.276 1.038 . . . . 1.9 112.469 170.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -53.72 -32.37 51.76 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.681 1.128 . . . . 3.49 113.63 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.49 0.56 6.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.177 1.391 . . . . 2.6 112.168 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 60.21 57.17 3.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.508 1.523 . . . . 1.55 111.896 177.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.83 160.65 20.16 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 121.46 -0.775 . . . . 2.58 112.118 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 72.43 0.82 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.998 -1.112 . . . . 4.39 107.998 -169.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -82.23 119.7 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.189 -0.671 . . . . 1.94 109.189 -175.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.9 mm -98.3 112.28 61.78 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 125.0 1.32 . . . . 2.71 108.7 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -73.44 83.14 1.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.017 1.811 . . . . 1.72 110.488 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -48.09 133.41 15.06 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.522 1.529 . . . . 3.2 110.62 173.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? 76.74 70.89 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.038 1.335 . . . . 6.63 111.384 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.58 124.32 46.09 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.808 1.643 . . . . 13.34 106.992 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.152 0 C-N-CA 126.801 2.041 . . . . 11.8 107.583 -177.723 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 109.657 -0.497 . . . . 11.66 109.657 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.95 152.36 11.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.266 -1.753 . . . . 6.93 106.266 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -86.18 50.78 2.05 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.667 1.187 . . . . 4.71 110.248 -163.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.69 134.8 54.51 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.544 1.937 . . . . 5.58 107.787 174.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.7 m -146.74 154.66 41.66 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.032 -1.47 . . . . 1.86 107.032 172.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.02 142.69 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 O-C-N 123.999 0.812 . . . . 1.88 110.151 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -127.67 140.45 52.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.732 -1.581 . . . . 3.16 106.732 -172.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.3 ttt-85 -84.62 126.34 33.26 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.735 -1.209 . . . . 6.41 107.735 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 p -111.39 146.4 16.41 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 107.356 -1.35 . . . . 1.67 107.356 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.02 171.96 14.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.335 0.397 . . . . 2.31 111.546 -176.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.26 56.77 21.77 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.379 -0.828 . . . . 2.26 112.418 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 pp -163.07 166.47 23.54 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.602 1.561 . . . . 3.8 107.854 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.3 p -174.76 66.11 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.091 0.557 . . . . 3.21 109.951 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.6 t -156.71 124.63 5.54 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.334 0.515 . . . . 3.38 111.436 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -58.29 -43.9 88.26 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.007 0.923 . . . . 2.21 111.727 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -57.42 -44.83 84.94 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.748 0.704 . . . . 2.62 110.533 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.6 m -61.27 -45.94 92.44 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.943 -0.391 . . . . 2.11 109.943 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.22 -47.02 72.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.717 0.407 . . . . 1.72 110.954 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.68 -51.3 69.0 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.533 1.133 . . . . 1.78 109.469 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -52.9 -45.17 67.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.883 -0.599 . . . . 3.73 109.603 174.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.59 -63.39 1.21 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.184 -0.436 . . . . 4.0 110.846 176.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -60.51 -38.02 83.01 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.314 0.961 . . . . 2.35 111.527 -172.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.3 ttt85 -61.3 -49.62 76.28 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.122 -0.325 . . . . 4.86 110.122 175.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -51.42 -50.58 59.41 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.266 -0.642 . . . . 1.72 109.266 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.4 t -56.83 -50.11 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 O-C-N 121.972 -0.455 . . . . 1.71 110.982 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -53.19 -34.69 58.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.449 1.099 . . . . 2.62 112.01 175.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -68.69 -16.55 63.86 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.178 0.899 . . . . 2.19 113.397 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.2 mt -77.28 111.21 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 120.036 1.289 . . . . 2.47 109.865 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -50.49 -31.39 15.22 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.187 2.195 . . . . 2.89 113.448 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.16 -25.05 74.68 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.286 0.946 . . . . 1.55 113.629 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -96.64 162.82 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 119.027 1.414 . . . . 2.15 110.723 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.1 m -110.43 -56.71 2.31 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.763 -1.199 . . . . 1.96 107.763 171.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -137.19 164.7 27.87 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.82 -0.437 . . . . 2.13 109.82 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -154.72 137.31 15.14 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.828 -1.175 . . . . 1.89 107.828 172.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.4 mm -112.6 101.55 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.035 -1.098 . . . . 3.15 108.035 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.69 120.87 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 108.681 -0.859 . . . . 3.73 108.681 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -117.09 97.22 5.82 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.901 -1.148 . . . . 2.77 107.901 171.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -82.15 -166.49 1.26 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.362 1.465 . . . . 4.87 110.93 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.64 -65.44 4.11 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.174 -1.57 . . . . 2.35 109.174 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -171.97 72.53 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.11 0.964 . . . . 2.75 108.41 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.3 m -156.74 -121.65 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 O-C-N 122.002 -0.436 . . . . 2.89 110.676 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -161.51 164.68 29.46 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.986 0.914 . . . . 4.93 110.056 -164.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.66 112.4 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.097 1.359 . . . . 1.93 108.089 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.7 m -88.25 147.7 24.7 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 123.746 0.819 . . . . 1.59 109.735 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.9 t -132.61 137.29 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 127.586 2.355 . . . . 2.3 105.729 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.3 m -145.89 101.17 3.51 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.798 -1.186 . . . . 1.74 107.798 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 178.77 -102.38 0.17 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 118.11 -1.995 . . . . 0.6 110.023 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -163.03 44.8 0.12 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.44 1.496 . . . . 2.44 108.278 172.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.03 169.62 17.31 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.329 1.052 . . . . 1.73 109.965 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.0 m -131.44 169.95 15.34 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.672 1.189 . . . . 1.43 110.066 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 tp -61.19 -30.59 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-O 117.363 -1.303 . . . . 2.64 112.727 -174.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -37.32 -52.76 1.1 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.892 1.223 . . . . 3.7 111.928 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -59.47 -46.77 87.82 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.742 0.645 . . . . 3.8 112.742 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.8 t -63.06 -42.72 97.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 123.694 0.797 . . . . 1.7 110.206 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.85 -52.75 64.09 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 127.154 2.182 . . . . 3.07 108.729 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -51.19 -52.36 45.07 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.622 -0.51 . . . . 3.59 109.622 173.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.43 74.8 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.803 -0.561 . . . . 1.7 110.721 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.0 -6.41 12.52 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.48 1.99 . . . . 0.5 113.867 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.37 -24.75 1.33 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.017 1.408 . . . . 1.9 112.071 171.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -54.52 -36.29 64.09 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.479 0.918 . . . . 3.52 113.479 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -121.92 -5.87 9.03 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.095 0.861 . . . . 2.35 113.088 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 68.55 58.0 0.42 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.24 1.016 . . . . 0.96 110.845 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.27 168.77 18.65 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.36 -0.838 . . . . 2.17 111.236 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.92 68.25 1.51 Allowed 'General case' 0 C--N 1.343 0.322 0 CA-C-O 122.239 1.019 . . . . 5.19 110.061 -170.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.4 mt -81.82 139.61 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.49 -0.777 . . . . 1.67 110.288 -172.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.5 mt -129.25 133.42 25.13 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.224 1.009 . . . . 2.51 109.942 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.59 87.6 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.408 2.739 . . . . 0.89 111.592 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -66.58 92.56 0.21 Allowed 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.337 1.055 . . . . 3.18 109.268 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -63.26 158.58 19.81 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.82 0.448 . . . . 6.65 110.325 165.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -116.5 132.74 56.6 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.898 1.679 . . . . 9.12 106.657 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.821 1.248 . . . . 8.95 111.102 -172.255 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 108.303 -0.999 . . . . 10.11 108.303 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.05 65.28 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.194 0.597 . . . . 7.26 110.009 -175.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -81.3 55.32 2.53 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.608 0.718 . . . . 4.64 111.625 -170.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.52 141.28 37.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.857 2.063 . . . . 4.33 108.155 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.0 m -150.55 140.59 22.03 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.077 -1.453 . . . . 2.28 107.077 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 p -127.47 140.92 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 124.195 0.934 . . . . 1.98 110.32 171.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -128.97 155.89 44.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.321 -1.363 . . . . 3.74 107.321 -174.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.0 ttt-85 -88.99 122.08 31.99 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.295 -0.859 . . . . 5.95 109.1 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.5 p -113.09 140.15 34.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 124.521 1.129 . . . . 1.82 108.033 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -153.28 164.81 37.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.853 -1.536 . . . . 3.47 106.853 -172.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.69 -54.6 0.54 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.467 1.032 . . . . 1.54 112.105 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.31 172.28 1.16 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.708 1.203 . . . . 3.81 113.142 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -168.44 67.62 0.07 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.723 -0.656 . . . . 3.43 111.498 170.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.1 t -160.03 133.69 7.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.817 1.19 . . . . 2.73 113.366 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 m -56.16 -49.88 72.73 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.342 1.457 . . . . 2.22 112.065 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -51.62 -45.14 63.14 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.661 0.744 . . . . 2.97 110.515 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.0 m -68.04 -37.9 81.87 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.001 -0.545 . . . . 1.84 110.567 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.42 -48.65 65.61 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.279 0.49 . . . . 1.93 110.605 170.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.48 -50.81 72.09 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.831 0.824 . . . . 1.76 109.193 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -53.67 -43.56 68.98 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.854 -0.612 . . . . 3.34 110.799 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -65.77 -60.65 2.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.643 0.377 . . . . 3.94 111.199 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.422 ' OE1' ' NZ ' ' A' ' 26' ' ' LYS . 1.8 pp20? -56.55 -41.42 76.81 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 118.818 0.736 . . . . 2.9 110.614 -175.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -60.01 -53.49 57.19 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 119.185 -0.436 . . . . 3.84 110.352 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -50.59 -46.73 58.06 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 118.672 0.669 . . . . 1.67 110.015 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.9 t -59.77 -49.15 84.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 109.713 -0.477 . . . . 1.88 109.713 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.422 ' NZ ' ' OE1' ' A' ' 22' ' ' GLU . 22.9 mttt -55.32 -36.36 66.15 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.547 -0.721 . . . . 2.46 112.643 175.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -72.35 -6.99 47.18 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.425 0.898 . . . . 1.89 113.425 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.3 141.92 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 120.46 1.482 . . . . 2.86 109.274 171.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -88.7 128.45 35.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.46 -1.311 . . . . 3.67 107.46 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.14 -39.26 2.95 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.264 0.935 . . . . 2.72 112.097 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 p -64.71 159.38 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 121.578 -0.954 . . . . 1.98 110.615 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.2 m -115.25 -61.86 1.68 Allowed 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.333 1.053 . . . . 1.93 108.208 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -122.44 154.21 38.08 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.288 0.367 . . . . 2.54 111.338 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.9 137.89 19.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.867 -0.52 . . . . 1.58 110.101 169.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.4 mt -128.59 91.02 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 106.766 -1.568 . . . . 2.75 106.766 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.99 103.39 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.742 -0.836 . . . . 3.76 108.742 -176.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -84.59 65.88 9.24 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 106.316 -1.735 . . . . 2.8 106.316 174.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.59 132.68 45.84 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.844 -0.799 . . . . 4.15 108.844 -177.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.16 -65.69 0.39 Allowed Glycine 0 C--O 1.226 -0.396 0 N-CA-C 107.853 -2.099 . . . . 2.84 107.853 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -175.64 69.36 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 125.081 1.352 . . . . 3.38 107.712 178.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.2 m -156.02 -103.95 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 O-C-N 121.767 -0.583 . . . . 2.76 111.19 -175.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 169.77 24.04 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.459 0.704 . . . . 6.8 110.944 -172.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.33 117.35 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 124.588 1.155 . . . . 1.91 108.141 176.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.7 m -97.07 134.67 40.12 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 123.545 0.738 . . . . 1.66 109.571 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.34 145.33 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 126.305 1.842 . . . . 2.24 106.673 168.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.6 m -146.81 136.72 23.29 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 106.625 -1.62 . . . . 1.62 106.625 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.05 -90.23 0.17 Allowed Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 109.343 -1.503 . . . . 0.74 109.343 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -173.17 55.72 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.321 1.448 . . . . 2.54 110.178 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.35 160.14 43.92 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.692 -1.255 . . . . 1.59 110.79 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.9 m -111.57 167.01 10.66 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.713 1.605 . . . . 1.3 110.315 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.3 tp -56.43 -30.2 30.45 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 CA-C-O 117.763 -1.113 . . . . 2.74 113.191 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -33.06 -53.8 0.37 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.615 1.166 . . . . 3.34 112.224 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -63.52 -47.73 80.48 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.655 0.74 . . . . 2.38 111.685 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.34 -45.36 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.008 0.923 . . . . 1.69 110.078 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.87 -51.63 69.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.663 1.985 . . . . 2.66 109.108 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -53.56 -44.33 69.19 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.597 0.359 . . . . 3.8 110.477 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.03 -54.99 40.74 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.16 0.505 . . . . 1.7 110.47 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.96 -17.19 9.05 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 126.957 2.218 . . . . 0.39 114.088 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -38.86 -35.79 0.23 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.944 0.872 . . . . 1.54 111.921 162.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -54.54 -31.52 56.55 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.723 1.008 . . . . 3.39 113.723 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -122.35 4.24 9.7 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.954 1.301 . . . . 2.46 111.921 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 58.69 53.98 5.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.694 1.198 . . . . 1.18 110.629 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -68.95 159.79 32.04 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.851 -0.531 . . . . 2.76 111.535 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.37 67.05 1.38 Allowed 'General case' 0 C--N 1.343 0.301 0 CA-C-O 121.42 0.628 . . . . 4.47 109.608 -172.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -81.56 140.28 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.069 -0.514 . . . . 1.64 109.888 -172.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 85.5 mt -127.66 132.35 24.29 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.164 0.986 . . . . 2.38 108.942 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.99 105.03 1.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.124 2.549 . . . . 0.88 110.033 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -58.58 -42.84 88.95 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.674 0.79 . . . . 3.36 111.001 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -147.18 169.25 19.72 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 105.273 -2.121 . . . . 7.01 105.273 168.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 27.38 89.16 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 128.235 2.614 . . . . 10.14 114.65 173.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.291 0 CA-C-O 117.186 -1.388 . . . . 14.96 112.35 178.848 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 109.081 -0.711 . . . . 16.37 109.081 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.93 -166.67 0.44 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.174 1.39 . . . . 9.25 107.305 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -146.45 -158.15 0.88 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.732 1.213 . . . . 4.77 108.08 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.61 153.21 22.54 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.199 0.599 . . . . 5.2 110.811 175.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.9 m -155.35 162.12 40.9 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.592 -1.262 . . . . 1.59 107.592 174.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.54 148.94 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 O-C-N 123.453 0.471 . . . . 1.68 111.531 164.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -135.56 143.49 45.7 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.069 1.348 . . . . 3.36 107.954 -170.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -91.57 126.93 36.83 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.576 0.625 . . . . 5.33 110.132 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.32 154.43 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 C-N-CA 123.929 0.892 . . . . 1.99 109.213 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -147.15 158.23 43.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.783 -0.821 . . . . 2.71 108.783 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.62 -56.82 0.68 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 125.16 1.362 . . . . 1.6 111.06 164.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.98 173.72 4.32 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.9 0.88 . . . . 3.48 112.483 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.3 p -162.82 63.01 0.2 Allowed 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.882 -0.511 . . . . 3.47 110.193 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.3 t -155.52 118.49 4.31 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.241 0.473 . . . . 2.09 111.709 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.1 t -52.87 -38.95 62.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.375 0.67 . . . . 3.6 111.354 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -56.23 -39.28 72.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.642 -0.661 . . . . 3.75 110.707 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.5 m -70.53 -39.9 73.78 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.786 -0.572 . . . . 2.2 110.373 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.05 -43.77 74.1 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.787 0.722 . . . . 1.86 110.764 171.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.74 -49.58 74.47 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.709 0.404 . . . . 1.67 110.344 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.4 tptt -49.76 -48.11 50.48 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.146 0.579 . . . . 3.73 109.668 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -56.08 -64.05 0.98 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.443 1.097 . . . . 4.09 111.148 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -56.33 -38.2 71.02 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.129 1.331 . . . . 2.64 111.85 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -63.61 -51.05 66.95 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.348 0.659 . . . . 3.5 111.38 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -53.96 -44.33 70.66 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.629 -0.669 . . . . 1.53 110.27 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.8 t -61.54 -48.14 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 122.777 0.431 . . . . 1.8 110.274 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -54.01 -34.92 61.2 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.801 0.84 . . . . 2.75 112.825 175.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -62.31 -23.95 67.03 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.763 0.711 . . . . 3.04 112.355 174.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.9 mt -70.81 131.69 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 O-C-N 120.963 -1.086 . . . . 2.38 108.777 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -75.75 -28.2 58.38 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.21 1.004 . . . . 3.01 112.722 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.74 -29.36 72.7 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.827 0.727 . . . . 1.58 113.013 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 p -89.59 166.95 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 118.633 1.217 . . . . 1.81 109.356 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.0 m -124.02 -61.25 1.38 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.825 -1.176 . . . . 1.84 107.825 173.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -129.17 111.12 12.6 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.195 -0.668 . . . . 2.68 109.195 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.22 131.96 49.85 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.147 -1.057 . . . . 1.75 108.147 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.7 mm -109.54 97.91 6.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.035 -1.839 . . . . 2.94 106.035 176.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -97.9 136.29 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 109.241 -0.651 . . . . 3.29 109.241 -175.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -111.41 -51.0 2.89 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.736 -0.838 . . . . 2.66 108.736 171.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 55.99 -161.98 0.17 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 110.316 -0.253 . . . . 3.66 110.316 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.08 -71.31 1.73 Allowed Glycine 0 C--N 1.339 0.746 0 O-C-N 121.184 -0.948 . . . . 2.89 111.037 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.78 55.79 0.31 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.303 -1.369 . . . . 3.01 107.303 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.0 m -155.75 -120.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.696 0.798 . . . . 2.96 109.871 -173.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -157.91 178.12 10.58 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.515 -0.741 . . . . 4.82 110.93 -167.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.4 111.94 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 125.466 1.506 . . . . 1.64 108.318 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.0 m -90.17 141.78 28.36 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 123.675 0.79 . . . . 1.98 109.168 171.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 69.2 t -120.95 130.15 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 127.115 2.166 . . . . 2.03 105.249 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.7 m -133.78 142.26 47.82 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 106.781 -1.563 . . . . 1.75 106.781 163.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.93 -102.54 0.23 Allowed Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 104.18 -3.568 . . . . 0.61 104.18 175.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -160.05 45.67 0.23 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.581 0.752 . . . . 3.1 110.983 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.07 176.21 9.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.003 0.921 . . . . 1.88 111.12 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.4 m -126.03 166.64 16.6 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.934 1.694 . . . . 1.47 110.757 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.52 -39.97 14.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-O 117.016 -1.469 . . . . 3.69 111.402 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -29.58 -53.5 0.14 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.419 1.488 . . . . 3.05 113.195 -177.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -66.03 -44.5 84.49 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.358 0.599 . . . . 2.21 112.282 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 t -58.4 -36.62 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.517 1.127 . . . . 1.63 110.895 171.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.35 -55.45 33.42 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 107.988 -1.116 . . . . 2.77 107.988 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.1 tp60 -52.31 -44.86 65.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.466 1.106 . . . . 4.66 110.509 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.4 -55.46 34.76 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.625 0.77 . . . . 1.83 111.049 171.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.2 -15.84 39.12 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 125.636 1.588 . . . . 0.33 113.41 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.96 -25.25 0.19 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.167 -0.92 . . . . 1.8 112.699 165.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -51.38 -40.32 58.98 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.914 1.234 . . . . 3.15 112.901 172.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -111.04 -13.07 14.13 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.31 1.044 . . . . 2.92 111.81 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 76.32 49.01 0.07 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.367 1.467 . . . . 0.88 110.095 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.32 159.83 28.47 Favored 'General case' 0 N--CA 1.462 0.142 0 O-C-N 121.648 -0.657 . . . . 2.51 111.804 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.02 112.71 17.49 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 106.477 -1.675 . . . . 5.28 106.477 174.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.56 130.86 71.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.528 -0.915 . . . . 1.88 108.528 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 49.0 mm -108.4 126.9 28.54 Favored Pre-proline 0 N--CA 1.452 -0.345 0 C-N-CA 125.07 1.348 . . . . 2.93 108.593 -174.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.67 97.69 0.73 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.641 2.227 . . . . 0.66 109.08 171.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -60.73 145.95 47.67 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 120.17 -0.612 . . . . 3.67 110.092 173.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.57 171.71 18.47 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 105.96 -1.867 . . . . 6.49 105.96 -170.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -154.54 -69.5 0.13 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.038 -1.467 . . . . 7.59 107.038 -170.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 N-CA-C 106.793 -1.558 . . . . 8.96 106.793 145.949 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 109.064 -0.717 . . . . 10.06 109.064 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.34 160.95 17.8 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.911 0.708 . . . . 7.42 112.911 -174.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.48 46.06 1.81 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.376 2.27 . . . . 6.61 109.508 -165.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -126.15 148.88 49.31 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.804 1.241 . . . . 4.03 109.974 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.2 m -148.28 150.07 32.99 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.367 -1.345 . . . . 1.49 107.367 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.82 140.18 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 O-C-N 123.901 0.751 . . . . 1.63 111.542 169.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -122.95 148.68 45.2 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.41 -1.7 . . . . 3.29 106.41 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.89 150.55 26.43 Favored 'General case' 0 N--CA 1.461 0.122 0 N-CA-C 108.31 -0.996 . . . . 7.64 108.31 173.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.67 146.78 23.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.478 0.711 . . . . 1.77 109.413 170.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.4 167.07 22.92 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.005 1.322 . . . . 2.42 107.923 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 120.44 -75.63 0.32 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.691 1.139 . . . . 1.65 111.156 173.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 pp -68.8 157.41 36.49 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-N 117.088 0.444 . . . . 3.87 109.855 -177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 p -146.83 62.15 1.2 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.29 0.636 . . . . 3.39 110.176 -176.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 t -160.03 123.08 3.48 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.715 0.635 . . . . 2.38 112.715 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.7 m -48.66 -45.0 38.2 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.672 1.189 . . . . 2.79 111.908 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -57.3 -36.65 71.33 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.755 -0.59 . . . . 3.18 111.24 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.5 m -70.15 -41.0 74.44 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 122.055 -0.403 . . . . 2.29 110.034 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.81 -47.74 73.66 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.01 0.368 . . . . 2.13 110.117 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.92 -52.34 65.88 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.756 0.822 . . . . 1.94 110.823 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -50.31 -52.3 37.89 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.105 0.962 . . . . 2.79 109.793 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -52.19 -62.1 1.85 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 118.571 -0.728 . . . . 4.07 111.571 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.55 -40.62 79.3 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.262 0.937 . . . . 2.66 110.975 -173.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.2 mtt180 -52.71 -56.01 18.57 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.774 0.716 . . . . 4.74 110.468 171.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -51.57 -43.38 62.42 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.355 0.597 . . . . 2.37 110.252 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.4 t -61.95 -50.08 81.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 C-N-CA 123.254 0.622 . . . . 1.77 111.141 175.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -57.75 -27.86 63.41 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.008 1.323 . . . . 3.2 112.318 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -68.36 -22.55 64.66 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.845 0.748 . . . . 2.21 112.825 171.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.7 mt -69.33 132.69 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.624 1.102 . . . . 2.49 108.13 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -74.32 -32.62 62.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.652 0.781 . . . . 2.76 112.446 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.15 -36.54 90.9 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.063 0.839 . . . . 1.55 112.435 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 p -86.31 159.1 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 O-C-N 121.115 -1.226 . . . . 1.86 109.937 -176.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -117.93 -57.34 2.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.858 1.263 . . . . 1.58 108.15 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -127.87 144.97 51.08 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.048 -0.661 . . . . 2.28 111.315 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.64 131.57 31.72 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.87 -0.789 . . . . 1.74 108.87 171.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mp -114.88 78.99 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 107.746 -1.205 . . . . 2.98 107.746 -173.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 m -84.08 136.51 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 115.636 -0.711 . . . . 3.15 110.821 -167.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -133.71 58.13 1.78 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.995 -1.854 . . . . 2.86 105.995 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -66.8 137.07 56.35 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.185 -1.043 . . . . 4.06 108.185 171.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.63 -54.59 0.47 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.589 -1.404 . . . . 3.0 109.589 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -175.72 53.39 0.01 OUTLIER 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.733 1.613 . . . . 2.98 107.136 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 m -157.31 -106.94 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.833 -0.542 . . . . 2.65 111.271 -173.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.59 172.51 18.43 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 112.831 0.678 . . . . 7.38 112.831 -161.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.31 112.43 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 106.776 -1.565 . . . . 1.65 106.776 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.8 m -92.78 135.94 33.67 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.221 -1.029 . . . . 1.68 108.221 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.53 142.31 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.237 1.815 . . . . 1.96 106.789 173.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.3 m -147.44 136.95 22.71 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 106.983 -1.488 . . . . 1.69 106.983 176.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.76 -94.75 0.16 Allowed Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 106.12 -2.792 . . . . 0.57 106.12 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -165.11 56.33 0.12 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.223 1.809 . . . . 2.5 108.984 173.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.09 170.6 15.64 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.072 -1.017 . . . . 1.73 110.945 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.2 m -129.62 160.66 32.62 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.387 1.475 . . . . 1.32 110.319 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 tp -53.41 -33.71 21.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 CA-C-O 117.299 -1.334 . . . . 2.73 113.059 -172.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -35.07 -48.15 0.41 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.826 1.194 . . . . 5.17 112.089 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -62.38 -49.74 74.33 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.169 0.985 . . . . 2.42 111.223 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.22 -38.52 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.884 1.274 . . . . 1.59 110.581 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -67.41 -46.64 72.61 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.833 1.653 . . . . 2.96 108.329 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -51.87 -52.6 48.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.798 0.439 . . . . 4.35 109.93 172.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.85 -51.31 52.63 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.508 0.595 . . . . 1.75 110.872 170.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.54 -13.9 18.9 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 125.373 1.464 . . . . 0.32 113.911 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.68 -25.92 1.36 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.751 1.275 . . . . 1.72 111.813 168.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -51.81 -31.43 27.33 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.478 1.036 . . . . 3.45 113.322 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -133.98 -6.25 2.74 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.802 1.038 . . . . 2.72 113.802 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 74.03 60.02 0.08 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.354 1.462 . . . . 0.82 111.106 173.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.98 161.86 25.23 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.701 -0.625 . . . . 2.69 110.466 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.67 72.31 1.33 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 107.508 -1.293 . . . . 5.33 107.508 -170.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 mt -82.24 135.49 24.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.2 -1.363 . . . . 1.85 109.247 -172.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 38.8 mm -124.89 127.41 25.12 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 123.629 0.771 . . . . 3.5 110.268 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.23 103.3 1.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.912 2.408 . . . . 0.65 110.108 174.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -55.49 -55.52 30.84 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.812 1.645 . . . . 4.82 110.5 170.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -72.77 113.06 9.39 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.169 -0.678 . . . . 8.57 109.169 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -115.12 -55.09 2.5 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.476 1.511 . . . . 11.37 108.19 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 N-CA-C 106.218 -1.771 . . . . 9.84 106.218 168.276 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ttt . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 108.416 -0.957 . . . . 11.2 108.416 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.77 59.17 3.31 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.819 0.848 . . . . 7.25 110.666 -170.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -141.62 177.38 8.19 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.565 1.546 . . . . 5.26 109.531 -173.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.44 158.06 24.71 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.447 1.099 . . . . 4.63 109.996 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.8 m -155.58 162.02 40.73 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.551 -0.907 . . . . 1.61 108.551 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.62 142.47 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 O-C-N 123.535 0.522 . . . . 1.81 110.962 165.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -126.88 154.57 44.25 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.217 1.407 . . . . 3.22 108.665 -171.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -92.02 114.63 27.23 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 118.574 -0.726 . . . . 4.72 109.209 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 p -100.63 137.08 29.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.797 0.839 . . . . 1.76 109.025 174.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.64 156.4 46.86 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.322 -0.992 . . . . 2.4 108.322 171.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 133.2 -74.71 0.43 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.386 -1.485 . . . . 1.39 109.386 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.64 171.14 9.88 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.007 0.743 . . . . 3.6 113.007 -174.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.3 m -158.22 83.08 0.85 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.263 1.425 . . . . 4.38 109.649 175.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.4 t -158.25 137.6 11.75 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.055 0.843 . . . . 2.61 112.158 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.3 m -61.19 -47.05 87.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.03 0.932 . . . . 2.49 111.305 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -60.15 -40.35 89.54 Favored 'General case' 0 C--O 1.233 0.196 0 O-C-N 121.164 -0.96 . . . . 2.8 110.265 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.1 m -60.77 -44.72 96.4 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.019 -0.426 . . . . 1.86 109.999 173.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.78 -46.72 71.11 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.404 0.282 . . . . 1.91 110.493 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.14 -50.55 72.45 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.952 0.501 . . . . 1.77 109.915 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.22 -50.07 40.07 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.235 0.614 . . . . 3.31 109.996 174.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -64.2 -57.58 9.08 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.081 0.552 . . . . 3.89 110.513 -173.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -59.05 -41.13 87.14 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.866 -0.733 . . . . 2.13 110.142 -176.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -61.87 -50.01 73.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.994 -0.527 . . . . 4.58 109.897 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -48.22 -50.58 28.89 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.614 -0.513 . . . . 2.27 109.614 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.7 t -57.74 -52.15 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 110.395 -0.224 . . . . 1.64 110.395 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -49.35 -39.74 32.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.503 1.121 . . . . 3.39 111.605 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -67.49 -19.96 65.4 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.872 0.693 . . . . 2.08 112.872 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.9 mt -76.12 122.22 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 119.857 1.208 . . . . 2.5 109.552 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -66.52 -18.67 65.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.745 1.218 . . . . 2.67 113.648 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.45 -34.2 68.17 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 123.51 0.576 . . . . 1.65 111.978 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.92 -173.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 O-C-N 121.799 -0.824 . . . . 2.07 110.542 -172.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.0 m -132.93 -62.0 0.82 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.834 -1.172 . . . . 1.85 107.834 170.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -120.64 164.48 16.45 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.076 0.465 . . . . 4.14 111.982 175.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.25 136.56 10.9 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.987 -1.006 . . . . 1.73 109.898 168.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mp -119.78 101.36 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 O-C-N 124.686 1.241 . . . . 2.99 107.812 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.5 p -84.96 137.16 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.588 0.755 . . . . 3.59 109.792 175.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -89.0 -59.77 2.14 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.838 0.745 . . . . 2.9 109.747 165.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 58.56 -177.37 0.08 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.076 0.95 . . . . 3.69 110.73 -162.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.18 36.41 79.72 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.162 -0.775 . . . . 2.37 111.162 -174.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 69.75 74.09 0.23 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.632 1.573 . . . . 3.6 108.455 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.3 m -155.2 -114.11 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.87 -0.604 . . . . 2.69 110.174 -172.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -158.51 165.8 33.7 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.619 0.768 . . . . 4.02 111.103 -173.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.45 119.11 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.63 1.172 . . . . 2.01 109.848 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.7 m -94.13 145.79 24.44 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.558 1.143 . . . . 1.89 111.098 175.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.41 ' C ' ' HG1' ' A' ' 46' ' ' THR . 90.0 t -131.75 134.22 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 127.557 2.343 . . . . 2.28 105.871 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.41 ' HG1' ' C ' ' A' ' 45' ' ' VAL . 82.1 m -145.71 75.46 1.43 Allowed 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 120.707 -1.245 . . . . 2.29 108.461 -173.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -157.92 -117.31 0.51 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 108.065 -2.014 . . . . 1.28 108.065 173.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.02 59.08 1.3 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.769 1.227 . . . . 4.31 108.185 177.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.73 162.02 41.07 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.686 -0.634 . . . . 1.5 110.063 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.9 m -110.92 161.43 15.85 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.343 1.457 . . . . 1.78 110.339 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.1 tp -51.21 -36.52 16.79 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 117.732 -1.128 . . . . 2.92 113.154 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -35.52 -47.37 0.45 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.685 1.194 . . . . 4.31 113.393 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -67.49 -39.73 85.21 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.361 -0.837 . . . . 2.35 111.659 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.7 t -68.05 -44.01 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.202 1.001 . . . . 1.56 109.524 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -53.37 -48.65 68.4 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.107 2.163 . . . . 2.8 109.163 174.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -52.9 -52.22 58.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.637 0.775 . . . . 4.14 110.605 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.29 -49.23 70.1 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.098 0.863 . . . . 1.74 110.666 172.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.78 -13.6 4.54 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.131 1.348 . . . . 0.46 113.957 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.69 -32.75 1.06 Allowed 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.545 1.173 . . . . 1.68 111.565 165.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -49.18 -37.01 21.1 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.656 0.984 . . . . 3.2 113.656 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -125.43 12.09 8.08 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.217 1.007 . . . . 2.84 111.127 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 60.77 47.91 7.52 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.805 1.242 . . . . 1.2 110.467 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 mp -65.15 153.04 42.06 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.524 -0.307 . . . . 3.62 110.764 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.65 108.65 11.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.612 -1.996 . . . . 4.59 105.612 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mt -112.55 126.29 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.481 -0.933 . . . . 1.87 108.481 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 mp -104.56 131.16 22.11 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 108.133 -1.062 . . . . 2.53 108.133 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.33 105.02 0.81 Allowed 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.783 1.656 . . . . 0.78 107.875 165.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -52.74 157.74 1.53 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.288 0.566 . . . . 4.41 111.195 171.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.4 tptt -71.65 148.8 46.17 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.161 -0.616 . . . . 7.18 110.114 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.56 79.62 0.27 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.938 0.895 . . . . 9.01 110.459 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.202 0 C-N-CA 126.875 2.07 . . . . 8.63 111.463 -179.324 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 ttt . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 106.346 -1.724 . . . . 13.23 106.346 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.23 153.93 42.86 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.417 1.008 . . . . 6.7 110.562 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -71.17 106.59 3.83 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.642 -0.873 . . . . 5.88 108.642 177.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 136.32 40.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.798 1.239 . . . . 4.65 108.799 175.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.0 m -149.48 154.41 38.76 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 107.804 -1.184 . . . . 1.55 107.804 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.34 140.07 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 O-C-N 124.431 1.082 . . . . 1.8 109.905 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -129.41 136.93 50.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.23 -1.396 . . . . 3.32 107.23 -167.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -84.56 133.11 34.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 118.189 -0.91 . . . . 5.53 109.384 -174.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -120.54 145.53 26.8 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 C-N-CA 124.63 1.172 . . . . 1.83 109.842 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -139.42 150.76 45.63 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.899 -1.519 . . . . 2.4 106.899 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.76 -71.11 0.42 Allowed Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.471 1.034 . . . . 1.41 110.729 168.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.98 165.92 8.24 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.265 1.026 . . . . 3.17 112.106 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.2 p -161.62 64.91 0.26 Allowed 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.875 -0.516 . . . . 3.33 110.055 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.6 t -159.34 134.59 8.3 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 110.047 -0.353 . . . . 2.75 110.047 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.7 p -53.34 -48.13 68.75 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.12 0.968 . . . . 3.18 109.89 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -43.4 -51.11 6.67 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.302 1.041 . . . . 3.03 111.772 173.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.4 m -64.06 -45.63 87.94 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 109.988 -0.375 . . . . 2.18 109.988 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -46.97 73.22 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.567 0.222 . . . . 1.56 111.401 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.45 -48.98 78.65 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.326 1.05 . . . . 1.86 109.86 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -53.77 -48.19 69.99 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.724 -0.473 . . . . 5.41 109.724 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.76 -59.81 4.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.695 0.798 . . . . 3.64 111.573 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -56.88 -41.22 77.64 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 119.347 -0.941 . . . . 2.73 109.961 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -60.04 -48.43 81.76 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 119.275 -0.393 . . . . 3.81 110.165 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -49.06 -51.77 29.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.072 0.397 . . . . 1.71 110.001 172.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.2 t -59.11 -48.04 88.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 O-C-N 122.027 -0.421 . . . . 1.55 110.76 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -54.47 -37.06 64.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.739 1.215 . . . . 2.33 112.086 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -65.31 -18.54 65.39 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.895 0.77 . . . . 2.09 112.963 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.1 mt -76.88 115.92 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 119.79 1.177 . . . . 2.32 109.538 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -77.68 60.76 2.26 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.595 1.958 . . . . 3.92 110.097 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -154.15 -36.72 0.03 OUTLIER Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.205 1.859 . . . . 1.79 111.965 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.94 172.31 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 121.46 -1.024 . . . . 2.11 109.124 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.2 m -121.58 -60.71 1.59 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.682 1.193 . . . . 2.02 108.032 171.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -122.89 134.33 54.38 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 109.887 -0.412 . . . . 2.1 109.887 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.19 126.09 42.21 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.149 -1.056 . . . . 1.56 108.149 171.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.19 95.07 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 105.408 -2.071 . . . . 3.38 105.408 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -91.79 141.38 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 120.398 -0.521 . . . . 3.17 109.856 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -127.5 46.23 2.58 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.951 -1.129 . . . . 2.54 107.951 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -54.06 122.94 11.22 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.12 0.568 . . . . 4.18 109.5 173.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.69 -55.9 0.43 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.401 -1.48 . . . . 2.61 109.401 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.98 34.66 0.1 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.73 0.412 . . . . 2.95 111.467 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.9 m -146.63 -111.38 0.09 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.562 0.345 . . . . 3.65 111.823 -170.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.457 ' NZ ' ' OE1' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -158.27 167.75 28.92 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.36 1.064 . . . . 4.8 109.98 -173.476 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.67 119.48 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 125.544 1.537 . . . . 1.85 108.386 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.1 m -96.83 144.76 26.49 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 118.313 0.506 . . . . 1.72 110.099 172.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.27 138.84 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 127.116 2.166 . . . . 2.0 106.87 174.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.4 m -145.47 134.47 22.61 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.536 -1.653 . . . . 2.28 106.536 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.55 -94.98 0.16 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 107.348 -2.301 . . . . 0.64 107.348 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -164.3 50.07 0.12 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.337 1.455 . . . . 2.57 109.349 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.14 173.71 11.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.897 0.879 . . . . 1.87 110.414 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.0 m -137.89 169.73 17.29 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.071 1.348 . . . . 1.71 111.039 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -50.46 -40.61 18.82 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 CA-C-O 117.222 -1.37 . . . . 3.86 110.694 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -34.63 -49.8 0.43 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.681 1.582 . . . . 5.51 113.773 -176.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -68.77 -45.39 71.5 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.441 0.639 . . . . 2.61 112.035 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.9 t -57.32 -33.84 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.271 1.028 . . . . 1.69 110.593 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -59.98 -57.29 13.48 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.667 1.587 . . . . 3.07 106.863 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -53.84 -47.34 71.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.868 -1.06 . . . . 3.85 110.01 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.62 -52.2 49.57 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.848 -0.532 . . . . 1.48 111.191 171.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.52 -9.7 26.17 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.64 1.114 . . . . 0.34 112.643 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.34 -23.68 3.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 119.151 1.476 . . . . 1.69 111.478 169.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -52.11 -32.11 33.78 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.277 0.944 . . . . 3.31 112.76 172.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -136.96 10.48 3.07 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.819 0.848 . . . . 2.76 112.682 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 57.33 65.75 1.3 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.855 1.262 . . . . 1.63 111.655 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.19 -166.53 0.73 Allowed 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.848 -0.533 . . . . 2.3 110.959 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.53 62.65 0.61 Allowed 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 120.49 -1.381 . . . . 5.43 107.5 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 mt -79.86 137.8 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.359 -1.291 . . . . 1.8 109.299 -173.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.9 mt -127.19 136.28 28.65 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 124.194 0.997 . . . . 2.65 109.599 -174.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.18 83.67 0.35 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.979 2.453 . . . . 0.82 110.968 172.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.457 ' OE1' ' NZ ' ' A' ' 42' ' ' LYS . 5.1 tt0 -40.63 120.21 1.23 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.526 1.931 . . . . 3.52 109.969 167.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -111.53 -55.88 2.45 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.52 0.728 . . . . 5.17 110.253 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -136.78 151.91 49.72 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 104.876 -2.268 . . . . 8.67 104.876 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.204 0 CA-C-O 116.125 -1.893 . . . . 11.33 107.724 -170.222 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 tpt . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 108.104 -1.072 . . . . 8.6 108.104 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.72 25.48 9.75 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.999 0.92 . . . . 5.97 112.76 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.79 91.48 0.14 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.132 0.973 . . . . 5.56 110.626 176.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.36 134.33 46.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.091 1.756 . . . . 5.33 107.361 164.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.7 m -155.1 151.97 28.95 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.372 -1.344 . . . . 2.06 107.372 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -119.3 141.12 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 O-C-N 124.448 1.092 . . . . 1.9 110.535 162.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -122.32 152.86 39.67 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.914 1.685 . . . . 3.08 106.746 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -94.26 134.71 36.45 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.41 1.005 . . . . 4.57 110.704 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 p -112.58 135.85 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 O-C-N 124.322 1.014 . . . . 1.63 109.71 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -135.82 172.08 13.52 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.147 0.43 . . . . 2.98 110.593 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.41 -47.43 2.6 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.43 1.491 . . . . 1.62 112.129 176.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.445 HD23 ' CE2' ' A' ' 38' ' ' PHE . 4.3 pp -60.49 167.28 2.66 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.475 0.71 . . . . 3.44 112.863 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.5 t -165.99 64.19 0.11 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.869 0.468 . . . . 3.68 111.125 172.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.8 t -156.85 134.68 10.94 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 120.949 -1.094 . . . . 2.19 110.582 171.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 91.4 m -68.18 -44.92 74.82 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 122.114 -0.367 . . . . 3.08 110.918 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -56.19 -40.52 74.11 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.141 -0.974 . . . . 3.06 110.803 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.0 m -55.82 -32.98 64.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.037 0.535 . . . . 2.13 111.364 174.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.96 95.21 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 122.843 0.457 . . . . 1.71 109.839 176.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.37 -45.34 91.59 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.635 0.731 . . . . 1.71 109.078 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.2 tmtp? -52.1 -46.63 65.35 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.749 -0.659 . . . . 3.9 109.325 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.416 ' CZ ' HG12 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -61.97 -58.21 8.75 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 119.007 -0.52 . . . . 3.83 112.325 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -54.27 -47.94 71.77 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.873 -0.788 . . . . 2.6 108.873 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 ttt-85 -63.03 -50.61 70.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.704 -0.48 . . . . 5.66 109.704 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -49.34 -47.77 47.09 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 117.904 0.32 . . . . 1.66 110.265 175.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.5 t -62.51 -49.4 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 122.088 -0.383 . . . . 1.89 110.102 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -50.95 -35.66 34.68 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.9 0.88 . . . . 3.43 112.162 173.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -70.36 -12.76 61.8 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.322 0.86 . . . . 2.87 113.322 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.3 mt -78.54 131.51 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 120.199 1.363 . . . . 2.54 109.791 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -86.3 20.77 2.26 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.638 1.975 . . . . 3.55 112.494 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.62 -12.87 4.87 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.845 1.212 . . . . 1.48 112.54 -178.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -115.67 157.17 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 C-N-CA 125.332 1.453 . . . . 1.91 107.433 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.9 m -109.32 -60.08 1.81 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.708 1.203 . . . . 1.97 108.454 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -117.27 148.62 41.51 Favored 'General case' 0 N--CA 1.462 0.125 0 O-C-N 123.207 0.317 . . . . 2.94 110.589 175.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.58 129.68 12.68 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.71 -0.478 . . . . 1.83 109.71 172.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.3 mt -130.19 102.49 7.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 107.269 -1.382 . . . . 2.52 107.269 -174.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 p -88.94 144.73 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 122.938 0.495 . . . . 3.18 110.81 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -134.66 64.03 1.61 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.076 1.351 . . . . 2.85 108.465 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.445 ' CE2' HD23 ' A' ' 12' ' ' LEU . 8.1 m-30 -54.69 -21.93 12.29 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 124.404 1.082 . . . . 3.89 112.486 171.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.27 -19.16 38.51 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 120.318 -0.944 . . . . 3.81 111.686 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.47 -106.37 0.33 Allowed 'General case' 0 C--N 1.344 0.337 0 CA-C-N 118.25 1.025 . . . . 4.59 108.677 159.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.1 m -157.25 68.58 0.54 Allowed 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.148 -1.797 . . . . 5.71 106.148 -173.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -153.63 140.29 18.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.678 -0.489 . . . . 6.87 109.678 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.89 114.78 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.263 1.025 . . . . 2.01 108.627 174.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.1 m -87.58 133.09 33.86 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 123.811 0.845 . . . . 1.6 109.034 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.4 t -121.91 140.52 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 126.657 1.983 . . . . 1.8 105.797 171.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.9 m -147.98 135.3 20.54 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.535 -1.283 . . . . 1.9 107.535 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.03 -96.46 0.16 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 106.509 -2.636 . . . . 0.63 106.509 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.4 49.24 0.26 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.611 1.164 . . . . 4.12 109.411 169.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.17 174.32 11.7 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.843 0.857 . . . . 1.96 111.131 177.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -125.05 170.57 11.04 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.926 1.691 . . . . 1.58 111.557 -174.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.4 tp -52.47 -37.61 24.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-O 117.513 -1.232 . . . . 2.8 112.269 -177.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -31.7 -52.47 0.24 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.019 1.328 . . . . 4.31 112.365 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -58.98 -50.75 72.89 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.584 1.183 . . . . 2.25 111.675 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.416 HG12 ' CZ ' ' A' ' 21' ' ' PHE . 65.1 t -61.89 -44.77 99.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.935 1.694 . . . . 1.79 110.433 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -63.29 -45.08 93.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.531 1.532 . . . . 3.55 109.495 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -51.58 -51.04 58.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.235 -0.654 . . . . 4.22 109.235 172.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.3 -48.97 67.92 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.912 -0.492 . . . . 1.77 110.682 173.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.02 -9.22 7.01 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.873 1.702 . . . . 0.37 113.96 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.53 -29.18 1.67 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.497 1.148 . . . . 1.58 111.49 166.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -51.69 -35.56 43.21 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.344 0.974 . . . . 3.38 113.555 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -121.61 4.73 10.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.41 1.084 . . . . 2.47 111.472 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 59.24 52.51 6.0 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.631 1.172 . . . . 1.07 110.054 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.22 158.03 29.91 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.575 -0.284 . . . . 3.54 110.481 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.75 119.2 25.24 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.747 -1.205 . . . . 4.89 107.747 167.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.0 mt -120.54 139.36 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.171 1.388 . . . . 1.77 107.97 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mp -128.28 133.31 25.01 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 108.358 -0.978 . . . . 2.78 108.358 -176.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.53 112.53 3.06 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.337 2.025 . . . . 0.84 108.87 170.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -45.82 -47.6 15.82 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.657 0.783 . . . . 3.24 111.27 172.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.0 tttm 61.86 50.0 4.48 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.243 1.017 . . . . 5.85 110.745 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -74.91 68.64 1.8 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.109 0.964 . . . . 7.22 110.024 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.286 0 CA-C-O 116.624 -1.655 . . . . 8.41 107.916 176.662 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 107.035 -1.468 . . . . 11.95 107.035 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.27 -144.54 0.18 Allowed 'General case' 0 CA--C 1.541 0.602 0 O-C-N 124.785 1.303 . . . . 6.15 111.316 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 18.44 62.09 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 129.251 3.02 . . . . 4.98 114.893 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.35 133.6 31.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.739 2.016 . . . . 5.68 107.639 175.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.7 m -150.15 156.53 41.78 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.579 -1.267 . . . . 1.55 107.579 174.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 p -137.21 139.65 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 123.761 0.663 . . . . 1.7 110.326 168.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -125.18 145.84 49.78 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.011 1.325 . . . . 3.76 108.156 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.18 125.18 32.63 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 118.307 -0.854 . . . . 4.61 109.484 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 p -115.92 132.59 64.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 C-N-CA 123.34 0.656 . . . . 1.81 110.132 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -135.09 166.85 22.12 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.38 1.472 . . . . 3.09 108.661 -175.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.23 -50.84 0.98 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.908 1.242 . . . . 1.31 111.407 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.04 161.48 4.03 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.735 1.214 . . . . 4.41 113.417 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.1 p -172.45 51.03 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.746 0.647 . . . . 3.75 112.746 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -160.86 143.0 12.46 Favored 'General case' 0 C--N 1.346 0.426 0 O-C-N 120.76 -1.212 . . . . 3.06 113.656 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.8 m -63.32 -49.32 74.41 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.074 0.95 . . . . 2.46 111.661 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -55.05 -40.49 70.34 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.571 -0.706 . . . . 4.46 110.674 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.0 m -64.56 -43.26 94.49 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 122.136 -0.352 . . . . 2.18 110.771 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.99 -48.58 64.36 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.009 0.368 . . . . 2.2 110.173 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.53 -51.49 69.23 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.715 0.806 . . . . 2.08 110.332 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -49.9 -44.98 50.39 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.872 0.469 . . . . 3.44 109.978 175.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.65 -58.49 6.16 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.22 -0.895 . . . . 3.84 111.536 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -51.98 -45.19 64.36 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.55 1.068 . . . . 3.53 108.91 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -61.61 -59.06 5.77 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.344 0.658 . . . . 6.62 111.082 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -49.67 -48.11 49.68 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.016 -0.735 . . . . 1.62 109.016 -178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.5 t -60.76 -48.24 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 122.994 0.518 . . . . 1.85 110.546 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -56.07 -36.06 67.67 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.663 1.185 . . . . 3.49 111.992 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.14 -9.71 58.53 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.255 0.835 . . . . 2.38 113.255 175.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.1 mm -78.69 110.52 14.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 120.039 1.291 . . . . 3.45 110.587 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.61 85.7 0.07 Allowed 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.166 1.786 . . . . 3.44 108.584 165.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.38 -42.1 0.12 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 109.865 -1.294 . . . . 1.89 109.865 -177.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -97.92 151.29 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 108.642 -0.873 . . . . 2.03 108.642 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.3 m -106.28 -55.95 2.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.943 1.297 . . . . 1.67 108.09 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -121.44 125.44 46.9 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.948 -0.76 . . . . 3.36 108.948 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.82 136.89 47.85 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.292 -1.003 . . . . 1.9 108.292 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.8 mt -129.39 110.84 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.871 -1.159 . . . . 2.15 107.871 -176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.6 p -95.24 111.48 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 118.413 0.551 . . . . 3.19 111.37 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -83.55 71.59 10.33 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 106.953 -1.499 . . . . 3.36 106.953 167.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.64 67.14 2.72 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.785 0.802 . . . . 4.01 109.286 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -161.46 52.38 0.33 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.356 -1.498 . . . . 3.15 109.356 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 68.6 63.35 0.34 Allowed 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 125.491 1.516 . . . . 3.06 108.766 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m -157.09 -113.69 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.46 -0.791 . . . . 2.74 110.258 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -157.79 155.73 30.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.812 -0.555 . . . . 4.23 110.731 -163.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.28 117.46 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 125.69 1.596 . . . . 1.93 108.367 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.3 m -89.18 144.63 25.97 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.727 0.811 . . . . 1.82 109.921 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.96 132.43 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 127.163 2.185 . . . . 1.95 106.617 175.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.9 m -143.27 132.41 23.11 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.996 -1.483 . . . . 2.47 106.996 173.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.9 -90.07 0.12 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.982 -1.647 . . . . 0.76 108.982 177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -165.41 54.65 0.11 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.72 1.608 . . . . 2.88 109.208 167.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.88 174.68 10.36 Favored 'General case' 0 C--N 1.34 0.172 0 O-C-N 121.032 -1.042 . . . . 1.79 112.175 -176.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.1 m -134.61 166.35 23.11 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.454 1.501 . . . . 1.64 110.518 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -48.1 -44.5 12.12 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.877 0 CA-C-O 117.199 -1.381 . . . . 4.1 111.098 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -31.7 -47.93 0.14 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.054 1.741 . . . . 3.69 114.113 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -66.73 -46.51 75.22 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.671 0.748 . . . . 2.76 111.32 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.1 -31.47 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.993 1.317 . . . . 1.74 111.161 172.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -60.24 -55.5 33.03 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.253 1.421 . . . . 3.19 107.274 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.06 -48.06 76.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.374 -0.83 . . . . 4.88 110.3 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.04 -51.1 44.95 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.414 0.552 . . . . 1.82 110.793 172.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.18 -10.7 29.07 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.112 -0.826 . . . . 0.3 113.533 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.04 -30.18 4.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.857 1.328 . . . . 2.05 112.24 172.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -57.57 -28.18 63.35 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.464 1.029 . . . . 3.66 113.213 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -128.38 -5.75 5.36 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.131 0.973 . . . . 3.09 112.471 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 63.22 61.39 1.08 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.715 1.206 . . . . 1.34 111.018 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -82.19 169.37 16.68 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 121.891 -0.506 . . . . 2.18 110.495 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.05 70.8 1.42 Allowed 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.114 -1.069 . . . . 5.2 108.114 -170.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.0 mt -79.96 135.41 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 108.678 -0.86 . . . . 1.77 108.678 -173.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.26 135.62 23.2 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 124.37 1.068 . . . . 2.5 108.291 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.33 100.46 0.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 121.847 1.698 . . . . 0.97 109.324 170.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -56.26 138.65 50.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.687 -0.857 . . . . 3.96 108.687 172.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -61.98 147.1 48.11 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.682 -0.488 . . . . 6.25 109.682 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -48.39 144.77 3.82 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.739 0.816 . . . . 7.63 110.992 171.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.431 0 N-CA-C 104.904 -2.258 . . . . 10.95 104.904 176.403 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 108.179 -1.045 . . . . 8.71 108.179 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.74 121.68 10.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.571 -1.27 . . . . 6.98 107.571 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -86.41 112.06 21.12 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.158 1.783 . . . . 5.65 109.945 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.37 147.2 46.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.659 -1.978 . . . . 6.0 105.659 166.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 88.9 m -153.5 156.07 37.42 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 106.301 -1.741 . . . . 1.65 106.301 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -132.69 145.99 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 O-C-N 123.992 0.807 . . . . 1.67 110.919 168.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -131.06 146.68 52.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.401 -1.703 . . . . 3.21 106.401 -172.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -85.17 128.15 34.55 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.816 -0.809 . . . . 6.04 108.816 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -112.31 135.26 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.91 -1.515 . . . . 1.67 106.91 174.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -142.59 154.74 44.69 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 104.964 -2.236 . . . . 3.05 104.964 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.52 -81.81 0.35 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.398 0.999 . . . . 1.6 110.999 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.31 163.06 23.19 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.304 0.552 . . . . 3.91 110.929 -174.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.2 t -149.26 79.21 1.4 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.197 0.599 . . . . 4.0 110.721 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.3 t -160.53 146.65 15.18 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.087 0.858 . . . . 2.34 112.387 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -68.39 -46.35 70.26 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.391 1.476 . . . . 2.63 111.996 -177.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -55.02 -43.52 73.76 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.426 -0.796 . . . . 3.03 110.424 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.3 m -56.96 -45.25 82.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.624 -0.716 . . . . 1.84 110.512 173.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.12 -49.89 72.63 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 122.941 0.497 . . . . 2.13 110.268 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.07 -46.42 68.58 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.235 0.54 . . . . 1.89 110.267 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -61.52 -46.11 91.35 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.446 -0.343 . . . . 4.54 110.849 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.21 -64.81 0.72 Allowed 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.848 0.859 . . . . 4.2 110.706 175.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -39.63 83.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.981 0.81 . . . . 2.42 111.086 -172.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -53.04 62.76 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.139 0.576 . . . . 3.65 110.393 172.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -53.33 -46.5 69.51 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.431 -0.581 . . . . 1.63 109.431 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.5 t -59.22 -51.25 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 122.678 0.391 . . . . 1.76 110.324 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.5 mttt -50.64 -38.43 46.18 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.036 0.935 . . . . 3.04 112.414 173.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.63 -12.53 54.08 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.488 0.921 . . . . 3.01 113.488 175.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.2 mt -86.29 113.47 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 120.319 1.418 . . . . 2.37 110.1 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -53.4 -25.16 14.59 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.833 1.653 . . . . 3.36 114.006 176.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.67 -31.13 65.43 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.886 0.755 . . . . 1.6 112.466 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.27 -172.99 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 121.278 -1.131 . . . . 2.01 109.99 -171.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.1 m -140.71 -57.97 0.52 Allowed 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 120.769 -1.207 . . . . 2.06 108.811 171.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -128.53 157.95 39.77 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 119.954 -0.698 . . . . 2.67 111.36 171.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -154.84 149.55 26.53 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.239 -0.652 . . . . 1.81 109.239 172.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.9 mt -130.32 131.07 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 107.047 -1.464 . . . . 2.84 107.047 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 p -118.61 110.04 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 124.389 1.076 . . . . 3.48 109.703 -175.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -101.21 78.0 1.86 Allowed 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.619 -1.252 . . . . 2.45 107.619 171.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -67.97 169.36 10.1 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 121.063 0.459 . . . . 3.91 110.431 169.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.27 -71.4 0.22 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 107.137 -2.385 . . . . 2.72 107.137 -173.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -170.59 67.26 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.234 1.013 . . . . 3.02 108.61 176.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 m -152.51 -113.06 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.493 0.553 . . . . 2.69 112.493 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -157.94 160.02 37.14 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.793 -0.567 . . . . 4.44 110.891 -158.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.26 115.7 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.145 -1.428 . . . . 1.99 107.145 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 79.6 m -90.84 141.76 28.48 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.322 1.449 . . . . 1.66 108.722 174.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.1 t -129.63 140.85 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 104.58 -2.378 . . . . 2.26 104.58 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.4 m -147.26 133.35 19.3 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 107.185 -1.413 . . . . 1.85 107.185 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.7 -96.26 0.16 Allowed Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 106.836 -2.505 . . . . 0.65 106.836 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -163.8 57.53 0.17 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.585 1.954 . . . . 3.31 108.475 172.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.71 168.12 25.32 Favored 'General case' 0 C--N 1.341 0.219 0 O-C-N 120.9 -1.125 . . . . 1.55 111.588 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -126.29 165.67 18.55 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.278 1.431 . . . . 1.95 111.696 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.7 tp -55.64 -28.93 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 117.352 -1.308 . . . . 2.87 113.321 -172.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -35.6 -51.03 0.63 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.78 1.173 . . . . 3.37 111.469 173.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -69.13 -41.46 77.34 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.289 0.566 . . . . 2.39 111.776 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.2 t -65.24 -38.42 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 O-C-N 121.624 -0.672 . . . . 1.77 110.22 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -61.38 -53.85 51.33 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 127.611 2.364 . . . . 3.35 107.97 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -49.03 -42.36 37.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.15 0.58 . . . . 4.52 111.135 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.77 -47.6 68.72 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.167 0.508 . . . . 1.9 110.849 174.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.27 -15.99 12.93 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 126.928 2.204 . . . . 0.33 113.117 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -40.5 -29.32 0.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.303 1.051 . . . . 1.79 112.465 163.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -50.23 -36.16 29.84 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.9 1.074 . . . . 3.11 113.9 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -126.16 -4.73 6.77 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.472 1.509 . . . . 2.39 112.47 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 73.03 57.46 0.11 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.092 1.357 . . . . 1.33 110.85 173.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.11 168.29 19.84 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.186 -0.946 . . . . 2.33 111.204 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.09 64.55 1.59 Allowed 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.492 -1.299 . . . . 5.78 107.492 -171.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.74 130.78 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 113.501 -1.681 . . . . 1.91 109.098 -174.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.8 mt -122.62 131.13 24.41 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 108.388 -0.967 . . . . 2.04 108.388 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.41 106.88 1.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.203 1.935 . . . . 0.85 109.128 169.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -48.53 -51.33 28.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.858 0.863 . . . . 3.41 109.881 172.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.7 tttm 61.2 -174.66 0.13 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.777 1.231 . . . . 6.11 110.961 -174.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -167.65 154.13 7.92 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.346 -1.724 . . . . 8.21 106.346 -176.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 C-N-CA 124.867 1.267 . . . . 9.43 111.197 -171.69 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.2 mtt . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 105.985 -1.858 . . . . 9.43 105.985 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.79 121.69 21.04 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 119.023 0.828 . . . . 7.12 109.27 -174.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -71.82 74.14 0.85 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.079 0.952 . . . . 5.2 110.971 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.75 144.26 51.0 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.078 1.351 . . . . 5.4 108.005 164.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.2 m -153.35 159.03 42.37 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 106.422 -1.696 . . . . 1.67 106.422 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 p -136.66 148.33 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 O-C-N 124.111 0.882 . . . . 1.72 110.778 173.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -133.27 141.8 48.19 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 106.729 -1.582 . . . . 3.42 106.729 -171.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.1 mtt85 -83.14 137.26 34.14 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.455 1.025 . . . . 5.34 108.416 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 p -121.78 140.65 45.11 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 124.093 0.957 . . . . 1.85 110.112 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -140.33 155.03 46.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.998 -1.482 . . . . 2.86 106.998 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.17 -81.68 0.35 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.811 1.196 . . . . 1.42 110.598 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.64 161.23 29.29 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.957 0.379 . . . . 3.87 110.522 -175.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 t -153.52 90.78 1.43 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.315 -0.624 . . . . 4.36 109.315 170.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.9 t -165.36 127.83 2.13 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.4 0.68 . . . . 2.23 110.077 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 m -50.32 -45.38 54.76 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.258 1.023 . . . . 2.28 111.743 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -59.34 -39.78 84.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.891 -0.506 . . . . 3.34 111.227 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.4 m -65.95 -46.29 78.67 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.686 -0.487 . . . . 2.09 109.686 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.58 -49.07 71.24 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.742 0.246 . . . . 1.87 110.417 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.87 67.59 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.57 0.748 . . . . 1.96 110.556 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.0 tttp -57.17 -46.93 82.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.135 -0.484 . . . . 3.76 110.349 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -49.61 -63.29 1.15 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 118.643 -0.694 . . . . 4.07 111.108 171.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -57.97 -39.75 78.92 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 119.099 0.863 . . . . 2.61 111.321 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -58.11 -51.06 71.28 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.698 -0.482 . . . . 3.55 109.698 173.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -53.5 -43.14 68.04 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.11 0.414 . . . . 2.69 110.223 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.68 -52.18 64.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 122.808 0.443 . . . . 1.55 111.28 174.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -53.84 -35.36 61.38 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.366 1.066 . . . . 2.98 111.515 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -72.53 10.26 0.87 Allowed 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 114.128 1.159 . . . . 2.75 114.128 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.0 mt -105.42 112.83 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.276 1.43 . . . . 2.24 110.714 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -52.59 -36.15 55.54 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 127.887 2.475 . . . . 3.62 113.758 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.2 -30.17 75.08 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.474 -0.785 . . . . 1.66 112.002 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.05 172.3 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 O-C-N 121.627 -0.925 . . . . 2.01 109.252 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.6 m -126.34 -59.83 1.29 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.466 -1.309 . . . . 1.87 107.466 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -122.58 164.2 18.59 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-O 121.351 0.596 . . . . 3.5 112.404 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.48 135.73 12.12 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.986 -0.746 . . . . 1.74 108.986 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.7 mm -118.82 102.39 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 105.389 -2.078 . . . . 3.13 105.389 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.51 118.93 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.651 -0.87 . . . . 3.04 108.651 -172.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -93.14 -49.35 6.03 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 108.857 -0.794 . . . . 2.66 108.857 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 60.18 -168.37 0.16 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.883 0.473 . . . . 4.6 111.771 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.32 -66.86 3.4 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.711 -0.956 . . . . 2.78 110.711 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.44 47.85 0.13 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.36 1.064 . . . . 3.06 108.765 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 m -143.72 -125.33 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.917 0.487 . . . . 3.26 110.968 -163.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.05 167.29 30.88 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.833 0.853 . . . . 4.74 109.885 -173.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.47 114.27 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 126.348 1.859 . . . . 2.09 107.541 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.1 m -91.55 136.26 33.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.37 -0.974 . . . . 1.61 108.37 171.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 t -119.96 147.93 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 126.584 1.954 . . . . 2.05 106.791 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.9 m -146.27 138.29 25.01 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.447 -1.316 . . . . 1.57 107.447 175.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.11 -91.84 0.15 Allowed Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 108.047 -2.021 . . . . 0.61 108.047 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -167.11 50.31 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.937 1.695 . . . . 2.31 109.196 173.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.12 178.05 8.87 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.968 -1.083 . . . . 1.88 110.821 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.2 m -138.21 171.37 14.5 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.21 1.404 . . . . 2.04 110.951 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -46.43 -47.41 6.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-O 116.68 -1.628 . . . . 3.93 110.875 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -33.18 -47.74 0.2 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 121.104 1.774 . . . . 3.86 114.155 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -70.16 -44.39 68.91 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.252 -0.905 . . . . 2.07 112.291 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.7 t -58.47 -27.83 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.139 1.376 . . . . 1.78 111.547 169.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.29 -52.23 29.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.876 1.67 . . . . 2.99 106.747 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -54.15 -45.67 72.06 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.808 0.843 . . . . 4.13 110.403 174.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.8 -57.65 10.13 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.408 0.549 . . . . 1.46 110.658 169.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.11 -16.18 25.11 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 125.407 1.479 . . . . 0.34 113.713 -174.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -42.7 -29.47 0.3 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.18 -0.914 . . . . 1.61 112.544 166.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -52.97 -35.26 58.73 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.836 1.198 . . . . 3.17 113.411 175.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.8 -1.55 9.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.682 1.193 . . . . 2.48 112.264 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 65.06 55.6 1.11 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.732 1.213 . . . . 0.9 110.519 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.05 171.66 11.49 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.156 -0.965 . . . . 2.28 110.955 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.57 64.3 1.52 Allowed 'General case' 0 C--N 1.341 0.218 0 N-CA-C 107.731 -1.211 . . . . 5.6 107.731 -175.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mt -80.7 139.47 18.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 113.982 -1.463 . . . . 1.9 108.429 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.5 mt -128.0 133.25 24.93 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.436 1.094 . . . . 2.42 108.116 -174.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -64.52 109.0 1.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.323 2.016 . . . . 0.78 109.621 172.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -61.66 138.59 58.32 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.725 -0.472 . . . . 4.54 109.725 172.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -130.1 125.46 35.19 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.548 -1.649 . . . . 5.44 106.548 -177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -157.92 138.2 12.63 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.263 -2.125 . . . . 8.23 105.263 -177.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.254 0 C-N-CA 126.822 2.049 . . . . 9.19 105.529 -175.846 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mtt . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 106.712 -1.588 . . . . 11.99 106.712 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 178.98 127.88 0.07 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.339 1.856 . . . . 6.42 106.534 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.401 ' CD ' ' HZ1' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -176.14 -178.95 1.05 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.328 2.251 . . . . 6.22 105.211 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.401 ' HZ1' ' CD ' ' A' ' 3' ' ' GLU . 0.1 OUTLIER -82.99 165.8 19.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.696 0.798 . . . . 4.61 109.77 170.577 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -150.25 148.4 28.84 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 105.838 -1.912 . . . . 1.69 105.838 170.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.67 147.64 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 124.204 0.94 . . . . 1.73 110.284 169.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -133.0 145.09 50.55 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.082 -1.451 . . . . 3.58 107.082 -173.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 50.8 mtm-85 -87.68 124.89 34.03 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 109.037 -0.727 . . . . 6.2 109.037 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.408 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.4 p -109.74 152.91 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.056 0 N-CA-C 108.638 -0.875 . . . . 1.65 108.638 172.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -147.37 166.81 26.02 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.284 -1.376 . . . . 2.35 107.284 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.6 -68.34 0.28 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.236 0.922 . . . . 1.61 112.14 171.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 pp -73.41 157.94 35.94 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 117.833 0.817 . . . . 3.95 110.347 -175.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.0 m -152.25 69.9 0.9 Allowed 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.92 0.488 . . . . 4.09 110.199 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.2 t -157.86 121.87 4.15 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.045 0.538 . . . . 2.21 110.775 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 m -47.18 -44.26 21.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.205 1.402 . . . . 2.18 111.947 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -53.52 -43.92 68.7 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.888 0.475 . . . . 3.02 110.787 178.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.1 m -70.43 -39.73 74.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.386 -0.34 . . . . 1.99 110.369 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.01 -44.64 78.86 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.681 0.673 . . . . 1.62 110.766 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.39 -49.12 72.85 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.345 0.658 . . . . 1.87 110.683 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -49.53 -49.38 46.27 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.494 0.717 . . . . 3.43 109.227 173.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -56.93 -63.43 1.21 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 118.449 -0.786 . . . . 4.12 111.646 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -40.17 74.76 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 119.173 -1.011 . . . . 2.47 110.671 -172.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -59.32 -51.71 68.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.216 0.207 . . . . 3.43 111.232 174.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -52.24 -45.77 65.46 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.76 -0.588 . . . . 1.71 110.702 175.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.0 t -65.51 -45.33 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.095 0.558 . . . . 1.82 110.399 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -54.03 -38.44 65.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.293 1.037 . . . . 2.99 110.867 173.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -70.33 -0.61 8.45 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.864 1.061 . . . . 2.99 113.864 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.9 mm -85.6 134.08 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 120.837 1.653 . . . . 3.47 110.287 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -74.74 124.7 27.25 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.839 1.656 . . . . 4.11 109.316 167.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.91 -39.86 1.95 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.578 1.085 . . . . 2.17 110.955 171.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.03 159.08 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 O-C-N 121.871 -0.782 . . . . 1.75 109.311 173.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.7 m -116.17 -55.68 2.38 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.871 1.668 . . . . 2.14 107.856 177.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -127.23 147.29 50.22 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.416 0.447 . . . . 2.89 110.554 170.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.79 140.53 40.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.719 -1.215 . . . . 1.85 107.719 166.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.6 mt -125.25 109.92 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 N-CA-C 106.451 -1.685 . . . . 2.4 106.451 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.78 129.96 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 123.106 0.253 . . . . 3.02 110.788 -171.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -120.7 57.53 0.97 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.034 -1.469 . . . . 2.89 107.034 169.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.408 ' CE2' HG23 ' A' ' 9' ' ' VAL . 72.6 m-85 -62.91 135.66 57.43 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 108.432 -0.951 . . . . 4.83 108.432 170.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.25 -56.75 0.5 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 109.214 -1.555 . . . . 2.84 109.214 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -171.78 53.98 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.68 1.192 . . . . 2.84 108.404 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.4 m -156.78 -112.77 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.898 -0.501 . . . . 2.73 111.659 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.409 ' HZ2' ' CD ' ' A' ' 68' ' ' GLU . 0.6 OUTLIER -160.34 168.54 25.03 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.692 -0.63 . . . . 4.73 111.669 -163.18 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.08 113.99 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.773 -1.195 . . . . 1.66 107.773 -176.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.8 m -91.88 141.58 28.49 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.49 1.116 . . . . 1.61 109.066 174.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.8 t -129.34 138.38 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 104.744 -2.317 . . . . 2.11 104.744 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.2 m -147.61 132.46 18.03 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 106.391 -1.707 . . . . 1.55 106.391 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.87 -95.82 0.17 Allowed Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 106.651 -2.579 . . . . 0.66 106.651 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.63 63.59 0.11 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.086 1.754 . . . . 3.81 108.53 174.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.22 164.69 36.84 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.075 -1.016 . . . . 1.51 110.629 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.0 m -118.26 162.61 17.98 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 125.939 1.696 . . . . 1.77 110.65 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 tp -54.02 -31.84 21.83 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 CA-C-O 117.466 -1.254 . . . . 2.71 112.632 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -32.17 -48.57 0.17 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.89 1.276 . . . . 5.06 111.953 175.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -59.83 -52.5 65.18 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.92 0.867 . . . . 2.34 111.465 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.06 -42.41 96.52 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 C-N-CA 125.44 1.496 . . . . 1.82 110.699 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -61.99 -48.96 78.01 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.049 1.34 . . . . 2.93 108.644 178.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -56.12 -51.59 67.39 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.162 0.585 . . . . 4.46 110.35 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.51 -52.98 19.83 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.654 0.661 . . . . 1.4 110.835 168.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.46 -18.4 29.67 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 125.382 1.468 . . . . 0.32 113.414 -177.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.23 -22.77 1.11 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.543 1.171 . . . . 1.72 112.335 170.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -55.49 -32.11 62.58 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 120.167 1.348 . . . . 3.18 112.894 172.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.91 -25.21 6.83 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.127 1.371 . . . . 2.57 111.657 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 83.48 60.41 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.674 2.39 . . . . 0.74 111.363 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.16 165.72 22.16 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.119 -0.988 . . . . 2.63 111.73 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.04 111.72 17.82 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.966 -1.494 . . . . 5.83 106.966 175.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.08 127.6 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 108.845 -0.798 . . . . 1.63 108.845 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.9 mm -111.64 125.3 30.63 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.027 1.331 . . . . 2.73 108.796 -172.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.14 92.24 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.04 2.493 . . . . 0.76 110.032 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.409 ' CD ' ' HZ2' ' A' ' 42' ' ' LYS . 22.8 pt-20 -61.28 116.2 4.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.531 0.681 . . . . 3.91 111.002 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -95.0 80.47 3.64 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.6 -1.259 . . . . 5.97 107.6 170.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -61.39 128.24 35.37 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.086 -1.079 . . . . 8.86 108.086 173.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.362 0 N-CA-C 105.765 -1.939 . . . . 8.56 105.765 -169.381 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.1 mtm . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 106.507 -1.664 . . . . 8.74 106.507 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.01 -63.55 0.64 Allowed 'General case' 0 C--O 1.227 -0.083 0 O-C-N 124.482 1.114 . . . . 6.46 108.573 -175.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 62.32 -140.25 0.43 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.218 1.007 . . . . 6.61 111.295 173.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -123.76 148.67 46.43 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.073 1.749 . . . . 4.54 108.117 -178.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.9 m -147.46 150.64 34.99 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 108.234 -1.025 . . . . 1.54 108.234 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -135.36 132.88 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 124.337 1.023 . . . . 1.77 111.114 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -115.57 153.65 30.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.772 1.629 . . . . 3.33 108.012 -169.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -92.89 112.72 24.78 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.484 -0.932 . . . . 5.08 108.484 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.9 p -96.18 144.03 11.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.572 1.149 . . . . 1.62 109.055 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -141.93 163.39 33.02 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.541 -0.541 . . . . 2.96 109.541 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.4 -70.26 0.24 Allowed Glycine 0 CA--C 1.528 0.906 0 C-N-CA 126.013 1.768 . . . . 1.55 111.024 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.94 173.3 8.99 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.388 0.884 . . . . 3.89 113.388 -170.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.1 p -167.06 82.63 0.23 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.846 0.859 . . . . 3.38 109.716 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.01 133.03 4.39 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.763 0.711 . . . . 3.13 112.422 176.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.4 m -54.59 -46.72 73.81 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.573 1.149 . . . . 2.26 111.71 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -59.42 -36.59 76.16 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.985 0.898 . . . . 3.93 111.142 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.9 m -69.79 -45.37 68.12 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 108.822 -0.807 . . . . 2.57 108.822 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.56 -43.85 68.82 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 122.759 0.424 . . . . 1.69 110.419 174.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.68 -55.21 37.83 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.471 0.708 . . . . 1.65 109.515 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -54.88 -41.09 70.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.53 -0.304 . . . . 3.74 111.037 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.427 ' CZ ' HG12 ' A' ' 54' ' ' VAL . 2.2 t80 -64.6 -60.16 3.45 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 119.403 -0.332 . . . . 3.7 111.096 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.31 -40.93 75.15 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 118.429 0.559 . . . . 2.52 109.781 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -57.97 -54.53 45.86 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.059 0.943 . . . . 3.2 109.352 175.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -49.67 -51.71 36.19 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.422 0.556 . . . . 1.95 109.851 176.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.5 t -55.5 -52.65 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 110.26 -0.274 . . . . 1.66 110.26 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -51.05 -39.24 55.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.194 1.398 . . . . 2.72 112.383 174.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -71.88 -14.17 61.87 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.057 0.762 . . . . 2.07 113.057 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mt -77.55 131.47 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 120.531 1.514 . . . . 2.39 108.761 171.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -77.22 -9.5 58.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.447 1.099 . . . . 2.44 113.75 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.91 -30.91 45.56 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.768 0.699 . . . . 1.55 112.09 -178.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.1 p -97.36 158.67 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 121.377 -1.072 . . . . 1.94 109.42 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.0 m -106.08 -55.0 2.39 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.677 -1.231 . . . . 1.84 107.677 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -129.32 154.62 46.69 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.758 -0.46 . . . . 2.92 109.758 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.72 143.9 23.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.892 -0.781 . . . . 1.66 108.892 173.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.5 mt -127.5 105.77 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.313 -1.366 . . . . 2.47 107.313 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.57 125.95 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.507 -0.923 . . . . 3.68 108.507 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -86.44 -57.74 2.88 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.408 1.004 . . . . 3.47 109.94 169.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 57.81 -171.91 0.1 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.273 0.629 . . . . 3.62 109.87 -162.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.28 35.79 88.52 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 121.62 -0.675 . . . . 2.49 111.48 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 69.88 72.26 0.23 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.548 1.539 . . . . 3.22 108.472 177.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 m -155.24 -109.3 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.445 -0.798 . . . . 2.77 109.898 -176.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.77 167.85 28.38 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 122.948 0.499 . . . . 4.29 110.637 -170.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.52 120.39 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.632 1.173 . . . . 1.81 108.892 174.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.7 m -98.09 145.29 26.7 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.408 1.083 . . . . 1.61 111.177 177.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.75 140.55 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 127.563 2.345 . . . . 1.9 107.551 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.1 m -148.5 89.66 1.72 Allowed 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 124.971 1.309 . . . . 1.81 108.486 -177.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.89 -106.98 0.19 Allowed Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 108.51 -1.836 . . . . 0.87 108.51 175.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -151.92 62.77 0.85 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.706 1.202 . . . . 3.61 108.114 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.15 162.61 36.65 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.121 0.969 . . . . 1.8 110.071 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -119.5 162.14 19.39 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.884 1.673 . . . . 1.82 109.043 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.0 tp -52.67 -33.51 18.5 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 CA-C-O 117.231 -1.366 . . . . 2.55 112.012 -176.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.3 mm-40 -28.7 -53.41 0.11 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.67 1.588 . . . . 3.16 112.802 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -69.09 -41.87 76.92 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.574 0.702 . . . . 2.39 111.708 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.427 HG12 ' CZ ' ' A' ' 21' ' ' PHE . 33.9 t -66.99 -38.04 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.278 1.031 . . . . 1.72 110.272 178.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -60.98 -49.76 76.14 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.229 1.812 . . . . 2.85 108.512 174.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -52.53 -51.62 58.73 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.83 0.452 . . . . 4.44 110.142 175.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.5 -48.61 62.85 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.627 0.649 . . . . 1.45 111.188 170.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.32 -9.64 6.42 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.918 -0.935 . . . . 0.35 114.036 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.91 -25.66 0.83 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 119.176 1.488 . . . . 1.7 112.682 170.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -53.73 -36.35 62.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.81 1.186 . . . . 3.47 113.235 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -121.0 -5.93 9.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.217 1.007 . . . . 2.61 112.894 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 67.46 50.57 0.92 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.75 1.22 . . . . 0.86 110.417 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -72.35 168.01 19.28 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.532 -0.73 . . . . 2.67 112.158 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.07 124.49 40.73 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.195 -1.78 . . . . 5.14 106.195 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.0 mt -130.85 134.49 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.708 1.203 . . . . 1.75 107.913 -175.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.6 mt -113.98 121.79 36.07 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.756 1.222 . . . . 2.73 108.169 -172.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -77.37 70.73 6.68 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 124.227 3.284 . . . . 1.41 109.5 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 46.92 -167.91 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.057 1.743 . . . . 6.96 112.913 -167.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? 62.58 122.06 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.053 1.341 . . . . 9.95 112.368 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -51.82 134.9 30.62 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.453 -0.943 . . . . 11.57 108.453 164.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.148 0 CA-C-O 116.813 -1.565 . . . . 15.02 109.464 -175.681 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 mtt . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 106.901 -1.518 . . . . 10.55 106.901 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.1 -72.08 0.02 OUTLIER 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 125.03 1.332 . . . . 6.86 107.584 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 59.03 -151.16 0.43 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.17 0.988 . . . . 5.68 110.384 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -99.1 156.35 16.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.059 -1.089 . . . . 4.57 108.059 168.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.1 m -150.2 147.19 27.4 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 107.766 -1.198 . . . . 1.64 107.766 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -123.02 143.84 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 124.947 1.404 . . . . 1.57 110.318 171.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -129.8 153.42 48.26 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.023 -1.843 . . . . 3.21 106.023 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -95.42 147.95 22.98 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.583 0.629 . . . . 4.59 110.156 173.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.34 121.7 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 123.045 0.538 . . . . 2.09 110.684 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.04 -173.45 2.31 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.069 0.548 . . . . 2.81 111.449 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.43 -46.94 3.34 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.666 1.603 . . . . 1.34 113.427 170.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.436 HD23 ' CD1' ' A' ' 38' ' ' PHE . 3.2 pp -50.13 156.8 0.74 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.874 1.269 . . . . 4.34 113.495 178.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 t -167.55 51.21 0.06 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.88 0.472 . . . . 3.56 111.221 173.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.1 t -159.16 117.74 2.9 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 120.807 -1.183 . . . . 2.2 112.854 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 m -53.04 -41.96 65.26 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.191 0.996 . . . . 2.55 112.212 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -57.25 -39.74 76.2 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.67 0.747 . . . . 3.15 109.982 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.0 m -69.39 -43.83 72.7 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.866 -0.606 . . . . 1.99 109.947 175.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.28 -48.57 45.9 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.062 0.545 . . . . 1.91 110.84 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.27 -48.86 80.04 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.573 -0.739 . . . . 1.51 109.879 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -58.51 -38.42 77.66 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.022 -0.535 . . . . 3.96 110.532 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -58.07 -60.52 3.62 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.45 0.7 . . . . 4.05 109.758 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -55.8 -45.04 78.35 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.278 0.49 . . . . 2.47 110.029 -175.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -64.06 -47.26 80.84 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.022 -0.535 . . . . 3.26 109.808 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -52.46 -46.39 66.47 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.918 -0.401 . . . . 1.97 109.918 173.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.4 t -60.33 -50.16 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 118.314 0.507 . . . . 1.74 109.727 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -51.63 -34.83 39.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.899 0.88 . . . . 2.29 112.996 173.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -67.26 -22.81 65.65 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.875 0.761 . . . . 3.03 112.533 176.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.1 mt -70.74 133.18 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.596 1.089 . . . . 2.69 109.213 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -77.66 -17.35 57.8 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.557 1.143 . . . . 2.94 113.093 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.48 -11.44 80.15 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.379 0.99 . . . . 1.62 113.768 -176.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.3 p -115.06 153.18 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 118.59 1.195 . . . . 1.67 108.949 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.8 m -103.1 -51.56 3.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.23 -1.026 . . . . 1.74 108.23 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -132.38 161.08 34.51 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.837 0.351 . . . . 2.1 110.278 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.77 138.05 16.6 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.874 -1.158 . . . . 1.64 107.874 174.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 22.0 mm -126.55 102.81 10.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 106.839 -1.541 . . . . 3.35 106.839 -177.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.2 p -98.42 144.38 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 122.507 0.323 . . . . 3.27 110.658 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -137.17 71.91 1.41 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.803 -0.814 . . . . 4.16 108.803 173.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.436 ' CD1' HD23 ' A' ' 12' ' ' LEU . 2.7 m-30 -44.68 -31.13 1.07 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.528 1.531 . . . . 4.38 111.876 167.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.49 -22.22 23.26 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.035 -0.87 . . . . 3.72 112.768 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.6 -103.3 0.41 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.408 1.104 . . . . 4.58 108.678 161.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.3 m -159.66 51.89 0.35 Allowed 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.32 -0.993 . . . . 5.81 108.32 -175.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -145.69 142.54 29.1 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.044 1.293 . . . . 6.63 112.407 -170.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.78 119.33 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.105 1.362 . . . . 1.92 110.151 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 m -98.56 139.96 33.5 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.941 1.296 . . . . 1.57 110.225 172.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.5 t -122.29 140.66 45.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 127.806 2.442 . . . . 1.95 105.576 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.5 m -147.22 85.72 1.61 Allowed 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.134 -0.979 . . . . 1.87 108.424 -173.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.88 -106.87 0.19 Allowed Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 109.43 -1.468 . . . . 0.94 109.43 176.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -152.21 54.87 0.81 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.733 0.813 . . . . 2.14 108.958 170.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.77 163.6 33.55 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.425 -0.797 . . . . 1.79 110.497 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.5 m -109.57 161.42 15.37 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.337 1.455 . . . . 1.66 110.136 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.0 tp -50.74 -31.63 9.96 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 CA-C-O 117.314 -1.327 . . . . 2.71 113.321 -178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -29.86 -50.04 0.11 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.07 1.348 . . . . 5.15 112.475 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -63.93 -45.49 89.02 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 122.025 0.917 . . . . 2.37 111.604 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.0 t -69.57 -30.73 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.507 1.123 . . . . 1.65 110.48 178.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -61.7 -50.06 73.97 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.046 -1.094 . . . . 3.19 108.046 172.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -51.97 -50.87 60.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.837 0.455 . . . . 3.68 110.617 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.14 -52.24 36.78 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.856 -0.527 . . . . 1.8 111.13 170.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.07 -22.31 35.09 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 126.002 1.763 . . . . 0.57 112.952 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.38 -31.49 4.08 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.733 1.266 . . . . 1.86 112.368 171.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.57 -36.32 55.72 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.314 0.961 . . . . 3.51 113.113 175.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -130.35 4.62 4.75 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.255 1.022 . . . . 3.08 112.122 -173.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 61.82 54.75 2.8 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.597 1.559 . . . . 1.04 112.884 171.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -80.17 -176.96 5.84 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.344 -0.542 . . . . 2.18 110.801 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.87 87.72 1.86 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.328 -1.73 . . . . 5.04 106.328 -176.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 mt -89.0 132.31 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.858 1.263 . . . . 2.37 109.9 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.7 mp -129.17 136.54 29.32 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.539 1.136 . . . . 2.71 109.025 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -72.51 64.93 3.76 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.812 3.008 . . . . 1.03 110.847 174.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -60.47 145.52 48.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.24 0.616 . . . . 6.4 109.928 170.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -152.79 159.72 43.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.912 -1.144 . . . . 7.79 107.912 176.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -148.98 -68.33 0.22 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 105.976 -1.861 . . . . 9.68 105.976 -175.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.288 0 N-CA-C 105.932 -1.877 . . . . 10.39 105.932 146.721 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 106.185 -1.783 . . . . 10.36 106.185 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 30.33 65.75 0.14 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.46 1.904 . . . . 7.96 113.233 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -58.31 178.71 0.09 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 122.6 1.191 . . . . 4.99 111.828 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -75.51 144.24 42.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.987 -1.006 . . . . 5.11 109.699 -169.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.0 m -146.84 143.72 28.78 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.44 -0.948 . . . . 1.92 108.44 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -116.34 134.44 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 124.869 1.356 . . . . 2.04 110.505 168.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -116.13 163.26 16.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.791 1.636 . . . . 3.5 106.593 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -106.21 131.41 53.49 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 118.619 -0.705 . . . . 4.61 110.39 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 p -116.87 142.64 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.366 -0.976 . . . . 1.53 108.366 -174.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -142.93 166.64 24.09 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.756 0.707 . . . . 2.9 109.885 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.25 66.0 3.0 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.464 1.507 . . . . 3.12 112.379 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.16 167.96 16.84 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.774 1.63 . . . . 3.71 109.712 175.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 m -64.41 -82.66 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.302 0.482 . . . . 7.54 112.302 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -172.71 -167.52 0.44 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.372 -0.83 . . . . 4.61 109.911 -175.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.7 t -47.95 -36.72 12.98 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.417 1.487 . . . . 3.57 112.969 -176.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -52.49 -50.93 61.76 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.929 0.871 . . . . 4.47 110.385 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.5 m -71.89 -32.66 67.63 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.871 -0.604 . . . . 1.82 110.909 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.71 -46.86 74.26 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 118.581 0.628 . . . . 1.64 110.044 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -49.99 75.43 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.495 -0.775 . . . . 1.56 109.085 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -53.65 -41.86 67.22 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.415 -0.357 . . . . 3.07 110.686 175.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -63.76 -57.39 10.08 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.362 0.665 . . . . 4.2 110.549 179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -55.16 -45.3 75.71 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.61 0.641 . . . . 2.53 109.609 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -60.82 -52.15 66.29 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.407 0.683 . . . . 4.47 109.462 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -48.78 -49.87 36.71 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 123.335 0.654 . . . . 2.91 109.961 176.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.8 t -61.65 -50.76 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 120.392 -0.523 . . . . 1.7 109.938 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -50.31 -33.92 21.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.187 0.995 . . . . 2.31 113.113 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -69.91 -22.39 63.21 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.459 0.704 . . . . 2.74 112.614 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.9 mt -76.97 138.95 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.674 1.124 . . . . 2.16 109.18 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -82.47 -21.12 35.7 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.33 1.052 . . . . 2.36 113.402 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.86 -31.11 72.52 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 123.845 0.736 . . . . 1.69 112.503 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -95.01 -178.95 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 124.846 1.258 . . . . 1.77 109.222 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.9 m -141.83 -57.95 0.47 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.372 1.069 . . . . 1.91 109.062 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.79 148.91 35.72 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-O 121.169 0.509 . . . . 2.56 110.228 172.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.11 124.0 11.3 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.729 -1.211 . . . . 2.21 107.729 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.0 mt -128.49 98.95 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 107.653 -1.24 . . . . 2.34 107.653 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 p -96.4 138.22 22.24 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 C-N-CA 122.85 0.46 . . . . 3.36 110.541 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -130.06 73.08 1.51 Allowed 'General case' 0 C--O 1.232 0.176 0 N-CA-C 107.952 -1.129 . . . . 3.17 107.952 166.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -49.48 -25.02 2.32 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 125.794 1.638 . . . . 3.77 112.251 165.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.14 -20.1 33.99 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 120.814 -0.708 . . . . 3.86 111.988 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.75 -105.99 0.38 Allowed 'General case' 0 C--N 1.344 0.331 0 CA-C-N 118.155 0.977 . . . . 4.89 109.223 161.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.5 m -159.47 60.51 0.39 Allowed 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.019 -1.475 . . . . 5.37 107.019 -172.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -152.35 140.84 20.69 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.611 0.641 . . . . 5.56 111.547 -176.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.9 106.91 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.226 1.411 . . . . 1.7 109.18 -177.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.2 m -84.39 134.12 34.49 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.67 1.188 . . . . 1.91 109.718 174.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.02 138.94 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.294 1.838 . . . . 1.87 106.67 171.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.5 m -148.71 136.58 20.74 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.045 -1.465 . . . . 2.04 107.045 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.74 -94.38 0.15 Allowed Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 106.188 -2.765 . . . . 0.64 106.188 173.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -159.97 49.16 0.29 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.27 0.628 . . . . 2.37 110.383 169.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.6 172.91 12.56 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.516 -0.74 . . . . 1.55 112.035 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.8 m -127.29 164.93 20.67 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.785 1.634 . . . . 1.56 111.316 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 tp -53.75 -28.54 16.66 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-O 117.846 -1.073 . . . . 2.78 113.228 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -32.48 -51.09 0.26 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.542 1.137 . . . . 3.11 111.831 171.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -68.91 -41.76 77.77 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.416 0.627 . . . . 2.5 111.601 -177.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 37.1 t -67.1 -37.13 78.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 123.691 0.796 . . . . 1.69 110.224 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -57.32 -54.5 46.05 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.496 1.518 . . . . 3.16 108.05 173.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.82 -53.68 49.07 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 110.081 -0.34 . . . . 3.86 110.081 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.46 -47.96 62.94 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.159 0.504 . . . . 1.66 111.161 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.23 -18.34 4.74 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 126.348 1.927 . . . . 0.5 113.208 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.97 -24.26 0.58 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.555 1.678 . . . . 1.74 112.837 171.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -53.96 -34.39 59.6 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.88 1.218 . . . . 3.66 113.35 172.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -120.84 -19.38 7.33 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.316 1.446 . . . . 2.67 112.394 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 73.71 55.45 0.1 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.415 1.886 . . . . 1.04 110.856 -177.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.26 166.42 23.49 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.279 -0.888 . . . . 2.56 111.079 -176.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.51 120.06 34.77 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.568 -1.271 . . . . 5.01 107.568 169.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.45 140.28 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 125.001 1.321 . . . . 2.01 108.049 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.77 131.93 24.1 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.288 1.035 . . . . 2.78 108.602 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.08 97.35 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.567 2.178 . . . . 0.76 108.998 170.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -47.85 -47.91 31.32 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.758 0.823 . . . . 3.32 111.107 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? 71.55 -65.58 0.34 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.848 1.659 . . . . 5.03 111.157 173.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -168.24 -53.55 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.051 1.34 . . . . 7.42 108.68 173.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.409 0 N-CA-C 105.107 -2.183 . . . . 8.95 105.107 179.639 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.0 mtt . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 107.299 -1.371 . . . . 14.47 107.299 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.45 -99.35 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 105.542 -2.022 . . . . 6.51 105.542 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -116.89 150.29 38.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.251 0.932 . . . . 7.38 109.086 166.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -155.35 133.35 11.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.251 1.02 . . . . 5.19 108.425 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.0 m -156.15 154.18 30.45 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 107.75 -1.204 . . . . 1.67 107.75 -173.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -129.36 143.15 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 124.499 1.125 . . . . 1.57 110.931 170.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -128.22 147.86 50.6 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.169 1.388 . . . . 3.11 107.574 -175.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -88.75 132.77 34.47 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.623 0.647 . . . . 7.13 109.392 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 p -109.62 148.95 12.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.9 1.28 . . . . 1.82 107.792 172.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.27 160.82 42.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.784 -0.821 . . . . 2.69 108.784 168.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.15 34.53 5.86 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.116 0.865 . . . . 1.99 113.785 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.96 171.5 20.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.362 1.081 . . . . 3.03 109.814 169.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.1 t -171.08 60.24 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.849 0.86 . . . . 3.99 110.404 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -142.58 121.69 12.93 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.503 0.592 . . . . 2.29 110.854 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m -51.57 -50.14 60.69 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.328 1.051 . . . . 2.37 111.321 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -54.11 -44.4 71.23 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.978 -0.451 . . . . 3.28 110.803 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.1 m -64.92 -46.67 80.68 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.942 -0.392 . . . . 1.93 109.942 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.87 74.73 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.918 0.487 . . . . 1.77 111.195 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.04 -49.18 66.03 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.587 0.755 . . . . 2.13 110.185 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -52.32 -47.84 65.77 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.642 -0.503 . . . . 3.43 109.642 173.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.17 -57.53 10.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.104 0.562 . . . . 3.55 110.93 174.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -56.63 -44.57 81.38 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.722 0.692 . . . . 2.39 110.089 -174.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -59.87 -53.86 52.97 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 108.834 -0.802 . . . . 6.71 108.834 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -44.94 -49.16 11.26 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.401 1.08 . . . . 2.69 110.342 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.5 t -60.39 -52.21 64.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 110.298 -0.26 . . . . 1.63 110.298 175.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -53.18 -31.88 45.03 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.277 0.843 . . . . 2.27 113.277 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -70.33 -15.42 62.87 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.388 0.994 . . . . 2.28 113.094 175.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.5 mt -71.99 115.92 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-O 122.474 1.13 . . . . 2.36 109.445 178.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.08 95.12 0.16 Allowed 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.76 1.624 . . . . 2.61 108.941 171.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.84 -36.74 0.72 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.227 -0.749 . . . . 2.31 111.227 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.2 p -79.67 155.25 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 121.677 -0.896 . . . . 2.16 109.757 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.2 m -109.44 -58.55 2.02 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.529 1.132 . . . . 2.02 108.133 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -123.74 157.74 33.29 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.206 0.527 . . . . 2.94 111.343 173.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.43 134.99 20.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.97 -1.493 . . . . 1.78 106.97 167.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.8 mt -124.85 102.61 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 104.541 -2.392 . . . . 2.57 104.541 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.0 m -117.14 133.05 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 110.328 -0.249 . . . . 3.45 110.328 -167.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -92.06 -53.37 4.28 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.358 -0.608 . . . . 2.88 109.358 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 47.1 58.81 4.48 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.226 1.011 . . . . 4.18 112.165 -176.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.04 71.48 0.11 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.503 -1.439 . . . . 2.56 109.503 173.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 62.7 51.11 3.19 Favored 'General case' 0 C--O 1.228 -0.061 0 C-N-CA 124.904 1.282 . . . . 3.4 108.856 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.0 m -155.53 -121.44 0.03 OUTLIER 'General case' 0 C--O 1.235 0.311 0 CA-C-O 118.338 -0.839 . . . . 2.74 109.479 -172.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -156.32 165.91 34.97 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.961 0.8 . . . . 4.66 112.199 -170.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.2 115.89 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 126.663 1.985 . . . . 2.04 107.706 -178.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.9 m -97.1 137.45 36.14 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.974 0.909 . . . . 1.62 109.026 173.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.18 143.98 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 126.564 1.946 . . . . 2.18 106.325 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 m -146.1 130.74 17.9 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 106.669 -1.604 . . . . 1.54 106.669 178.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 147.23 -101.52 0.23 Allowed Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 105.888 -2.885 . . . . 0.56 105.888 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -163.57 56.94 0.17 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.719 1.608 . . . . 2.29 109.069 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.09 164.21 31.31 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.155 0.982 . . . . 1.81 109.16 173.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.3 m -131.26 163.38 27.92 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.662 1.185 . . . . 1.48 111.211 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -45.83 -48.73 4.86 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.859 0 CA-C-O 117.19 -1.386 . . . . 3.88 111.178 -174.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -30.97 -50.91 0.15 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.296 1.438 . . . . 3.38 113.318 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -66.15 -44.66 83.49 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 122.027 0.917 . . . . 3.5 110.67 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.5 t -65.89 -33.37 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.815 1.246 . . . . 1.64 110.63 174.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.85 -55.35 36.02 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.951 -1.5 . . . . 4.0 106.951 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -51.55 -45.74 63.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.901 -1.045 . . . . 4.0 110.837 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.88 -53.95 52.12 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.706 0.685 . . . . 1.73 111.138 171.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.85 -20.51 19.36 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 125.179 1.371 . . . . 0.3 112.703 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.81 -22.48 0.31 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.418 1.109 . . . . 1.6 113.156 168.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -53.76 -31.66 49.41 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.223 1.374 . . . . 3.21 112.825 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -128.62 -10.85 5.02 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.463 1.505 . . . . 2.93 112.593 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 74.59 60.57 0.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.631 1.973 . . . . 0.89 111.507 172.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -84.35 -179.05 7.1 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.469 -0.769 . . . . 2.23 112.429 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.22 110.22 8.25 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 105.872 -1.899 . . . . 5.1 105.872 176.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.12 135.65 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.908 -1.145 . . . . 1.76 107.908 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.22 137.15 29.39 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.818 1.247 . . . . 1.99 108.967 -169.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.77 89.82 0.63 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.193 2.595 . . . . 1.18 111.184 174.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -56.97 84.48 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.579 1.951 . . . . 3.7 111.156 171.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -152.87 102.68 2.7 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.418 0.687 . . . . 5.27 109.302 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 56.27 71.43 0.56 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.271 1.428 . . . . 7.69 111.28 174.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 N-CA-C 105.374 -2.084 . . . . 10.84 105.374 176.46 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 106.227 -1.768 . . . . 10.34 106.227 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 29.51 65.95 0.12 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.495 1.918 . . . . 7.97 113.349 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -58.91 179.12 0.09 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 122.548 1.166 . . . . 4.96 111.792 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -75.66 144.35 41.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.096 -0.956 . . . . 5.11 109.697 -169.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.1 m -147.11 143.65 28.45 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.471 -0.937 . . . . 1.92 108.471 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -116.37 134.64 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 O-C-N 124.899 1.374 . . . . 2.04 110.454 168.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -116.41 163.12 16.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.522 -1.659 . . . . 3.48 106.522 -177.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -106.55 131.06 54.15 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 118.644 -0.693 . . . . 4.62 110.323 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 p -117.12 142.63 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 108.354 -0.98 . . . . 1.55 108.354 -173.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -143.34 166.84 23.63 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.752 0.706 . . . . 2.91 109.648 176.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.73 64.77 3.81 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.421 1.486 . . . . 3.12 112.339 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.64 167.55 17.03 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.799 1.639 . . . . 3.71 109.748 175.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.4 m -64.88 -82.35 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.254 0.464 . . . . 7.52 112.254 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -172.46 -167.67 0.47 Allowed 'General case' 0 C--N 1.344 0.333 0 O-C-N 121.323 -0.861 . . . . 4.6 110.06 -175.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.0 t -48.28 -36.55 14.32 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.339 1.456 . . . . 3.57 113.021 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -52.63 -50.73 62.56 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.949 0.88 . . . . 4.45 110.349 176.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.7 m -71.81 -33.07 68.23 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.744 -0.662 . . . . 1.83 110.823 176.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.56 -47.1 73.64 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 118.46 0.573 . . . . 1.64 110.035 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.46 -50.09 74.97 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.571 -0.741 . . . . 1.56 109.072 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -53.53 -41.68 66.64 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.44 -0.345 . . . . 3.08 110.758 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -63.84 -57.22 10.53 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.478 0.711 . . . . 4.2 110.561 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -55.25 -45.16 76.06 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 118.61 0.641 . . . . 2.53 109.674 -177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -60.7 -52.29 65.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.307 0.643 . . . . 4.47 109.378 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -48.75 -49.88 36.3 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.351 0.661 . . . . 2.92 109.908 176.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.0 t -61.71 -50.88 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 120.499 -0.48 . . . . 1.7 109.912 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 55.4 mttt -50.61 -33.43 22.13 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.128 0.971 . . . . 2.31 113.214 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -69.97 -22.3 63.16 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.498 0.719 . . . . 2.71 112.582 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.9 mt -77.25 139.29 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 119.64 1.109 . . . . 2.15 109.232 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -82.83 -21.1 34.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.283 1.033 . . . . 2.37 113.419 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.97 -31.23 72.36 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.9 0.762 . . . . 1.69 112.359 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -94.41 -177.61 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.855 1.262 . . . . 1.78 109.104 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.2 m -143.91 -57.47 0.39 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.04 -1.037 . . . . 1.95 109.092 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -113.97 149.25 35.58 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-O 121.236 0.541 . . . . 2.59 110.251 171.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.4 124.51 11.43 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.791 -1.188 . . . . 2.2 107.791 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.91 99.13 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 107.692 -1.225 . . . . 2.34 107.692 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 p -96.07 138.67 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 C-N-CA 122.807 0.443 . . . . 3.39 110.429 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -130.51 73.02 1.51 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.945 -1.131 . . . . 3.13 107.945 166.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -49.32 -25.6 2.53 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.812 1.645 . . . . 3.77 112.225 165.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.99 -20.12 32.94 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 120.884 -0.674 . . . . 3.86 112.02 176.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.4 -105.43 0.39 Allowed 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.104 0.952 . . . . 4.9 109.321 161.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.5 m -159.97 59.96 0.36 Allowed 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.983 -1.488 . . . . 5.38 106.983 -172.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -151.87 141.18 21.45 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.7 0.682 . . . . 5.53 111.719 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.07 107.08 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.294 1.438 . . . . 1.7 109.186 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.8 m -84.38 134.1 34.49 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.686 1.195 . . . . 1.88 109.73 173.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -122.74 139.15 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.199 1.8 . . . . 1.86 106.679 171.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.1 m -148.81 136.87 20.85 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 107.031 -1.47 . . . . 2.04 107.031 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.89 -94.62 0.15 Allowed Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 106.261 -2.736 . . . . 0.64 106.261 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -159.86 49.22 0.29 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.325 0.65 . . . . 2.43 110.381 169.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.6 173.07 12.37 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.503 -0.748 . . . . 1.55 112.022 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.1 m -127.7 164.73 21.45 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.709 1.603 . . . . 1.55 111.358 -174.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 tp -53.71 -28.71 16.72 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 CA-C-O 117.809 -1.091 . . . . 2.77 113.231 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -32.73 -50.92 0.28 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.391 1.076 . . . . 3.12 111.825 171.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -68.89 -41.44 78.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.385 0.612 . . . . 2.49 111.652 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.0 t -67.44 -37.15 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.662 0.785 . . . . 1.69 110.111 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -57.41 -54.42 47.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.596 1.558 . . . . 3.15 107.944 173.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.63 -53.73 47.65 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 110.101 -0.333 . . . . 3.86 110.101 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.63 -47.95 63.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.132 0.491 . . . . 1.67 111.132 173.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.27 -18.44 4.89 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 126.336 1.922 . . . . 0.5 113.245 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.73 -24.52 0.58 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.468 1.634 . . . . 1.74 112.878 171.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -54.01 -34.33 59.59 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.893 1.224 . . . . 3.66 113.315 172.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -120.35 -19.73 7.51 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.195 1.398 . . . . 2.66 112.339 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 74.13 55.24 0.09 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.494 1.918 . . . . 1.02 110.729 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.95 166.09 23.98 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.261 -0.899 . . . . 2.56 111.082 -176.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.98 121.16 38.34 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.523 -1.288 . . . . 4.98 107.523 169.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.33 140.6 44.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 125.007 1.323 . . . . 2.03 108.029 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.12 131.74 23.99 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.356 1.062 . . . . 2.8 108.525 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.28 97.82 0.79 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.537 2.158 . . . . 0.76 108.829 170.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -49.19 -46.85 46.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.532 0.733 . . . . 3.35 111.028 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? 71.69 -65.89 0.33 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.758 1.623 . . . . 5.01 111.145 172.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -167.87 -54.03 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.168 1.387 . . . . 7.42 108.526 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.471 0 N-CA-C 105.09 -2.189 . . . . 8.95 105.09 179.206 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.5 pttt . . . . . 0 N--CA 1.444 -0.754 0 N-CA-C 105.946 -1.872 . . . . 3.81 105.946 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.5 m -151.9 154.76 36.75 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 105.888 -1.893 . . . . 0.88 105.888 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.25 137.99 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 O-C-N 124.428 1.08 . . . . 0.66 109.851 169.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -116.49 151.21 36.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.517 -1.661 . . . . 1.88 106.517 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 -87.86 131.94 34.38 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 107.67 -1.233 . . . . 5.55 107.67 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.87 147.7 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 119.677 1.126 . . . . 0.64 109.963 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . 32.5 t0 -141.21 151.76 44.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.007 -0.738 . . . . 2.84 109.007 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.68 -79.78 0.37 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.253 1.406 . . . . 1.92 110.941 174.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 12' ' ' LEU . 1.2 pp -73.38 150.93 41.42 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 122.348 -0.501 . . . . 2.87 110.629 -171.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 p -144.51 63.81 1.31 Allowed 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.762 0.825 . . . . 2.64 110.793 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.8 t -155.49 123.77 5.88 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.861 -0.525 . . . . 2.22 111.653 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m -48.43 -41.06 28.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.349 1.46 . . . . 2.12 112.222 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -61.27 -42.44 98.63 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.481 -0.762 . . . . 3.13 110.681 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.8 m -67.83 -40.6 83.75 Favored 'General case' 0 C--O 1.231 0.124 0 O-C-N 121.355 -0.841 . . . . 1.17 110.248 176.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.33 -46.22 72.84 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 122.2 -0.313 . . . . 0.8 110.326 171.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.91 -43.92 97.88 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.767 0.827 . . . . 0.94 110.987 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -54.19 -51.62 63.81 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.745 -0.597 . . . . 3.2 109.599 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.26 -60.51 3.3 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.293 0.637 . . . . 2.45 112.508 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -38.57 72.48 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.383 0.992 . . . . 2.91 110.57 -173.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -64.68 -46.38 82.67 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.643 0.377 . . . . 2.8 110.894 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -52.44 -41.91 63.69 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 122.052 -0.405 . . . . 1.3 110.604 173.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.635 HG12 HG11 ' A' ' 31' ' ' VAL . 51.5 t -62.68 -55.12 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.971 -0.455 . . . . 0.69 110.106 174.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.7 mttt -48.47 -37.74 18.16 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.772 1.027 . . . . 1.56 113.772 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -54.0 -34.72 60.64 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.805 0.729 . . . . 3.3 112.717 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.587 HG22 ' H ' ' A' ' 30' ' ' GLY . 13.9 mt -70.0 129.72 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.66 -0.867 . . . . 1.27 108.66 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -71.06 -11.11 60.78 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.906 -1.121 . . . . 2.58 113.472 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.587 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -81.24 -21.95 61.68 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.873 0.749 . . . . 0.91 112.397 -177.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.635 HG11 HG12 ' A' ' 25' ' ' VAL . 9.7 p -111.65 152.67 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 O-C-N 121.365 -1.08 . . . . 0.96 109.143 -175.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.8 m -106.72 -56.51 2.18 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.208 1.403 . . . . 0.95 107.848 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -125.49 161.33 27.36 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.374 0.607 . . . . 2.36 112.323 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.16 139.91 20.78 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.729 -1.212 . . . . 0.82 107.729 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.0 mt -133.01 106.38 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 106.065 -1.828 . . . . 1.35 106.065 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.453 HG12 HG13 ' A' ' 43' ' ' ILE . 2.2 m -120.76 118.59 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 122.79 0.436 . . . . 2.04 109.937 -162.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 . . . . . 0 CA--C 1.528 0.106 0 O-C-N 122.425 -0.172 . . . . 2.44 110.778 -167.757 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.1 m . . . . . 0 CA--C 1.534 0.357 0 CA-C-O 120.48 0.181 . . . . 2.48 111.135 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -158.64 165.59 34.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.61 -0.681 . . . . 3.66 109.933 -158.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.463 HG21 HD13 ' A' ' 65' ' ' ILE . 11.1 tt -129.38 104.8 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 126.084 1.754 . . . . 2.81 108.171 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.7 m -84.81 139.5 31.88 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.673 -0.862 . . . . 0.73 108.673 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.2 t -134.35 138.63 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 104.556 -2.387 . . . . 1.04 104.556 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.3 m -147.91 133.8 19.09 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.111 -1.07 . . . . 0.93 108.111 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.79 -92.68 0.14 Allowed Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 107.398 -2.281 . . . . 0.71 107.398 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -165.88 51.97 0.09 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.996 1.718 . . . . 2.26 109.489 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.52 166.59 29.73 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 120.657 -1.277 . . . . 0.48 111.591 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.0 m -119.67 165.44 14.48 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.424 1.49 . . . . 0.58 111.155 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.433 HD11 HD12 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -46.88 -46.86 8.23 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 CA-C-O 117.214 -1.374 . . . . 2.69 110.725 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -29.87 -50.69 0.12 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.16 1.784 . . . . 2.55 114.052 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -65.02 -48.37 74.13 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 122.38 1.086 . . . . 2.51 110.827 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 25' ' ' VAL . 14.6 t -61.34 -32.79 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.058 1.743 . . . . 0.52 110.93 174.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -60.45 -53.75 53.81 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 126.696 1.998 . . . . 3.27 107.176 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.59 -56.44 13.53 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.434 -0.803 . . . . 3.15 109.571 176.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.21 -51.48 25.15 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.247 0.619 . . . . 0.5 110.81 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.68 -16.06 28.76 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 124.297 0.951 . . . . 0.37 113.197 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.65 -21.67 1.69 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.481 1.14 . . . . 0.48 112.293 169.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -54.07 -35.99 62.65 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.001 1.273 . . . . 1.85 112.705 173.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -121.29 -7.59 9.28 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.651 1.18 . . . . 2.45 112.528 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 71.85 53.86 0.2 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.515 1.526 . . . . 0.99 111.09 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.75 164.42 25.26 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.225 -0.922 . . . . 1.19 111.181 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.454 ' HD2' ' HB3' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -121.66 112.56 18.58 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.162 -1.792 . . . . 3.77 106.162 172.707 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.463 HD13 HG21 ' A' ' 43' ' ' ILE . 1.1 mt -113.58 143.51 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 106.735 -1.58 . . . . 0.66 106.735 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.9 mt -128.14 122.66 22.23 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 106.64 -1.615 . . . . 1.38 106.64 -173.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.53 111.76 2.19 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.665 1.577 . . . . 0.83 108.028 169.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 121.377 0.608 . . . . 4.4 110.71 169.529 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? . . . . . 0 C--O 1.233 0.216 0 N-CA-C 109.231 -0.655 . . . . 4.49 109.231 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.8 m -148.36 154.27 39.73 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 107.668 -1.234 . . . . 0.59 107.668 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 p -135.6 142.24 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 123.616 0.573 . . . . 0.39 110.438 169.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -127.52 147.15 50.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.602 1.161 . . . . 1.74 107.905 -169.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -89.0 128.5 35.71 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.372 -0.973 . . . . 3.81 108.372 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.29 149.23 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.095 -1.076 . . . . 0.6 108.095 169.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -143.47 148.95 36.85 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.423 -0.584 . . . . 2.62 109.423 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.51 -58.37 0.62 Allowed Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.146 0.879 . . . . 1.55 111.586 166.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.404 ' HB3' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -69.86 172.08 8.27 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.309 0.643 . . . . 2.51 112.157 -176.447 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.401 ' N ' HD22 ' A' ' 12' ' ' LEU . 11.2 t -163.8 77.63 0.39 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.692 0.397 . . . . 3.28 109.962 171.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.9 t -168.11 126.91 1.21 Allowed 'General case' 0 C--N 1.342 0.266 0 O-C-N 121.969 -0.457 . . . . 1.76 111.427 172.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.4 m -49.91 -42.09 47.44 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.475 1.11 . . . . 1.37 112.233 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -53.76 -40.92 66.62 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.648 -0.657 . . . . 3.4 111.451 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.44 -47.08 83.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.381 -0.6 . . . . 2.46 109.381 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.15 -42.81 77.56 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.802 0.441 . . . . 0.54 111.098 175.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.81 -49.39 73.08 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.401 0.62 . . . . 0.63 109.87 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -53.83 -48.41 69.94 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.415 -0.587 . . . . 4.22 109.415 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -53.94 -65.33 0.59 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.723 0.809 . . . . 2.83 111.899 176.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.94 -40.69 70.2 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.976 0.807 . . . . 2.87 110.828 -171.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -61.81 -48.87 78.67 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 110.201 -0.296 . . . . 3.43 110.201 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -57.36 -41.17 79.59 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.986 -0.446 . . . . 2.4 110.473 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.452 HG22 HG22 ' A' ' 54' ' ' VAL . 59.1 t -64.41 -46.02 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 O-C-N 121.809 -0.557 . . . . 0.49 110.782 175.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -57.06 -33.95 67.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.913 0.885 . . . . 1.7 112.054 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.25 -21.54 65.26 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.932 0.716 . . . . 2.65 112.932 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.5 mm -77.8 106.71 8.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 O-C-N 120.739 -1.226 . . . . 2.35 110.748 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -65.95 85.19 0.08 Allowed 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 125.71 1.604 . . . . 2.57 108.653 163.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.47 -40.37 0.08 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.459 -1.056 . . . . 0.99 110.459 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.9 p -97.14 156.65 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 108.347 -0.982 . . . . 0.85 108.347 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 55.0 m -105.4 -54.9 2.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.171 1.388 . . . . 0.65 107.69 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -126.29 134.9 51.01 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 109.552 -0.536 . . . . 2.42 109.552 170.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.11 126.27 40.82 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.972 -1.122 . . . . 0.52 107.972 170.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.0 mm -111.22 101.91 13.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.237 -1.394 . . . . 2.22 107.237 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.03 145.88 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 116.618 -0.265 . . . . 2.04 110.553 -175.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 107.429 -1.323 . . . . 2.04 107.429 173.031 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 111.942 0.349 . . . . 2.9 111.942 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.92 171.1 20.02 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.639 0.775 . . . . 4.4 110.063 -165.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.81 113.99 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 108.48 -0.934 . . . . 0.8 108.48 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 m -91.2 143.33 26.78 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 123.983 0.913 . . . . 0.44 109.976 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.18 133.75 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.842 2.057 . . . . 0.61 106.761 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.8 m -143.05 124.34 14.62 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 106.96 -1.496 . . . . 0.86 106.96 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.12 -93.07 0.11 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 118.663 -1.732 . . . . 0.63 109.172 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -166.66 53.76 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.454 1.102 . . . . 2.34 109.931 166.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.51 172.93 15.23 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.022 -1.048 . . . . 0.81 110.643 176.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.0 m -117.14 162.83 17.2 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.678 1.591 . . . . 0.69 111.154 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 tp -52.27 -32.17 15.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.719 0 CA-C-O 117.525 -1.226 . . . . 1.92 112.973 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -34.93 -47.22 0.34 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.387 1.075 . . . . 3.52 112.103 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -57.46 -51.66 68.55 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.405 1.098 . . . . 2.21 111.465 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.452 HG22 HG22 ' A' ' 25' ' ' VAL . 58.1 t -66.11 -42.18 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.681 1.592 . . . . 0.36 110.902 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -63.22 -43.77 97.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.84 0.856 . . . . 4.02 108.836 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -52.11 -54.88 25.03 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.813 -0.613 . . . . 3.01 109.62 171.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.41 -54.15 15.08 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.926 0.784 . . . . 0.42 110.162 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.96 -15.99 15.93 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 125.395 1.474 . . . . 0.33 114.442 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.0 -26.01 2.3 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.424 1.112 . . . . 0.64 111.534 167.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -51.03 -41.77 60.05 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.111 0.869 . . . . 2.23 112.857 173.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.35 -3.67 12.43 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.164 0.986 . . . . 4.3 111.216 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 73.85 49.83 0.12 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.846 1.659 . . . . 1.07 110.835 175.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 63' ' ' LEU . 4.5 mm? -74.47 166.81 22.89 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.641 -0.662 . . . . 1.34 111.311 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.62 122.5 33.27 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.652 -1.61 . . . . 4.23 106.652 171.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 mt -122.98 108.2 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.363 0.665 . . . . 1.17 110.079 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 91.7 mt -94.12 130.79 33.17 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.436 0.694 . . . . 1.17 109.315 -172.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.01 91.8 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.387 2.058 . . . . 0.64 109.008 168.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.252 0 C-N-CA 123.409 0.684 . . . . 4.42 109.987 168.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 109.306 -0.628 . . . . 5.13 109.306 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.5 m -149.08 146.25 27.63 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 106.212 -1.773 . . . . 0.81 106.212 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.15 140.16 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 124.226 0.954 . . . . 0.55 110.847 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -128.67 148.86 50.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.774 1.23 . . . . 2.07 107.92 -172.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -88.02 122.73 31.95 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.815 -0.809 . . . . 4.32 108.815 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 p -109.81 140.05 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 124.386 1.074 . . . . 0.5 108.332 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -138.82 157.59 45.79 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.878 -1.156 . . . . 2.74 107.878 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 120.97 -77.37 0.32 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.925 1.25 . . . . 1.66 110.614 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.452 ' C ' HD12 ' A' ' 12' ' ' LEU . 3.1 pp -76.3 177.63 7.11 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.549 0.69 . . . . 2.63 111.486 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.6 t -161.59 -43.91 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.994 0.918 . . . . 4.29 110.401 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.3 t -50.97 126.23 15.65 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.351 1.06 . . . . 1.9 113.301 -168.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 m -45.32 -44.64 11.73 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.237 1.815 . . . . 1.5 112.914 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -54.37 -48.12 71.85 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.63 0.729 . . . . 3.68 111.016 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.06 -43.18 88.17 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 123.474 0.71 . . . . 1.16 109.367 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.55 -49.31 70.64 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.335 0.254 . . . . 0.87 110.958 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.37 -52.95 63.45 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.523 1.129 . . . . 0.71 109.651 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -48.94 -49.5 39.99 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.888 -0.412 . . . . 2.7 109.888 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.8 -64.18 0.96 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 112.69 0.626 . . . . 2.47 112.69 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -55.82 -44.58 78.04 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.83 0.741 . . . . 3.03 109.552 -172.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -57.03 -53.02 62.82 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.874 -0.417 . . . . 4.47 109.874 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -48.16 -48.65 34.24 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.303 -0.628 . . . . 1.52 109.303 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.436 HG22 HG22 ' A' ' 54' ' ' VAL . 34.6 t -60.99 -47.0 95.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 117.915 0.325 . . . . 0.42 110.789 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -36.52 63.87 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.017 0.527 . . . . 2.5 111.765 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -70.84 -9.91 58.53 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 119.109 0.868 . . . . 1.98 113.161 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.1 mm -83.72 128.91 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 120.539 1.518 . . . . 2.43 109.812 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.44 -28.83 61.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.412 1.485 . . . . 2.44 113.411 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.54 -16.03 64.8 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 123.983 0.801 . . . . 1.3 113.685 -174.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.8 p -118.8 153.47 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.928 1.291 . . . . 1.0 109.232 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 93.0 m -93.95 -51.1 5.02 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.723 -0.843 . . . . 0.62 108.723 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -135.47 160.23 39.13 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.057 0.456 . . . . 2.64 110.517 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -154.08 140.33 18.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.078 -1.082 . . . . 0.49 108.078 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.6 mt -127.59 118.98 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 105.73 -1.952 . . . . 1.28 105.73 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.736 HG12 HG12 ' A' ' 43' ' ' ILE . 5.5 m -105.56 133.76 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.767 -0.827 . . . . 1.98 108.767 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 m120 . . . . . 0 CA--C 1.523 -0.089 0 N-CA-C 108.286 -1.005 . . . . 2.62 108.286 167.528 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 m . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 108.435 -0.95 . . . . 2.64 108.435 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.52 174.82 14.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.911 0.778 . . . . 4.22 111.522 -174.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.736 HG12 HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -130.4 118.98 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.168 1.787 . . . . 0.76 107.764 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.8 m -97.03 138.11 35.07 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.61 1.164 . . . . 0.52 109.58 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.0 t -118.24 143.66 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 127.871 2.468 . . . . 0.73 105.823 171.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.1 m -146.32 88.25 1.78 Allowed 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 125.111 1.364 . . . . 1.01 107.547 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.37 -113.12 0.27 Allowed Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 108.638 -1.785 . . . . 0.89 108.638 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -155.94 48.45 0.5 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.932 -0.766 . . . . 2.99 108.932 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -155.61 177.68 11.11 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.792 -0.567 . . . . 1.28 110.234 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.4 m -114.27 169.81 8.75 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.235 1.414 . . . . 0.9 111.274 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.6 tp -53.92 -33.07 23.17 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 CA-C-O 117.685 -1.15 . . . . 1.81 111.728 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -35.37 -48.59 0.48 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.538 1.063 . . . . 2.68 112.48 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -61.13 -50.27 73.88 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.301 0.572 . . . . 2.22 112.287 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 HG22 ' A' ' 25' ' ' VAL . 58.6 t -58.34 -44.91 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 125.127 1.371 . . . . 0.5 110.536 177.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -67.27 -41.84 84.84 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.111 0.964 . . . . 3.53 110.112 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -54.42 -51.57 64.5 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.062 -0.718 . . . . 3.0 109.062 171.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.05 -48.36 44.01 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.005 -0.434 . . . . 0.44 110.785 170.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.93 -9.79 16.03 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.064 1.316 . . . . 0.36 114.795 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.58 -21.63 10.92 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.232 1.516 . . . . 0.68 112.122 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -56.69 -33.28 66.29 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.414 1.006 . . . . 2.08 112.854 172.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.06 -12.31 9.13 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.862 1.265 . . . . 2.51 112.683 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 72.26 62.29 0.13 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.571 1.148 . . . . 0.8 110.369 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.3 174.21 11.48 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.489 -0.757 . . . . 1.13 110.458 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -143.22 68.34 1.3 Allowed 'General case' 0 C--N 1.34 0.162 0 N-CA-C 106.935 -1.505 . . . . 4.82 106.935 -169.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.8 mt -84.82 107.18 15.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 113.922 -1.49 . . . . 0.96 110.138 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.4 mt -92.7 129.19 41.14 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 108.98 -0.748 . . . . 1.31 108.98 -172.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.07 100.9 0.66 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.397 2.065 . . . . 0.7 109.797 172.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 . . . . . 0 CA--C 1.533 0.308 0 C-N-CA 122.609 0.364 . . . . 3.31 111.293 169.328 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 107.31 -1.367 . . . . 4.5 107.31 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.0 m -151.55 156.12 39.87 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.315 -1.365 . . . . 0.93 107.315 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.01 139.81 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 O-C-N 124.593 1.183 . . . . 0.5 111.545 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.522 ' CD2' HD13 ' A' ' 51' ' ' ILE . 5.6 m-85 -127.43 143.22 51.24 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.713 1.605 . . . . 2.34 107.691 -163.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.33 140.73 31.41 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 118.876 0.762 . . . . 3.62 109.279 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.89 137.33 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 123.822 0.849 . . . . 0.71 109.106 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -140.77 152.11 44.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.03 1.332 . . . . 2.72 107.74 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.02 -56.68 0.73 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 125.225 1.393 . . . . 1.44 110.409 164.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.456 ' C ' HD22 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -61.72 157.71 17.21 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.103 0.561 . . . . 2.5 111.456 -178.704 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 t -161.55 73.56 0.44 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.319 -0.622 . . . . 2.81 109.319 174.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -169.39 134.05 1.43 Allowed 'General case' 0 C--N 1.338 0.099 0 O-C-N 121.62 -0.675 . . . . 2.43 110.734 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 m -59.84 -43.07 94.79 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.313 0.645 . . . . 1.72 111.147 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -58.44 -48.59 80.22 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.791 -0.568 . . . . 2.39 110.17 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.0 m -57.32 -48.05 79.98 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.625 -0.509 . . . . 1.12 109.625 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.46 -50.41 65.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.736 0.414 . . . . 1.08 111.007 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.31 -52.34 66.02 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.154 0.981 . . . . 0.72 109.64 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -54.93 -44.65 74.45 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 119.881 -0.727 . . . . 3.81 110.669 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.36 -63.24 1.21 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.12 0.568 . . . . 2.34 110.131 177.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.86 -40.01 87.17 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.835 0.35 . . . . 2.58 110.612 -171.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -49.52 72.92 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.896 0.878 . . . . 3.22 109.647 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -51.64 -48.44 63.34 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.14 0.576 . . . . 1.66 109.587 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.6 t -60.15 -48.38 88.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 O-C-N 122.179 -0.326 . . . . 0.53 110.628 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -55.04 -34.78 63.83 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.594 -0.691 . . . . 1.89 112.539 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -70.9 -8.79 55.39 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.47 0.915 . . . . 2.12 113.47 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.5 mm -70.86 140.19 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 120.282 1.401 . . . . 2.17 109.768 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -89.74 139.96 30.05 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 125.373 1.469 . . . . 2.73 109.172 171.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.34 -46.54 1.16 Allowed Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.327 1.442 . . . . 1.81 110.601 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.3 p -64.33 158.54 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 122.386 -0.479 . . . . 0.96 110.062 174.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.8 m -108.34 -60.2 1.76 Allowed 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 107.996 -1.113 . . . . 1.13 107.996 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -127.78 161.8 28.13 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.659 0.614 . . . . 2.21 112.659 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.65 141.58 21.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.431 -0.951 . . . . 0.68 108.431 166.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.8 mt -127.96 104.57 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 106.433 -1.692 . . . . 1.39 106.433 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.44 122.1 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.704 -1.221 . . . . 1.94 107.704 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 . . . . . 0 CA--C 1.52 -0.176 0 N-CA-C 105.9 -1.889 . . . . 2.58 105.9 175.374 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 119.356 -0.354 . . . . 3.32 111.582 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt -162.45 153.96 18.14 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.03 1.332 . . . . 4.08 111.269 -165.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.64 117.9 52.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.712 1.205 . . . . 0.79 109.23 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.4 m -91.3 141.17 29.07 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 124.599 1.16 . . . . 0.51 109.338 173.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 t -122.23 145.83 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.439 -1.689 . . . . 0.68 106.439 166.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.2 m -145.89 138.67 25.75 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.265 -1.383 . . . . 0.85 107.265 175.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.94 -91.98 0.18 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 108.224 -1.95 . . . . 0.74 108.224 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -170.75 58.34 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.276 1.83 . . . . 2.2 109.737 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.73 162.44 41.26 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.165 -0.96 . . . . 0.51 111.4 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 61.8 m -109.76 168.01 9.73 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.43 1.892 . . . . 0.94 110.09 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.522 HD13 ' CD2' ' A' ' 7' ' ' TYR . 7.7 tp -52.06 -35.53 18.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 CA-C-O 117.083 -1.437 . . . . 1.53 111.736 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -28.37 -52.67 0.09 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.53 1.532 . . . . 2.36 112.661 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -61.85 -46.01 91.32 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.789 0.804 . . . . 2.17 111.484 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.1 t -70.15 -37.45 71.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.157 1.383 . . . . 0.37 110.913 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -48.6 80.86 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.525 1.53 . . . . 3.3 108.452 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -51.07 -47.94 61.71 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.75 0.42 . . . . 3.93 110.752 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.64 -51.18 71.02 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.424 0.556 . . . . 0.77 110.771 173.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.84 -26.23 25.3 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 126.54 2.019 . . . . 0.51 112.308 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -44.31 -31.77 1.12 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.276 1.038 . . . . 0.54 112.469 170.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -53.72 -32.37 51.76 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.681 1.128 . . . . 2.13 113.63 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.49 0.56 6.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.177 1.391 . . . . 2.6 112.168 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 60.21 57.17 3.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.508 1.523 . . . . 1.54 111.896 177.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.83 160.65 20.16 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 121.46 -0.775 . . . . 1.34 112.118 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 72.43 0.82 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.998 -1.112 . . . . 3.65 107.998 -169.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -82.23 119.7 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.189 -0.671 . . . . 0.64 109.189 -175.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.9 mm -98.3 112.28 61.78 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 125.0 1.32 . . . . 1.48 108.7 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -73.44 83.14 1.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.017 1.811 . . . . 1.42 110.488 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 . . . . . 0 N--CA 1.447 -0.582 0 C-N-CA 125.522 1.529 . . . . 3.11 110.62 173.386 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 107.787 -1.19 . . . . 4.5 107.787 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.7 m -146.74 154.66 41.66 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.032 -1.47 . . . . 0.53 107.032 172.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.02 142.69 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 O-C-N 123.999 0.812 . . . . 0.54 110.151 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -127.67 140.45 52.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.732 -1.581 . . . . 1.86 106.732 -172.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.3 ttt-85 -84.62 126.34 33.26 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.735 -1.209 . . . . 5.16 107.735 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.448 ' CG2' HD21 ' A' ' 12' ' ' LEU . 1.7 p -111.39 146.4 16.41 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 107.356 -1.35 . . . . 0.51 107.356 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.02 171.96 14.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.335 0.397 . . . . 2.31 111.546 -176.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.26 56.77 21.77 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.379 -0.828 . . . . 2.26 112.418 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.448 HD21 ' CG2' ' A' ' 9' ' ' VAL . 2.5 pp -163.07 166.47 23.54 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.602 1.561 . . . . 2.72 107.854 174.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.3 p -174.76 66.11 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.091 0.557 . . . . 2.71 109.951 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.6 t -156.71 124.63 5.54 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.334 0.515 . . . . 2.18 111.436 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -58.29 -43.9 88.26 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.007 0.923 . . . . 1.37 111.727 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -57.42 -44.83 84.94 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.748 0.704 . . . . 2.5 110.533 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.6 m -61.27 -45.94 92.44 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.943 -0.391 . . . . 0.81 109.943 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.22 -47.02 72.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.717 0.407 . . . . 0.56 110.954 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.68 -51.3 69.0 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.533 1.133 . . . . 0.58 109.469 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -52.9 -45.17 67.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.883 -0.599 . . . . 2.91 109.603 174.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.417 ' CZ ' HD11 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -56.59 -63.39 1.21 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.184 -0.436 . . . . 2.58 110.846 176.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -60.51 -38.02 83.01 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.314 0.961 . . . . 2.35 111.527 -172.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.3 ttt85 -61.3 -49.62 76.28 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.122 -0.325 . . . . 3.62 110.122 175.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -51.42 -50.58 59.41 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.266 -0.642 . . . . 1.36 109.266 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.654 HG22 HG22 ' A' ' 54' ' ' VAL . 39.4 t -56.83 -50.11 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 O-C-N 121.972 -0.455 . . . . 0.38 110.982 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -53.19 -34.69 58.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.449 1.099 . . . . 1.47 112.01 175.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -68.69 -16.55 63.86 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.178 0.899 . . . . 2.19 113.397 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.2 mt -77.28 111.21 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 120.036 1.289 . . . . 1.44 109.865 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -50.49 -31.39 15.22 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.187 2.195 . . . . 2.89 113.448 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.16 -25.05 74.68 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.286 0.946 . . . . 0.8 113.629 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -96.64 162.82 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 119.027 1.414 . . . . 0.84 110.723 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.1 m -110.43 -56.71 2.31 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.763 -1.199 . . . . 0.6 107.763 171.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -137.19 164.7 27.87 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.82 -0.437 . . . . 2.13 109.82 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.432 ' CB ' HG11 ' A' ' 25' ' ' VAL . . . -154.72 137.31 15.14 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.828 -1.175 . . . . 0.66 107.828 172.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.4 mm -112.6 101.55 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.035 -1.098 . . . . 1.8 108.035 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.69 120.87 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 108.681 -0.859 . . . . 2.52 108.681 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 107.901 -1.148 . . . . 2.17 107.901 171.599 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 CA--C 1.533 0.312 0 CA-C-O 119.789 -0.148 . . . . 2.88 110.676 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -161.51 164.68 29.46 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.986 0.914 . . . . 4.13 110.056 -164.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.66 112.4 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.097 1.359 . . . . 0.76 108.089 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.7 m -88.25 147.7 24.7 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 123.746 0.819 . . . . 0.56 109.735 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.9 t -132.61 137.29 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 127.586 2.355 . . . . 1.05 105.729 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.3 m -145.89 101.17 3.51 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.798 -1.186 . . . . 0.99 107.798 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 178.77 -102.38 0.17 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 118.11 -1.995 . . . . 0.48 110.023 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -163.03 44.8 0.12 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.44 1.496 . . . . 2.44 108.278 172.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.03 169.62 17.31 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.329 1.052 . . . . 0.71 109.965 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.0 m -131.44 169.95 15.34 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.672 1.189 . . . . 0.64 110.066 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 tp -61.19 -30.59 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-O 117.363 -1.303 . . . . 1.74 112.727 -174.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -37.32 -52.76 1.1 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.892 1.223 . . . . 2.75 111.928 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -59.47 -46.77 87.82 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.742 0.645 . . . . 3.8 112.742 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.654 HG22 HG22 ' A' ' 25' ' ' VAL . 34.8 t -63.06 -42.72 97.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 123.694 0.797 . . . . 0.44 110.206 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.85 -52.75 64.09 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 127.154 2.182 . . . . 3.07 108.729 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -51.19 -52.36 45.07 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.622 -0.51 . . . . 2.95 109.622 173.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.43 74.8 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.803 -0.561 . . . . 0.59 110.721 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.0 -6.41 12.52 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.48 1.99 . . . . 0.45 113.867 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.37 -24.75 1.33 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.017 1.408 . . . . 0.69 112.071 171.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -54.52 -36.29 64.09 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.479 0.918 . . . . 2.09 113.479 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -121.92 -5.87 9.03 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.095 0.861 . . . . 2.35 113.088 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 68.55 58.0 0.42 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.24 1.016 . . . . 0.88 110.845 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.437 ' HG ' HD23 ' A' ' 12' ' ' LEU . 2.0 mm? -80.27 168.77 18.65 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.36 -0.838 . . . . 1.16 111.236 -176.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.92 68.25 1.51 Allowed 'General case' 0 C--N 1.343 0.322 0 CA-C-O 122.239 1.019 . . . . 4.23 110.061 -170.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.417 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 1.4 mt -81.82 139.61 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.49 -0.777 . . . . 0.53 110.288 -172.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.5 mt -129.25 133.42 25.13 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.224 1.009 . . . . 1.18 109.942 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.59 87.6 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.408 2.739 . . . . 0.89 111.592 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 N--CA 1.44 -0.973 0 C-N-CA 124.337 1.055 . . . . 3.18 109.268 169.776 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 108.155 -1.054 . . . . 3.5 108.155 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.0 m -150.55 140.59 22.03 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.077 -1.453 . . . . 0.94 107.077 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 p -127.47 140.92 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 124.195 0.934 . . . . 0.66 110.32 171.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -128.97 155.89 44.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.321 -1.363 . . . . 2.32 107.321 -174.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.0 ttt-85 -88.99 122.08 31.99 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.295 -0.859 . . . . 4.56 109.1 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.5 p -113.09 140.15 34.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 124.521 1.129 . . . . 0.77 108.033 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -153.28 164.81 37.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.853 -1.536 . . . . 3.47 106.853 -172.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.69 -54.6 0.54 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.467 1.032 . . . . 1.54 112.105 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.506 ' HB3' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -61.31 172.28 1.16 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.708 1.203 . . . . 2.67 113.142 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -168.44 67.62 0.07 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.723 -0.656 . . . . 2.93 111.498 170.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.1 t -160.03 133.69 7.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.817 1.19 . . . . 1.91 113.366 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 m -56.16 -49.88 72.73 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.342 1.457 . . . . 1.58 112.065 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -51.62 -45.14 63.14 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.661 0.744 . . . . 2.39 110.515 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.0 m -68.04 -37.9 81.87 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.001 -0.545 . . . . 1.04 110.567 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.42 -48.65 65.61 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.279 0.49 . . . . 0.79 110.605 170.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.48 -50.81 72.09 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.831 0.824 . . . . 0.74 109.193 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -53.67 -43.56 68.98 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.854 -0.612 . . . . 2.67 110.799 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.496 ' HZ ' HD11 ' A' ' 65' ' ' ILE . 1.3 t80 -65.77 -60.65 2.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.643 0.377 . . . . 2.51 111.199 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -56.55 -41.42 76.81 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 118.818 0.736 . . . . 2.9 110.614 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -60.01 -53.49 57.19 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 119.185 -0.436 . . . . 3.21 110.352 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.405 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 2.2 m120 -50.59 -46.73 58.06 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 118.672 0.669 . . . . 1.32 110.015 178.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.9 t -59.77 -49.15 84.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 109.713 -0.477 . . . . 0.57 109.713 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -55.32 -36.36 66.15 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.547 -0.721 . . . . 1.58 112.643 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -72.35 -6.99 47.18 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.425 0.898 . . . . 1.89 113.425 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.3 141.92 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 120.46 1.482 . . . . 1.83 109.274 171.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -88.7 128.45 35.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.46 -1.311 . . . . 3.67 107.46 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.14 -39.26 2.95 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.264 0.935 . . . . 2.03 112.097 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 p -64.71 159.38 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 121.578 -0.954 . . . . 0.96 110.615 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.2 m -115.25 -61.86 1.68 Allowed 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.333 1.053 . . . . 1.07 108.208 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -122.44 154.21 38.08 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.288 0.367 . . . . 2.54 111.338 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.9 137.89 19.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.867 -0.52 . . . . 0.48 110.101 169.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.4 mt -128.59 91.02 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 106.766 -1.568 . . . . 1.57 106.766 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.99 103.39 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.742 -0.836 . . . . 2.57 108.742 -176.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.4 m120 . . . . . 0 C--O 1.231 0.086 0 N-CA-C 106.316 -1.735 . . . . 1.86 106.316 174.893 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 119.855 -0.117 . . . . 2.58 111.19 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 169.77 24.04 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.459 0.704 . . . . 5.99 110.944 -172.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.401 HD13 ' C ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -129.33 117.35 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 124.588 1.155 . . . . 0.82 108.141 176.656 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.7 m -97.07 134.67 40.12 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 123.545 0.738 . . . . 0.44 109.571 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.34 145.33 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 126.305 1.842 . . . . 0.97 106.673 168.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.6 m -146.81 136.72 23.29 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 106.625 -1.62 . . . . 0.62 106.625 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.05 -90.23 0.17 Allowed Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 109.343 -1.503 . . . . 0.59 109.343 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -173.17 55.72 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.321 1.448 . . . . 2.54 110.178 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.35 160.14 43.92 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.692 -1.255 . . . . 0.57 110.79 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.9 m -111.57 167.01 10.66 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.713 1.605 . . . . 0.6 110.315 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.3 tp -56.43 -30.2 30.45 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 CA-C-O 117.763 -1.113 . . . . 1.75 113.191 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -33.06 -53.8 0.37 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.615 1.166 . . . . 2.44 112.224 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -63.52 -47.73 80.48 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.655 0.74 . . . . 2.38 111.685 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.34 -45.36 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.008 0.923 . . . . 0.38 110.078 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.87 -51.63 69.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.663 1.985 . . . . 2.66 109.108 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -53.56 -44.33 69.19 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.597 0.359 . . . . 3.07 110.477 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.405 ' HB1' ' OD1' ' A' ' 24' ' ' ASN . . . -58.03 -54.99 40.74 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.16 0.505 . . . . 0.44 110.47 169.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.96 -17.19 9.05 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 126.957 2.218 . . . . 0.39 114.088 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -38.86 -35.79 0.23 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.944 0.872 . . . . 0.7 111.921 162.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -54.54 -31.52 56.55 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.723 1.008 . . . . 1.98 113.723 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -122.35 4.24 9.7 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.954 1.301 . . . . 2.25 111.921 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 58.69 53.98 5.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.694 1.198 . . . . 1.18 110.629 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 12' ' ' LEU . 4.6 mm? -68.95 159.79 32.04 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.851 -0.531 . . . . 1.69 111.535 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.37 67.05 1.38 Allowed 'General case' 0 C--N 1.343 0.301 0 CA-C-O 121.42 0.628 . . . . 3.65 109.608 -172.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.496 HD11 ' HZ ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -81.56 140.28 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.069 -0.514 . . . . 0.68 109.888 -172.563 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 85.5 mt -127.66 132.35 24.29 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.164 0.986 . . . . 1.23 108.942 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.99 105.03 1.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.124 2.549 . . . . 0.88 110.033 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 123.674 0.79 . . . . 3.36 111.001 177.812 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.155 0 N-CA-C 110.811 -0.07 . . . . 4.27 110.811 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.9 m -155.35 162.12 40.9 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.592 -1.262 . . . . 0.95 107.592 174.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.54 148.94 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 O-C-N 123.453 0.471 . . . . 0.54 111.531 164.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -135.56 143.49 45.7 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.069 1.348 . . . . 1.95 107.954 -170.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -91.57 126.93 36.83 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.576 0.625 . . . . 4.59 110.132 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.32 154.43 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 C-N-CA 123.929 0.892 . . . . 0.76 109.213 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.422 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . 51.0 t0 -147.15 158.23 43.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.783 -0.821 . . . . 2.71 108.783 171.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.62 -56.82 0.68 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 125.16 1.362 . . . . 1.6 111.06 164.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.98 173.72 4.32 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.9 0.88 . . . . 2.4 112.483 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.3 p -162.82 63.01 0.2 Allowed 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.882 -0.511 . . . . 3.04 110.193 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.3 t -155.52 118.49 4.31 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.241 0.473 . . . . 1.87 111.709 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.1 t -52.87 -38.95 62.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.375 0.67 . . . . 2.24 111.354 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -56.23 -39.28 72.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.642 -0.661 . . . . 2.91 110.707 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.5 m -70.53 -39.9 73.78 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.786 -0.572 . . . . 0.79 110.373 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.05 -43.77 74.1 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.787 0.722 . . . . 0.66 110.764 171.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.74 -49.58 74.47 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.709 0.404 . . . . 0.62 110.344 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.4 tptt -49.76 -48.11 50.48 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.146 0.579 . . . . 3.1 109.668 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -56.08 -64.05 0.98 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.443 1.097 . . . . 2.72 111.148 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -56.33 -38.2 71.02 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.129 1.331 . . . . 2.64 111.85 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -63.61 -51.05 66.95 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.348 0.659 . . . . 2.82 111.38 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -53.96 -44.33 70.66 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.629 -0.669 . . . . 1.4 110.27 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 54' ' ' VAL . 89.8 t -61.54 -48.14 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 122.777 0.431 . . . . 0.41 110.274 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -54.01 -34.92 61.2 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.801 0.84 . . . . 1.58 112.825 175.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -62.31 -23.95 67.03 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.763 0.711 . . . . 3.04 112.355 174.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.425 HG22 ' H ' ' A' ' 30' ' ' GLY . 41.9 mt -70.81 131.69 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 O-C-N 120.963 -1.086 . . . . 1.33 108.777 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -75.75 -28.2 58.38 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.21 1.004 . . . . 3.01 112.722 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.425 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -68.74 -29.36 72.7 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.827 0.727 . . . . 0.86 113.013 -176.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 p -89.59 166.95 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 118.633 1.217 . . . . 0.63 109.356 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.0 m -124.02 -61.25 1.38 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.825 -1.176 . . . . 0.57 107.825 173.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -129.17 111.12 12.6 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.195 -0.668 . . . . 2.68 109.195 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.22 131.96 49.85 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.147 -1.057 . . . . 0.5 108.147 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.7 mm -109.54 97.91 6.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.035 -1.839 . . . . 1.72 106.035 176.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -97.9 136.29 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 109.241 -0.651 . . . . 2.21 109.241 -175.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 . . . . . 0 N--CA 1.456 -0.141 0 N-CA-C 108.736 -0.838 . . . . 2.66 108.736 171.398 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.0 m . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 109.871 -0.418 . . . . 2.85 109.871 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -157.91 178.12 10.58 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.515 -0.741 . . . . 3.83 110.93 -167.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.4 111.94 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 125.466 1.506 . . . . 0.75 108.318 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.0 m -90.17 141.78 28.36 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 123.675 0.79 . . . . 0.55 109.168 171.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 69.2 t -120.95 130.15 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 127.115 2.166 . . . . 0.81 105.249 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.7 m -133.78 142.26 47.82 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 106.781 -1.563 . . . . 0.78 106.781 163.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.93 -102.54 0.23 Allowed Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 104.18 -3.568 . . . . 0.53 104.18 175.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -160.05 45.67 0.23 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.581 0.752 . . . . 3.1 110.983 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.07 176.21 9.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.003 0.921 . . . . 0.51 111.12 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.4 m -126.03 166.64 16.6 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.934 1.694 . . . . 0.58 110.757 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.42 HD11 HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -49.52 -39.97 14.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-O 117.016 -1.469 . . . . 2.52 111.402 178.415 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -29.58 -53.5 0.14 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.419 1.488 . . . . 2.47 113.195 -177.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -66.03 -44.5 84.49 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.358 0.599 . . . . 2.21 112.282 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 25' ' ' VAL . 14.7 t -58.4 -36.62 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.517 1.127 . . . . 0.34 110.895 171.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.35 -55.45 33.42 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 107.988 -1.116 . . . . 2.77 107.988 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.1 tp60 -52.31 -44.86 65.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.466 1.106 . . . . 3.98 110.509 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.4 -55.46 34.76 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.625 0.77 . . . . 0.44 111.049 171.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.2 -15.84 39.12 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 125.636 1.588 . . . . 0.27 113.41 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.96 -25.25 0.19 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.167 -0.92 . . . . 0.54 112.699 165.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -51.38 -40.32 58.98 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.914 1.234 . . . . 1.88 112.901 172.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -111.04 -13.07 14.13 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.31 1.044 . . . . 2.92 111.81 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 76.32 49.01 0.07 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.367 1.467 . . . . 0.88 110.095 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 63' ' ' LEU . 4.4 mm? -67.32 159.83 28.47 Favored 'General case' 0 N--CA 1.462 0.142 0 O-C-N 121.648 -0.657 . . . . 1.35 111.804 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HD2' ' HB3' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -124.02 112.71 17.49 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 106.477 -1.675 . . . . 4.43 106.477 174.195 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.42 HD12 HD11 ' A' ' 51' ' ' ILE . 0.9 OUTLIER -117.56 130.86 71.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.528 -0.915 . . . . 0.67 108.528 -178.228 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 49.0 mm -108.4 126.9 28.54 Favored Pre-proline 0 N--CA 1.452 -0.345 0 C-N-CA 125.07 1.348 . . . . 1.56 108.593 -174.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.67 97.69 0.73 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.641 2.227 . . . . 0.64 109.08 171.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 . . . . . 0 CA--C 1.537 0.471 0 C-N-CA 120.17 -0.612 . . . . 3.66 110.092 173.087 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 pttp . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 109.974 -0.38 . . . . 3.24 109.974 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.2 m -148.28 150.07 32.99 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.367 -1.345 . . . . 0.52 107.367 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.82 140.18 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 O-C-N 123.901 0.751 . . . . 0.39 111.542 169.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -122.95 148.68 45.2 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.41 -1.7 . . . . 1.9 106.41 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.89 150.55 26.43 Favored 'General case' 0 N--CA 1.461 0.122 0 N-CA-C 108.31 -0.996 . . . . 6.62 108.31 173.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.67 146.78 23.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.478 0.711 . . . . 0.57 109.413 170.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.4 167.07 22.92 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.005 1.322 . . . . 2.42 107.923 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 120.44 -75.63 0.32 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.691 1.139 . . . . 1.65 111.156 173.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.474 HD22 ' HB3' ' A' ' 17' ' ' CYS . 1.6 pp -68.8 157.41 36.49 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-N 117.088 0.444 . . . . 2.67 109.855 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 p -146.83 62.15 1.2 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.29 0.636 . . . . 2.81 110.176 -176.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 t -160.03 123.08 3.48 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.715 0.635 . . . . 1.81 112.715 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.7 m -48.66 -45.0 38.2 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.672 1.189 . . . . 1.73 111.908 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -57.3 -36.65 71.33 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.755 -0.59 . . . . 3.18 111.24 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.474 ' HB3' HD22 ' A' ' 12' ' ' LEU . 20.5 m -70.15 -41.0 74.44 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 122.055 -0.403 . . . . 0.9 110.034 177.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.81 -47.74 73.66 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.01 0.368 . . . . 0.78 110.117 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.92 -52.34 65.88 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.756 0.822 . . . . 0.71 110.823 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -50.31 -52.3 37.89 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.105 0.962 . . . . 2.21 109.793 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -52.19 -62.1 1.85 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 118.571 -0.728 . . . . 2.71 111.571 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.55 -40.62 79.3 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.262 0.937 . . . . 2.66 110.975 -173.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.2 mtt180 -52.71 -56.01 18.57 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.774 0.716 . . . . 3.91 110.468 171.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -51.57 -43.38 62.42 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.355 0.597 . . . . 2.37 110.252 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.549 HG22 HG22 ' A' ' 54' ' ' VAL . 92.4 t -61.95 -50.08 81.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 C-N-CA 123.254 0.622 . . . . 0.48 111.141 175.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -57.75 -27.86 63.41 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.008 1.323 . . . . 1.92 112.318 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -68.36 -22.55 64.66 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.845 0.748 . . . . 2.21 112.825 171.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.7 mt -69.33 132.69 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.624 1.102 . . . . 1.36 108.13 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -74.32 -32.62 62.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.652 0.781 . . . . 2.76 112.446 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.15 -36.54 90.9 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.063 0.839 . . . . 0.91 112.435 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 p -86.31 159.1 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 O-C-N 121.115 -1.226 . . . . 0.63 109.937 -176.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -117.93 -57.34 2.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.858 1.263 . . . . 0.57 108.15 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -127.87 144.97 51.08 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.048 -0.661 . . . . 2.28 111.315 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.64 131.57 31.72 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.87 -0.789 . . . . 0.5 108.87 171.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mp -114.88 78.99 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 107.746 -1.205 . . . . 2.01 107.746 -173.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 m -84.08 136.51 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 115.636 -0.711 . . . . 2.14 110.821 -167.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.1 m120 . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 105.995 -1.854 . . . . 2.05 105.995 179.097 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 120.619 0.247 . . . . 2.48 111.271 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.59 172.51 18.43 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 112.831 0.678 . . . . 6.53 112.831 -161.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.31 112.43 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 106.776 -1.565 . . . . 0.71 106.776 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.8 m -92.78 135.94 33.67 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.221 -1.029 . . . . 0.53 108.221 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.53 142.31 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.237 1.815 . . . . 0.74 106.789 173.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.3 m -147.44 136.95 22.71 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 106.983 -1.488 . . . . 0.72 106.983 176.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.76 -94.75 0.16 Allowed Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 106.12 -2.792 . . . . 0.53 106.12 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -165.11 56.33 0.12 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.223 1.809 . . . . 2.5 108.984 173.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.09 170.6 15.64 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.072 -1.017 . . . . 0.65 110.945 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.2 m -129.62 160.66 32.62 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.387 1.475 . . . . 0.69 110.319 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 tp -53.41 -33.71 21.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 CA-C-O 117.299 -1.334 . . . . 1.71 113.059 -172.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -35.07 -48.15 0.41 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.826 1.194 . . . . 3.63 112.089 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -62.38 -49.74 74.33 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.169 0.985 . . . . 2.42 111.223 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.549 HG22 HG22 ' A' ' 25' ' ' VAL . 45.7 t -63.22 -38.52 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.884 1.274 . . . . 0.28 110.581 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -67.41 -46.64 72.61 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.833 1.653 . . . . 2.96 108.329 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -51.87 -52.6 48.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.798 0.439 . . . . 3.22 109.93 172.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.85 -51.31 52.63 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.508 0.595 . . . . 0.4 110.872 170.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.54 -13.9 18.9 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 125.373 1.464 . . . . 0.27 113.911 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.68 -25.92 1.36 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.751 1.275 . . . . 0.42 111.813 168.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -51.81 -31.43 27.33 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.478 1.036 . . . . 2.03 113.322 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -133.98 -6.25 2.74 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.802 1.038 . . . . 2.31 113.802 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 74.03 60.02 0.08 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.354 1.462 . . . . 0.82 111.106 173.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.98 161.86 25.23 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.701 -0.625 . . . . 1.36 110.466 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.67 72.31 1.33 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 107.508 -1.293 . . . . 4.47 107.508 -170.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 mt -82.24 135.49 24.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.2 -1.363 . . . . 0.51 109.247 -172.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 38.8 mm -124.89 127.41 25.12 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 123.629 0.771 . . . . 2.25 110.268 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.23 103.3 1.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.912 2.408 . . . . 0.65 110.108 174.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 N--CA 1.44 -0.94 0 C-N-CA 125.812 1.645 . . . . 4.82 110.5 170.985 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.178 0 N-CA-C 109.996 -0.372 . . . . 3.91 109.996 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.8 m -155.58 162.02 40.73 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.551 -0.907 . . . . 0.63 108.551 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.62 142.47 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 O-C-N 123.535 0.522 . . . . 0.46 110.962 165.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.466 ' CD1' HD13 ' A' ' 51' ' ' ILE . 35.1 m-85 -126.88 154.57 44.25 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.217 1.407 . . . . 1.93 108.665 -171.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -92.02 114.63 27.23 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 118.574 -0.726 . . . . 3.7 109.209 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 p -100.63 137.08 29.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.797 0.839 . . . . 0.47 109.025 174.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.64 156.4 46.86 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.322 -0.992 . . . . 2.4 108.322 171.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 133.2 -74.71 0.43 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.386 -1.485 . . . . 1.39 109.386 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.64 171.14 9.88 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.007 0.743 . . . . 2.61 113.007 -174.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.3 m -158.22 83.08 0.85 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.263 1.425 . . . . 3.84 109.649 175.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.4 t -158.25 137.6 11.75 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.055 0.843 . . . . 1.9 112.158 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.3 m -61.19 -47.05 87.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.03 0.932 . . . . 1.48 111.305 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -60.15 -40.35 89.54 Favored 'General case' 0 C--O 1.233 0.196 0 O-C-N 121.164 -0.96 . . . . 2.69 110.265 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.1 m -60.77 -44.72 96.4 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.019 -0.426 . . . . 0.9 109.999 173.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.78 -46.72 71.11 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.404 0.282 . . . . 0.72 110.493 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.14 -50.55 72.45 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.952 0.501 . . . . 0.69 109.915 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.22 -50.07 40.07 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.235 0.614 . . . . 2.16 109.996 174.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.554 ' O ' HG23 ' A' ' 25' ' ' VAL . 2.8 t80 -64.2 -57.58 9.08 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.081 0.552 . . . . 2.63 110.513 -173.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -59.05 -41.13 87.14 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.866 -0.733 . . . . 2.13 110.142 -176.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -61.87 -50.01 73.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.994 -0.527 . . . . 3.8 109.897 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -48.22 -50.58 28.89 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.614 -0.513 . . . . 1.62 109.614 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.563 HG22 HG22 ' A' ' 54' ' ' VAL . 18.7 t -57.74 -52.15 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 110.395 -0.224 . . . . 0.51 110.395 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -49.35 -39.74 32.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.503 1.121 . . . . 2.16 111.605 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -67.49 -19.96 65.4 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.872 0.693 . . . . 2.08 112.872 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.594 HG22 ' H ' ' A' ' 30' ' ' GLY . 19.9 mt -76.12 122.22 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 119.857 1.208 . . . . 1.35 109.552 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -66.52 -18.67 65.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.745 1.218 . . . . 2.67 113.648 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.594 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -70.45 -34.2 68.17 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 123.51 0.576 . . . . 0.9 111.978 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.512 HG11 HG12 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -92.92 -173.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 O-C-N 121.799 -0.824 . . . . 0.87 110.542 -172.125 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.0 m -132.93 -62.0 0.82 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.834 -1.172 . . . . 0.83 107.834 170.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -120.64 164.48 16.45 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.076 0.465 . . . . 4.14 111.982 175.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.462 ' CB ' HG11 ' A' ' 25' ' ' VAL . . . -158.25 136.56 10.9 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.987 -1.006 . . . . 0.5 109.898 168.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 35' ' ' ILE . 3.4 mp -119.78 101.36 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 O-C-N 124.686 1.241 . . . . 1.73 107.812 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.5 p -84.96 137.16 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.588 0.755 . . . . 2.33 109.792 175.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 . . . . . 0 N--CA 1.465 0.283 0 CA-C-N 118.838 0.745 . . . . 2.78 109.747 165.752 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 119.444 -0.312 . . . . 2.48 110.174 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -158.51 165.8 33.7 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.619 0.768 . . . . 3.49 111.103 -173.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.45 119.11 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.63 1.172 . . . . 0.77 109.848 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.7 m -94.13 145.79 24.44 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.558 1.143 . . . . 0.54 111.098 175.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 90.0 t -131.75 134.22 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 127.557 2.343 . . . . 1.0 105.871 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.1 m -145.71 75.46 1.43 Allowed 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 120.707 -1.245 . . . . 1.39 108.461 -173.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -157.92 -117.31 0.51 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 108.065 -2.014 . . . . 1.19 108.065 173.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.02 59.08 1.3 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.769 1.227 . . . . 4.31 108.185 177.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.73 162.02 41.07 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.686 -0.634 . . . . 0.5 110.063 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.9 m -110.92 161.43 15.85 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.343 1.457 . . . . 0.59 110.339 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.466 HD13 ' CD1' ' A' ' 7' ' ' TYR . 6.1 tp -51.21 -36.52 16.79 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 117.732 -1.128 . . . . 1.92 113.154 -175.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -35.52 -47.37 0.45 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.685 1.194 . . . . 3.38 113.393 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -67.49 -39.73 85.21 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.361 -0.837 . . . . 2.35 111.659 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.563 HG22 HG22 ' A' ' 25' ' ' VAL . 43.7 t -68.05 -44.01 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.202 1.001 . . . . 0.38 109.524 178.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -53.37 -48.65 68.4 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.107 2.163 . . . . 2.8 109.163 174.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -52.9 -52.22 58.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.637 0.775 . . . . 4.02 110.605 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.29 -49.23 70.1 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.098 0.863 . . . . 0.6 110.666 172.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.78 -13.6 4.54 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.131 1.348 . . . . 0.46 113.957 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.69 -32.75 1.06 Allowed 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.545 1.173 . . . . 0.72 111.565 165.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -49.18 -37.01 21.1 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.656 0.984 . . . . 1.9 113.656 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -125.43 12.09 8.08 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.217 1.007 . . . . 2.84 111.127 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 60.77 47.91 7.52 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.805 1.242 . . . . 1.15 110.467 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 mp -65.15 153.04 42.06 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.524 -0.307 . . . . 2.33 110.764 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.65 108.65 11.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.612 -1.996 . . . . 3.6 105.612 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.551 HD11 ' HZ ' ' A' ' 21' ' ' PHE . 1.5 mt -112.55 126.29 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.481 -0.933 . . . . 0.57 108.481 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 mp -104.56 131.16 22.11 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 108.133 -1.062 . . . . 1.3 108.133 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.33 105.02 0.81 Allowed 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.783 1.656 . . . . 0.78 107.875 165.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 121.288 0.566 . . . . 4.41 111.195 171.619 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 108.799 -0.815 . . . . 3.86 108.799 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.0 m -149.48 154.41 38.76 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 107.804 -1.184 . . . . 0.59 107.804 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.34 140.07 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 O-C-N 124.431 1.082 . . . . 0.49 109.905 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -129.41 136.93 50.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.23 -1.396 . . . . 1.9 107.23 -167.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -84.56 133.11 34.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 118.189 -0.91 . . . . 4.69 109.384 -174.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -120.54 145.53 26.8 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 C-N-CA 124.63 1.172 . . . . 0.66 109.842 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -139.42 150.76 45.63 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.899 -1.519 . . . . 2.4 106.899 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.76 -71.11 0.42 Allowed Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.471 1.034 . . . . 1.41 110.729 168.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.98 165.92 8.24 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.265 1.026 . . . . 2.32 112.106 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.2 p -161.62 64.91 0.26 Allowed 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.875 -0.516 . . . . 2.84 110.055 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.6 t -159.34 134.59 8.3 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 110.047 -0.353 . . . . 1.83 110.047 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.7 p -53.34 -48.13 68.75 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.12 0.968 . . . . 2.18 109.89 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -43.4 -51.11 6.67 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.302 1.041 . . . . 2.53 111.772 173.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.4 m -64.06 -45.63 87.94 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 109.988 -0.375 . . . . 0.8 109.988 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -46.97 73.22 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.567 0.222 . . . . 0.55 111.401 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.45 -48.98 78.65 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.326 1.05 . . . . 0.58 109.86 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -53.77 -48.19 69.99 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.724 -0.473 . . . . 4.23 109.724 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.76 -59.81 4.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.695 0.798 . . . . 2.37 111.573 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -56.88 -41.22 77.64 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 119.347 -0.941 . . . . 2.73 109.961 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -60.04 -48.43 81.76 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 119.275 -0.393 . . . . 3.22 110.165 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -49.06 -51.77 29.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.072 0.397 . . . . 1.34 110.001 172.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 54' ' ' VAL . 45.2 t -59.11 -48.04 88.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 O-C-N 122.027 -0.421 . . . . 0.34 110.76 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -54.47 -37.06 64.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.739 1.215 . . . . 1.48 112.086 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -65.31 -18.54 65.39 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.895 0.77 . . . . 2.09 112.963 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.1 mt -76.88 115.92 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 119.79 1.177 . . . . 1.22 109.538 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -77.68 60.76 2.26 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.595 1.958 . . . . 3.92 110.097 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -154.15 -36.72 0.03 OUTLIER Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.205 1.859 . . . . 0.81 111.965 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.94 172.31 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 121.46 -1.024 . . . . 0.68 109.124 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.2 m -121.58 -60.71 1.59 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.682 1.193 . . . . 0.68 108.032 171.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -122.89 134.33 54.38 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 109.887 -0.412 . . . . 2.1 109.887 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.19 126.09 42.21 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.149 -1.056 . . . . 0.45 108.149 171.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.19 95.07 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 105.408 -2.071 . . . . 2.22 105.408 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -91.79 141.38 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 120.398 -0.521 . . . . 2.05 109.856 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 . . . . . 0 CA--C 1.529 0.161 0 N-CA-C 107.951 -1.129 . . . . 1.73 107.951 168.894 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.9 m . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 111.823 0.305 . . . . 2.73 111.823 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.457 ' NZ ' ' OE1' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -158.27 167.75 28.92 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.36 1.064 . . . . 4.01 109.98 -173.476 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.67 119.48 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 125.544 1.537 . . . . 0.82 108.386 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.1 m -96.83 144.76 26.49 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 118.313 0.506 . . . . 0.48 110.099 172.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.27 138.84 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 127.116 2.166 . . . . 0.75 106.87 174.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.4 m -145.47 134.47 22.61 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.536 -1.653 . . . . 0.69 106.536 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.55 -94.98 0.16 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 107.348 -2.301 . . . . 0.52 107.348 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -164.3 50.07 0.12 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.337 1.455 . . . . 2.57 109.349 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.14 173.71 11.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.897 0.879 . . . . 0.67 110.414 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.0 m -137.89 169.73 17.29 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.071 1.348 . . . . 0.9 111.039 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.468 ' O ' HD13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -50.46 -40.61 18.82 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 CA-C-O 117.222 -1.37 . . . . 2.65 110.694 -179.221 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -34.63 -49.8 0.43 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.681 1.582 . . . . 4.19 113.773 -176.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -68.77 -45.39 71.5 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.441 0.639 . . . . 2.19 112.035 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 25' ' ' VAL . 21.9 t -57.32 -33.84 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.271 1.028 . . . . 0.37 110.593 174.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -59.98 -57.29 13.48 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.667 1.587 . . . . 3.07 106.863 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -53.84 -47.34 71.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.868 -1.06 . . . . 3.26 110.01 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.62 -52.2 49.57 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.848 -0.532 . . . . 0.42 111.191 171.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.52 -9.7 26.17 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.64 1.114 . . . . 0.34 112.643 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.34 -23.68 3.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 119.151 1.476 . . . . 0.47 111.478 169.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -52.11 -32.11 33.78 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.277 0.944 . . . . 2.01 112.76 172.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -136.96 10.48 3.07 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.819 0.848 . . . . 2.49 112.682 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 57.33 65.75 1.3 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.855 1.262 . . . . 1.29 111.655 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.404 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.2 mm? -77.19 -166.53 0.73 Allowed 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.848 -0.533 . . . . 1.32 110.959 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.401 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -155.53 62.65 0.61 Allowed 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 120.49 -1.381 . . . . 4.63 107.5 -179.643 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.465 HD12 HD11 ' A' ' 51' ' ' ILE . 1.1 mt -79.86 137.8 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.359 -1.291 . . . . 0.61 109.299 -173.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.9 mt -127.19 136.28 28.65 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 124.194 0.997 . . . . 1.31 109.599 -174.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.18 83.67 0.35 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.979 2.453 . . . . 0.82 110.968 172.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.457 ' OE1' ' NZ ' ' A' ' 42' ' ' LYS . 5.1 tt0 . . . . . 0 CA--C 1.542 0.671 0 C-N-CA 126.526 1.931 . . . . 3.52 109.969 167.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 107.361 -1.348 . . . . 4.38 107.361 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.7 m -155.1 151.97 28.95 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.372 -1.344 . . . . 0.78 107.372 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -119.3 141.12 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 O-C-N 124.448 1.092 . . . . 0.68 110.535 162.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -122.32 152.86 39.67 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.914 1.685 . . . . 1.79 106.746 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -94.26 134.71 36.45 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.41 1.005 . . . . 3.87 110.704 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 p -112.58 135.85 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 O-C-N 124.322 1.014 . . . . 0.64 109.71 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -135.82 172.08 13.52 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.147 0.43 . . . . 2.98 110.593 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.41 -47.43 2.6 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.43 1.491 . . . . 1.62 112.129 176.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.49 167.28 2.66 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.475 0.71 . . . . 2.55 112.863 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.5 t -165.99 64.19 0.11 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.869 0.468 . . . . 2.91 111.125 172.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.8 t -156.85 134.68 10.94 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 120.949 -1.094 . . . . 2.05 110.582 171.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.411 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 91.4 m -68.18 -44.92 74.82 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 122.114 -0.367 . . . . 2.16 110.918 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -56.19 -40.52 74.11 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.141 -0.974 . . . . 2.74 110.803 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.0 m -55.82 -32.98 64.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.037 0.535 . . . . 0.82 111.364 174.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 15' ' ' THR . . . -60.46 -41.96 95.21 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 122.843 0.457 . . . . 0.52 109.839 176.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.37 -45.34 91.59 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.635 0.731 . . . . 0.52 109.078 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.2 tmtp? -52.1 -46.63 65.35 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.749 -0.659 . . . . 2.86 109.325 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.619 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -61.97 -58.21 8.75 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 119.007 -0.52 . . . . 2.58 112.325 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -54.27 -47.94 71.77 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.873 -0.788 . . . . 2.6 108.873 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 ttt-85 -63.03 -50.61 70.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.704 -0.48 . . . . 4.25 109.704 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.605 HD22 ' HB1' ' A' ' 57' ' ' ALA . 29.0 m-20 -49.34 -47.77 47.09 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 117.904 0.32 . . . . 1.39 110.265 175.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 21' ' ' PHE . 19.5 t -62.51 -49.4 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 122.088 -0.383 . . . . 0.5 110.102 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -50.95 -35.66 34.68 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.9 0.88 . . . . 2.27 112.162 173.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -70.36 -12.76 61.8 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.322 0.86 . . . . 2.87 113.322 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.679 HG22 ' H ' ' A' ' 30' ' ' GLY . 36.3 mt -78.54 131.51 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 120.199 1.363 . . . . 1.41 109.791 177.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -86.3 20.77 2.26 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.638 1.975 . . . . 3.55 112.494 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.679 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -122.62 -12.87 4.87 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.845 1.212 . . . . 1.13 112.54 -178.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -115.67 157.17 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 C-N-CA 125.332 1.453 . . . . 0.6 107.433 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.9 m -109.32 -60.08 1.81 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.708 1.203 . . . . 0.65 108.454 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -117.27 148.62 41.51 Favored 'General case' 0 N--CA 1.462 0.125 0 O-C-N 123.207 0.317 . . . . 2.94 110.589 175.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.416 ' CB ' HG11 ' A' ' 25' ' ' VAL . . . -150.58 129.68 12.68 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.71 -0.478 . . . . 0.58 109.71 172.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.3 mt -130.19 102.49 7.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 107.269 -1.382 . . . . 1.33 107.269 -174.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 p -88.94 144.73 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 122.938 0.495 . . . . 1.99 110.81 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 . . . . . 0 CA--C 1.536 0.418 0 C-N-CA 125.076 1.351 . . . . 1.98 108.465 176.735 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.441 -0.888 0 N-CA-C 106.148 -1.797 . . . . 5.46 106.148 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -153.63 140.29 18.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.678 -0.489 . . . . 5.63 109.678 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.89 114.78 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.263 1.025 . . . . 0.78 108.627 174.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.1 m -87.58 133.09 33.86 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 123.811 0.845 . . . . 0.55 109.034 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.4 t -121.91 140.52 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 126.657 1.983 . . . . 0.7 105.797 171.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.9 m -147.98 135.3 20.54 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.535 -1.283 . . . . 0.78 107.535 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.03 -96.46 0.16 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 106.509 -2.636 . . . . 0.56 106.509 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.4 49.24 0.26 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.611 1.164 . . . . 4.12 109.411 169.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.17 174.32 11.7 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.843 0.857 . . . . 0.73 111.131 177.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -125.05 170.57 11.04 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.926 1.691 . . . . 0.78 111.557 -174.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.4 tp -52.47 -37.61 24.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-O 117.513 -1.232 . . . . 1.77 112.269 -177.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -31.7 -52.47 0.24 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.019 1.328 . . . . 3.24 112.365 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -58.98 -50.75 72.89 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.584 1.183 . . . . 2.25 111.675 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.568 HG12 ' CZ ' ' A' ' 21' ' ' PHE . 65.1 t -61.89 -44.77 99.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.935 1.694 . . . . 0.48 110.433 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -63.29 -45.08 93.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.531 1.532 . . . . 3.55 109.495 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -51.58 -51.04 58.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.235 -0.654 . . . . 4.11 109.235 172.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.605 ' HB1' HD22 ' A' ' 24' ' ' ASN . . . -53.3 -48.97 67.92 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.912 -0.492 . . . . 0.38 110.682 173.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.02 -9.22 7.01 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.873 1.702 . . . . 0.31 113.96 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.53 -29.18 1.67 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.497 1.148 . . . . 0.47 111.49 166.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -51.69 -35.56 43.21 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.344 0.974 . . . . 1.95 113.555 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -121.61 4.73 10.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.41 1.084 . . . . 2.47 111.472 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 59.24 52.51 6.0 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.631 1.172 . . . . 1.07 110.054 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.22 158.03 29.91 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.575 -0.284 . . . . 2.18 110.481 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.75 119.2 25.24 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.747 -1.205 . . . . 3.95 107.747 167.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.0 mt -120.54 139.36 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.171 1.388 . . . . 0.49 107.97 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mp -128.28 133.31 25.01 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 108.358 -0.978 . . . . 1.39 108.358 -176.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.53 112.53 3.06 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.337 2.025 . . . . 0.84 108.87 170.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 . . . . . 0 CA--C 1.532 0.285 0 C-N-CA 123.657 0.783 . . . . 3.24 111.27 172.341 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 107.639 -1.245 . . . . 4.64 107.639 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.7 m -150.15 156.53 41.78 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.579 -1.267 . . . . 0.58 107.579 174.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 p -137.21 139.65 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 123.761 0.663 . . . . 0.42 110.326 168.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -125.18 145.84 49.78 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.011 1.325 . . . . 2.32 108.156 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.18 125.18 32.63 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 118.307 -0.854 . . . . 3.64 109.484 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 p -115.92 132.59 64.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 C-N-CA 123.34 0.656 . . . . 0.64 110.132 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -135.09 166.85 22.12 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.38 1.472 . . . . 3.09 108.661 -175.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.23 -50.84 0.98 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.908 1.242 . . . . 1.31 111.407 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.04 161.48 4.03 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.735 1.214 . . . . 3.25 113.417 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.1 p -172.45 51.03 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.746 0.647 . . . . 3.17 112.746 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -160.86 143.0 12.46 Favored 'General case' 0 C--N 1.346 0.426 0 O-C-N 120.76 -1.212 . . . . 2.0 113.656 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.8 m -63.32 -49.32 74.41 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.074 0.95 . . . . 1.82 111.661 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -55.05 -40.49 70.34 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.571 -0.706 . . . . 4.46 110.674 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.0 m -64.56 -43.26 94.49 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 122.136 -0.352 . . . . 0.95 110.771 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.99 -48.58 64.36 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.009 0.368 . . . . 0.96 110.173 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.53 -51.49 69.23 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.715 0.806 . . . . 0.86 110.332 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -49.9 -44.98 50.39 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.872 0.469 . . . . 2.55 109.978 175.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.414 ' HZ ' HD11 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -64.65 -58.49 6.16 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.22 -0.895 . . . . 2.51 111.536 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -51.98 -45.19 64.36 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.55 1.068 . . . . 3.53 108.91 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -61.61 -59.06 5.77 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.344 0.658 . . . . 5.54 111.082 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.475 ' HB3' ' HB1' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -49.67 -48.11 49.68 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.016 -0.735 . . . . 1.61 109.016 -178.668 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.403 HG22 HG13 ' A' ' 54' ' ' VAL . 90.5 t -60.76 -48.24 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 122.994 0.518 . . . . 0.76 110.546 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -56.07 -36.06 67.67 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.663 1.185 . . . . 2.45 111.992 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.14 -9.71 58.53 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.255 0.835 . . . . 2.38 113.255 175.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.1 mm -78.69 110.52 14.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 120.039 1.291 . . . . 2.19 110.587 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.61 85.7 0.07 Allowed 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.166 1.786 . . . . 3.44 108.584 165.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.38 -42.1 0.12 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 109.865 -1.294 . . . . 0.96 109.865 -177.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -97.92 151.29 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 108.642 -0.873 . . . . 0.97 108.642 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.3 m -106.28 -55.95 2.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.943 1.297 . . . . 0.6 108.09 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -121.44 125.44 46.9 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.948 -0.76 . . . . 3.36 108.948 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.82 136.89 47.85 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.292 -1.003 . . . . 0.63 108.292 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.8 mt -129.39 110.84 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.871 -1.159 . . . . 1.27 107.871 -176.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.6 p -95.24 111.48 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 118.413 0.551 . . . . 2.04 111.37 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 C--N 1.341 0.228 0 N-CA-C 106.953 -1.499 . . . . 2.19 106.953 167.266 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 110.258 -0.275 . . . . 2.61 110.258 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -157.79 155.73 30.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.812 -0.555 . . . . 3.37 110.731 -163.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.28 117.46 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 125.69 1.596 . . . . 0.81 108.367 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.3 m -89.18 144.63 25.97 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.727 0.811 . . . . 0.54 109.921 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.96 132.43 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 127.163 2.185 . . . . 0.73 106.617 175.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.9 m -143.27 132.41 23.11 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.996 -1.483 . . . . 0.88 106.996 173.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.9 -90.07 0.12 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.982 -1.647 . . . . 0.76 108.982 177.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -165.41 54.65 0.11 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.72 1.608 . . . . 2.88 109.208 167.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.88 174.68 10.36 Favored 'General case' 0 C--N 1.34 0.172 0 O-C-N 121.032 -1.042 . . . . 0.69 112.175 -176.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.1 m -134.61 166.35 23.11 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.454 1.501 . . . . 0.59 110.518 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.803 HD11 HD12 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -48.1 -44.5 12.12 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.877 0 CA-C-O 117.199 -1.381 . . . . 2.73 111.098 -178.802 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -31.7 -47.93 0.14 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.054 1.741 . . . . 2.79 114.113 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -66.73 -46.51 75.22 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.671 0.748 . . . . 2.76 111.32 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.403 HG13 HG22 ' A' ' 25' ' ' VAL . 25.1 t -62.1 -31.47 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.993 1.317 . . . . 0.43 111.161 172.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -60.24 -55.5 33.03 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.253 1.421 . . . . 3.19 107.274 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.06 -48.06 76.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.374 -0.83 . . . . 3.69 110.3 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.475 ' HB1' ' HB3' ' A' ' 24' ' ' ASN . . . -50.04 -51.1 44.95 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.414 0.552 . . . . 0.63 110.793 172.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.18 -10.7 29.07 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.112 -0.826 . . . . 0.28 113.533 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.04 -30.18 4.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.857 1.328 . . . . 0.59 112.24 172.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -57.57 -28.18 63.35 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.464 1.029 . . . . 2.22 113.213 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -128.38 -5.75 5.36 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.131 0.973 . . . . 3.09 112.471 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 63.22 61.39 1.08 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.715 1.206 . . . . 1.24 111.018 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 63' ' ' LEU . 2.0 mm? -82.19 169.37 16.68 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 121.891 -0.506 . . . . 1.02 110.495 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.05 70.8 1.42 Allowed 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.114 -1.069 . . . . 4.54 108.114 -170.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.803 HD12 HD11 ' A' ' 51' ' ' ILE . 2.0 mt -79.96 135.41 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 108.678 -0.86 . . . . 0.56 108.678 -173.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.26 135.62 23.2 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 124.37 1.068 . . . . 1.37 108.291 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.33 100.46 0.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 121.847 1.698 . . . . 0.97 109.324 170.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 108.687 -0.857 . . . . 3.96 108.687 172.33 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 105.659 -1.978 . . . . 4.96 105.659 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 88.9 m -153.5 156.07 37.42 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 106.301 -1.741 . . . . 0.69 106.301 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -132.69 145.99 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 O-C-N 123.992 0.807 . . . . 0.42 110.919 168.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -131.06 146.68 52.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.401 -1.703 . . . . 1.9 106.401 -172.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -85.17 128.15 34.55 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.816 -0.809 . . . . 5.15 108.816 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -112.31 135.26 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.91 -1.515 . . . . 0.49 106.91 174.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -142.59 154.74 44.69 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 104.964 -2.236 . . . . 3.05 104.964 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.52 -81.81 0.35 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.398 0.999 . . . . 1.6 110.999 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.557 HD23 HD21 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -81.31 163.06 23.19 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.304 0.552 . . . . 2.72 110.929 -174.278 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.545 ' N ' HD12 ' A' ' 12' ' ' LEU . 18.2 t -149.26 79.21 1.4 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.197 0.599 . . . . 3.67 110.721 177.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.3 t -160.53 146.65 15.18 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.087 0.858 . . . . 1.78 112.387 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -68.39 -46.35 70.26 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.391 1.476 . . . . 1.56 111.996 -177.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -55.02 -43.52 73.76 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.426 -0.796 . . . . 2.75 110.424 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.3 m -56.96 -45.25 82.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.624 -0.716 . . . . 0.97 110.512 173.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.413 ' HB1' HG13 ' A' ' 36' ' ' VAL . . . -56.12 -49.89 72.63 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 122.941 0.497 . . . . 0.92 110.268 176.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.07 -46.42 68.58 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.235 0.54 . . . . 0.8 110.267 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -61.52 -46.11 91.35 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.446 -0.343 . . . . 3.49 110.849 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.21 -64.81 0.72 Allowed 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.848 0.859 . . . . 2.79 110.706 175.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -39.63 83.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.981 0.81 . . . . 2.42 111.086 -172.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -53.04 62.76 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.139 0.576 . . . . 2.82 110.393 172.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -53.33 -46.5 69.51 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.431 -0.581 . . . . 1.33 109.431 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.578 HG11 ' CB ' ' A' ' 34' ' ' ALA . 48.5 t -59.22 -51.25 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 122.678 0.391 . . . . 0.55 110.324 176.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.5 mttt -50.64 -38.43 46.18 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.036 0.935 . . . . 1.87 112.414 173.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.63 -12.53 54.08 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.488 0.921 . . . . 3.01 113.488 175.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 30' ' ' GLY . 19.2 mt -86.29 113.47 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 120.319 1.418 . . . . 1.36 110.1 178.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -53.4 -25.16 14.59 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.833 1.653 . . . . 3.36 114.006 176.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.496 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -71.67 -31.13 65.43 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.886 0.755 . . . . 0.8 112.466 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.54 HG11 HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -92.27 -172.99 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 121.278 -1.131 . . . . 0.8 109.99 -171.556 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.1 m -140.71 -57.97 0.52 Allowed 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 120.769 -1.207 . . . . 0.79 108.811 171.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -128.53 157.95 39.77 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 119.954 -0.698 . . . . 2.67 111.36 171.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.578 ' CB ' HG11 ' A' ' 25' ' ' VAL . . . -154.84 149.55 26.53 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.239 -0.652 . . . . 0.57 109.239 172.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.9 mt -130.32 131.07 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 107.047 -1.464 . . . . 1.61 107.047 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.413 HG13 ' HB1' ' A' ' 18' ' ' ALA . 2.8 p -118.61 110.04 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 124.389 1.076 . . . . 2.32 109.703 -175.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 107.619 -1.252 . . . . 2.12 107.619 171.73 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 112.493 0.553 . . . . 2.64 112.493 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -157.94 160.02 37.14 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.793 -0.567 . . . . 3.76 110.891 -158.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.26 115.7 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.145 -1.428 . . . . 0.81 107.145 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 79.6 m -90.84 141.76 28.48 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.322 1.449 . . . . 0.46 108.722 174.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.1 t -129.63 140.85 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 104.58 -2.378 . . . . 1.01 104.58 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.4 m -147.26 133.35 19.3 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 107.185 -1.413 . . . . 0.88 107.185 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.7 -96.26 0.16 Allowed Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 106.836 -2.505 . . . . 0.62 106.836 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -163.8 57.53 0.17 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.585 1.954 . . . . 3.31 108.475 172.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.71 168.12 25.32 Favored 'General case' 0 C--N 1.341 0.219 0 O-C-N 120.9 -1.125 . . . . 0.53 111.588 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -126.29 165.67 18.55 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.278 1.431 . . . . 1.05 111.696 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.7 tp -55.64 -28.93 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 117.352 -1.308 . . . . 1.85 113.321 -172.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -35.6 -51.03 0.63 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.78 1.173 . . . . 2.46 111.469 173.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -69.13 -41.46 77.34 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.289 0.566 . . . . 2.39 111.776 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.449 HG22 HG22 ' A' ' 25' ' ' VAL . 18.2 t -65.24 -38.42 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 O-C-N 121.624 -0.672 . . . . 0.36 110.22 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -61.38 -53.85 51.33 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 127.611 2.364 . . . . 3.35 107.97 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -49.03 -42.36 37.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.15 0.58 . . . . 3.8 111.135 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.77 -47.6 68.72 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.167 0.508 . . . . 0.49 110.849 174.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.27 -15.99 12.93 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 126.928 2.204 . . . . 0.31 113.117 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -40.5 -29.32 0.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.303 1.051 . . . . 0.43 112.465 163.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -50.23 -36.16 29.84 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.9 1.074 . . . . 1.85 113.9 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -126.16 -4.73 6.77 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.472 1.509 . . . . 2.39 112.47 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 73.03 57.46 0.11 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.092 1.357 . . . . 1.33 110.85 173.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.557 HD21 HD23 ' A' ' 12' ' ' LEU . 3.8 mm? -79.11 168.29 19.84 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.186 -0.946 . . . . 1.18 111.204 -175.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -135.09 64.55 1.59 Allowed 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.492 -1.299 . . . . 4.92 107.492 -171.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.74 130.78 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 113.501 -1.681 . . . . 0.6 109.098 -174.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.8 mt -122.62 131.13 24.41 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 108.388 -0.967 . . . . 1.04 108.388 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.41 106.88 1.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.203 1.935 . . . . 0.85 109.128 169.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 CA--C 1.536 0.405 0 C-N-CA 123.858 0.863 . . . . 3.41 109.881 172.617 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 108.005 -1.109 . . . . 4.53 108.005 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.2 m -153.35 159.03 42.37 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 106.422 -1.696 . . . . 0.65 106.422 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 p -136.66 148.33 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 O-C-N 124.111 0.882 . . . . 0.49 110.778 173.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -133.27 141.8 48.19 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 106.729 -1.582 . . . . 2.01 106.729 -171.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.1 mtt85 -83.14 137.26 34.14 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.455 1.025 . . . . 3.92 108.416 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 p -121.78 140.65 45.11 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 124.093 0.957 . . . . 0.52 110.112 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -140.33 155.03 46.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.998 -1.482 . . . . 2.86 106.998 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.17 -81.68 0.35 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.811 1.196 . . . . 1.42 110.598 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.5 ' C ' HD12 ' A' ' 12' ' ' LEU . 1.3 pp -75.64 161.23 29.29 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.957 0.379 . . . . 2.67 110.522 -175.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 t -153.52 90.78 1.43 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.315 -0.624 . . . . 3.7 109.315 170.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.9 t -165.36 127.83 2.13 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.4 0.68 . . . . 1.91 110.077 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 m -50.32 -45.38 54.76 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.258 1.023 . . . . 1.43 111.743 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -59.34 -39.78 84.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.891 -0.506 . . . . 2.68 111.227 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.419 ' HB3' HD22 ' A' ' 12' ' ' LEU . 9.4 m -65.95 -46.29 78.67 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.686 -0.487 . . . . 0.84 109.686 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.58 -49.07 71.24 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.742 0.246 . . . . 0.66 110.417 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.87 67.59 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.57 0.748 . . . . 0.74 110.556 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.0 tttp -57.17 -46.93 82.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.135 -0.484 . . . . 2.8 110.349 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -49.61 -63.29 1.15 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 118.643 -0.694 . . . . 2.69 111.108 171.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -57.97 -39.75 78.92 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 119.099 0.863 . . . . 2.61 111.321 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -58.11 -51.06 71.28 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.698 -0.482 . . . . 3.06 109.698 173.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -53.5 -43.14 68.04 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.11 0.414 . . . . 2.69 110.223 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 54' ' ' VAL . 47.1 t -60.68 -52.18 64.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 122.808 0.443 . . . . 0.36 111.28 174.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -53.84 -35.36 61.38 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.366 1.066 . . . . 1.86 111.515 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -72.53 10.26 0.87 Allowed 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 114.128 1.159 . . . . 2.75 114.128 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.0 mt -105.42 112.83 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.276 1.43 . . . . 1.23 110.714 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -52.59 -36.15 55.54 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 127.887 2.475 . . . . 3.62 113.758 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.2 -30.17 75.08 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.474 -0.785 . . . . 0.85 112.002 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.05 172.3 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 O-C-N 121.627 -0.925 . . . . 0.89 109.252 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.6 m -126.34 -59.83 1.29 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.466 -1.309 . . . . 0.66 107.466 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -122.58 164.2 18.59 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-O 121.351 0.596 . . . . 3.5 112.404 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.48 135.73 12.12 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.986 -0.746 . . . . 0.48 108.986 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.7 mm -118.82 102.39 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 105.389 -2.078 . . . . 2.11 105.389 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.51 118.93 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.651 -0.87 . . . . 2.01 108.651 -172.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 . . . . . 0 C--N 1.338 0.1 0 N-CA-C 108.857 -0.794 . . . . 2.3 108.857 -176.387 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 m . . . . . 0 CA--C 1.534 0.33 0 CA-C-O 120.648 0.261 . . . . 2.61 110.968 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.05 167.29 30.88 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.833 0.853 . . . . 3.92 109.885 -173.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.47 114.27 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 126.348 1.859 . . . . 0.89 107.541 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.1 m -91.55 136.26 33.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.37 -0.974 . . . . 0.44 108.37 171.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 t -119.96 147.93 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 126.584 1.954 . . . . 0.82 106.791 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.9 m -146.27 138.29 25.01 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.447 -1.316 . . . . 0.81 107.447 175.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.11 -91.84 0.15 Allowed Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 108.047 -2.021 . . . . 0.54 108.047 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -167.11 50.31 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.937 1.695 . . . . 2.31 109.196 173.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.12 178.05 8.87 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.968 -1.083 . . . . 0.49 110.821 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.2 m -138.21 171.37 14.5 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.21 1.404 . . . . 1.17 110.951 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -46.43 -47.41 6.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-O 116.68 -1.628 . . . . 2.74 110.875 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -33.18 -47.74 0.2 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 121.104 1.774 . . . . 2.96 114.155 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -70.16 -44.39 68.91 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.252 -0.905 . . . . 2.05 112.291 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 25' ' ' VAL . 13.7 t -58.47 -27.83 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.139 1.376 . . . . 0.37 111.547 169.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.29 -52.23 29.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.876 1.67 . . . . 2.99 106.747 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -54.15 -45.67 72.06 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.808 0.843 . . . . 3.9 110.403 174.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.8 -57.65 10.13 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.408 0.549 . . . . 0.45 110.658 169.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.11 -16.18 25.11 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 125.407 1.479 . . . . 0.31 113.713 -174.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -42.7 -29.47 0.3 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.18 -0.914 . . . . 0.49 112.544 166.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -52.97 -35.26 58.73 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.836 1.198 . . . . 1.9 113.411 175.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.8 -1.55 9.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.682 1.193 . . . . 2.48 112.264 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 65.06 55.6 1.11 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.732 1.213 . . . . 0.88 110.519 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.05 171.66 11.49 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.156 -0.965 . . . . 1.16 110.955 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -137.57 64.3 1.52 Allowed 'General case' 0 C--N 1.341 0.218 0 N-CA-C 107.731 -1.211 . . . . 4.79 107.731 -175.733 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mt -80.7 139.47 18.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 113.982 -1.463 . . . . 0.83 108.429 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.5 mt -128.0 133.25 24.93 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.436 1.094 . . . . 1.14 108.116 -174.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -64.52 109.0 1.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.323 2.016 . . . . 0.78 109.621 172.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 109.725 -0.472 . . . . 4.54 109.725 172.804 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.114 0.483 . . . . 3.79 109.77 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -150.25 148.4 28.84 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 105.838 -1.912 . . . . 0.65 105.838 170.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.67 147.64 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 124.204 0.94 . . . . 0.54 110.284 169.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -133.0 145.09 50.55 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.082 -1.451 . . . . 2.17 107.082 -173.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 50.8 mtm-85 -87.68 124.89 34.03 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 109.037 -0.727 . . . . 5.33 109.037 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 p -109.74 152.91 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.056 0 N-CA-C 108.638 -0.875 . . . . 0.55 108.638 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.418 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . 57.2 t0 -147.37 166.81 26.02 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.284 -1.376 . . . . 2.35 107.284 177.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.6 -68.34 0.28 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.236 0.922 . . . . 1.61 112.14 171.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 12' ' ' LEU . 1.3 pp -73.41 157.94 35.94 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 117.833 0.817 . . . . 2.68 110.347 -175.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.0 m -152.25 69.9 0.9 Allowed 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.92 0.488 . . . . 3.31 110.199 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.2 t -157.86 121.87 4.15 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.045 0.538 . . . . 1.82 110.775 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 m -47.18 -44.26 21.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.205 1.402 . . . . 1.39 111.947 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -53.52 -43.92 68.7 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.888 0.475 . . . . 3.02 110.787 178.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.443 ' HB3' HD22 ' A' ' 12' ' ' LEU . 4.1 m -70.43 -39.73 74.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.386 -0.34 . . . . 0.85 110.369 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.01 -44.64 78.86 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.681 0.673 . . . . 0.56 110.766 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.39 -49.12 72.85 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.345 0.658 . . . . 0.58 110.683 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -49.53 -49.38 46.27 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.494 0.717 . . . . 2.7 109.227 173.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -56.93 -63.43 1.21 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 118.449 -0.786 . . . . 2.77 111.646 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -40.17 74.76 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 119.173 -1.011 . . . . 2.47 110.671 -172.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -59.32 -51.71 68.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.216 0.207 . . . . 2.74 111.232 174.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -52.24 -45.77 65.46 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.76 -0.588 . . . . 1.61 110.702 175.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.0 t -65.51 -45.33 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.095 0.558 . . . . 0.55 110.399 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -54.03 -38.44 65.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.293 1.037 . . . . 2.04 110.867 173.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -70.33 -0.61 8.45 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.864 1.061 . . . . 2.99 113.864 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.9 mm -85.6 134.08 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 120.837 1.653 . . . . 2.11 110.287 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -74.74 124.7 27.25 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.839 1.656 . . . . 4.11 109.316 167.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.91 -39.86 1.95 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.578 1.085 . . . . 1.1 110.955 171.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.03 159.08 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 O-C-N 121.871 -0.782 . . . . 0.59 109.311 173.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.7 m -116.17 -55.68 2.38 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.871 1.668 . . . . 0.74 107.856 177.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -127.23 147.29 50.22 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.416 0.447 . . . . 2.89 110.554 170.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.79 140.53 40.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.719 -1.215 . . . . 0.51 107.719 166.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.6 mt -125.25 109.92 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 N-CA-C 106.451 -1.685 . . . . 1.42 106.451 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.78 129.96 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 123.106 0.253 . . . . 1.94 110.788 -171.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 107.034 -1.469 . . . . 1.92 107.034 169.191 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 111.659 0.244 . . . . 2.59 111.659 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.34 168.54 25.03 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.692 -0.63 . . . . 4.05 111.669 -163.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.08 113.99 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.773 -1.195 . . . . 0.77 107.773 -176.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.8 m -91.88 141.58 28.49 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.49 1.116 . . . . 0.48 109.066 174.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.8 t -129.34 138.38 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 104.744 -2.317 . . . . 0.84 104.744 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.2 m -147.61 132.46 18.03 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 106.391 -1.707 . . . . 0.67 106.391 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.87 -95.82 0.17 Allowed Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 106.651 -2.579 . . . . 0.57 106.651 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.63 63.59 0.11 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.086 1.754 . . . . 3.81 108.53 174.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.22 164.69 36.84 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.075 -1.016 . . . . 0.5 110.629 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.0 m -118.26 162.61 17.98 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 125.939 1.696 . . . . 0.68 110.65 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 tp -54.02 -31.84 21.83 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 CA-C-O 117.466 -1.254 . . . . 1.77 112.632 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -32.17 -48.57 0.17 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.89 1.276 . . . . 3.6 111.953 175.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -59.83 -52.5 65.18 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.92 0.867 . . . . 2.34 111.465 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.06 -42.41 96.52 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 C-N-CA 125.44 1.496 . . . . 0.44 110.699 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -61.99 -48.96 78.01 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.049 1.34 . . . . 2.93 108.644 178.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -56.12 -51.59 67.39 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.162 0.585 . . . . 3.31 110.35 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.51 -52.98 19.83 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.654 0.661 . . . . 0.37 110.835 168.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.46 -18.4 29.67 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 125.382 1.468 . . . . 0.31 113.414 -177.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.23 -22.77 1.11 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.543 1.171 . . . . 0.47 112.335 170.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -55.49 -32.11 62.58 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 120.167 1.348 . . . . 1.89 112.894 172.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.91 -25.21 6.83 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.127 1.371 . . . . 2.16 111.657 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 83.48 60.41 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.674 2.39 . . . . 0.74 111.363 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.16 165.72 22.16 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.119 -0.988 . . . . 1.32 111.73 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.418 ' HD2' ' HB3' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -121.04 111.72 17.82 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.966 -1.494 . . . . 4.9 106.966 175.073 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.08 127.6 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 108.845 -0.798 . . . . 0.51 108.845 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.9 mm -111.64 125.3 30.63 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.027 1.331 . . . . 1.42 108.796 -172.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.14 92.24 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.04 2.493 . . . . 0.7 110.032 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 121.531 0.681 . . . . 3.91 111.002 177.923 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.6 pttt . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 108.117 -1.068 . . . . 3.81 108.117 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.9 m -147.46 150.64 34.99 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 108.234 -1.025 . . . . 0.67 108.234 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -135.36 132.88 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 124.337 1.023 . . . . 0.71 111.114 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -115.57 153.65 30.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.772 1.629 . . . . 2.02 108.012 -169.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -92.89 112.72 24.78 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.484 -0.932 . . . . 4.1 108.484 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.9 p -96.18 144.03 11.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.572 1.149 . . . . 0.51 109.055 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -141.93 163.39 33.02 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.541 -0.541 . . . . 2.96 109.541 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.4 -70.26 0.24 Allowed Glycine 0 CA--C 1.528 0.906 0 C-N-CA 126.013 1.768 . . . . 1.55 111.024 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.94 173.3 8.99 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.388 0.884 . . . . 2.54 113.388 -170.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.1 p -167.06 82.63 0.23 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.846 0.859 . . . . 2.73 109.716 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.01 133.03 4.39 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.763 0.711 . . . . 2.03 112.422 176.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.4 m -54.59 -46.72 73.81 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.573 1.149 . . . . 1.5 111.71 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -59.42 -36.59 76.16 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.985 0.898 . . . . 3.21 111.142 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.9 m -69.79 -45.37 68.12 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 108.822 -0.807 . . . . 1.17 108.822 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.56 -43.85 68.82 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 122.759 0.424 . . . . 0.66 110.419 174.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.68 -55.21 37.83 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.471 0.708 . . . . 0.64 109.515 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -54.88 -41.09 70.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.53 -0.304 . . . . 2.88 111.037 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.522 ' CZ ' HG12 ' A' ' 54' ' ' VAL . 2.2 t80 -64.6 -60.16 3.45 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 119.403 -0.332 . . . . 2.44 111.096 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.31 -40.93 75.15 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 118.429 0.559 . . . . 2.52 109.781 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -57.97 -54.53 45.86 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.059 0.943 . . . . 2.76 109.352 175.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -49.67 -51.71 36.19 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.422 0.556 . . . . 1.95 109.851 176.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.581 HG22 HG22 ' A' ' 54' ' ' VAL . 32.5 t -55.5 -52.65 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 110.26 -0.274 . . . . 0.4 110.26 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -51.05 -39.24 55.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.194 1.398 . . . . 1.63 112.383 174.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -71.88 -14.17 61.87 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.057 0.762 . . . . 2.07 113.057 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.687 HG22 ' H ' ' A' ' 30' ' ' GLY . 17.0 mt -77.55 131.47 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 120.531 1.514 . . . . 1.33 108.761 171.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -77.22 -9.5 58.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.447 1.099 . . . . 2.44 113.75 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.687 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -78.91 -30.91 45.56 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.768 0.699 . . . . 0.81 112.09 -178.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.454 HG11 HG12 ' A' ' 25' ' ' VAL . 12.1 p -97.36 158.67 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 121.377 -1.072 . . . . 0.61 109.42 -178.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.0 m -106.08 -55.0 2.39 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.677 -1.231 . . . . 0.6 107.677 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -129.32 154.62 46.69 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.758 -0.46 . . . . 2.92 109.758 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.72 143.9 23.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.892 -0.781 . . . . 0.44 108.892 173.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.5 mt -127.5 105.77 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.313 -1.366 . . . . 1.48 107.313 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.57 125.95 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.507 -0.923 . . . . 2.56 108.507 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.0 m120 . . . . . 0 N--CA 1.465 0.296 0 CA-C-N 119.408 1.004 . . . . 2.79 109.94 169.32 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 m . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.898 -0.408 . . . . 2.55 109.898 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.77 167.85 28.38 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 122.948 0.499 . . . . 3.56 110.637 -170.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.52 120.39 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.632 1.173 . . . . 0.72 108.892 174.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.7 m -98.09 145.29 26.7 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.408 1.083 . . . . 0.54 111.177 177.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.75 140.55 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 127.563 2.345 . . . . 0.61 107.551 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.1 m -148.5 89.66 1.72 Allowed 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 124.971 1.309 . . . . 1.08 108.486 -177.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.89 -106.98 0.19 Allowed Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 108.51 -1.836 . . . . 0.72 108.51 175.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -151.92 62.77 0.85 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.706 1.202 . . . . 3.61 108.114 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.15 162.61 36.65 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.121 0.969 . . . . 0.67 110.071 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -119.5 162.14 19.39 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.884 1.673 . . . . 0.62 109.043 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.0 tp -52.67 -33.51 18.5 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 CA-C-O 117.231 -1.366 . . . . 1.64 112.012 -176.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.3 mm-40 -28.7 -53.41 0.11 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.67 1.588 . . . . 2.53 112.802 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -69.09 -41.87 76.92 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.574 0.702 . . . . 2.39 111.708 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.581 HG22 HG22 ' A' ' 25' ' ' VAL . 33.9 t -66.99 -38.04 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.278 1.031 . . . . 0.31 110.272 178.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -60.98 -49.76 76.14 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.229 1.812 . . . . 2.85 108.512 174.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -52.53 -51.62 58.73 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.83 0.452 . . . . 3.31 110.142 175.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.5 -48.61 62.85 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.627 0.649 . . . . 0.37 111.188 170.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.32 -9.64 6.42 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.918 -0.935 . . . . 0.35 114.036 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.91 -25.66 0.83 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 119.176 1.488 . . . . 0.53 112.682 170.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -53.73 -36.35 62.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.81 1.186 . . . . 2.0 113.235 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -121.0 -5.93 9.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.217 1.007 . . . . 2.61 112.894 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 67.46 50.57 0.92 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.75 1.22 . . . . 0.79 110.417 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -72.35 168.01 19.28 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.532 -0.73 . . . . 1.36 112.158 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.07 124.49 40.73 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.195 -1.78 . . . . 4.36 106.195 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.0 mt -130.85 134.49 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.708 1.203 . . . . 0.57 107.913 -175.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.6 mt -113.98 121.79 36.07 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.756 1.222 . . . . 1.47 108.169 -172.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -77.37 70.73 6.68 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 124.227 3.284 . . . . 1.41 109.5 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 . . . . . 0 N--CA 1.441 -0.913 0 C-N-CA 126.057 1.743 . . . . 6.96 112.913 -167.927 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 30.8 pttt . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 108.059 -1.089 . . . . 3.75 108.059 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.1 m -150.2 147.19 27.4 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 107.766 -1.198 . . . . 0.53 107.766 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -123.02 143.84 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 124.947 1.404 . . . . 0.38 110.318 171.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -129.8 153.42 48.26 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.023 -1.843 . . . . 1.9 106.023 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -95.42 147.95 22.98 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.583 0.629 . . . . 3.92 110.156 173.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.34 121.7 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 123.045 0.538 . . . . 0.97 110.684 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.04 -173.45 2.31 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.069 0.548 . . . . 2.81 111.449 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.43 -46.94 3.34 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.666 1.603 . . . . 1.34 113.427 170.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 pp -50.13 156.8 0.74 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.874 1.269 . . . . 3.3 113.495 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 t -167.55 51.21 0.06 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.88 0.472 . . . . 2.83 111.221 173.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.1 t -159.16 117.74 2.9 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 120.807 -1.183 . . . . 2.2 112.854 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 m -53.04 -41.96 65.26 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.191 0.996 . . . . 1.65 112.212 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -57.25 -39.74 76.2 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.67 0.747 . . . . 3.15 109.982 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.0 m -69.39 -43.83 72.7 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.866 -0.606 . . . . 0.92 109.947 175.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.28 -48.57 45.9 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.062 0.545 . . . . 0.63 110.84 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.27 -48.86 80.04 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.573 -0.739 . . . . 0.51 109.879 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -58.51 -38.42 77.66 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.022 -0.535 . . . . 3.34 110.532 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.525 ' O ' HG23 ' A' ' 25' ' ' VAL . 2.2 t80 -58.07 -60.52 3.62 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.45 0.7 . . . . 2.72 109.758 174.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -55.8 -45.04 78.35 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.278 0.49 . . . . 2.47 110.029 -175.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -64.06 -47.26 80.84 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.022 -0.535 . . . . 2.76 109.808 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -52.46 -46.39 66.47 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.918 -0.401 . . . . 1.33 109.918 173.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 21' ' ' PHE . 15.4 t -60.33 -50.16 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 118.314 0.507 . . . . 0.49 109.727 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -51.63 -34.83 39.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.899 0.88 . . . . 1.42 112.996 173.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -67.26 -22.81 65.65 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.875 0.761 . . . . 3.03 112.533 176.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.665 HG22 ' H ' ' A' ' 30' ' ' GLY . 25.1 mt -70.74 133.18 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.596 1.089 . . . . 1.5 109.213 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -77.66 -17.35 57.8 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.557 1.143 . . . . 2.94 113.093 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.665 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -83.48 -11.44 80.15 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.379 0.99 . . . . 1.03 113.768 -176.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.3 p -115.06 153.18 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 118.59 1.195 . . . . 0.66 108.949 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.8 m -103.1 -51.56 3.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.23 -1.026 . . . . 0.6 108.23 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -132.38 161.08 34.51 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.837 0.351 . . . . 2.1 110.278 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.77 138.05 16.6 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.874 -1.158 . . . . 0.42 107.874 174.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 22.0 mm -126.55 102.81 10.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 106.839 -1.541 . . . . 2.03 106.839 -177.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.2 p -98.42 144.38 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 122.507 0.323 . . . . 2.04 110.658 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.0 m120 . . . . . 0 C--O 1.235 0.295 0 N-CA-C 108.803 -0.814 . . . . 2.87 108.803 173.423 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.444 -0.725 0 N-CA-C 108.32 -0.993 . . . . 5.22 108.32 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -145.69 142.54 29.1 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.044 1.293 . . . . 5.24 112.407 -170.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.78 119.33 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.105 1.362 . . . . 0.74 110.151 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 m -98.56 139.96 33.5 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.941 1.296 . . . . 0.42 110.225 172.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.5 t -122.29 140.66 45.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 127.806 2.442 . . . . 0.74 105.576 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.5 m -147.22 85.72 1.61 Allowed 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.134 -0.979 . . . . 1.03 108.424 -173.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.88 -106.87 0.19 Allowed Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 109.43 -1.468 . . . . 0.67 109.43 176.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -152.21 54.87 0.81 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.733 0.813 . . . . 2.14 108.958 170.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.77 163.6 33.55 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.425 -0.797 . . . . 0.6 110.497 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.5 m -109.57 161.42 15.37 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.337 1.455 . . . . 0.85 110.136 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.0 tp -50.74 -31.63 9.96 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 CA-C-O 117.314 -1.327 . . . . 1.74 113.321 -178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -29.86 -50.04 0.11 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.07 1.348 . . . . 3.69 112.475 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -63.93 -45.49 89.02 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 122.025 0.917 . . . . 2.37 111.604 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.43 HG22 HG22 ' A' ' 25' ' ' VAL . 28.0 t -69.57 -30.73 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.507 1.123 . . . . 0.43 110.48 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -61.7 -50.06 73.97 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.046 -1.094 . . . . 3.19 108.046 172.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -51.97 -50.87 60.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.837 0.455 . . . . 3.1 110.617 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.14 -52.24 36.78 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.856 -0.527 . . . . 0.81 111.13 170.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.07 -22.31 35.09 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 126.002 1.763 . . . . 0.41 112.952 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.38 -31.49 4.08 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.733 1.266 . . . . 0.44 112.368 171.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.57 -36.32 55.72 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.314 0.961 . . . . 2.13 113.113 175.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -130.35 4.62 4.75 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.255 1.022 . . . . 3.08 112.122 -173.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 61.82 54.75 2.8 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.597 1.559 . . . . 0.86 112.884 171.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.412 ' H ' HD22 ' A' ' 63' ' ' LEU . 1.6 mm? -80.17 -176.96 5.84 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.344 -0.542 . . . . 1.11 110.801 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -144.87 87.72 1.86 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.328 -1.73 . . . . 4.3 106.328 -176.285 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 mt -89.0 132.31 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.858 1.263 . . . . 0.9 109.9 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.7 mp -129.17 136.54 29.32 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.539 1.136 . . . . 1.44 109.025 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -72.51 64.93 3.76 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.812 3.008 . . . . 1.03 110.847 174.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 . . . . . 0 N--CA 1.453 -0.297 0 C-N-CA 123.24 0.616 . . . . 6.4 109.928 170.992 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.8 pttt . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.226 0.536 . . . . 4.23 109.699 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.0 m -146.84 143.72 28.78 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.44 -0.948 . . . . 0.74 108.44 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -116.34 134.44 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 124.869 1.356 . . . . 0.69 110.505 168.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -116.13 163.26 16.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.791 1.636 . . . . 2.08 106.593 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -106.21 131.41 53.49 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 118.619 -0.705 . . . . 3.84 110.39 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 p -116.87 142.64 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.366 -0.976 . . . . 0.42 108.366 -174.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -142.93 166.64 24.09 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.756 0.707 . . . . 2.9 109.885 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.25 66.0 3.0 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.464 1.507 . . . . 3.12 112.379 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.578 HD13 ' H ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -129.16 167.96 16.84 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.774 1.63 . . . . 2.68 109.712 175.411 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 m -64.41 -82.66 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.302 0.482 . . . . 6.73 112.302 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -172.71 -167.52 0.44 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.372 -0.83 . . . . 4.39 109.911 -175.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.7 t -47.95 -36.72 12.98 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.417 1.487 . . . . 2.35 112.969 -176.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -52.49 -50.93 61.76 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.929 0.871 . . . . 3.68 110.385 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.5 m -71.89 -32.66 67.63 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.909 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.71 -46.86 74.26 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 118.581 0.628 . . . . 0.59 110.044 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -49.99 75.43 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.495 -0.775 . . . . 0.58 109.085 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -53.65 -41.86 67.22 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.415 -0.357 . . . . 2.33 110.686 175.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -63.76 -57.39 10.08 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.362 0.665 . . . . 2.82 110.549 179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -55.16 -45.3 75.71 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.61 0.641 . . . . 2.53 109.609 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -60.82 -52.15 66.29 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.407 0.683 . . . . 3.71 109.462 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -48.78 -49.87 36.71 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 123.335 0.654 . . . . 2.01 109.961 176.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.496 HG22 HG22 ' A' ' 54' ' ' VAL . 38.8 t -61.65 -50.76 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 120.392 -0.523 . . . . 0.43 109.938 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -50.31 -33.92 21.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.187 0.995 . . . . 1.52 113.113 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -69.91 -22.39 63.21 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.459 0.704 . . . . 2.74 112.614 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.61 HG22 ' H ' ' A' ' 30' ' ' GLY . 21.9 mt -76.97 138.95 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.674 1.124 . . . . 1.2 109.18 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -82.47 -21.12 35.7 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.33 1.052 . . . . 2.36 113.402 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.61 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -68.86 -31.11 72.52 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 123.845 0.736 . . . . 1.0 112.503 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 32' ' ' THR . 9.8 p -95.01 -178.95 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 124.846 1.258 . . . . 0.7 109.222 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.43 ' H ' HG22 ' A' ' 31' ' ' VAL . 82.9 m -141.83 -57.95 0.47 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.372 1.069 . . . . 0.98 109.062 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.79 148.91 35.72 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-O 121.169 0.509 . . . . 2.56 110.228 172.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.11 124.0 11.3 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.729 -1.211 . . . . 0.83 107.729 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.0 mt -128.49 98.95 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 107.653 -1.24 . . . . 1.33 107.653 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 p -96.4 138.22 22.24 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 C-N-CA 122.85 0.46 . . . . 2.17 110.541 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 . . . . . 0 C--O 1.232 0.176 0 N-CA-C 107.952 -1.129 . . . . 2.45 107.952 166.486 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.5 m . . . . . 0 N--CA 1.44 -0.926 0 N-CA-C 107.019 -1.475 . . . . 4.89 107.019 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -152.35 140.84 20.69 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.611 0.641 . . . . 4.77 111.547 -176.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.9 106.91 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.226 1.411 . . . . 0.72 109.18 -177.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.2 m -84.39 134.12 34.49 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.67 1.188 . . . . 0.79 109.718 174.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.02 138.94 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.294 1.838 . . . . 0.68 106.67 171.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.5 m -148.71 136.58 20.74 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.045 -1.465 . . . . 0.94 107.045 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.74 -94.38 0.15 Allowed Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 106.188 -2.765 . . . . 0.63 106.188 173.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -159.97 49.16 0.29 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.27 0.628 . . . . 2.37 110.383 169.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.6 172.91 12.56 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.516 -0.74 . . . . 0.59 112.035 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.8 m -127.29 164.93 20.67 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.785 1.634 . . . . 0.58 111.316 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 tp -53.75 -28.54 16.66 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-O 117.846 -1.073 . . . . 1.8 113.228 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -32.48 -51.09 0.26 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.542 1.137 . . . . 2.2 111.831 171.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -68.91 -41.76 77.77 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.416 0.627 . . . . 2.5 111.601 -177.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.496 HG22 HG22 ' A' ' 25' ' ' VAL . 37.1 t -67.1 -37.13 78.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 123.691 0.796 . . . . 0.38 110.224 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -57.32 -54.5 46.05 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.496 1.518 . . . . 3.16 108.05 173.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.82 -53.68 49.07 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 110.081 -0.34 . . . . 3.08 110.081 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.46 -47.96 62.94 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.159 0.504 . . . . 0.51 111.161 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.23 -18.34 4.74 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 126.348 1.927 . . . . 0.5 113.208 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.97 -24.26 0.58 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.555 1.678 . . . . 0.74 112.837 171.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -53.96 -34.39 59.6 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.88 1.218 . . . . 2.24 113.35 172.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -120.84 -19.38 7.33 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.316 1.446 . . . . 2.67 112.394 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 73.71 55.45 0.1 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.415 1.886 . . . . 1.04 110.856 -177.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.26 166.42 23.49 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.279 -0.888 . . . . 1.39 111.079 -176.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.51 120.06 34.77 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.568 -1.271 . . . . 4.16 107.568 169.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.45 140.28 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 125.001 1.321 . . . . 0.64 108.049 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.77 131.93 24.1 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.288 1.035 . . . . 1.59 108.602 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.08 97.35 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.567 2.178 . . . . 0.76 108.998 170.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 . . . . . 0 N--CA 1.451 -0.408 0 C-N-CA 123.758 0.823 . . . . 3.32 111.107 176.433 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.7 pttt . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 108.425 -0.954 . . . . 4.19 108.425 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.0 m -156.15 154.18 30.45 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 107.75 -1.204 . . . . 0.52 107.75 -173.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -129.36 143.15 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 124.499 1.125 . . . . 0.4 110.931 170.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -128.22 147.86 50.6 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.169 1.388 . . . . 1.83 107.574 -175.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -88.75 132.77 34.47 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.623 0.647 . . . . 6.03 109.392 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 p -109.62 148.95 12.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.9 1.28 . . . . 0.63 107.792 172.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.27 160.82 42.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.784 -0.821 . . . . 2.69 108.784 168.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.15 34.53 5.86 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.116 0.865 . . . . 1.99 113.785 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.96 171.5 20.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.362 1.081 . . . . 2.18 109.814 169.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.1 t -171.08 60.24 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.849 0.86 . . . . 3.53 110.404 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -142.58 121.69 12.93 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.503 0.592 . . . . 2.29 110.854 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m -51.57 -50.14 60.69 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.328 1.051 . . . . 1.28 111.321 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -54.11 -44.4 71.23 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.978 -0.451 . . . . 2.68 110.803 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.1 m -64.92 -46.67 80.68 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.942 -0.392 . . . . 0.82 109.942 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.87 74.73 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.918 0.487 . . . . 0.59 111.195 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.04 -49.18 66.03 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.587 0.755 . . . . 0.77 110.185 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -52.32 -47.84 65.77 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.642 -0.503 . . . . 2.64 109.642 173.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.17 -57.53 10.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.104 0.562 . . . . 2.28 110.93 174.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -56.63 -44.57 81.38 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.722 0.692 . . . . 2.39 110.089 -174.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -59.87 -53.86 52.97 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 108.834 -0.802 . . . . 5.57 108.834 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -44.94 -49.16 11.26 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.401 1.08 . . . . 1.76 110.342 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 54' ' ' VAL . 59.5 t -60.39 -52.21 64.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 110.298 -0.26 . . . . 0.38 110.298 175.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -53.18 -31.88 45.03 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.277 0.843 . . . . 1.37 113.277 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -70.33 -15.42 62.87 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.388 0.994 . . . . 2.28 113.094 175.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.5 mt -71.99 115.92 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-O 122.474 1.13 . . . . 1.31 109.445 178.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.08 95.12 0.16 Allowed 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.76 1.624 . . . . 2.61 108.941 171.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.84 -36.74 0.72 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.227 -0.749 . . . . 1.39 111.227 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.2 p -79.67 155.25 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 121.677 -0.896 . . . . 0.84 109.757 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.2 m -109.44 -58.55 2.02 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.529 1.132 . . . . 0.81 108.133 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -123.74 157.74 33.29 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.206 0.527 . . . . 2.94 111.343 173.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.43 134.99 20.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.97 -1.493 . . . . 0.55 106.97 167.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.8 mt -124.85 102.61 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 104.541 -2.392 . . . . 1.71 104.541 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.458 HG12 HG12 ' A' ' 43' ' ' ILE . 2.0 m -117.14 133.05 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 110.328 -0.249 . . . . 2.4 110.328 -167.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 . . . . . 0 C--O 1.227 -0.116 0 N-CA-C 109.358 -0.608 . . . . 2.88 109.358 176.755 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.0 m . . . . . 0 C--O 1.235 0.311 0 CA-C-O 118.338 -0.839 . . . . 2.51 109.479 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -156.32 165.91 34.97 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.961 0.8 . . . . 3.97 112.199 -170.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -128.2 115.89 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 126.663 1.985 . . . . 0.98 107.706 -178.401 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.9 m -97.1 137.45 36.14 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.974 0.909 . . . . 0.44 109.026 173.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.18 143.98 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 126.564 1.946 . . . . 0.79 106.325 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 m -146.1 130.74 17.9 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 106.669 -1.604 . . . . 0.64 106.669 178.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 147.23 -101.52 0.23 Allowed Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 105.888 -2.885 . . . . 0.53 105.888 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -163.57 56.94 0.17 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.719 1.608 . . . . 2.29 109.069 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.09 164.21 31.31 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.155 0.982 . . . . 0.9 109.16 173.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.3 m -131.26 163.38 27.92 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.662 1.185 . . . . 0.87 111.211 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.573 HD11 HD12 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -45.83 -48.73 4.86 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.859 0 CA-C-O 117.19 -1.386 . . . . 2.62 111.178 -174.621 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -30.97 -50.91 0.15 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.296 1.438 . . . . 2.85 113.318 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -66.15 -44.66 83.49 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 122.027 0.917 . . . . 3.5 110.67 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 25' ' ' VAL . 24.5 t -65.89 -33.37 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.815 1.246 . . . . 0.38 110.63 174.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.85 -55.35 36.02 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.951 -1.5 . . . . 4.0 106.951 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -51.55 -45.74 63.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.901 -1.045 . . . . 3.28 110.837 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.88 -53.95 52.12 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.706 0.685 . . . . 0.37 111.138 171.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.85 -20.51 19.36 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 125.179 1.371 . . . . 0.29 112.703 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.81 -22.48 0.31 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.418 1.109 . . . . 0.44 113.156 168.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -53.76 -31.66 49.41 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.223 1.374 . . . . 1.9 112.825 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -128.62 -10.85 5.02 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.463 1.505 . . . . 2.93 112.593 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 74.59 60.57 0.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.631 1.973 . . . . 0.89 111.507 172.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -84.35 -179.05 7.1 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.469 -0.769 . . . . 1.25 112.429 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.22 110.22 8.25 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 105.872 -1.899 . . . . 4.22 105.872 176.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.573 HD12 HD11 ' A' ' 51' ' ' ILE . 0.9 OUTLIER -117.12 135.65 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.908 -1.145 . . . . 0.56 107.908 -179.293 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.22 137.15 29.39 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.818 1.247 . . . . 1.1 108.967 -169.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.77 89.82 0.63 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.193 2.595 . . . . 1.12 111.184 174.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 . . . . . 0 CA--C 1.54 0.573 0 C-N-CA 126.579 1.951 . . . . 3.7 111.156 171.887 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.8 pttt . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 121.326 0.584 . . . . 4.22 109.697 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.1 m -147.11 143.65 28.45 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.471 -0.937 . . . . 0.74 108.471 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -116.37 134.64 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 O-C-N 124.899 1.374 . . . . 0.69 110.454 168.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -116.41 163.12 16.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.522 -1.659 . . . . 2.07 106.522 -177.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -106.55 131.06 54.15 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 118.644 -0.693 . . . . 3.84 110.323 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 p -117.12 142.63 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 108.354 -0.98 . . . . 0.43 108.354 -173.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -143.34 166.84 23.63 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.752 0.706 . . . . 2.91 109.648 176.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.73 64.77 3.81 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.421 1.486 . . . . 3.12 112.339 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.578 HD13 ' H ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -128.64 167.55 17.03 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.799 1.639 . . . . 2.69 109.748 175.444 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.4 m -64.88 -82.35 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.254 0.464 . . . . 6.71 112.254 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -172.46 -167.67 0.47 Allowed 'General case' 0 C--N 1.344 0.333 0 O-C-N 121.323 -0.861 . . . . 4.38 110.06 -175.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.0 t -48.28 -36.55 14.32 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.339 1.456 . . . . 2.35 113.021 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -52.63 -50.73 62.56 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.949 0.88 . . . . 3.65 110.349 176.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.7 m -71.81 -33.07 68.23 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.744 -0.662 . . . . 0.98 110.823 176.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.56 -47.1 73.64 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 118.46 0.573 . . . . 0.59 110.035 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.46 -50.09 74.97 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.571 -0.741 . . . . 0.59 109.072 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -53.53 -41.68 66.64 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.44 -0.345 . . . . 2.34 110.758 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -63.84 -57.22 10.53 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.478 0.711 . . . . 2.81 110.561 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -55.25 -45.16 76.06 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 118.61 0.641 . . . . 2.53 109.674 -177.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -60.7 -52.29 65.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.307 0.643 . . . . 3.7 109.378 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -48.75 -49.88 36.3 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.351 0.661 . . . . 2.0 109.908 176.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 54' ' ' VAL . 39.0 t -61.71 -50.88 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 120.499 -0.48 . . . . 0.42 109.912 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 55.4 mttt -50.61 -33.43 22.13 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.128 0.971 . . . . 1.52 113.214 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -69.97 -22.3 63.16 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.498 0.719 . . . . 2.71 112.582 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.6 HG22 ' H ' ' A' ' 30' ' ' GLY . 21.9 mt -77.25 139.29 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 119.64 1.109 . . . . 1.2 109.232 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -82.83 -21.1 34.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.283 1.033 . . . . 2.37 113.419 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.6 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -68.97 -31.23 72.36 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.9 0.762 . . . . 0.99 112.359 -178.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 ' H ' ' A' ' 32' ' ' THR . 9.8 p -94.41 -177.61 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.855 1.262 . . . . 0.72 109.104 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.452 ' H ' HG22 ' A' ' 31' ' ' VAL . 62.2 m -143.91 -57.47 0.39 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.04 -1.037 . . . . 1.0 109.092 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -113.97 149.25 35.58 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-O 121.236 0.541 . . . . 2.59 110.251 171.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.4 124.51 11.43 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.791 -1.188 . . . . 0.82 107.791 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.91 99.13 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 107.692 -1.225 . . . . 1.33 107.692 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 p -96.07 138.67 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 C-N-CA 122.807 0.443 . . . . 2.18 110.429 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 . . . . . 0 C--O 1.233 0.19 0 N-CA-C 107.945 -1.131 . . . . 2.45 107.945 166.016 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.5 m . . . . . 0 N--CA 1.442 -0.87 0 N-CA-C 106.983 -1.488 . . . . 4.87 106.983 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -151.87 141.18 21.45 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.7 0.682 . . . . 4.75 111.719 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.07 107.08 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.294 1.438 . . . . 0.72 109.186 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.8 m -84.38 134.1 34.49 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.686 1.195 . . . . 0.81 109.73 173.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -122.74 139.15 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.199 1.8 . . . . 0.68 106.679 171.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.1 m -148.81 136.87 20.85 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 107.031 -1.47 . . . . 0.95 107.031 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.89 -94.62 0.15 Allowed Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 106.261 -2.736 . . . . 0.63 106.261 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -159.86 49.22 0.29 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.325 0.65 . . . . 2.43 110.381 169.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.6 173.07 12.37 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.503 -0.748 . . . . 0.59 112.022 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.1 m -127.7 164.73 21.45 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.709 1.603 . . . . 0.58 111.358 -174.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 tp -53.71 -28.71 16.72 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 CA-C-O 117.809 -1.091 . . . . 1.8 113.231 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -32.73 -50.92 0.28 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.391 1.076 . . . . 2.21 111.825 171.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -68.89 -41.44 78.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.385 0.612 . . . . 2.49 111.652 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 25' ' ' VAL . 38.0 t -67.44 -37.15 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.662 0.785 . . . . 0.38 110.111 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -57.41 -54.42 47.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.596 1.558 . . . . 3.15 107.944 173.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.63 -53.73 47.65 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 110.101 -0.333 . . . . 3.07 110.101 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.63 -47.95 63.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.132 0.491 . . . . 0.51 111.132 173.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.27 -18.44 4.89 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 126.336 1.922 . . . . 0.5 113.245 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.73 -24.52 0.58 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.468 1.634 . . . . 0.72 112.878 171.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -54.01 -34.33 59.59 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.893 1.224 . . . . 2.24 113.315 172.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -120.35 -19.73 7.51 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.195 1.398 . . . . 2.66 112.339 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 74.13 55.24 0.09 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.494 1.918 . . . . 1.02 110.729 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.95 166.09 23.98 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.261 -0.899 . . . . 1.39 111.082 -176.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.98 121.16 38.34 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.523 -1.288 . . . . 4.13 107.523 169.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.33 140.6 44.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 125.007 1.323 . . . . 0.66 108.029 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.12 131.74 23.99 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.356 1.062 . . . . 1.61 108.525 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.28 97.82 0.79 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.537 2.158 . . . . 0.76 108.829 170.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 . . . . . 0 N--CA 1.45 -0.441 0 C-N-CA 123.532 0.733 . . . . 3.35 111.028 177.105 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mtt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 109.492 -0.559 . . . . 9.18 109.492 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.41 ' H ' ' CD ' ' A' ' 3' ' ' GLU . . . -173.7 -53.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.766 1.226 . . . . 6.65 109.1 -175.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.41 ' CD ' ' H ' ' A' ' 2' ' ' ALA . 1.1 mp0 49.03 44.84 22.91 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.447 1.499 . . . . 4.6 111.511 166.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -136.48 143.79 44.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 127.634 2.374 . . . . 3.81 105.946 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.5 m -151.9 154.76 36.75 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 105.888 -1.893 . . . . 0.88 105.888 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.25 137.99 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 O-C-N 124.428 1.08 . . . . 0.66 109.851 169.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -116.49 151.21 36.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.517 -1.661 . . . . 1.88 106.517 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 -87.86 131.94 34.38 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 107.67 -1.233 . . . . 5.55 107.67 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.505 HG21 ' CE1' ' A' ' 38' ' ' PHE . 7.5 p -125.87 147.7 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 119.677 1.126 . . . . 0.64 109.963 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . 32.5 t0 -141.21 151.76 44.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.007 -0.738 . . . . 2.84 109.007 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.68 -79.78 0.37 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.253 1.406 . . . . 1.92 110.941 174.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 12' ' ' LEU . 1.2 pp -73.38 150.93 41.42 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 122.348 -0.501 . . . . 2.87 110.629 -171.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 p -144.51 63.81 1.31 Allowed 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.762 0.825 . . . . 2.64 110.793 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.8 t -155.49 123.77 5.88 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.861 -0.525 . . . . 2.22 111.653 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m -48.43 -41.06 28.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.349 1.46 . . . . 2.12 112.222 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -61.27 -42.44 98.63 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.481 -0.762 . . . . 3.13 110.681 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.8 m -67.83 -40.6 83.75 Favored 'General case' 0 C--O 1.231 0.124 0 O-C-N 121.355 -0.841 . . . . 1.17 110.248 176.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.33 -46.22 72.84 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 122.2 -0.313 . . . . 0.8 110.326 171.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.91 -43.92 97.88 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.767 0.827 . . . . 0.94 110.987 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -54.19 -51.62 63.81 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.745 -0.597 . . . . 3.2 109.599 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.26 -60.51 3.3 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.293 0.637 . . . . 2.45 112.508 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -38.57 72.48 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.383 0.992 . . . . 2.91 110.57 -173.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -64.68 -46.38 82.67 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.643 0.377 . . . . 2.8 110.894 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -52.44 -41.91 63.69 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 122.052 -0.405 . . . . 1.3 110.604 173.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.635 HG12 HG11 ' A' ' 31' ' ' VAL . 51.5 t -62.68 -55.12 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.971 -0.455 . . . . 0.69 110.106 174.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.7 mttt -48.47 -37.74 18.16 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.772 1.027 . . . . 1.56 113.772 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -54.0 -34.72 60.64 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.805 0.729 . . . . 3.3 112.717 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.587 HG22 ' H ' ' A' ' 30' ' ' GLY . 13.9 mt -70.0 129.72 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.66 -0.867 . . . . 1.27 108.66 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -71.06 -11.11 60.78 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.906 -1.121 . . . . 2.58 113.472 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.587 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -81.24 -21.95 61.68 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.873 0.749 . . . . 0.91 112.397 -177.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.635 HG11 HG12 ' A' ' 25' ' ' VAL . 9.7 p -111.65 152.67 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 O-C-N 121.365 -1.08 . . . . 0.96 109.143 -175.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.8 m -106.72 -56.51 2.18 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.208 1.403 . . . . 0.95 107.848 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -125.49 161.33 27.36 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.374 0.607 . . . . 2.36 112.323 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.16 139.91 20.78 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.729 -1.212 . . . . 0.82 107.729 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.0 mt -133.01 106.38 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 106.065 -1.828 . . . . 1.35 106.065 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.453 HG12 HG13 ' A' ' 43' ' ' ILE . 2.2 m -120.76 118.59 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 122.79 0.436 . . . . 2.04 109.937 -162.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -99.13 -49.34 4.53 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 122.425 -0.172 . . . . 2.44 110.778 -167.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.505 ' CE1' HG21 ' A' ' 9' ' ' VAL . 88.9 m-85 58.46 -162.77 0.22 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.443 0.697 . . . . 2.59 112.094 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.12 -69.91 2.65 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 110.084 -1.206 . . . . 3.06 110.084 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.2 61.57 0.1 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.312 -1.736 . . . . 2.25 106.312 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.1 m -155.06 -125.03 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 O-C-N 122.052 -0.405 . . . . 2.48 111.135 -171.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -158.64 165.59 34.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.61 -0.681 . . . . 3.66 109.933 -158.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.463 HG21 HD13 ' A' ' 65' ' ' ILE . 11.1 tt -129.38 104.8 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 126.084 1.754 . . . . 2.81 108.171 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.7 m -84.81 139.5 31.88 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.673 -0.862 . . . . 0.73 108.673 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.2 t -134.35 138.63 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 104.556 -2.387 . . . . 1.04 104.556 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.3 m -147.91 133.8 19.09 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.111 -1.07 . . . . 0.93 108.111 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.79 -92.68 0.14 Allowed Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 107.398 -2.281 . . . . 0.71 107.398 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -165.88 51.97 0.09 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.996 1.718 . . . . 2.26 109.489 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.52 166.59 29.73 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 120.657 -1.277 . . . . 0.48 111.591 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.0 m -119.67 165.44 14.48 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.424 1.49 . . . . 0.58 111.155 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.433 HD11 HD12 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -46.88 -46.86 8.23 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 CA-C-O 117.214 -1.374 . . . . 2.69 110.725 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -29.87 -50.69 0.12 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.16 1.784 . . . . 2.55 114.052 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -65.02 -48.37 74.13 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 122.38 1.086 . . . . 2.51 110.827 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 25' ' ' VAL . 14.6 t -61.34 -32.79 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.058 1.743 . . . . 0.52 110.93 174.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -60.45 -53.75 53.81 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 126.696 1.998 . . . . 3.27 107.176 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.59 -56.44 13.53 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.434 -0.803 . . . . 3.15 109.571 176.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.21 -51.48 25.15 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.247 0.619 . . . . 0.5 110.81 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.68 -16.06 28.76 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 124.297 0.951 . . . . 0.37 113.197 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.65 -21.67 1.69 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.481 1.14 . . . . 0.48 112.293 169.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -54.07 -35.99 62.65 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.001 1.273 . . . . 1.85 112.705 173.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -121.29 -7.59 9.28 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.651 1.18 . . . . 2.45 112.528 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 71.85 53.86 0.2 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.515 1.526 . . . . 0.99 111.09 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.75 164.42 25.26 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.225 -0.922 . . . . 1.19 111.181 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.454 ' HD2' ' HB3' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -121.66 112.56 18.58 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.162 -1.792 . . . . 3.77 106.162 172.707 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.463 HD13 HG21 ' A' ' 43' ' ' ILE . 1.1 mt -113.58 143.51 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 106.735 -1.58 . . . . 0.66 106.735 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.9 mt -128.14 122.66 22.23 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 106.64 -1.615 . . . . 1.38 106.64 -173.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.53 111.76 2.19 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.665 1.577 . . . . 0.83 108.028 169.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -54.27 147.11 13.91 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.377 0.608 . . . . 4.4 110.71 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.9 tptp -152.46 136.77 16.65 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.321 -1.733 . . . . 4.25 106.321 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -140.04 98.02 3.36 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.081 -1.822 . . . . 7.84 106.081 164.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.37 0 C-N-CA 129.078 2.951 . . . . 9.51 104.652 -179.294 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.6 mtt . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 109.286 -0.635 . . . . 9.07 109.286 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.02 160.96 40.48 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.153 -1.425 . . . . 5.98 107.153 174.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -142.77 37.39 1.45 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.256 1.023 . . . . 6.67 110.908 -168.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -126.13 135.48 51.73 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.787 1.635 . . . . 4.49 109.231 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.8 m -148.36 154.27 39.73 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 107.668 -1.234 . . . . 0.59 107.668 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 p -135.6 142.24 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 123.616 0.573 . . . . 0.39 110.438 169.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -127.52 147.15 50.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.602 1.161 . . . . 1.74 107.905 -169.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -89.0 128.5 35.71 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.372 -0.973 . . . . 3.81 108.372 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.437 HG21 ' CD2' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -105.29 149.23 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.095 -1.076 . . . . 0.6 108.095 169.02 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -143.47 148.95 36.85 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.423 -0.584 . . . . 2.62 109.423 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.51 -58.37 0.62 Allowed Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.146 0.879 . . . . 1.55 111.586 166.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.404 ' HB3' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -69.86 172.08 8.27 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.309 0.643 . . . . 2.51 112.157 -176.447 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.401 ' N ' HD22 ' A' ' 12' ' ' LEU . 11.2 t -163.8 77.63 0.39 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.692 0.397 . . . . 3.28 109.962 171.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.9 t -168.11 126.91 1.21 Allowed 'General case' 0 C--N 1.342 0.266 0 O-C-N 121.969 -0.457 . . . . 1.76 111.427 172.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.4 m -49.91 -42.09 47.44 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.475 1.11 . . . . 1.37 112.233 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -53.76 -40.92 66.62 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.648 -0.657 . . . . 3.4 111.451 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.44 -47.08 83.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.381 -0.6 . . . . 2.46 109.381 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.15 -42.81 77.56 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.802 0.441 . . . . 0.54 111.098 175.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.81 -49.39 73.08 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.401 0.62 . . . . 0.63 109.87 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -53.83 -48.41 69.94 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.415 -0.587 . . . . 4.22 109.415 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -53.94 -65.33 0.59 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.723 0.809 . . . . 2.83 111.899 176.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.94 -40.69 70.2 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.976 0.807 . . . . 2.87 110.828 -171.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -61.81 -48.87 78.67 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 110.201 -0.296 . . . . 3.43 110.201 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -57.36 -41.17 79.59 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.986 -0.446 . . . . 2.4 110.473 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.452 HG22 HG22 ' A' ' 54' ' ' VAL . 59.1 t -64.41 -46.02 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 O-C-N 121.809 -0.557 . . . . 0.49 110.782 175.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -57.06 -33.95 67.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.913 0.885 . . . . 1.7 112.054 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.25 -21.54 65.26 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.932 0.716 . . . . 2.65 112.932 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.5 mm -77.8 106.71 8.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 O-C-N 120.739 -1.226 . . . . 2.35 110.748 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -65.95 85.19 0.08 Allowed 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 125.71 1.604 . . . . 2.57 108.653 163.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.47 -40.37 0.08 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.459 -1.056 . . . . 0.99 110.459 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.9 p -97.14 156.65 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 108.347 -0.982 . . . . 0.85 108.347 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 55.0 m -105.4 -54.9 2.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.171 1.388 . . . . 0.65 107.69 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -126.29 134.9 51.01 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 109.552 -0.536 . . . . 2.42 109.552 170.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.11 126.27 40.82 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.972 -1.122 . . . . 0.52 107.972 170.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.0 mm -111.22 101.91 13.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.237 -1.394 . . . . 2.22 107.237 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.03 145.88 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 116.618 -0.265 . . . . 2.04 110.553 -175.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -140.2 51.89 1.68 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.429 -1.323 . . . . 2.04 107.429 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.437 ' CD2' HG21 ' A' ' 9' ' ' VAL . 66.0 m-85 -60.36 123.2 16.57 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.566 0.746 . . . . 3.14 109.186 174.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.19 -60.47 0.38 Allowed Glycine 0 C--O 1.225 -0.455 0 N-CA-C 109.061 -1.616 . . . . 2.76 109.061 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.4 56.04 0.18 Allowed 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.874 -1.158 . . . . 2.12 107.874 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.63 -113.51 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.913 -0.492 . . . . 2.9 111.942 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.92 171.1 20.02 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.639 0.775 . . . . 4.4 110.063 -165.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.81 113.99 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 108.48 -0.934 . . . . 0.8 108.48 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 m -91.2 143.33 26.78 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 123.983 0.913 . . . . 0.44 109.976 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.18 133.75 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.842 2.057 . . . . 0.61 106.761 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.8 m -143.05 124.34 14.62 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 106.96 -1.496 . . . . 0.86 106.96 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.12 -93.07 0.11 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 118.663 -1.732 . . . . 0.63 109.172 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -166.66 53.76 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.454 1.102 . . . . 2.34 109.931 166.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.51 172.93 15.23 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.022 -1.048 . . . . 0.81 110.643 176.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.0 m -117.14 162.83 17.2 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.678 1.591 . . . . 0.69 111.154 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 tp -52.27 -32.17 15.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.719 0 CA-C-O 117.525 -1.226 . . . . 1.92 112.973 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -34.93 -47.22 0.34 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.387 1.075 . . . . 3.52 112.103 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -57.46 -51.66 68.55 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.405 1.098 . . . . 2.21 111.465 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.452 HG22 HG22 ' A' ' 25' ' ' VAL . 58.1 t -66.11 -42.18 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.681 1.592 . . . . 0.36 110.902 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -63.22 -43.77 97.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.84 0.856 . . . . 4.02 108.836 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -52.11 -54.88 25.03 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.813 -0.613 . . . . 3.01 109.62 171.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.41 -54.15 15.08 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.926 0.784 . . . . 0.42 110.162 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.96 -15.99 15.93 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 125.395 1.474 . . . . 0.33 114.442 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.0 -26.01 2.3 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.424 1.112 . . . . 0.64 111.534 167.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -51.03 -41.77 60.05 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.111 0.869 . . . . 2.23 112.857 173.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.35 -3.67 12.43 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.164 0.986 . . . . 4.3 111.216 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 73.85 49.83 0.12 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.846 1.659 . . . . 1.07 110.835 175.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 63' ' ' LEU . 4.5 mm? -74.47 166.81 22.89 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.641 -0.662 . . . . 1.34 111.311 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.62 122.5 33.27 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.652 -1.61 . . . . 4.23 106.652 171.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 mt -122.98 108.2 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.363 0.665 . . . . 1.17 110.079 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 91.7 mt -94.12 130.79 33.17 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.436 0.694 . . . . 1.17 109.315 -172.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.01 91.8 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.387 2.058 . . . . 0.64 109.008 168.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.48 154.11 1.39 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.409 0.684 . . . . 4.42 109.987 168.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.86 130.8 16.2 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.877 -0.786 . . . . 6.98 108.877 -176.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -59.19 146.68 38.17 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.529 0.68 . . . . 7.8 110.892 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 N-CA-C 105.773 -1.936 . . . . 9.4 105.773 -176.951 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 mtt . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 107.735 -1.209 . . . . 8.96 107.735 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.97 155.92 3.19 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.536 -1.653 . . . . 5.08 106.536 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -160.35 170.79 20.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.247 1.419 . . . . 4.79 108.461 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.41 160.65 20.56 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.306 -0.628 . . . . 5.13 109.306 171.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.5 m -149.08 146.25 27.63 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 106.212 -1.773 . . . . 0.81 106.212 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.15 140.16 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 124.226 0.954 . . . . 0.55 110.847 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -128.67 148.86 50.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.774 1.23 . . . . 2.07 107.92 -172.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -88.02 122.73 31.95 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.815 -0.809 . . . . 4.32 108.815 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 p -109.81 140.05 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 124.386 1.074 . . . . 0.5 108.332 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -138.82 157.59 45.79 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.878 -1.156 . . . . 2.74 107.878 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 120.97 -77.37 0.32 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.925 1.25 . . . . 1.66 110.614 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.452 ' C ' HD12 ' A' ' 12' ' ' LEU . 3.1 pp -76.3 177.63 7.11 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.549 0.69 . . . . 2.63 111.486 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.6 t -161.59 -43.91 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.994 0.918 . . . . 4.29 110.401 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.3 t -50.97 126.23 15.65 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.351 1.06 . . . . 1.9 113.301 -168.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 m -45.32 -44.64 11.73 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.237 1.815 . . . . 1.5 112.914 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -54.37 -48.12 71.85 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.63 0.729 . . . . 3.68 111.016 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.06 -43.18 88.17 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 123.474 0.71 . . . . 1.16 109.367 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.55 -49.31 70.64 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.335 0.254 . . . . 0.87 110.958 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.37 -52.95 63.45 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.523 1.129 . . . . 0.71 109.651 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -48.94 -49.5 39.99 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.888 -0.412 . . . . 2.7 109.888 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.8 -64.18 0.96 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 112.69 0.626 . . . . 2.47 112.69 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -55.82 -44.58 78.04 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.83 0.741 . . . . 3.03 109.552 -172.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -57.03 -53.02 62.82 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.874 -0.417 . . . . 4.47 109.874 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -48.16 -48.65 34.24 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.303 -0.628 . . . . 1.52 109.303 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.436 HG22 HG22 ' A' ' 54' ' ' VAL . 34.6 t -60.99 -47.0 95.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 117.915 0.325 . . . . 0.42 110.789 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -36.52 63.87 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.017 0.527 . . . . 2.5 111.765 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -70.84 -9.91 58.53 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 119.109 0.868 . . . . 1.98 113.161 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.1 mm -83.72 128.91 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 120.539 1.518 . . . . 2.43 109.812 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.44 -28.83 61.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.412 1.485 . . . . 2.44 113.411 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.54 -16.03 64.8 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 123.983 0.801 . . . . 1.3 113.685 -174.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.8 p -118.8 153.47 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.928 1.291 . . . . 1.0 109.232 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 93.0 m -93.95 -51.1 5.02 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.723 -0.843 . . . . 0.62 108.723 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -135.47 160.23 39.13 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.057 0.456 . . . . 2.64 110.517 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -154.08 140.33 18.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.078 -1.082 . . . . 0.49 108.078 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.6 mt -127.59 118.98 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 105.73 -1.952 . . . . 1.28 105.73 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.736 HG12 HG12 ' A' ' 43' ' ' ILE . 5.5 m -105.56 133.76 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.767 -0.827 . . . . 1.98 108.767 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -90.89 -59.05 2.27 Favored 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 108.286 -1.005 . . . . 2.62 108.286 167.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 56.97 -168.77 0.11 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.03 0.932 . . . . 2.75 111.15 -165.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.92 38.01 94.72 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.537 -0.625 . . . . 2.65 111.537 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 76.84 69.23 0.06 Allowed 'General case' 0 C--N 1.338 0.094 0 C-N-CA 126.735 2.014 . . . . 2.26 109.152 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 m -157.42 -120.48 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.387 1.075 . . . . 2.64 108.435 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.52 174.82 14.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.911 0.778 . . . . 4.22 111.522 -174.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.736 HG12 HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -130.4 118.98 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.168 1.787 . . . . 0.76 107.764 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.8 m -97.03 138.11 35.07 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.61 1.164 . . . . 0.52 109.58 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.0 t -118.24 143.66 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 127.871 2.468 . . . . 0.73 105.823 171.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.1 m -146.32 88.25 1.78 Allowed 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 125.111 1.364 . . . . 1.01 107.547 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.37 -113.12 0.27 Allowed Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 108.638 -1.785 . . . . 0.89 108.638 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -155.94 48.45 0.5 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.932 -0.766 . . . . 2.99 108.932 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -155.61 177.68 11.11 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.792 -0.567 . . . . 1.28 110.234 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.4 m -114.27 169.81 8.75 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.235 1.414 . . . . 0.9 111.274 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.6 tp -53.92 -33.07 23.17 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 CA-C-O 117.685 -1.15 . . . . 1.81 111.728 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -35.37 -48.59 0.48 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.538 1.063 . . . . 2.68 112.48 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -61.13 -50.27 73.88 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.301 0.572 . . . . 2.22 112.287 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 HG22 ' A' ' 25' ' ' VAL . 58.6 t -58.34 -44.91 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 125.127 1.371 . . . . 0.5 110.536 177.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -67.27 -41.84 84.84 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.111 0.964 . . . . 3.53 110.112 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -54.42 -51.57 64.5 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.062 -0.718 . . . . 3.0 109.062 171.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.05 -48.36 44.01 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.005 -0.434 . . . . 0.44 110.785 170.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.93 -9.79 16.03 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.064 1.316 . . . . 0.36 114.795 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.58 -21.63 10.92 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.232 1.516 . . . . 0.68 112.122 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -56.69 -33.28 66.29 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.414 1.006 . . . . 2.08 112.854 172.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.06 -12.31 9.13 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.862 1.265 . . . . 2.51 112.683 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 72.26 62.29 0.13 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.571 1.148 . . . . 0.8 110.369 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.3 174.21 11.48 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.489 -0.757 . . . . 1.13 110.458 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -143.22 68.34 1.3 Allowed 'General case' 0 C--N 1.34 0.162 0 N-CA-C 106.935 -1.505 . . . . 4.82 106.935 -169.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.8 mt -84.82 107.18 15.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 113.922 -1.49 . . . . 0.96 110.138 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.4 mt -92.7 129.19 41.14 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 108.98 -0.748 . . . . 1.31 108.98 -172.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.07 100.9 0.66 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.397 2.065 . . . . 0.7 109.797 172.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -46.87 -49.97 19.4 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.609 0.364 . . . . 3.31 111.293 169.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.83 83.17 0.16 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.684 0.794 . . . . 4.62 109.455 175.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 82.23 -175.69 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.691 2.396 . . . . 7.73 108.943 -169.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.26 0 CA-C-O 115.816 -2.04 . . . . 9.34 105.991 -174.371 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.0 mtt . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 117.565 -1.207 . . . . 9.62 110.295 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -34.47 -68.13 0.12 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.104 1.362 . . . . 5.39 112.675 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.45 141.78 9.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.859 -1.163 . . . . 6.44 107.859 163.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.37 119.0 3.35 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.997 2.119 . . . . 4.5 107.31 174.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.0 m -151.55 156.12 39.87 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.315 -1.365 . . . . 0.93 107.315 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.01 139.81 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 O-C-N 124.593 1.183 . . . . 0.5 111.545 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.522 ' CD2' HD13 ' A' ' 51' ' ' ILE . 5.6 m-85 -127.43 143.22 51.24 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.713 1.605 . . . . 2.34 107.691 -163.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.33 140.73 31.41 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 118.876 0.762 . . . . 3.62 109.279 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.89 137.33 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 123.822 0.849 . . . . 0.71 109.106 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -140.77 152.11 44.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.03 1.332 . . . . 2.72 107.74 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.02 -56.68 0.73 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 125.225 1.393 . . . . 1.44 110.409 164.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.469 HD21 ' HB3' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -61.72 157.71 17.21 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.103 0.561 . . . . 2.5 111.456 -178.704 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 t -161.55 73.56 0.44 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.319 -0.622 . . . . 2.81 109.319 174.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -169.39 134.05 1.43 Allowed 'General case' 0 C--N 1.338 0.099 0 O-C-N 121.62 -0.675 . . . . 2.43 110.734 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 m -59.84 -43.07 94.79 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.313 0.645 . . . . 1.72 111.147 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -58.44 -48.59 80.22 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.791 -0.568 . . . . 2.39 110.17 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.0 m -57.32 -48.05 79.98 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.625 -0.509 . . . . 1.12 109.625 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.46 -50.41 65.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.736 0.414 . . . . 1.08 111.007 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.31 -52.34 66.02 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.154 0.981 . . . . 0.72 109.64 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -54.93 -44.65 74.45 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 119.881 -0.727 . . . . 3.81 110.669 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.36 -63.24 1.21 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.12 0.568 . . . . 2.34 110.131 177.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.86 -40.01 87.17 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.835 0.35 . . . . 2.58 110.612 -171.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -49.52 72.92 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.896 0.878 . . . . 3.22 109.647 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -51.64 -48.44 63.34 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.14 0.576 . . . . 1.66 109.587 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.6 t -60.15 -48.38 88.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 O-C-N 122.179 -0.326 . . . . 0.53 110.628 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -55.04 -34.78 63.83 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.594 -0.691 . . . . 1.89 112.539 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -70.9 -8.79 55.39 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.47 0.915 . . . . 2.12 113.47 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.5 mm -70.86 140.19 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 120.282 1.401 . . . . 2.17 109.768 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -89.74 139.96 30.05 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 125.373 1.469 . . . . 2.73 109.172 171.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.34 -46.54 1.16 Allowed Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.327 1.442 . . . . 1.81 110.601 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.3 p -64.33 158.54 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 122.386 -0.479 . . . . 0.96 110.062 174.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.8 m -108.34 -60.2 1.76 Allowed 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 107.996 -1.113 . . . . 1.13 107.996 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -127.78 161.8 28.13 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.659 0.614 . . . . 2.21 112.659 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.65 141.58 21.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.431 -0.951 . . . . 0.68 108.431 166.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.8 mt -127.96 104.57 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 106.433 -1.692 . . . . 1.39 106.433 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.44 122.1 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.704 -1.221 . . . . 1.94 107.704 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -122.11 102.63 8.27 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 105.9 -1.889 . . . . 2.58 105.9 175.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.469 ' HB3' HD21 ' A' ' 12' ' ' LEU . 26.8 m-85 -100.51 -161.47 0.87 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.092 0.557 . . . . 2.8 110.992 -174.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.02 -61.47 4.34 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.825 -1.31 . . . . 2.4 109.825 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.35 61.9 0.22 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.961 0.905 . . . . 2.63 108.701 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.4 m -155.58 -129.21 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.836 -0.54 . . . . 3.32 111.582 -175.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt -162.45 153.96 18.14 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.03 1.332 . . . . 4.08 111.269 -165.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.64 117.9 52.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.712 1.205 . . . . 0.79 109.23 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.4 m -91.3 141.17 29.07 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 124.599 1.16 . . . . 0.51 109.338 173.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 t -122.23 145.83 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.439 -1.689 . . . . 0.68 106.439 166.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.2 m -145.89 138.67 25.75 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.265 -1.383 . . . . 0.85 107.265 175.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.94 -91.98 0.18 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 108.224 -1.95 . . . . 0.74 108.224 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -170.75 58.34 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.276 1.83 . . . . 2.2 109.737 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.73 162.44 41.26 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.165 -0.96 . . . . 0.51 111.4 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 61.8 m -109.76 168.01 9.73 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.43 1.892 . . . . 0.94 110.09 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.522 HD13 ' CD2' ' A' ' 7' ' ' TYR . 7.7 tp -52.06 -35.53 18.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 CA-C-O 117.083 -1.437 . . . . 1.53 111.736 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -28.37 -52.67 0.09 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.53 1.532 . . . . 2.36 112.661 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -61.85 -46.01 91.32 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.789 0.804 . . . . 2.17 111.484 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.1 t -70.15 -37.45 71.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.157 1.383 . . . . 0.37 110.913 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -48.6 80.86 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.525 1.53 . . . . 3.3 108.452 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -51.07 -47.94 61.71 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.75 0.42 . . . . 3.93 110.752 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.64 -51.18 71.02 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.424 0.556 . . . . 0.77 110.771 173.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.84 -26.23 25.3 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 126.54 2.019 . . . . 0.51 112.308 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -44.31 -31.77 1.12 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.276 1.038 . . . . 0.54 112.469 170.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -53.72 -32.37 51.76 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.681 1.128 . . . . 2.13 113.63 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.49 0.56 6.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.177 1.391 . . . . 2.6 112.168 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 60.21 57.17 3.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.508 1.523 . . . . 1.54 111.896 177.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.83 160.65 20.16 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 121.46 -0.775 . . . . 1.34 112.118 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 72.43 0.82 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.998 -1.112 . . . . 3.65 107.998 -169.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -82.23 119.7 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.189 -0.671 . . . . 0.64 109.189 -175.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.9 mm -98.3 112.28 61.78 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 125.0 1.32 . . . . 1.48 108.7 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -73.44 83.14 1.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.017 1.811 . . . . 1.42 110.488 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -48.09 133.41 15.06 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.522 1.529 . . . . 3.11 110.62 173.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? 76.74 70.89 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.038 1.335 . . . . 6.15 111.384 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.58 124.32 46.09 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.808 1.643 . . . . 13.34 106.992 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.152 0 C-N-CA 126.801 2.041 . . . . 11.8 107.583 -177.723 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 109.657 -0.497 . . . . 10.61 109.657 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.95 152.36 11.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.266 -1.753 . . . . 6.1 106.266 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -86.18 50.78 2.05 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.667 1.187 . . . . 4.71 110.248 -163.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.69 134.8 54.51 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.544 1.937 . . . . 4.5 107.787 174.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.7 m -146.74 154.66 41.66 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.032 -1.47 . . . . 0.53 107.032 172.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.02 142.69 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 O-C-N 123.999 0.812 . . . . 0.54 110.151 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -127.67 140.45 52.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.732 -1.581 . . . . 1.86 106.732 -172.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.3 ttt-85 -84.62 126.34 33.26 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.735 -1.209 . . . . 5.16 107.735 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.448 ' CG2' HD21 ' A' ' 12' ' ' LEU . 1.7 p -111.39 146.4 16.41 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 107.356 -1.35 . . . . 0.51 107.356 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.02 171.96 14.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.335 0.397 . . . . 2.31 111.546 -176.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.26 56.77 21.77 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.379 -0.828 . . . . 2.26 112.418 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.64 HD22 ' CE2' ' A' ' 38' ' ' PHE . 2.5 pp -163.07 166.47 23.54 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.602 1.561 . . . . 2.72 107.854 174.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.3 p -174.76 66.11 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.091 0.557 . . . . 2.71 109.951 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.6 t -156.71 124.63 5.54 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.334 0.515 . . . . 2.18 111.436 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -58.29 -43.9 88.26 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.007 0.923 . . . . 1.37 111.727 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -57.42 -44.83 84.94 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.748 0.704 . . . . 2.5 110.533 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.6 m -61.27 -45.94 92.44 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.943 -0.391 . . . . 0.81 109.943 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.22 -47.02 72.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.717 0.407 . . . . 0.56 110.954 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.68 -51.3 69.0 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.533 1.133 . . . . 0.58 109.469 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -52.9 -45.17 67.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.883 -0.599 . . . . 2.91 109.603 174.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.417 ' CZ ' HD11 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -56.59 -63.39 1.21 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.184 -0.436 . . . . 2.58 110.846 176.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -60.51 -38.02 83.01 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.314 0.961 . . . . 2.35 111.527 -172.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.3 ttt85 -61.3 -49.62 76.28 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.122 -0.325 . . . . 3.62 110.122 175.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -51.42 -50.58 59.41 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.266 -0.642 . . . . 1.36 109.266 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.654 HG22 HG22 ' A' ' 54' ' ' VAL . 39.4 t -56.83 -50.11 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 O-C-N 121.972 -0.455 . . . . 0.38 110.982 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -53.19 -34.69 58.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.449 1.099 . . . . 1.47 112.01 175.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -68.69 -16.55 63.86 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.178 0.899 . . . . 2.19 113.397 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.2 mt -77.28 111.21 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 120.036 1.289 . . . . 1.44 109.865 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -50.49 -31.39 15.22 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.187 2.195 . . . . 2.89 113.448 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.16 -25.05 74.68 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.286 0.946 . . . . 0.8 113.629 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -96.64 162.82 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 119.027 1.414 . . . . 0.84 110.723 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.1 m -110.43 -56.71 2.31 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.763 -1.199 . . . . 0.6 107.763 171.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -137.19 164.7 27.87 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.82 -0.437 . . . . 2.13 109.82 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.432 ' CB ' HG11 ' A' ' 25' ' ' VAL . . . -154.72 137.31 15.14 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.828 -1.175 . . . . 0.66 107.828 172.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.4 mm -112.6 101.55 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.035 -1.098 . . . . 1.8 108.035 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.69 120.87 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 108.681 -0.859 . . . . 2.52 108.681 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -117.09 97.22 5.82 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.901 -1.148 . . . . 2.17 107.901 171.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.64 ' CE2' HD22 ' A' ' 12' ' ' LEU . 2.7 m-30 -82.15 -166.49 1.26 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.362 1.465 . . . . 3.37 110.93 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.64 -65.44 4.11 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.174 -1.57 . . . . 2.34 109.174 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -171.97 72.53 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.11 0.964 . . . . 1.94 108.41 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.3 m -156.74 -121.65 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 O-C-N 122.002 -0.436 . . . . 2.88 110.676 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -161.51 164.68 29.46 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.986 0.914 . . . . 4.13 110.056 -164.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.66 112.4 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.097 1.359 . . . . 0.76 108.089 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.7 m -88.25 147.7 24.7 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 123.746 0.819 . . . . 0.56 109.735 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.9 t -132.61 137.29 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 127.586 2.355 . . . . 1.05 105.729 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.3 m -145.89 101.17 3.51 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.798 -1.186 . . . . 0.99 107.798 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 178.77 -102.38 0.17 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 118.11 -1.995 . . . . 0.48 110.023 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -163.03 44.8 0.12 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.44 1.496 . . . . 2.44 108.278 172.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.03 169.62 17.31 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.329 1.052 . . . . 0.71 109.965 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.0 m -131.44 169.95 15.34 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.672 1.189 . . . . 0.64 110.066 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 tp -61.19 -30.59 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-O 117.363 -1.303 . . . . 1.74 112.727 -174.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -37.32 -52.76 1.1 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.892 1.223 . . . . 2.75 111.928 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -59.47 -46.77 87.82 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.742 0.645 . . . . 3.8 112.742 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.654 HG22 HG22 ' A' ' 25' ' ' VAL . 34.8 t -63.06 -42.72 97.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 123.694 0.797 . . . . 0.44 110.206 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.85 -52.75 64.09 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 127.154 2.182 . . . . 3.07 108.729 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -51.19 -52.36 45.07 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.622 -0.51 . . . . 2.95 109.622 173.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.43 74.8 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.803 -0.561 . . . . 0.59 110.721 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.0 -6.41 12.52 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.48 1.99 . . . . 0.45 113.867 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.37 -24.75 1.33 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.017 1.408 . . . . 0.69 112.071 171.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -54.52 -36.29 64.09 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.479 0.918 . . . . 2.09 113.479 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -121.92 -5.87 9.03 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.095 0.861 . . . . 2.35 113.088 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 68.55 58.0 0.42 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.24 1.016 . . . . 0.88 110.845 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.437 ' HG ' HD23 ' A' ' 12' ' ' LEU . 2.0 mm? -80.27 168.77 18.65 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.36 -0.838 . . . . 1.16 111.236 -176.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.92 68.25 1.51 Allowed 'General case' 0 C--N 1.343 0.322 0 CA-C-O 122.239 1.019 . . . . 4.23 110.061 -170.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.417 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 1.4 mt -81.82 139.61 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.49 -0.777 . . . . 0.53 110.288 -172.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.5 mt -129.25 133.42 25.13 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.224 1.009 . . . . 1.18 109.942 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.59 87.6 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.408 2.739 . . . . 0.89 111.592 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -66.58 92.56 0.21 Allowed 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.337 1.055 . . . . 3.18 109.268 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -63.26 158.58 19.81 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.82 0.448 . . . . 5.75 110.325 165.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -116.5 132.74 56.6 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.898 1.679 . . . . 9.12 106.657 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.821 1.248 . . . . 8.16 111.102 -172.255 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 108.303 -0.999 . . . . 9.17 108.303 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.05 65.28 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.194 0.597 . . . . 6.43 110.009 -175.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -81.3 55.32 2.53 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.608 0.718 . . . . 4.62 111.625 -170.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.52 141.28 37.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.857 2.063 . . . . 3.5 108.155 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.0 m -150.55 140.59 22.03 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.077 -1.453 . . . . 0.94 107.077 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 p -127.47 140.92 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 124.195 0.934 . . . . 0.66 110.32 171.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -128.97 155.89 44.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.321 -1.363 . . . . 2.32 107.321 -174.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.0 ttt-85 -88.99 122.08 31.99 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.295 -0.859 . . . . 4.56 109.1 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.5 p -113.09 140.15 34.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 124.521 1.129 . . . . 0.77 108.033 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -153.28 164.81 37.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.853 -1.536 . . . . 3.47 106.853 -172.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.69 -54.6 0.54 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.467 1.032 . . . . 1.54 112.105 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.506 ' HB3' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -61.31 172.28 1.16 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.708 1.203 . . . . 2.67 113.142 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -168.44 67.62 0.07 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.723 -0.656 . . . . 2.93 111.498 170.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.1 t -160.03 133.69 7.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.817 1.19 . . . . 1.91 113.366 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 m -56.16 -49.88 72.73 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.342 1.457 . . . . 1.58 112.065 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -51.62 -45.14 63.14 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.661 0.744 . . . . 2.39 110.515 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.0 m -68.04 -37.9 81.87 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.001 -0.545 . . . . 1.04 110.567 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.421 ' HA ' ' CD2' ' A' ' 38' ' ' PHE . . . -52.42 -48.65 65.61 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.279 0.49 . . . . 0.79 110.605 170.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.48 -50.81 72.09 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.831 0.824 . . . . 0.74 109.193 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -53.67 -43.56 68.98 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.854 -0.612 . . . . 2.67 110.799 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.496 ' HZ ' HD11 ' A' ' 65' ' ' ILE . 1.3 t80 -65.77 -60.65 2.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.643 0.377 . . . . 2.51 111.199 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -56.55 -41.42 76.81 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 118.818 0.736 . . . . 2.9 110.614 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -60.01 -53.49 57.19 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 119.185 -0.436 . . . . 3.21 110.352 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.405 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 2.2 m120 -50.59 -46.73 58.06 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 118.672 0.669 . . . . 1.32 110.015 178.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.9 t -59.77 -49.15 84.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 109.713 -0.477 . . . . 0.57 109.713 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -55.32 -36.36 66.15 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.547 -0.721 . . . . 1.58 112.643 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -72.35 -6.99 47.18 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.425 0.898 . . . . 1.89 113.425 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.3 141.92 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 120.46 1.482 . . . . 1.83 109.274 171.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -88.7 128.45 35.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.46 -1.311 . . . . 3.67 107.46 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.14 -39.26 2.95 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.264 0.935 . . . . 2.03 112.097 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 p -64.71 159.38 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 121.578 -0.954 . . . . 0.96 110.615 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.2 m -115.25 -61.86 1.68 Allowed 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.333 1.053 . . . . 1.07 108.208 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -122.44 154.21 38.08 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.288 0.367 . . . . 2.54 111.338 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.9 137.89 19.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.867 -0.52 . . . . 0.48 110.101 169.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.4 mt -128.59 91.02 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 106.766 -1.568 . . . . 1.57 106.766 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.99 103.39 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.742 -0.836 . . . . 2.57 108.742 -176.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -84.59 65.88 9.24 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 106.316 -1.735 . . . . 1.86 106.316 174.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 18' ' ' ALA . 0.3 OUTLIER -70.59 132.68 45.84 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.844 -0.799 . . . . 3.07 108.844 -177.263 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.16 -65.69 0.39 Allowed Glycine 0 C--O 1.226 -0.396 0 N-CA-C 107.853 -2.099 . . . . 2.84 107.853 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -175.64 69.36 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 125.081 1.352 . . . . 2.13 107.712 178.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.2 m -156.02 -103.95 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 O-C-N 121.767 -0.583 . . . . 2.58 111.19 -175.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 169.77 24.04 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.459 0.704 . . . . 5.99 110.944 -172.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.401 HD13 ' C ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -129.33 117.35 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 124.588 1.155 . . . . 0.82 108.141 176.656 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.7 m -97.07 134.67 40.12 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 123.545 0.738 . . . . 0.44 109.571 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.34 145.33 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 126.305 1.842 . . . . 0.97 106.673 168.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.6 m -146.81 136.72 23.29 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 106.625 -1.62 . . . . 0.62 106.625 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.05 -90.23 0.17 Allowed Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 109.343 -1.503 . . . . 0.59 109.343 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -173.17 55.72 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.321 1.448 . . . . 2.54 110.178 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.35 160.14 43.92 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.692 -1.255 . . . . 0.57 110.79 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.9 m -111.57 167.01 10.66 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.713 1.605 . . . . 0.6 110.315 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.3 tp -56.43 -30.2 30.45 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 CA-C-O 117.763 -1.113 . . . . 1.75 113.191 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -33.06 -53.8 0.37 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.615 1.166 . . . . 2.44 112.224 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -63.52 -47.73 80.48 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.655 0.74 . . . . 2.38 111.685 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.34 -45.36 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.008 0.923 . . . . 0.38 110.078 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.87 -51.63 69.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.663 1.985 . . . . 2.66 109.108 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -53.56 -44.33 69.19 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.597 0.359 . . . . 3.07 110.477 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.405 ' HB1' ' OD1' ' A' ' 24' ' ' ASN . . . -58.03 -54.99 40.74 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.16 0.505 . . . . 0.44 110.47 169.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.96 -17.19 9.05 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 126.957 2.218 . . . . 0.39 114.088 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -38.86 -35.79 0.23 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.944 0.872 . . . . 0.7 111.921 162.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -54.54 -31.52 56.55 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.723 1.008 . . . . 1.98 113.723 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -122.35 4.24 9.7 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.954 1.301 . . . . 2.25 111.921 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 58.69 53.98 5.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.694 1.198 . . . . 1.18 110.629 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 12' ' ' LEU . 4.6 mm? -68.95 159.79 32.04 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.851 -0.531 . . . . 1.69 111.535 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.37 67.05 1.38 Allowed 'General case' 0 C--N 1.343 0.301 0 CA-C-O 121.42 0.628 . . . . 3.65 109.608 -172.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.496 HD11 ' HZ ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -81.56 140.28 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.069 -0.514 . . . . 0.68 109.888 -172.563 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 85.5 mt -127.66 132.35 24.29 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.164 0.986 . . . . 1.23 108.942 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.99 105.03 1.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.124 2.549 . . . . 0.88 110.033 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -58.58 -42.84 88.95 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.674 0.79 . . . . 3.36 111.001 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -147.18 169.25 19.72 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 105.273 -2.121 . . . . 6.26 105.273 168.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 27.38 89.16 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 128.235 2.614 . . . . 9.97 114.65 173.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.291 0 CA-C-O 117.186 -1.388 . . . . 14.96 112.35 178.848 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 109.081 -0.711 . . . . 15.07 109.081 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.93 -166.67 0.44 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.174 1.39 . . . . 7.91 107.305 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -146.45 -158.15 0.88 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.732 1.213 . . . . 4.77 108.08 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.61 153.21 22.54 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.199 0.599 . . . . 4.27 110.811 175.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.9 m -155.35 162.12 40.9 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.592 -1.262 . . . . 0.95 107.592 174.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.54 148.94 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 O-C-N 123.453 0.471 . . . . 0.54 111.531 164.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -135.56 143.49 45.7 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.069 1.348 . . . . 1.95 107.954 -170.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -91.57 126.93 36.83 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.576 0.625 . . . . 4.59 110.132 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.32 154.43 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 C-N-CA 123.929 0.892 . . . . 0.76 109.213 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.422 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . 51.0 t0 -147.15 158.23 43.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.783 -0.821 . . . . 2.71 108.783 171.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.62 -56.82 0.68 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 125.16 1.362 . . . . 1.6 111.06 164.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.98 173.72 4.32 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.9 0.88 . . . . 2.4 112.483 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.3 p -162.82 63.01 0.2 Allowed 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.882 -0.511 . . . . 3.04 110.193 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.3 t -155.52 118.49 4.31 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.241 0.473 . . . . 1.87 111.709 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.1 t -52.87 -38.95 62.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.375 0.67 . . . . 2.24 111.354 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -56.23 -39.28 72.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.642 -0.661 . . . . 2.91 110.707 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.5 m -70.53 -39.9 73.78 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.786 -0.572 . . . . 0.79 110.373 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.05 -43.77 74.1 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.787 0.722 . . . . 0.66 110.764 171.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.74 -49.58 74.47 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.709 0.404 . . . . 0.62 110.344 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.4 tptt -49.76 -48.11 50.48 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.146 0.579 . . . . 3.1 109.668 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -56.08 -64.05 0.98 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.443 1.097 . . . . 2.72 111.148 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -56.33 -38.2 71.02 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.129 1.331 . . . . 2.64 111.85 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -63.61 -51.05 66.95 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.348 0.659 . . . . 2.82 111.38 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -53.96 -44.33 70.66 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.629 -0.669 . . . . 1.4 110.27 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 54' ' ' VAL . 89.8 t -61.54 -48.14 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 122.777 0.431 . . . . 0.41 110.274 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -54.01 -34.92 61.2 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.801 0.84 . . . . 1.58 112.825 175.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -62.31 -23.95 67.03 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.763 0.711 . . . . 3.04 112.355 174.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.425 HG22 ' H ' ' A' ' 30' ' ' GLY . 41.9 mt -70.81 131.69 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 O-C-N 120.963 -1.086 . . . . 1.33 108.777 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -75.75 -28.2 58.38 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.21 1.004 . . . . 3.01 112.722 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.425 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -68.74 -29.36 72.7 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.827 0.727 . . . . 0.86 113.013 -176.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 p -89.59 166.95 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 118.633 1.217 . . . . 0.63 109.356 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.0 m -124.02 -61.25 1.38 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.825 -1.176 . . . . 0.57 107.825 173.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -129.17 111.12 12.6 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.195 -0.668 . . . . 2.68 109.195 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.22 131.96 49.85 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.147 -1.057 . . . . 0.5 108.147 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.7 mm -109.54 97.91 6.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.035 -1.839 . . . . 1.72 106.035 176.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -97.9 136.29 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 109.241 -0.651 . . . . 2.21 109.241 -175.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -111.41 -51.0 2.89 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.736 -0.838 . . . . 2.66 108.736 171.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 55.99 -161.98 0.17 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 110.316 -0.253 . . . . 2.76 110.316 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.08 -71.31 1.73 Allowed Glycine 0 C--N 1.339 0.746 0 O-C-N 121.184 -0.948 . . . . 2.89 111.037 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.78 55.79 0.31 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.303 -1.369 . . . . 2.12 107.303 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.0 m -155.75 -120.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.696 0.798 . . . . 2.85 109.871 -173.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -157.91 178.12 10.58 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.515 -0.741 . . . . 3.83 110.93 -167.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.4 111.94 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 125.466 1.506 . . . . 0.75 108.318 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.0 m -90.17 141.78 28.36 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 123.675 0.79 . . . . 0.55 109.168 171.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 69.2 t -120.95 130.15 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 127.115 2.166 . . . . 0.81 105.249 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.7 m -133.78 142.26 47.82 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 106.781 -1.563 . . . . 0.78 106.781 163.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.93 -102.54 0.23 Allowed Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 104.18 -3.568 . . . . 0.53 104.18 175.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -160.05 45.67 0.23 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.581 0.752 . . . . 3.1 110.983 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.07 176.21 9.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.003 0.921 . . . . 0.51 111.12 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.4 m -126.03 166.64 16.6 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.934 1.694 . . . . 0.58 110.757 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.42 HD11 HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -49.52 -39.97 14.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-O 117.016 -1.469 . . . . 2.52 111.402 178.415 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -29.58 -53.5 0.14 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.419 1.488 . . . . 2.47 113.195 -177.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -66.03 -44.5 84.49 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.358 0.599 . . . . 2.21 112.282 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 25' ' ' VAL . 14.7 t -58.4 -36.62 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.517 1.127 . . . . 0.34 110.895 171.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.35 -55.45 33.42 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 107.988 -1.116 . . . . 2.77 107.988 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.1 tp60 -52.31 -44.86 65.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.466 1.106 . . . . 3.98 110.509 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.4 -55.46 34.76 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.625 0.77 . . . . 0.44 111.049 171.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.2 -15.84 39.12 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 125.636 1.588 . . . . 0.27 113.41 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.96 -25.25 0.19 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.167 -0.92 . . . . 0.54 112.699 165.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -51.38 -40.32 58.98 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.914 1.234 . . . . 1.88 112.901 172.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -111.04 -13.07 14.13 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.31 1.044 . . . . 2.92 111.81 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 76.32 49.01 0.07 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.367 1.467 . . . . 0.88 110.095 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 63' ' ' LEU . 4.4 mm? -67.32 159.83 28.47 Favored 'General case' 0 N--CA 1.462 0.142 0 O-C-N 121.648 -0.657 . . . . 1.35 111.804 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HD2' ' HB3' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -124.02 112.71 17.49 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 106.477 -1.675 . . . . 4.43 106.477 174.195 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.42 HD12 HD11 ' A' ' 51' ' ' ILE . 0.9 OUTLIER -117.56 130.86 71.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.528 -0.915 . . . . 0.67 108.528 -178.228 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 49.0 mm -108.4 126.9 28.54 Favored Pre-proline 0 N--CA 1.452 -0.345 0 C-N-CA 125.07 1.348 . . . . 1.56 108.593 -174.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.67 97.69 0.73 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.641 2.227 . . . . 0.64 109.08 171.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -60.73 145.95 47.67 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 120.17 -0.612 . . . . 3.66 110.092 173.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.57 171.71 18.47 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 105.96 -1.867 . . . . 5.81 105.96 -170.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -154.54 -69.5 0.13 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.038 -1.467 . . . . 7.59 107.038 -170.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 N-CA-C 106.793 -1.558 . . . . 8.41 106.793 145.949 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 109.064 -0.717 . . . . 9.25 109.064 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.34 160.95 17.8 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.911 0.708 . . . . 6.45 112.911 -174.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.48 46.06 1.81 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.376 2.27 . . . . 6.61 109.508 -165.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -126.15 148.88 49.31 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.804 1.241 . . . . 3.24 109.974 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.2 m -148.28 150.07 32.99 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.367 -1.345 . . . . 0.52 107.367 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.82 140.18 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 O-C-N 123.901 0.751 . . . . 0.39 111.542 169.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -122.95 148.68 45.2 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.41 -1.7 . . . . 1.9 106.41 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.89 150.55 26.43 Favored 'General case' 0 N--CA 1.461 0.122 0 N-CA-C 108.31 -0.996 . . . . 6.62 108.31 173.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.67 146.78 23.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.478 0.711 . . . . 0.57 109.413 170.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.4 167.07 22.92 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.005 1.322 . . . . 2.42 107.923 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 120.44 -75.63 0.32 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.691 1.139 . . . . 1.65 111.156 173.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.474 HD22 ' HB3' ' A' ' 17' ' ' CYS . 1.6 pp -68.8 157.41 36.49 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-N 117.088 0.444 . . . . 2.67 109.855 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 p -146.83 62.15 1.2 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.29 0.636 . . . . 2.81 110.176 -176.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 t -160.03 123.08 3.48 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.715 0.635 . . . . 1.81 112.715 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.7 m -48.66 -45.0 38.2 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.672 1.189 . . . . 1.73 111.908 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -57.3 -36.65 71.33 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.755 -0.59 . . . . 3.18 111.24 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.474 ' HB3' HD22 ' A' ' 12' ' ' LEU . 20.5 m -70.15 -41.0 74.44 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 122.055 -0.403 . . . . 0.9 110.034 177.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.81 -47.74 73.66 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.01 0.368 . . . . 0.78 110.117 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.92 -52.34 65.88 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.756 0.822 . . . . 0.71 110.823 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -50.31 -52.3 37.89 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.105 0.962 . . . . 2.21 109.793 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -52.19 -62.1 1.85 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 118.571 -0.728 . . . . 2.71 111.571 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.55 -40.62 79.3 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.262 0.937 . . . . 2.66 110.975 -173.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.2 mtt180 -52.71 -56.01 18.57 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.774 0.716 . . . . 3.91 110.468 171.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -51.57 -43.38 62.42 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.355 0.597 . . . . 2.37 110.252 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.549 HG22 HG22 ' A' ' 54' ' ' VAL . 92.4 t -61.95 -50.08 81.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 C-N-CA 123.254 0.622 . . . . 0.48 111.141 175.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -57.75 -27.86 63.41 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.008 1.323 . . . . 1.92 112.318 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -68.36 -22.55 64.66 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.845 0.748 . . . . 2.21 112.825 171.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.7 mt -69.33 132.69 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.624 1.102 . . . . 1.36 108.13 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -74.32 -32.62 62.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.652 0.781 . . . . 2.76 112.446 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.15 -36.54 90.9 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.063 0.839 . . . . 0.91 112.435 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 p -86.31 159.1 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 O-C-N 121.115 -1.226 . . . . 0.63 109.937 -176.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -117.93 -57.34 2.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.858 1.263 . . . . 0.57 108.15 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -127.87 144.97 51.08 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.048 -0.661 . . . . 2.28 111.315 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.64 131.57 31.72 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.87 -0.789 . . . . 0.5 108.87 171.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mp -114.88 78.99 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 107.746 -1.205 . . . . 2.01 107.746 -173.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 m -84.08 136.51 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 115.636 -0.711 . . . . 2.14 110.821 -167.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -133.71 58.13 1.78 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.995 -1.854 . . . . 2.05 105.995 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -66.8 137.07 56.35 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.185 -1.043 . . . . 3.08 108.185 171.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.63 -54.59 0.47 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.589 -1.404 . . . . 3.0 109.589 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -175.72 53.39 0.01 OUTLIER 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.733 1.613 . . . . 2.16 107.136 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 m -157.31 -106.94 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.833 -0.542 . . . . 2.48 111.271 -173.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.59 172.51 18.43 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 112.831 0.678 . . . . 6.53 112.831 -161.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.31 112.43 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 106.776 -1.565 . . . . 0.71 106.776 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.8 m -92.78 135.94 33.67 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.221 -1.029 . . . . 0.53 108.221 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.53 142.31 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.237 1.815 . . . . 0.74 106.789 173.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.3 m -147.44 136.95 22.71 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 106.983 -1.488 . . . . 0.72 106.983 176.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.76 -94.75 0.16 Allowed Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 106.12 -2.792 . . . . 0.53 106.12 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -165.11 56.33 0.12 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.223 1.809 . . . . 2.5 108.984 173.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.09 170.6 15.64 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.072 -1.017 . . . . 0.65 110.945 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.2 m -129.62 160.66 32.62 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.387 1.475 . . . . 0.69 110.319 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 tp -53.41 -33.71 21.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 CA-C-O 117.299 -1.334 . . . . 1.71 113.059 -172.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -35.07 -48.15 0.41 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.826 1.194 . . . . 3.63 112.089 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -62.38 -49.74 74.33 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.169 0.985 . . . . 2.42 111.223 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.549 HG22 HG22 ' A' ' 25' ' ' VAL . 45.7 t -63.22 -38.52 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.884 1.274 . . . . 0.28 110.581 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -67.41 -46.64 72.61 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.833 1.653 . . . . 2.96 108.329 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -51.87 -52.6 48.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.798 0.439 . . . . 3.22 109.93 172.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.85 -51.31 52.63 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.508 0.595 . . . . 0.4 110.872 170.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.54 -13.9 18.9 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 125.373 1.464 . . . . 0.27 113.911 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.68 -25.92 1.36 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.751 1.275 . . . . 0.42 111.813 168.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -51.81 -31.43 27.33 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.478 1.036 . . . . 2.03 113.322 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -133.98 -6.25 2.74 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.802 1.038 . . . . 2.31 113.802 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 74.03 60.02 0.08 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.354 1.462 . . . . 0.82 111.106 173.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.98 161.86 25.23 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.701 -0.625 . . . . 1.36 110.466 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.67 72.31 1.33 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 107.508 -1.293 . . . . 4.47 107.508 -170.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 mt -82.24 135.49 24.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.2 -1.363 . . . . 0.51 109.247 -172.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 38.8 mm -124.89 127.41 25.12 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 123.629 0.771 . . . . 2.25 110.268 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.23 103.3 1.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.912 2.408 . . . . 0.65 110.108 174.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -55.49 -55.52 30.84 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.812 1.645 . . . . 4.82 110.5 170.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -72.77 113.06 9.39 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.169 -0.678 . . . . 7.33 109.169 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -115.12 -55.09 2.5 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.476 1.511 . . . . 11.37 108.19 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 N-CA-C 106.218 -1.771 . . . . 9.04 106.218 168.276 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ttt . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 108.416 -0.957 . . . . 10.61 108.416 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.77 59.17 3.31 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.819 0.848 . . . . 6.27 110.666 -170.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -141.62 177.38 8.19 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.565 1.546 . . . . 5.26 109.531 -173.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.44 158.06 24.71 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.447 1.099 . . . . 3.91 109.996 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.8 m -155.58 162.02 40.73 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.551 -0.907 . . . . 0.63 108.551 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.62 142.47 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 O-C-N 123.535 0.522 . . . . 0.46 110.962 165.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.466 ' CD1' HD13 ' A' ' 51' ' ' ILE . 35.1 m-85 -126.88 154.57 44.25 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.217 1.407 . . . . 1.93 108.665 -171.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -92.02 114.63 27.23 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 118.574 -0.726 . . . . 3.7 109.209 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 p -100.63 137.08 29.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.797 0.839 . . . . 0.47 109.025 174.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.64 156.4 46.86 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.322 -0.992 . . . . 2.4 108.322 171.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 133.2 -74.71 0.43 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.386 -1.485 . . . . 1.39 109.386 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.413 HD21 ' CE2' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -89.64 171.14 9.88 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.007 0.743 . . . . 2.61 113.007 -174.429 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.3 m -158.22 83.08 0.85 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.263 1.425 . . . . 3.84 109.649 175.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.4 t -158.25 137.6 11.75 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.055 0.843 . . . . 1.9 112.158 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.3 m -61.19 -47.05 87.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.03 0.932 . . . . 1.48 111.305 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -60.15 -40.35 89.54 Favored 'General case' 0 C--O 1.233 0.196 0 O-C-N 121.164 -0.96 . . . . 2.69 110.265 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.1 m -60.77 -44.72 96.4 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.019 -0.426 . . . . 0.9 109.999 173.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.78 -46.72 71.11 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.404 0.282 . . . . 0.72 110.493 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.14 -50.55 72.45 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.952 0.501 . . . . 0.69 109.915 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.22 -50.07 40.07 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.235 0.614 . . . . 2.16 109.996 174.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.554 ' O ' HG23 ' A' ' 25' ' ' VAL . 2.8 t80 -64.2 -57.58 9.08 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.081 0.552 . . . . 2.63 110.513 -173.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -59.05 -41.13 87.14 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.866 -0.733 . . . . 2.13 110.142 -176.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -61.87 -50.01 73.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.994 -0.527 . . . . 3.8 109.897 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -48.22 -50.58 28.89 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.614 -0.513 . . . . 1.62 109.614 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.563 HG22 HG22 ' A' ' 54' ' ' VAL . 18.7 t -57.74 -52.15 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 110.395 -0.224 . . . . 0.51 110.395 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -49.35 -39.74 32.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.503 1.121 . . . . 2.16 111.605 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -67.49 -19.96 65.4 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.872 0.693 . . . . 2.08 112.872 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.594 HG22 ' H ' ' A' ' 30' ' ' GLY . 19.9 mt -76.12 122.22 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 119.857 1.208 . . . . 1.35 109.552 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -66.52 -18.67 65.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.745 1.218 . . . . 2.67 113.648 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.594 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -70.45 -34.2 68.17 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 123.51 0.576 . . . . 0.9 111.978 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.512 HG11 HG12 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -92.92 -173.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 O-C-N 121.799 -0.824 . . . . 0.87 110.542 -172.125 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.0 m -132.93 -62.0 0.82 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.834 -1.172 . . . . 0.83 107.834 170.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -120.64 164.48 16.45 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.076 0.465 . . . . 4.14 111.982 175.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.462 ' CB ' HG11 ' A' ' 25' ' ' VAL . . . -158.25 136.56 10.9 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.987 -1.006 . . . . 0.5 109.898 168.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 35' ' ' ILE . 3.4 mp -119.78 101.36 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 O-C-N 124.686 1.241 . . . . 1.73 107.812 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.5 p -84.96 137.16 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.588 0.755 . . . . 2.33 109.792 175.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -89.0 -59.77 2.14 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.838 0.745 . . . . 2.78 109.747 165.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.413 ' CE2' HD21 ' A' ' 12' ' ' LEU . 10.6 m-30 58.56 -177.37 0.08 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.076 0.95 . . . . 2.66 110.73 -162.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.18 36.41 79.72 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.162 -0.775 . . . . 2.32 111.162 -174.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 69.75 74.09 0.23 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.632 1.573 . . . . 2.81 108.455 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.3 m -155.2 -114.11 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.87 -0.604 . . . . 2.48 110.174 -172.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -158.51 165.8 33.7 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.619 0.768 . . . . 3.49 111.103 -173.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.45 119.11 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.63 1.172 . . . . 0.77 109.848 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.7 m -94.13 145.79 24.44 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.558 1.143 . . . . 0.54 111.098 175.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 90.0 t -131.75 134.22 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 127.557 2.343 . . . . 1.0 105.871 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.1 m -145.71 75.46 1.43 Allowed 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 120.707 -1.245 . . . . 1.39 108.461 -173.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -157.92 -117.31 0.51 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 108.065 -2.014 . . . . 1.19 108.065 173.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.02 59.08 1.3 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.769 1.227 . . . . 4.31 108.185 177.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.73 162.02 41.07 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.686 -0.634 . . . . 0.5 110.063 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.9 m -110.92 161.43 15.85 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.343 1.457 . . . . 0.59 110.339 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.466 HD13 ' CD1' ' A' ' 7' ' ' TYR . 6.1 tp -51.21 -36.52 16.79 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 117.732 -1.128 . . . . 1.92 113.154 -175.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -35.52 -47.37 0.45 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.685 1.194 . . . . 3.38 113.393 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -67.49 -39.73 85.21 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.361 -0.837 . . . . 2.35 111.659 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.563 HG22 HG22 ' A' ' 25' ' ' VAL . 43.7 t -68.05 -44.01 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.202 1.001 . . . . 0.38 109.524 178.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -53.37 -48.65 68.4 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.107 2.163 . . . . 2.8 109.163 174.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -52.9 -52.22 58.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.637 0.775 . . . . 4.02 110.605 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.29 -49.23 70.1 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.098 0.863 . . . . 0.6 110.666 172.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.78 -13.6 4.54 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.131 1.348 . . . . 0.46 113.957 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.69 -32.75 1.06 Allowed 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.545 1.173 . . . . 0.72 111.565 165.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -49.18 -37.01 21.1 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.656 0.984 . . . . 1.9 113.656 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -125.43 12.09 8.08 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.217 1.007 . . . . 2.84 111.127 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 60.77 47.91 7.52 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.805 1.242 . . . . 1.15 110.467 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 mp -65.15 153.04 42.06 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.524 -0.307 . . . . 2.33 110.764 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.65 108.65 11.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.612 -1.996 . . . . 3.6 105.612 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.551 HD11 ' HZ ' ' A' ' 21' ' ' PHE . 1.5 mt -112.55 126.29 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.481 -0.933 . . . . 0.57 108.481 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 mp -104.56 131.16 22.11 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 108.133 -1.062 . . . . 1.3 108.133 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.33 105.02 0.81 Allowed 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.783 1.656 . . . . 0.78 107.875 165.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -52.74 157.74 1.53 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.288 0.566 . . . . 4.41 111.195 171.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.4 tptt -71.65 148.8 46.17 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.161 -0.616 . . . . 6.1 110.114 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.56 79.62 0.27 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.938 0.895 . . . . 9.01 110.459 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.202 0 C-N-CA 126.875 2.07 . . . . 8.08 111.463 -179.324 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 ttt . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 106.346 -1.724 . . . . 12.5 106.346 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.23 153.93 42.86 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.417 1.008 . . . . 5.83 110.562 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -71.17 106.59 3.83 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.642 -0.873 . . . . 5.88 108.642 177.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 136.32 40.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.798 1.239 . . . . 3.86 108.799 175.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.0 m -149.48 154.41 38.76 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 107.804 -1.184 . . . . 0.59 107.804 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.34 140.07 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 O-C-N 124.431 1.082 . . . . 0.49 109.905 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -129.41 136.93 50.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.23 -1.396 . . . . 1.9 107.23 -167.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -84.56 133.11 34.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 118.189 -0.91 . . . . 4.69 109.384 -174.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -120.54 145.53 26.8 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 C-N-CA 124.63 1.172 . . . . 0.66 109.842 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -139.42 150.76 45.63 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.899 -1.519 . . . . 2.4 106.899 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.76 -71.11 0.42 Allowed Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.471 1.034 . . . . 1.41 110.729 168.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.615 HD21 ' HB3' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -63.98 165.92 8.24 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.265 1.026 . . . . 2.32 112.106 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.2 p -161.62 64.91 0.26 Allowed 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.875 -0.516 . . . . 2.84 110.055 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.6 t -159.34 134.59 8.3 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 110.047 -0.353 . . . . 1.83 110.047 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.7 p -53.34 -48.13 68.75 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.12 0.968 . . . . 2.18 109.89 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -43.4 -51.11 6.67 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.302 1.041 . . . . 2.53 111.772 173.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.4 m -64.06 -45.63 87.94 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 109.988 -0.375 . . . . 0.8 109.988 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -46.97 73.22 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.567 0.222 . . . . 0.55 111.401 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.45 -48.98 78.65 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.326 1.05 . . . . 0.58 109.86 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -53.77 -48.19 69.99 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.724 -0.473 . . . . 4.23 109.724 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.76 -59.81 4.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.695 0.798 . . . . 2.37 111.573 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -56.88 -41.22 77.64 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 119.347 -0.941 . . . . 2.73 109.961 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -60.04 -48.43 81.76 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 119.275 -0.393 . . . . 3.22 110.165 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -49.06 -51.77 29.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.072 0.397 . . . . 1.34 110.001 172.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 54' ' ' VAL . 45.2 t -59.11 -48.04 88.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 O-C-N 122.027 -0.421 . . . . 0.34 110.76 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -54.47 -37.06 64.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.739 1.215 . . . . 1.48 112.086 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -65.31 -18.54 65.39 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.895 0.77 . . . . 2.09 112.963 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.1 mt -76.88 115.92 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 119.79 1.177 . . . . 1.22 109.538 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -77.68 60.76 2.26 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.595 1.958 . . . . 3.92 110.097 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -154.15 -36.72 0.03 OUTLIER Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.205 1.859 . . . . 0.81 111.965 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.94 172.31 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 121.46 -1.024 . . . . 0.68 109.124 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.2 m -121.58 -60.71 1.59 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.682 1.193 . . . . 0.68 108.032 171.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -122.89 134.33 54.38 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 109.887 -0.412 . . . . 2.1 109.887 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.19 126.09 42.21 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.149 -1.056 . . . . 0.45 108.149 171.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.19 95.07 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 105.408 -2.071 . . . . 2.22 105.408 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -91.79 141.38 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 120.398 -0.521 . . . . 2.05 109.856 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -127.5 46.23 2.58 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.951 -1.129 . . . . 1.73 107.951 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.615 ' HB3' HD21 ' A' ' 12' ' ' LEU . 53.7 m-85 -54.06 122.94 11.22 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.12 0.568 . . . . 3.19 109.5 173.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.69 -55.9 0.43 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.401 -1.48 . . . . 2.61 109.401 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.98 34.66 0.1 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.73 0.412 . . . . 2.14 111.467 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.9 m -146.63 -111.38 0.09 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.562 0.345 . . . . 2.73 111.823 -170.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.457 ' NZ ' ' OE1' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -158.27 167.75 28.92 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.36 1.064 . . . . 4.01 109.98 -173.476 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.67 119.48 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 125.544 1.537 . . . . 0.82 108.386 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.1 m -96.83 144.76 26.49 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 118.313 0.506 . . . . 0.48 110.099 172.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.27 138.84 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 127.116 2.166 . . . . 0.75 106.87 174.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.4 m -145.47 134.47 22.61 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.536 -1.653 . . . . 0.69 106.536 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.55 -94.98 0.16 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 107.348 -2.301 . . . . 0.52 107.348 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -164.3 50.07 0.12 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.337 1.455 . . . . 2.57 109.349 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.14 173.71 11.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.897 0.879 . . . . 0.67 110.414 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.0 m -137.89 169.73 17.29 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.071 1.348 . . . . 0.9 111.039 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.468 ' O ' HD13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -50.46 -40.61 18.82 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 CA-C-O 117.222 -1.37 . . . . 2.65 110.694 -179.221 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -34.63 -49.8 0.43 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.681 1.582 . . . . 4.19 113.773 -176.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -68.77 -45.39 71.5 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.441 0.639 . . . . 2.19 112.035 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 25' ' ' VAL . 21.9 t -57.32 -33.84 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.271 1.028 . . . . 0.37 110.593 174.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -59.98 -57.29 13.48 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.667 1.587 . . . . 3.07 106.863 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -53.84 -47.34 71.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.868 -1.06 . . . . 3.26 110.01 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.62 -52.2 49.57 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.848 -0.532 . . . . 0.42 111.191 171.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.52 -9.7 26.17 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.64 1.114 . . . . 0.34 112.643 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.34 -23.68 3.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 119.151 1.476 . . . . 0.47 111.478 169.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -52.11 -32.11 33.78 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.277 0.944 . . . . 2.01 112.76 172.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -136.96 10.48 3.07 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.819 0.848 . . . . 2.49 112.682 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 57.33 65.75 1.3 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.855 1.262 . . . . 1.29 111.655 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.404 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.2 mm? -77.19 -166.53 0.73 Allowed 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.848 -0.533 . . . . 1.32 110.959 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.401 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -155.53 62.65 0.61 Allowed 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 120.49 -1.381 . . . . 4.63 107.5 -179.643 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.465 HD12 HD11 ' A' ' 51' ' ' ILE . 1.1 mt -79.86 137.8 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.359 -1.291 . . . . 0.61 109.299 -173.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.9 mt -127.19 136.28 28.65 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 124.194 0.997 . . . . 1.31 109.599 -174.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.18 83.67 0.35 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.979 2.453 . . . . 0.82 110.968 172.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.457 ' OE1' ' NZ ' ' A' ' 42' ' ' LYS . 5.1 tt0 -40.63 120.21 1.23 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.526 1.931 . . . . 3.52 109.969 167.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -111.53 -55.88 2.45 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.52 0.728 . . . . 4.49 110.253 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -136.78 151.91 49.72 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 104.876 -2.268 . . . . 8.67 104.876 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.204 0 CA-C-O 116.125 -1.893 . . . . 11.31 107.724 -170.222 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 tpt . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 108.104 -1.072 . . . . 8.14 108.104 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.72 25.48 9.75 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.999 0.92 . . . . 5.22 112.76 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.79 91.48 0.14 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.132 0.973 . . . . 5.24 110.626 176.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.36 134.33 46.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.091 1.756 . . . . 4.38 107.361 164.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.7 m -155.1 151.97 28.95 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.372 -1.344 . . . . 0.78 107.372 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -119.3 141.12 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 O-C-N 124.448 1.092 . . . . 0.68 110.535 162.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -122.32 152.86 39.67 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.914 1.685 . . . . 1.79 106.746 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -94.26 134.71 36.45 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.41 1.005 . . . . 3.87 110.704 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 p -112.58 135.85 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 O-C-N 124.322 1.014 . . . . 0.64 109.71 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -135.82 172.08 13.52 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.147 0.43 . . . . 2.98 110.593 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.41 -47.43 2.6 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.43 1.491 . . . . 1.62 112.129 176.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.513 HD22 ' CE2' ' A' ' 38' ' ' PHE . 4.3 pp -60.49 167.28 2.66 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.475 0.71 . . . . 2.55 112.863 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.5 t -165.99 64.19 0.11 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.869 0.468 . . . . 2.91 111.125 172.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.8 t -156.85 134.68 10.94 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 120.949 -1.094 . . . . 2.05 110.582 171.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.411 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 91.4 m -68.18 -44.92 74.82 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 122.114 -0.367 . . . . 2.16 110.918 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -56.19 -40.52 74.11 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.141 -0.974 . . . . 2.74 110.803 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.0 m -55.82 -32.98 64.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.037 0.535 . . . . 0.82 111.364 174.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 15' ' ' THR . . . -60.46 -41.96 95.21 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 122.843 0.457 . . . . 0.52 109.839 176.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.37 -45.34 91.59 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.635 0.731 . . . . 0.52 109.078 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.2 tmtp? -52.1 -46.63 65.35 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.749 -0.659 . . . . 2.86 109.325 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.619 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -61.97 -58.21 8.75 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 119.007 -0.52 . . . . 2.58 112.325 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -54.27 -47.94 71.77 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.873 -0.788 . . . . 2.6 108.873 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 ttt-85 -63.03 -50.61 70.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.704 -0.48 . . . . 4.25 109.704 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.605 HD22 ' HB1' ' A' ' 57' ' ' ALA . 29.0 m-20 -49.34 -47.77 47.09 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 117.904 0.32 . . . . 1.39 110.265 175.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 21' ' ' PHE . 19.5 t -62.51 -49.4 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 122.088 -0.383 . . . . 0.5 110.102 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -50.95 -35.66 34.68 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.9 0.88 . . . . 2.27 112.162 173.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -70.36 -12.76 61.8 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.322 0.86 . . . . 2.87 113.322 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.679 HG22 ' H ' ' A' ' 30' ' ' GLY . 36.3 mt -78.54 131.51 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 120.199 1.363 . . . . 1.41 109.791 177.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -86.3 20.77 2.26 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.638 1.975 . . . . 3.55 112.494 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.679 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -122.62 -12.87 4.87 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.845 1.212 . . . . 1.13 112.54 -178.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -115.67 157.17 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 C-N-CA 125.332 1.453 . . . . 0.6 107.433 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.9 m -109.32 -60.08 1.81 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.708 1.203 . . . . 0.65 108.454 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -117.27 148.62 41.51 Favored 'General case' 0 N--CA 1.462 0.125 0 O-C-N 123.207 0.317 . . . . 2.94 110.589 175.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.416 ' CB ' HG11 ' A' ' 25' ' ' VAL . . . -150.58 129.68 12.68 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.71 -0.478 . . . . 0.58 109.71 172.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.3 mt -130.19 102.49 7.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 107.269 -1.382 . . . . 1.33 107.269 -174.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 p -88.94 144.73 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 122.938 0.495 . . . . 1.99 110.81 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -134.66 64.03 1.61 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.076 1.351 . . . . 1.98 108.465 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.513 ' CE2' HD22 ' A' ' 12' ' ' LEU . 8.1 m-30 -54.69 -21.93 12.29 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 124.404 1.082 . . . . 2.88 112.486 171.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.27 -19.16 38.51 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 120.318 -0.944 . . . . 3.39 111.686 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.47 -106.37 0.33 Allowed 'General case' 0 C--N 1.344 0.337 0 CA-C-N 118.25 1.025 . . . . 3.44 108.677 159.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.1 m -157.25 68.58 0.54 Allowed 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.148 -1.797 . . . . 5.46 106.148 -173.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -153.63 140.29 18.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.678 -0.489 . . . . 5.63 109.678 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.89 114.78 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.263 1.025 . . . . 0.78 108.627 174.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.1 m -87.58 133.09 33.86 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 123.811 0.845 . . . . 0.55 109.034 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.4 t -121.91 140.52 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 126.657 1.983 . . . . 0.7 105.797 171.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.9 m -147.98 135.3 20.54 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.535 -1.283 . . . . 0.78 107.535 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.03 -96.46 0.16 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 106.509 -2.636 . . . . 0.56 106.509 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.4 49.24 0.26 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.611 1.164 . . . . 4.12 109.411 169.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.17 174.32 11.7 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.843 0.857 . . . . 0.73 111.131 177.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -125.05 170.57 11.04 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.926 1.691 . . . . 0.78 111.557 -174.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.4 tp -52.47 -37.61 24.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-O 117.513 -1.232 . . . . 1.77 112.269 -177.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -31.7 -52.47 0.24 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.019 1.328 . . . . 3.24 112.365 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -58.98 -50.75 72.89 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.584 1.183 . . . . 2.25 111.675 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.568 HG12 ' CZ ' ' A' ' 21' ' ' PHE . 65.1 t -61.89 -44.77 99.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.935 1.694 . . . . 0.48 110.433 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -63.29 -45.08 93.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.531 1.532 . . . . 3.55 109.495 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -51.58 -51.04 58.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.235 -0.654 . . . . 4.11 109.235 172.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.605 ' HB1' HD22 ' A' ' 24' ' ' ASN . . . -53.3 -48.97 67.92 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.912 -0.492 . . . . 0.38 110.682 173.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.02 -9.22 7.01 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.873 1.702 . . . . 0.31 113.96 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.53 -29.18 1.67 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.497 1.148 . . . . 0.47 111.49 166.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -51.69 -35.56 43.21 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.344 0.974 . . . . 1.95 113.555 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -121.61 4.73 10.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.41 1.084 . . . . 2.47 111.472 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 59.24 52.51 6.0 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.631 1.172 . . . . 1.07 110.054 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.22 158.03 29.91 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.575 -0.284 . . . . 2.18 110.481 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.75 119.2 25.24 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.747 -1.205 . . . . 3.95 107.747 167.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.0 mt -120.54 139.36 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.171 1.388 . . . . 0.49 107.97 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mp -128.28 133.31 25.01 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 108.358 -0.978 . . . . 1.39 108.358 -176.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.53 112.53 3.06 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.337 2.025 . . . . 0.84 108.87 170.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -45.82 -47.6 15.82 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.657 0.783 . . . . 3.24 111.27 172.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.0 tttm 61.86 50.0 4.48 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.243 1.017 . . . . 5.17 110.745 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -74.91 68.64 1.8 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.109 0.964 . . . . 7.22 110.024 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.286 0 CA-C-O 116.624 -1.655 . . . . 8.41 107.916 176.662 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 107.035 -1.468 . . . . 10.9 107.035 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.27 -144.54 0.18 Allowed 'General case' 0 CA--C 1.541 0.602 0 O-C-N 124.785 1.303 . . . . 5.16 111.316 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 18.44 62.09 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 129.251 3.02 . . . . 4.98 114.893 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.35 133.6 31.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.739 2.016 . . . . 4.64 107.639 175.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.7 m -150.15 156.53 41.78 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.579 -1.267 . . . . 0.58 107.579 174.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 p -137.21 139.65 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 123.761 0.663 . . . . 0.42 110.326 168.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -125.18 145.84 49.78 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.011 1.325 . . . . 2.32 108.156 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.18 125.18 32.63 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 118.307 -0.854 . . . . 3.64 109.484 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 p -115.92 132.59 64.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 C-N-CA 123.34 0.656 . . . . 0.64 110.132 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -135.09 166.85 22.12 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.38 1.472 . . . . 3.09 108.661 -175.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.23 -50.84 0.98 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.908 1.242 . . . . 1.31 111.407 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.04 161.48 4.03 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.735 1.214 . . . . 3.25 113.417 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.1 p -172.45 51.03 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.746 0.647 . . . . 3.17 112.746 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -160.86 143.0 12.46 Favored 'General case' 0 C--N 1.346 0.426 0 O-C-N 120.76 -1.212 . . . . 2.0 113.656 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.8 m -63.32 -49.32 74.41 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.074 0.95 . . . . 1.82 111.661 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -55.05 -40.49 70.34 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.571 -0.706 . . . . 4.46 110.674 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.0 m -64.56 -43.26 94.49 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 122.136 -0.352 . . . . 0.95 110.771 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.99 -48.58 64.36 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.009 0.368 . . . . 0.96 110.173 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.53 -51.49 69.23 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.715 0.806 . . . . 0.86 110.332 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -49.9 -44.98 50.39 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.872 0.469 . . . . 2.55 109.978 175.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.414 ' HZ ' HD11 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -64.65 -58.49 6.16 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.22 -0.895 . . . . 2.51 111.536 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -51.98 -45.19 64.36 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.55 1.068 . . . . 3.53 108.91 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -61.61 -59.06 5.77 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.344 0.658 . . . . 5.54 111.082 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.475 ' HB3' ' HB1' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -49.67 -48.11 49.68 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.016 -0.735 . . . . 1.61 109.016 -178.668 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.403 HG22 HG13 ' A' ' 54' ' ' VAL . 90.5 t -60.76 -48.24 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 122.994 0.518 . . . . 0.76 110.546 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -56.07 -36.06 67.67 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.663 1.185 . . . . 2.45 111.992 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.14 -9.71 58.53 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.255 0.835 . . . . 2.38 113.255 175.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.1 mm -78.69 110.52 14.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 120.039 1.291 . . . . 2.19 110.587 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.61 85.7 0.07 Allowed 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.166 1.786 . . . . 3.44 108.584 165.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.38 -42.1 0.12 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 109.865 -1.294 . . . . 0.96 109.865 -177.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -97.92 151.29 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 108.642 -0.873 . . . . 0.97 108.642 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.3 m -106.28 -55.95 2.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.943 1.297 . . . . 0.6 108.09 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -121.44 125.44 46.9 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.948 -0.76 . . . . 3.36 108.948 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.82 136.89 47.85 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.292 -1.003 . . . . 0.63 108.292 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.8 mt -129.39 110.84 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.871 -1.159 . . . . 1.27 107.871 -176.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.6 p -95.24 111.48 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 118.413 0.551 . . . . 2.04 111.37 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -83.55 71.59 10.33 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 106.953 -1.499 . . . . 2.19 106.953 167.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.64 67.14 2.72 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.785 0.802 . . . . 2.95 109.286 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -161.46 52.38 0.33 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.356 -1.498 . . . . 3.15 109.356 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 68.6 63.35 0.34 Allowed 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 125.491 1.516 . . . . 2.04 108.766 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m -157.09 -113.69 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.46 -0.791 . . . . 2.61 110.258 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -157.79 155.73 30.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.812 -0.555 . . . . 3.37 110.731 -163.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.28 117.46 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 125.69 1.596 . . . . 0.81 108.367 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.3 m -89.18 144.63 25.97 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.727 0.811 . . . . 0.54 109.921 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.96 132.43 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 127.163 2.185 . . . . 0.73 106.617 175.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.9 m -143.27 132.41 23.11 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.996 -1.483 . . . . 0.88 106.996 173.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.9 -90.07 0.12 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.982 -1.647 . . . . 0.76 108.982 177.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -165.41 54.65 0.11 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.72 1.608 . . . . 2.88 109.208 167.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.88 174.68 10.36 Favored 'General case' 0 C--N 1.34 0.172 0 O-C-N 121.032 -1.042 . . . . 0.69 112.175 -176.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.1 m -134.61 166.35 23.11 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.454 1.501 . . . . 0.59 110.518 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.803 HD11 HD12 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -48.1 -44.5 12.12 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.877 0 CA-C-O 117.199 -1.381 . . . . 2.73 111.098 -178.802 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -31.7 -47.93 0.14 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.054 1.741 . . . . 2.79 114.113 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -66.73 -46.51 75.22 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.671 0.748 . . . . 2.76 111.32 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.403 HG13 HG22 ' A' ' 25' ' ' VAL . 25.1 t -62.1 -31.47 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.993 1.317 . . . . 0.43 111.161 172.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -60.24 -55.5 33.03 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.253 1.421 . . . . 3.19 107.274 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.06 -48.06 76.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.374 -0.83 . . . . 3.69 110.3 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.475 ' HB1' ' HB3' ' A' ' 24' ' ' ASN . . . -50.04 -51.1 44.95 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.414 0.552 . . . . 0.63 110.793 172.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.18 -10.7 29.07 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.112 -0.826 . . . . 0.28 113.533 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.04 -30.18 4.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.857 1.328 . . . . 0.59 112.24 172.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -57.57 -28.18 63.35 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.464 1.029 . . . . 2.22 113.213 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -128.38 -5.75 5.36 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.131 0.973 . . . . 3.09 112.471 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 63.22 61.39 1.08 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.715 1.206 . . . . 1.24 111.018 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 63' ' ' LEU . 2.0 mm? -82.19 169.37 16.68 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 121.891 -0.506 . . . . 1.02 110.495 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.05 70.8 1.42 Allowed 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.114 -1.069 . . . . 4.54 108.114 -170.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.803 HD12 HD11 ' A' ' 51' ' ' ILE . 2.0 mt -79.96 135.41 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 108.678 -0.86 . . . . 0.56 108.678 -173.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.26 135.62 23.2 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 124.37 1.068 . . . . 1.37 108.291 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.33 100.46 0.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 121.847 1.698 . . . . 0.97 109.324 170.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -56.26 138.65 50.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.687 -0.857 . . . . 3.96 108.687 172.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -61.98 147.1 48.11 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.682 -0.488 . . . . 5.08 109.682 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -48.39 144.77 3.82 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.739 0.816 . . . . 7.63 110.992 171.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.431 0 N-CA-C 104.904 -2.258 . . . . 10.95 104.904 176.403 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 108.179 -1.045 . . . . 8.11 108.179 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.74 121.68 10.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.571 -1.27 . . . . 6.12 107.571 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -86.41 112.06 21.12 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.158 1.783 . . . . 5.65 109.945 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.413 ' H ' ' HE3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -122.37 147.2 46.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.659 -1.978 . . . . 4.96 105.659 166.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 88.9 m -153.5 156.07 37.42 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 106.301 -1.741 . . . . 0.69 106.301 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -132.69 145.99 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 O-C-N 123.992 0.807 . . . . 0.42 110.919 168.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -131.06 146.68 52.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.401 -1.703 . . . . 1.9 106.401 -172.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -85.17 128.15 34.55 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.816 -0.809 . . . . 5.15 108.816 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -112.31 135.26 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.91 -1.515 . . . . 0.49 106.91 174.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -142.59 154.74 44.69 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 104.964 -2.236 . . . . 3.05 104.964 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.52 -81.81 0.35 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.398 0.999 . . . . 1.6 110.999 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.574 HD21 ' CZ ' ' A' ' 38' ' ' PHE . 0.5 OUTLIER -81.31 163.06 23.19 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.304 0.552 . . . . 2.72 110.929 -174.278 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.545 ' N ' HD12 ' A' ' 12' ' ' LEU . 18.2 t -149.26 79.21 1.4 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.197 0.599 . . . . 3.67 110.721 177.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.3 t -160.53 146.65 15.18 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.087 0.858 . . . . 1.78 112.387 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -68.39 -46.35 70.26 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.391 1.476 . . . . 1.56 111.996 -177.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -55.02 -43.52 73.76 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.426 -0.796 . . . . 2.75 110.424 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.3 m -56.96 -45.25 82.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.624 -0.716 . . . . 0.97 110.512 173.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.413 ' HB1' HG13 ' A' ' 36' ' ' VAL . . . -56.12 -49.89 72.63 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 122.941 0.497 . . . . 0.92 110.268 176.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.07 -46.42 68.58 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.235 0.54 . . . . 0.8 110.267 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -61.52 -46.11 91.35 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.446 -0.343 . . . . 3.49 110.849 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.21 -64.81 0.72 Allowed 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.848 0.859 . . . . 2.79 110.706 175.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -39.63 83.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.981 0.81 . . . . 2.42 111.086 -172.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -53.04 62.76 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.139 0.576 . . . . 2.82 110.393 172.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -53.33 -46.5 69.51 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.431 -0.581 . . . . 1.33 109.431 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.578 HG11 ' CB ' ' A' ' 34' ' ' ALA . 48.5 t -59.22 -51.25 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 122.678 0.391 . . . . 0.55 110.324 176.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.5 mttt -50.64 -38.43 46.18 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.036 0.935 . . . . 1.87 112.414 173.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.63 -12.53 54.08 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.488 0.921 . . . . 3.01 113.488 175.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 30' ' ' GLY . 19.2 mt -86.29 113.47 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 120.319 1.418 . . . . 1.36 110.1 178.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -53.4 -25.16 14.59 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.833 1.653 . . . . 3.36 114.006 176.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.496 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -71.67 -31.13 65.43 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.886 0.755 . . . . 0.8 112.466 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.54 HG11 HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -92.27 -172.99 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 121.278 -1.131 . . . . 0.8 109.99 -171.556 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.1 m -140.71 -57.97 0.52 Allowed 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 120.769 -1.207 . . . . 0.79 108.811 171.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -128.53 157.95 39.77 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 119.954 -0.698 . . . . 2.67 111.36 171.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.578 ' CB ' HG11 ' A' ' 25' ' ' VAL . . . -154.84 149.55 26.53 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.239 -0.652 . . . . 0.57 109.239 172.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.9 mt -130.32 131.07 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 107.047 -1.464 . . . . 1.61 107.047 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.413 HG13 ' HB1' ' A' ' 18' ' ' ALA . 2.8 p -118.61 110.04 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 124.389 1.076 . . . . 2.32 109.703 -175.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -101.21 78.0 1.86 Allowed 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.619 -1.252 . . . . 2.12 107.619 171.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.574 ' CZ ' HD21 ' A' ' 12' ' ' LEU . 18.6 m-85 -67.97 169.36 10.1 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 121.063 0.459 . . . . 2.71 110.431 169.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.27 -71.4 0.22 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 107.137 -2.385 . . . . 2.72 107.137 -173.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -170.59 67.26 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.234 1.013 . . . . 2.18 108.61 176.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 m -152.51 -113.06 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.493 0.553 . . . . 2.64 112.493 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -157.94 160.02 37.14 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.793 -0.567 . . . . 3.76 110.891 -158.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.26 115.7 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.145 -1.428 . . . . 0.81 107.145 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 79.6 m -90.84 141.76 28.48 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.322 1.449 . . . . 0.46 108.722 174.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.1 t -129.63 140.85 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 104.58 -2.378 . . . . 1.01 104.58 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.4 m -147.26 133.35 19.3 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 107.185 -1.413 . . . . 0.88 107.185 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.7 -96.26 0.16 Allowed Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 106.836 -2.505 . . . . 0.62 106.836 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -163.8 57.53 0.17 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.585 1.954 . . . . 3.31 108.475 172.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.71 168.12 25.32 Favored 'General case' 0 C--N 1.341 0.219 0 O-C-N 120.9 -1.125 . . . . 0.53 111.588 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -126.29 165.67 18.55 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.278 1.431 . . . . 1.05 111.696 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.7 tp -55.64 -28.93 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 117.352 -1.308 . . . . 1.85 113.321 -172.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -35.6 -51.03 0.63 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.78 1.173 . . . . 2.46 111.469 173.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -69.13 -41.46 77.34 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.289 0.566 . . . . 2.39 111.776 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.449 HG22 HG22 ' A' ' 25' ' ' VAL . 18.2 t -65.24 -38.42 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 O-C-N 121.624 -0.672 . . . . 0.36 110.22 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -61.38 -53.85 51.33 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 127.611 2.364 . . . . 3.35 107.97 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -49.03 -42.36 37.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.15 0.58 . . . . 3.8 111.135 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.77 -47.6 68.72 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.167 0.508 . . . . 0.49 110.849 174.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.27 -15.99 12.93 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 126.928 2.204 . . . . 0.31 113.117 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -40.5 -29.32 0.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.303 1.051 . . . . 0.43 112.465 163.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -50.23 -36.16 29.84 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.9 1.074 . . . . 1.85 113.9 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -126.16 -4.73 6.77 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.472 1.509 . . . . 2.39 112.47 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 73.03 57.46 0.11 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.092 1.357 . . . . 1.33 110.85 173.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.557 HD21 HD23 ' A' ' 12' ' ' LEU . 3.8 mm? -79.11 168.29 19.84 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.186 -0.946 . . . . 1.18 111.204 -175.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -135.09 64.55 1.59 Allowed 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.492 -1.299 . . . . 4.92 107.492 -171.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.74 130.78 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 113.501 -1.681 . . . . 0.6 109.098 -174.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.8 mt -122.62 131.13 24.41 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 108.388 -0.967 . . . . 1.04 108.388 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.41 106.88 1.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.203 1.935 . . . . 0.85 109.128 169.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -48.53 -51.33 28.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.858 0.863 . . . . 3.41 109.881 172.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.7 tttm 61.2 -174.66 0.13 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.777 1.231 . . . . 5.32 110.961 -174.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -167.65 154.13 7.92 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.346 -1.724 . . . . 8.21 106.346 -176.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 C-N-CA 124.867 1.267 . . . . 8.83 111.197 -171.69 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.2 mtt . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 105.985 -1.858 . . . . 8.84 105.985 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.79 121.69 21.04 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 119.023 0.828 . . . . 6.32 109.27 -174.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -71.82 74.14 0.85 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.079 0.952 . . . . 5.2 110.971 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.75 144.26 51.0 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.078 1.351 . . . . 4.53 108.005 164.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.2 m -153.35 159.03 42.37 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 106.422 -1.696 . . . . 0.65 106.422 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 p -136.66 148.33 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 O-C-N 124.111 0.882 . . . . 0.49 110.778 173.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -133.27 141.8 48.19 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 106.729 -1.582 . . . . 2.01 106.729 -171.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.1 mtt85 -83.14 137.26 34.14 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.455 1.025 . . . . 3.92 108.416 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.484 HG21 ' CE2' ' A' ' 38' ' ' PHE . 2.7 p -121.78 140.65 45.11 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 124.093 0.957 . . . . 0.52 110.112 178.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -140.33 155.03 46.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.998 -1.482 . . . . 2.86 106.998 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.17 -81.68 0.35 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.811 1.196 . . . . 1.42 110.598 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.5 ' C ' HD12 ' A' ' 12' ' ' LEU . 1.3 pp -75.64 161.23 29.29 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.957 0.379 . . . . 2.67 110.522 -175.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 t -153.52 90.78 1.43 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.315 -0.624 . . . . 3.7 109.315 170.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.9 t -165.36 127.83 2.13 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.4 0.68 . . . . 1.91 110.077 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 m -50.32 -45.38 54.76 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.258 1.023 . . . . 1.43 111.743 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -59.34 -39.78 84.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.891 -0.506 . . . . 2.68 111.227 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.419 ' HB3' HD22 ' A' ' 12' ' ' LEU . 9.4 m -65.95 -46.29 78.67 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.686 -0.487 . . . . 0.84 109.686 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.58 -49.07 71.24 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.742 0.246 . . . . 0.66 110.417 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.87 67.59 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.57 0.748 . . . . 0.74 110.556 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.0 tttp -57.17 -46.93 82.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.135 -0.484 . . . . 2.8 110.349 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -49.61 -63.29 1.15 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 118.643 -0.694 . . . . 2.69 111.108 171.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -57.97 -39.75 78.92 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 119.099 0.863 . . . . 2.61 111.321 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -58.11 -51.06 71.28 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.698 -0.482 . . . . 3.06 109.698 173.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -53.5 -43.14 68.04 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.11 0.414 . . . . 2.69 110.223 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 54' ' ' VAL . 47.1 t -60.68 -52.18 64.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 122.808 0.443 . . . . 0.36 111.28 174.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -53.84 -35.36 61.38 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.366 1.066 . . . . 1.86 111.515 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -72.53 10.26 0.87 Allowed 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 114.128 1.159 . . . . 2.75 114.128 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.0 mt -105.42 112.83 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.276 1.43 . . . . 1.23 110.714 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -52.59 -36.15 55.54 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 127.887 2.475 . . . . 3.62 113.758 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.2 -30.17 75.08 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.474 -0.785 . . . . 0.85 112.002 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.05 172.3 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 O-C-N 121.627 -0.925 . . . . 0.89 109.252 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.6 m -126.34 -59.83 1.29 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.466 -1.309 . . . . 0.66 107.466 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -122.58 164.2 18.59 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-O 121.351 0.596 . . . . 3.5 112.404 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.48 135.73 12.12 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.986 -0.746 . . . . 0.48 108.986 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.7 mm -118.82 102.39 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 105.389 -2.078 . . . . 2.11 105.389 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.51 118.93 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.651 -0.87 . . . . 2.01 108.651 -172.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -93.14 -49.35 6.03 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 108.857 -0.794 . . . . 2.3 108.857 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.484 ' CE2' HG21 ' A' ' 9' ' ' VAL . 12.0 m-85 60.18 -168.37 0.16 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.883 0.473 . . . . 3.09 111.771 176.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.32 -66.86 3.4 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.711 -0.956 . . . . 2.78 110.711 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.44 47.85 0.13 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.36 1.064 . . . . 2.01 108.765 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 m -143.72 -125.33 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.917 0.487 . . . . 2.61 110.968 -163.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.05 167.29 30.88 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.833 0.853 . . . . 3.92 109.885 -173.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.47 114.27 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 126.348 1.859 . . . . 0.89 107.541 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.1 m -91.55 136.26 33.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.37 -0.974 . . . . 0.44 108.37 171.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 t -119.96 147.93 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 126.584 1.954 . . . . 0.82 106.791 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.9 m -146.27 138.29 25.01 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.447 -1.316 . . . . 0.81 107.447 175.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.11 -91.84 0.15 Allowed Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 108.047 -2.021 . . . . 0.54 108.047 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -167.11 50.31 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.937 1.695 . . . . 2.31 109.196 173.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.12 178.05 8.87 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.968 -1.083 . . . . 0.49 110.821 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.2 m -138.21 171.37 14.5 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.21 1.404 . . . . 1.17 110.951 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -46.43 -47.41 6.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-O 116.68 -1.628 . . . . 2.74 110.875 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -33.18 -47.74 0.2 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 121.104 1.774 . . . . 2.96 114.155 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -70.16 -44.39 68.91 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.252 -0.905 . . . . 2.05 112.291 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 25' ' ' VAL . 13.7 t -58.47 -27.83 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.139 1.376 . . . . 0.37 111.547 169.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.29 -52.23 29.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.876 1.67 . . . . 2.99 106.747 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -54.15 -45.67 72.06 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.808 0.843 . . . . 3.9 110.403 174.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.8 -57.65 10.13 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.408 0.549 . . . . 0.45 110.658 169.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.11 -16.18 25.11 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 125.407 1.479 . . . . 0.31 113.713 -174.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -42.7 -29.47 0.3 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.18 -0.914 . . . . 0.49 112.544 166.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -52.97 -35.26 58.73 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.836 1.198 . . . . 1.9 113.411 175.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.8 -1.55 9.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.682 1.193 . . . . 2.48 112.264 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 65.06 55.6 1.11 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.732 1.213 . . . . 0.88 110.519 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.05 171.66 11.49 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.156 -0.965 . . . . 1.16 110.955 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -137.57 64.3 1.52 Allowed 'General case' 0 C--N 1.341 0.218 0 N-CA-C 107.731 -1.211 . . . . 4.79 107.731 -175.733 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mt -80.7 139.47 18.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 113.982 -1.463 . . . . 0.83 108.429 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.5 mt -128.0 133.25 24.93 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.436 1.094 . . . . 1.14 108.116 -174.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -64.52 109.0 1.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.323 2.016 . . . . 0.78 109.621 172.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -61.66 138.59 58.32 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.725 -0.472 . . . . 4.54 109.725 172.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -130.1 125.46 35.19 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.548 -1.649 . . . . 4.73 106.548 -177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -157.92 138.2 12.63 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.263 -2.125 . . . . 8.23 105.263 -177.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.254 0 C-N-CA 126.822 2.049 . . . . 9.19 105.529 -175.846 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mtt . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 106.712 -1.588 . . . . 11.13 106.712 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 178.98 127.88 0.07 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.339 1.856 . . . . 5.34 106.534 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.14 -178.95 1.05 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.328 2.251 . . . . 6.22 105.211 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.99 165.8 19.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.696 0.798 . . . . 3.79 109.77 170.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -150.25 148.4 28.84 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 105.838 -1.912 . . . . 0.65 105.838 170.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.67 147.64 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 124.204 0.94 . . . . 0.54 110.284 169.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -133.0 145.09 50.55 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.082 -1.451 . . . . 2.17 107.082 -173.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 50.8 mtm-85 -87.68 124.89 34.03 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 109.037 -0.727 . . . . 5.33 109.037 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.461 HG21 ' CE2' ' A' ' 38' ' ' PHE . 2.4 p -109.74 152.91 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.056 0 N-CA-C 108.638 -0.875 . . . . 0.55 108.638 172.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.418 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . 57.2 t0 -147.37 166.81 26.02 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.284 -1.376 . . . . 2.35 107.284 177.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.6 -68.34 0.28 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.236 0.922 . . . . 1.61 112.14 171.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 12' ' ' LEU . 1.3 pp -73.41 157.94 35.94 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 117.833 0.817 . . . . 2.68 110.347 -175.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.0 m -152.25 69.9 0.9 Allowed 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.92 0.488 . . . . 3.31 110.199 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.2 t -157.86 121.87 4.15 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.045 0.538 . . . . 1.82 110.775 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 m -47.18 -44.26 21.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.205 1.402 . . . . 1.39 111.947 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -53.52 -43.92 68.7 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.888 0.475 . . . . 3.02 110.787 178.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.443 ' HB3' HD22 ' A' ' 12' ' ' LEU . 4.1 m -70.43 -39.73 74.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.386 -0.34 . . . . 0.85 110.369 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.01 -44.64 78.86 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.681 0.673 . . . . 0.56 110.766 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.39 -49.12 72.85 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.345 0.658 . . . . 0.58 110.683 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -49.53 -49.38 46.27 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.494 0.717 . . . . 2.7 109.227 173.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -56.93 -63.43 1.21 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 118.449 -0.786 . . . . 2.77 111.646 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -40.17 74.76 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 119.173 -1.011 . . . . 2.47 110.671 -172.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -59.32 -51.71 68.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.216 0.207 . . . . 2.74 111.232 174.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -52.24 -45.77 65.46 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.76 -0.588 . . . . 1.61 110.702 175.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.0 t -65.51 -45.33 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.095 0.558 . . . . 0.55 110.399 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -54.03 -38.44 65.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.293 1.037 . . . . 2.04 110.867 173.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -70.33 -0.61 8.45 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.864 1.061 . . . . 2.99 113.864 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.9 mm -85.6 134.08 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 120.837 1.653 . . . . 2.11 110.287 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -74.74 124.7 27.25 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.839 1.656 . . . . 4.11 109.316 167.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.91 -39.86 1.95 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.578 1.085 . . . . 1.1 110.955 171.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.03 159.08 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 O-C-N 121.871 -0.782 . . . . 0.59 109.311 173.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.7 m -116.17 -55.68 2.38 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.871 1.668 . . . . 0.74 107.856 177.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -127.23 147.29 50.22 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.416 0.447 . . . . 2.89 110.554 170.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.79 140.53 40.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.719 -1.215 . . . . 0.51 107.719 166.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.6 mt -125.25 109.92 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 N-CA-C 106.451 -1.685 . . . . 1.42 106.451 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.78 129.96 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 123.106 0.253 . . . . 1.94 110.788 -171.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -120.7 57.53 0.97 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.034 -1.469 . . . . 1.92 107.034 169.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.461 ' CE2' HG21 ' A' ' 9' ' ' VAL . 72.6 m-85 -62.91 135.66 57.43 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 108.432 -0.951 . . . . 3.4 108.432 170.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.25 -56.75 0.5 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 109.214 -1.555 . . . . 2.84 109.214 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -171.78 53.98 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.68 1.192 . . . . 2.04 108.404 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.4 m -156.78 -112.77 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.898 -0.501 . . . . 2.59 111.659 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.34 168.54 25.03 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.692 -0.63 . . . . 4.05 111.669 -163.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.08 113.99 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.773 -1.195 . . . . 0.77 107.773 -176.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.8 m -91.88 141.58 28.49 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.49 1.116 . . . . 0.48 109.066 174.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.8 t -129.34 138.38 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 104.744 -2.317 . . . . 0.84 104.744 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.2 m -147.61 132.46 18.03 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 106.391 -1.707 . . . . 0.67 106.391 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.87 -95.82 0.17 Allowed Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 106.651 -2.579 . . . . 0.57 106.651 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.63 63.59 0.11 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.086 1.754 . . . . 3.81 108.53 174.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.22 164.69 36.84 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.075 -1.016 . . . . 0.5 110.629 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.0 m -118.26 162.61 17.98 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 125.939 1.696 . . . . 0.68 110.65 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 tp -54.02 -31.84 21.83 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 CA-C-O 117.466 -1.254 . . . . 1.77 112.632 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -32.17 -48.57 0.17 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.89 1.276 . . . . 3.6 111.953 175.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -59.83 -52.5 65.18 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.92 0.867 . . . . 2.34 111.465 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.06 -42.41 96.52 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 C-N-CA 125.44 1.496 . . . . 0.44 110.699 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -61.99 -48.96 78.01 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.049 1.34 . . . . 2.93 108.644 178.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -56.12 -51.59 67.39 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.162 0.585 . . . . 3.31 110.35 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.51 -52.98 19.83 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.654 0.661 . . . . 0.37 110.835 168.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.46 -18.4 29.67 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 125.382 1.468 . . . . 0.31 113.414 -177.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.23 -22.77 1.11 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.543 1.171 . . . . 0.47 112.335 170.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -55.49 -32.11 62.58 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 120.167 1.348 . . . . 1.89 112.894 172.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.91 -25.21 6.83 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.127 1.371 . . . . 2.16 111.657 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 83.48 60.41 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.674 2.39 . . . . 0.74 111.363 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.16 165.72 22.16 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.119 -0.988 . . . . 1.32 111.73 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.418 ' HD2' ' HB3' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -121.04 111.72 17.82 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.966 -1.494 . . . . 4.9 106.966 175.073 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.08 127.6 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 108.845 -0.798 . . . . 0.51 108.845 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.9 mm -111.64 125.3 30.63 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.027 1.331 . . . . 1.42 108.796 -172.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.14 92.24 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.04 2.493 . . . . 0.7 110.032 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -61.28 116.2 4.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.531 0.681 . . . . 3.91 111.002 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -95.0 80.47 3.64 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.6 -1.259 . . . . 5.1 107.6 170.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -61.39 128.24 35.37 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.086 -1.079 . . . . 8.86 108.086 173.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.362 0 N-CA-C 105.765 -1.939 . . . . 8.56 105.765 -169.381 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.1 mtm . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 106.507 -1.664 . . . . 7.97 106.507 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.01 -63.55 0.64 Allowed 'General case' 0 C--O 1.227 -0.083 0 O-C-N 124.482 1.114 . . . . 5.4 108.573 -175.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 62.32 -140.25 0.43 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.218 1.007 . . . . 6.61 111.295 173.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -123.76 148.67 46.43 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.073 1.749 . . . . 3.81 108.117 -178.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.9 m -147.46 150.64 34.99 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 108.234 -1.025 . . . . 0.67 108.234 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -135.36 132.88 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 124.337 1.023 . . . . 0.71 111.114 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -115.57 153.65 30.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.772 1.629 . . . . 2.02 108.012 -169.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -92.89 112.72 24.78 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.484 -0.932 . . . . 4.1 108.484 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.9 p -96.18 144.03 11.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.572 1.149 . . . . 0.51 109.055 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -141.93 163.39 33.02 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.541 -0.541 . . . . 2.96 109.541 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.4 -70.26 0.24 Allowed Glycine 0 CA--C 1.528 0.906 0 C-N-CA 126.013 1.768 . . . . 1.55 111.024 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.94 173.3 8.99 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.388 0.884 . . . . 2.54 113.388 -170.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.1 p -167.06 82.63 0.23 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.846 0.859 . . . . 2.73 109.716 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.01 133.03 4.39 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.763 0.711 . . . . 2.03 112.422 176.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.4 m -54.59 -46.72 73.81 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.573 1.149 . . . . 1.5 111.71 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -59.42 -36.59 76.16 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.985 0.898 . . . . 3.21 111.142 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.9 m -69.79 -45.37 68.12 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 108.822 -0.807 . . . . 1.17 108.822 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.56 -43.85 68.82 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 122.759 0.424 . . . . 0.66 110.419 174.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.68 -55.21 37.83 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.471 0.708 . . . . 0.64 109.515 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -54.88 -41.09 70.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.53 -0.304 . . . . 2.88 111.037 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.522 ' CZ ' HG12 ' A' ' 54' ' ' VAL . 2.2 t80 -64.6 -60.16 3.45 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 119.403 -0.332 . . . . 2.44 111.096 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.31 -40.93 75.15 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 118.429 0.559 . . . . 2.52 109.781 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -57.97 -54.53 45.86 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.059 0.943 . . . . 2.76 109.352 175.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -49.67 -51.71 36.19 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.422 0.556 . . . . 1.95 109.851 176.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.581 HG22 HG22 ' A' ' 54' ' ' VAL . 32.5 t -55.5 -52.65 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 110.26 -0.274 . . . . 0.4 110.26 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -51.05 -39.24 55.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.194 1.398 . . . . 1.63 112.383 174.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -71.88 -14.17 61.87 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.057 0.762 . . . . 2.07 113.057 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.687 HG22 ' H ' ' A' ' 30' ' ' GLY . 17.0 mt -77.55 131.47 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 120.531 1.514 . . . . 1.33 108.761 171.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -77.22 -9.5 58.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.447 1.099 . . . . 2.44 113.75 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.687 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -78.91 -30.91 45.56 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.768 0.699 . . . . 0.81 112.09 -178.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.454 HG11 HG12 ' A' ' 25' ' ' VAL . 12.1 p -97.36 158.67 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 121.377 -1.072 . . . . 0.61 109.42 -178.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.0 m -106.08 -55.0 2.39 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.677 -1.231 . . . . 0.6 107.677 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -129.32 154.62 46.69 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.758 -0.46 . . . . 2.92 109.758 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.72 143.9 23.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.892 -0.781 . . . . 0.44 108.892 173.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.5 mt -127.5 105.77 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.313 -1.366 . . . . 1.48 107.313 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.57 125.95 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.507 -0.923 . . . . 2.56 108.507 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -86.44 -57.74 2.88 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.408 1.004 . . . . 2.79 109.94 169.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 57.81 -171.91 0.1 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.273 0.629 . . . . 2.6 109.87 -162.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.28 35.79 88.52 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 121.62 -0.675 . . . . 2.49 111.48 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 69.88 72.26 0.23 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.548 1.539 . . . . 2.42 108.472 177.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 m -155.24 -109.3 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.445 -0.798 . . . . 2.55 109.898 -176.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.77 167.85 28.38 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 122.948 0.499 . . . . 3.56 110.637 -170.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.52 120.39 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.632 1.173 . . . . 0.72 108.892 174.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.7 m -98.09 145.29 26.7 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.408 1.083 . . . . 0.54 111.177 177.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.75 140.55 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 127.563 2.345 . . . . 0.61 107.551 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.1 m -148.5 89.66 1.72 Allowed 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 124.971 1.309 . . . . 1.08 108.486 -177.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.89 -106.98 0.19 Allowed Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 108.51 -1.836 . . . . 0.72 108.51 175.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -151.92 62.77 0.85 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.706 1.202 . . . . 3.61 108.114 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.15 162.61 36.65 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.121 0.969 . . . . 0.67 110.071 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -119.5 162.14 19.39 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.884 1.673 . . . . 0.62 109.043 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.0 tp -52.67 -33.51 18.5 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 CA-C-O 117.231 -1.366 . . . . 1.64 112.012 -176.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.3 mm-40 -28.7 -53.41 0.11 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.67 1.588 . . . . 2.53 112.802 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -69.09 -41.87 76.92 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.574 0.702 . . . . 2.39 111.708 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.581 HG22 HG22 ' A' ' 25' ' ' VAL . 33.9 t -66.99 -38.04 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.278 1.031 . . . . 0.31 110.272 178.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -60.98 -49.76 76.14 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.229 1.812 . . . . 2.85 108.512 174.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -52.53 -51.62 58.73 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.83 0.452 . . . . 3.31 110.142 175.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.5 -48.61 62.85 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.627 0.649 . . . . 0.37 111.188 170.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.32 -9.64 6.42 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.918 -0.935 . . . . 0.35 114.036 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.91 -25.66 0.83 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 119.176 1.488 . . . . 0.53 112.682 170.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -53.73 -36.35 62.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.81 1.186 . . . . 2.0 113.235 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -121.0 -5.93 9.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.217 1.007 . . . . 2.61 112.894 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 67.46 50.57 0.92 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.75 1.22 . . . . 0.79 110.417 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -72.35 168.01 19.28 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.532 -0.73 . . . . 1.36 112.158 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.07 124.49 40.73 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.195 -1.78 . . . . 4.36 106.195 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.0 mt -130.85 134.49 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.708 1.203 . . . . 0.57 107.913 -175.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.6 mt -113.98 121.79 36.07 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.756 1.222 . . . . 1.47 108.169 -172.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -77.37 70.73 6.68 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 124.227 3.284 . . . . 1.41 109.5 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 46.92 -167.91 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.057 1.743 . . . . 6.96 112.913 -167.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? 62.58 122.06 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.053 1.341 . . . . 9.11 112.368 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -51.82 134.9 30.62 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.453 -0.943 . . . . 10.54 108.453 164.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.148 0 CA-C-O 116.813 -1.565 . . . . 14.22 109.464 -175.681 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 mtt . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 106.901 -1.518 . . . . 9.51 106.901 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.1 -72.08 0.02 OUTLIER 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 125.03 1.332 . . . . 5.89 107.584 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 59.03 -151.16 0.43 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.17 0.988 . . . . 5.23 110.384 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -99.1 156.35 16.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.059 -1.089 . . . . 3.75 108.059 168.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.1 m -150.2 147.19 27.4 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 107.766 -1.198 . . . . 0.53 107.766 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -123.02 143.84 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 124.947 1.404 . . . . 0.38 110.318 171.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -129.8 153.42 48.26 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.023 -1.843 . . . . 1.9 106.023 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -95.42 147.95 22.98 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.583 0.629 . . . . 3.92 110.156 173.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.34 121.7 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 123.045 0.538 . . . . 0.97 110.684 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.04 -173.45 2.31 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.069 0.548 . . . . 2.81 111.449 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.43 -46.94 3.34 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.666 1.603 . . . . 1.34 113.427 170.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.476 HD22 ' CD1' ' A' ' 38' ' ' PHE . 3.2 pp -50.13 156.8 0.74 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.874 1.269 . . . . 3.3 113.495 178.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 t -167.55 51.21 0.06 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.88 0.472 . . . . 2.83 111.221 173.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.1 t -159.16 117.74 2.9 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 120.807 -1.183 . . . . 2.2 112.854 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 m -53.04 -41.96 65.26 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.191 0.996 . . . . 1.65 112.212 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -57.25 -39.74 76.2 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.67 0.747 . . . . 3.15 109.982 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.0 m -69.39 -43.83 72.7 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.866 -0.606 . . . . 0.92 109.947 175.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.462 ' HB2' ' CG ' ' A' ' 38' ' ' PHE . . . -49.28 -48.57 45.9 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.062 0.545 . . . . 0.63 110.84 176.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.27 -48.86 80.04 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.573 -0.739 . . . . 0.51 109.879 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -58.51 -38.42 77.66 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.022 -0.535 . . . . 3.34 110.532 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.525 ' O ' HG23 ' A' ' 25' ' ' VAL . 2.2 t80 -58.07 -60.52 3.62 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.45 0.7 . . . . 2.72 109.758 174.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -55.8 -45.04 78.35 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.278 0.49 . . . . 2.47 110.029 -175.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -64.06 -47.26 80.84 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.022 -0.535 . . . . 2.76 109.808 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -52.46 -46.39 66.47 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.918 -0.401 . . . . 1.33 109.918 173.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 21' ' ' PHE . 15.4 t -60.33 -50.16 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 118.314 0.507 . . . . 0.49 109.727 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -51.63 -34.83 39.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.899 0.88 . . . . 1.42 112.996 173.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -67.26 -22.81 65.65 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.875 0.761 . . . . 3.03 112.533 176.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.665 HG22 ' H ' ' A' ' 30' ' ' GLY . 25.1 mt -70.74 133.18 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.596 1.089 . . . . 1.5 109.213 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -77.66 -17.35 57.8 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.557 1.143 . . . . 2.94 113.093 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.665 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -83.48 -11.44 80.15 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.379 0.99 . . . . 1.03 113.768 -176.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.3 p -115.06 153.18 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 118.59 1.195 . . . . 0.66 108.949 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.8 m -103.1 -51.56 3.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.23 -1.026 . . . . 0.6 108.23 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -132.38 161.08 34.51 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.837 0.351 . . . . 2.1 110.278 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.77 138.05 16.6 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.874 -1.158 . . . . 0.42 107.874 174.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 22.0 mm -126.55 102.81 10.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 106.839 -1.541 . . . . 2.03 106.839 -177.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.2 p -98.42 144.38 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 122.507 0.323 . . . . 2.04 110.658 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -137.17 71.91 1.41 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.803 -0.814 . . . . 2.87 108.803 173.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.476 ' CD1' HD22 ' A' ' 12' ' ' LEU . 2.7 m-30 -44.68 -31.13 1.07 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.528 1.531 . . . . 3.35 111.876 167.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.49 -22.22 23.26 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.035 -0.87 . . . . 3.31 112.768 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.6 -103.3 0.41 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.408 1.104 . . . . 3.48 108.678 161.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.3 m -159.66 51.89 0.35 Allowed 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.32 -0.993 . . . . 5.22 108.32 -175.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -145.69 142.54 29.1 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.044 1.293 . . . . 5.24 112.407 -170.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.78 119.33 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.105 1.362 . . . . 0.74 110.151 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 m -98.56 139.96 33.5 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.941 1.296 . . . . 0.42 110.225 172.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.5 t -122.29 140.66 45.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 127.806 2.442 . . . . 0.74 105.576 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.5 m -147.22 85.72 1.61 Allowed 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.134 -0.979 . . . . 1.03 108.424 -173.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.88 -106.87 0.19 Allowed Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 109.43 -1.468 . . . . 0.67 109.43 176.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -152.21 54.87 0.81 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.733 0.813 . . . . 2.14 108.958 170.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.77 163.6 33.55 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.425 -0.797 . . . . 0.6 110.497 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.5 m -109.57 161.42 15.37 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.337 1.455 . . . . 0.85 110.136 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.0 tp -50.74 -31.63 9.96 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 CA-C-O 117.314 -1.327 . . . . 1.74 113.321 -178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -29.86 -50.04 0.11 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.07 1.348 . . . . 3.69 112.475 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -63.93 -45.49 89.02 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 122.025 0.917 . . . . 2.37 111.604 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.43 HG22 HG22 ' A' ' 25' ' ' VAL . 28.0 t -69.57 -30.73 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.507 1.123 . . . . 0.43 110.48 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -61.7 -50.06 73.97 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.046 -1.094 . . . . 3.19 108.046 172.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -51.97 -50.87 60.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.837 0.455 . . . . 3.1 110.617 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.14 -52.24 36.78 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.856 -0.527 . . . . 0.81 111.13 170.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.07 -22.31 35.09 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 126.002 1.763 . . . . 0.41 112.952 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.38 -31.49 4.08 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.733 1.266 . . . . 0.44 112.368 171.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.57 -36.32 55.72 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.314 0.961 . . . . 2.13 113.113 175.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -130.35 4.62 4.75 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.255 1.022 . . . . 3.08 112.122 -173.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 61.82 54.75 2.8 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.597 1.559 . . . . 0.86 112.884 171.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.412 ' H ' HD22 ' A' ' 63' ' ' LEU . 1.6 mm? -80.17 -176.96 5.84 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.344 -0.542 . . . . 1.11 110.801 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -144.87 87.72 1.86 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.328 -1.73 . . . . 4.3 106.328 -176.285 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 mt -89.0 132.31 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.858 1.263 . . . . 0.9 109.9 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.7 mp -129.17 136.54 29.32 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.539 1.136 . . . . 1.44 109.025 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -72.51 64.93 3.76 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.812 3.008 . . . . 1.03 110.847 174.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -60.47 145.52 48.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.24 0.616 . . . . 6.4 109.928 170.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -152.79 159.72 43.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.912 -1.144 . . . . 7.04 107.912 176.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -148.98 -68.33 0.22 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 105.976 -1.861 . . . . 9.68 105.976 -175.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.288 0 N-CA-C 105.932 -1.877 . . . . 9.81 105.932 146.721 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 106.185 -1.783 . . . . 9.8 106.185 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 30.33 65.75 0.14 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.46 1.904 . . . . 7.08 113.233 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -58.31 178.71 0.09 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 122.6 1.191 . . . . 4.99 111.828 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -75.51 144.24 42.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.987 -1.006 . . . . 4.23 109.699 -169.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.0 m -146.84 143.72 28.78 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.44 -0.948 . . . . 0.74 108.44 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -116.34 134.44 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 124.869 1.356 . . . . 0.69 110.505 168.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -116.13 163.26 16.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.791 1.636 . . . . 2.08 106.593 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -106.21 131.41 53.49 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 118.619 -0.705 . . . . 3.84 110.39 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 p -116.87 142.64 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.366 -0.976 . . . . 0.42 108.366 -174.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -142.93 166.64 24.09 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.756 0.707 . . . . 2.9 109.885 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.25 66.0 3.0 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.464 1.507 . . . . 3.12 112.379 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.578 HD13 ' H ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -129.16 167.96 16.84 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.774 1.63 . . . . 2.68 109.712 175.411 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 m -64.41 -82.66 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.302 0.482 . . . . 6.73 112.302 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -172.71 -167.52 0.44 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.372 -0.83 . . . . 4.39 109.911 -175.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.7 t -47.95 -36.72 12.98 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.417 1.487 . . . . 2.35 112.969 -176.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -52.49 -50.93 61.76 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.929 0.871 . . . . 3.68 110.385 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.5 m -71.89 -32.66 67.63 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.909 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.71 -46.86 74.26 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 118.581 0.628 . . . . 0.59 110.044 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -49.99 75.43 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.495 -0.775 . . . . 0.58 109.085 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -53.65 -41.86 67.22 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.415 -0.357 . . . . 2.33 110.686 175.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -63.76 -57.39 10.08 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.362 0.665 . . . . 2.82 110.549 179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -55.16 -45.3 75.71 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.61 0.641 . . . . 2.53 109.609 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -60.82 -52.15 66.29 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.407 0.683 . . . . 3.71 109.462 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -48.78 -49.87 36.71 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 123.335 0.654 . . . . 2.01 109.961 176.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.496 HG22 HG22 ' A' ' 54' ' ' VAL . 38.8 t -61.65 -50.76 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 120.392 -0.523 . . . . 0.43 109.938 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -50.31 -33.92 21.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.187 0.995 . . . . 1.52 113.113 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -69.91 -22.39 63.21 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.459 0.704 . . . . 2.74 112.614 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.61 HG22 ' H ' ' A' ' 30' ' ' GLY . 21.9 mt -76.97 138.95 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.674 1.124 . . . . 1.2 109.18 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -82.47 -21.12 35.7 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.33 1.052 . . . . 2.36 113.402 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.61 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -68.86 -31.11 72.52 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 123.845 0.736 . . . . 1.0 112.503 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 32' ' ' THR . 9.8 p -95.01 -178.95 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 124.846 1.258 . . . . 0.7 109.222 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.43 ' H ' HG22 ' A' ' 31' ' ' VAL . 82.9 m -141.83 -57.95 0.47 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.372 1.069 . . . . 0.98 109.062 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.79 148.91 35.72 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-O 121.169 0.509 . . . . 2.56 110.228 172.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.11 124.0 11.3 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.729 -1.211 . . . . 0.83 107.729 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.0 mt -128.49 98.95 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 107.653 -1.24 . . . . 1.33 107.653 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 p -96.4 138.22 22.24 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 C-N-CA 122.85 0.46 . . . . 2.17 110.541 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -130.06 73.08 1.51 Allowed 'General case' 0 C--O 1.232 0.176 0 N-CA-C 107.952 -1.129 . . . . 2.45 107.952 166.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.439 ' CD2' HD23 ' A' ' 12' ' ' LEU . 3.3 m-30 -49.48 -25.02 2.32 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 125.794 1.638 . . . . 2.76 112.251 165.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.14 -20.1 33.99 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 120.814 -0.708 . . . . 3.52 111.988 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.75 -105.99 0.38 Allowed 'General case' 0 C--N 1.344 0.331 0 CA-C-N 118.155 0.977 . . . . 3.83 109.223 161.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.5 m -159.47 60.51 0.39 Allowed 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.019 -1.475 . . . . 4.89 107.019 -172.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -152.35 140.84 20.69 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.611 0.641 . . . . 4.77 111.547 -176.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.9 106.91 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.226 1.411 . . . . 0.72 109.18 -177.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.2 m -84.39 134.12 34.49 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.67 1.188 . . . . 0.79 109.718 174.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.02 138.94 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.294 1.838 . . . . 0.68 106.67 171.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.5 m -148.71 136.58 20.74 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.045 -1.465 . . . . 0.94 107.045 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.74 -94.38 0.15 Allowed Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 106.188 -2.765 . . . . 0.63 106.188 173.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -159.97 49.16 0.29 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.27 0.628 . . . . 2.37 110.383 169.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.6 172.91 12.56 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.516 -0.74 . . . . 0.59 112.035 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.8 m -127.29 164.93 20.67 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.785 1.634 . . . . 0.58 111.316 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 tp -53.75 -28.54 16.66 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-O 117.846 -1.073 . . . . 1.8 113.228 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -32.48 -51.09 0.26 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.542 1.137 . . . . 2.2 111.831 171.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -68.91 -41.76 77.77 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.416 0.627 . . . . 2.5 111.601 -177.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.496 HG22 HG22 ' A' ' 25' ' ' VAL . 37.1 t -67.1 -37.13 78.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 123.691 0.796 . . . . 0.38 110.224 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -57.32 -54.5 46.05 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.496 1.518 . . . . 3.16 108.05 173.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.82 -53.68 49.07 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 110.081 -0.34 . . . . 3.08 110.081 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.46 -47.96 62.94 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.159 0.504 . . . . 0.51 111.161 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.23 -18.34 4.74 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 126.348 1.927 . . . . 0.5 113.208 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.97 -24.26 0.58 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.555 1.678 . . . . 0.74 112.837 171.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -53.96 -34.39 59.6 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.88 1.218 . . . . 2.24 113.35 172.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -120.84 -19.38 7.33 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.316 1.446 . . . . 2.67 112.394 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 73.71 55.45 0.1 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.415 1.886 . . . . 1.04 110.856 -177.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.26 166.42 23.49 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.279 -0.888 . . . . 1.39 111.079 -176.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.51 120.06 34.77 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.568 -1.271 . . . . 4.16 107.568 169.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.45 140.28 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 125.001 1.321 . . . . 0.64 108.049 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.77 131.93 24.1 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.288 1.035 . . . . 1.59 108.602 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.08 97.35 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.567 2.178 . . . . 0.76 108.998 170.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -47.85 -47.91 31.32 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.758 0.823 . . . . 3.32 111.107 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? 71.55 -65.58 0.34 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.848 1.659 . . . . 4.51 111.157 173.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -168.24 -53.55 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.051 1.34 . . . . 7.42 108.68 173.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.409 0 N-CA-C 105.107 -2.183 . . . . 8.6 105.107 179.639 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.0 mtt . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 107.299 -1.371 . . . . 13.66 107.299 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.45 -99.35 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 105.542 -2.022 . . . . 5.88 105.542 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -116.89 150.29 38.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.251 0.932 . . . . 7.38 109.086 166.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -155.35 133.35 11.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.251 1.02 . . . . 4.19 108.425 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.0 m -156.15 154.18 30.45 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 107.75 -1.204 . . . . 0.52 107.75 -173.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -129.36 143.15 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 124.499 1.125 . . . . 0.4 110.931 170.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -128.22 147.86 50.6 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.169 1.388 . . . . 1.83 107.574 -175.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -88.75 132.77 34.47 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.623 0.647 . . . . 6.03 109.392 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 p -109.62 148.95 12.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.9 1.28 . . . . 0.63 107.792 172.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.27 160.82 42.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.784 -0.821 . . . . 2.69 108.784 168.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.15 34.53 5.86 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.116 0.865 . . . . 1.99 113.785 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.96 171.5 20.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.362 1.081 . . . . 2.18 109.814 169.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.1 t -171.08 60.24 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.849 0.86 . . . . 3.53 110.404 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -142.58 121.69 12.93 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.503 0.592 . . . . 2.29 110.854 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m -51.57 -50.14 60.69 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.328 1.051 . . . . 1.28 111.321 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -54.11 -44.4 71.23 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.978 -0.451 . . . . 2.68 110.803 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.1 m -64.92 -46.67 80.68 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.942 -0.392 . . . . 0.82 109.942 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.87 74.73 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.918 0.487 . . . . 0.59 111.195 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.04 -49.18 66.03 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.587 0.755 . . . . 0.77 110.185 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -52.32 -47.84 65.77 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.642 -0.503 . . . . 2.64 109.642 173.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.17 -57.53 10.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.104 0.562 . . . . 2.28 110.93 174.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -56.63 -44.57 81.38 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.722 0.692 . . . . 2.39 110.089 -174.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -59.87 -53.86 52.97 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 108.834 -0.802 . . . . 5.57 108.834 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -44.94 -49.16 11.26 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.401 1.08 . . . . 1.76 110.342 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 54' ' ' VAL . 59.5 t -60.39 -52.21 64.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 110.298 -0.26 . . . . 0.38 110.298 175.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -53.18 -31.88 45.03 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.277 0.843 . . . . 1.37 113.277 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -70.33 -15.42 62.87 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.388 0.994 . . . . 2.28 113.094 175.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.5 mt -71.99 115.92 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-O 122.474 1.13 . . . . 1.31 109.445 178.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.08 95.12 0.16 Allowed 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.76 1.624 . . . . 2.61 108.941 171.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.84 -36.74 0.72 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.227 -0.749 . . . . 1.39 111.227 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.2 p -79.67 155.25 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 121.677 -0.896 . . . . 0.84 109.757 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.2 m -109.44 -58.55 2.02 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.529 1.132 . . . . 0.81 108.133 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -123.74 157.74 33.29 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.206 0.527 . . . . 2.94 111.343 173.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.43 134.99 20.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.97 -1.493 . . . . 0.55 106.97 167.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.8 mt -124.85 102.61 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 104.541 -2.392 . . . . 1.71 104.541 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.458 HG12 HG12 ' A' ' 43' ' ' ILE . 2.0 m -117.14 133.05 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 110.328 -0.249 . . . . 2.4 110.328 -167.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -92.06 -53.37 4.28 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.358 -0.608 . . . . 2.88 109.358 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 47.1 58.81 4.48 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.226 1.011 . . . . 3.17 112.165 -176.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.04 71.48 0.11 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.503 -1.439 . . . . 2.56 109.503 173.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 62.7 51.11 3.19 Favored 'General case' 0 C--O 1.228 -0.061 0 C-N-CA 124.904 1.282 . . . . 2.28 108.856 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.0 m -155.53 -121.44 0.03 OUTLIER 'General case' 0 C--O 1.235 0.311 0 CA-C-O 118.338 -0.839 . . . . 2.51 109.479 -172.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -156.32 165.91 34.97 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.961 0.8 . . . . 3.97 112.199 -170.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -128.2 115.89 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 126.663 1.985 . . . . 0.98 107.706 -178.401 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.9 m -97.1 137.45 36.14 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.974 0.909 . . . . 0.44 109.026 173.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.18 143.98 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 126.564 1.946 . . . . 0.79 106.325 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 m -146.1 130.74 17.9 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 106.669 -1.604 . . . . 0.64 106.669 178.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 147.23 -101.52 0.23 Allowed Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 105.888 -2.885 . . . . 0.53 105.888 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -163.57 56.94 0.17 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.719 1.608 . . . . 2.29 109.069 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.09 164.21 31.31 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.155 0.982 . . . . 0.9 109.16 173.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.3 m -131.26 163.38 27.92 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.662 1.185 . . . . 0.87 111.211 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.573 HD11 HD12 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -45.83 -48.73 4.86 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.859 0 CA-C-O 117.19 -1.386 . . . . 2.62 111.178 -174.621 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -30.97 -50.91 0.15 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.296 1.438 . . . . 2.85 113.318 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -66.15 -44.66 83.49 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 122.027 0.917 . . . . 3.5 110.67 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 25' ' ' VAL . 24.5 t -65.89 -33.37 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.815 1.246 . . . . 0.38 110.63 174.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.85 -55.35 36.02 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.951 -1.5 . . . . 4.0 106.951 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -51.55 -45.74 63.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.901 -1.045 . . . . 3.28 110.837 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.88 -53.95 52.12 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.706 0.685 . . . . 0.37 111.138 171.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.85 -20.51 19.36 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 125.179 1.371 . . . . 0.29 112.703 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.81 -22.48 0.31 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.418 1.109 . . . . 0.44 113.156 168.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -53.76 -31.66 49.41 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.223 1.374 . . . . 1.9 112.825 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -128.62 -10.85 5.02 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.463 1.505 . . . . 2.93 112.593 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 74.59 60.57 0.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.631 1.973 . . . . 0.89 111.507 172.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -84.35 -179.05 7.1 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.469 -0.769 . . . . 1.25 112.429 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.22 110.22 8.25 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 105.872 -1.899 . . . . 4.22 105.872 176.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.573 HD12 HD11 ' A' ' 51' ' ' ILE . 0.9 OUTLIER -117.12 135.65 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.908 -1.145 . . . . 0.56 107.908 -179.293 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.22 137.15 29.39 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.818 1.247 . . . . 1.1 108.967 -169.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.77 89.82 0.63 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.193 2.595 . . . . 1.12 111.184 174.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -56.97 84.48 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.579 1.951 . . . . 3.7 111.156 171.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -152.87 102.68 2.7 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.418 0.687 . . . . 4.64 109.302 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 56.27 71.43 0.56 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.271 1.428 . . . . 7.69 111.28 174.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 N-CA-C 105.374 -2.084 . . . . 10.72 105.374 176.46 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 106.227 -1.768 . . . . 9.79 106.227 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 29.51 65.95 0.12 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.495 1.918 . . . . 7.1 113.349 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -58.91 179.12 0.09 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 122.548 1.166 . . . . 4.96 111.792 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -75.66 144.35 41.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.096 -0.956 . . . . 4.22 109.697 -169.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.1 m -147.11 143.65 28.45 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.471 -0.937 . . . . 0.74 108.471 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -116.37 134.64 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 O-C-N 124.899 1.374 . . . . 0.69 110.454 168.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -116.41 163.12 16.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.522 -1.659 . . . . 2.07 106.522 -177.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -106.55 131.06 54.15 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 118.644 -0.693 . . . . 3.84 110.323 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 p -117.12 142.63 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 108.354 -0.98 . . . . 0.43 108.354 -173.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -143.34 166.84 23.63 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.752 0.706 . . . . 2.91 109.648 176.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.73 64.77 3.81 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.421 1.486 . . . . 3.12 112.339 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.578 HD13 ' H ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -128.64 167.55 17.03 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.799 1.639 . . . . 2.69 109.748 175.444 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.4 m -64.88 -82.35 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.254 0.464 . . . . 6.71 112.254 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -172.46 -167.67 0.47 Allowed 'General case' 0 C--N 1.344 0.333 0 O-C-N 121.323 -0.861 . . . . 4.38 110.06 -175.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.0 t -48.28 -36.55 14.32 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.339 1.456 . . . . 2.35 113.021 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -52.63 -50.73 62.56 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.949 0.88 . . . . 3.65 110.349 176.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.7 m -71.81 -33.07 68.23 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.744 -0.662 . . . . 0.98 110.823 176.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.56 -47.1 73.64 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 118.46 0.573 . . . . 0.59 110.035 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.46 -50.09 74.97 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.571 -0.741 . . . . 0.59 109.072 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -53.53 -41.68 66.64 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.44 -0.345 . . . . 2.34 110.758 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -63.84 -57.22 10.53 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.478 0.711 . . . . 2.81 110.561 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -55.25 -45.16 76.06 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 118.61 0.641 . . . . 2.53 109.674 -177.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -60.7 -52.29 65.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.307 0.643 . . . . 3.7 109.378 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -48.75 -49.88 36.3 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.351 0.661 . . . . 2.0 109.908 176.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 54' ' ' VAL . 39.0 t -61.71 -50.88 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 120.499 -0.48 . . . . 0.42 109.912 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 55.4 mttt -50.61 -33.43 22.13 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.128 0.971 . . . . 1.52 113.214 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -69.97 -22.3 63.16 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.498 0.719 . . . . 2.71 112.582 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.6 HG22 ' H ' ' A' ' 30' ' ' GLY . 21.9 mt -77.25 139.29 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 119.64 1.109 . . . . 1.2 109.232 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -82.83 -21.1 34.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.283 1.033 . . . . 2.37 113.419 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.6 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -68.97 -31.23 72.36 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.9 0.762 . . . . 0.99 112.359 -178.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 ' H ' ' A' ' 32' ' ' THR . 9.8 p -94.41 -177.61 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.855 1.262 . . . . 0.72 109.104 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.452 ' H ' HG22 ' A' ' 31' ' ' VAL . 62.2 m -143.91 -57.47 0.39 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.04 -1.037 . . . . 1.0 109.092 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -113.97 149.25 35.58 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-O 121.236 0.541 . . . . 2.59 110.251 171.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.4 124.51 11.43 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.791 -1.188 . . . . 0.82 107.791 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.91 99.13 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 107.692 -1.225 . . . . 1.33 107.692 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 p -96.07 138.67 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 C-N-CA 122.807 0.443 . . . . 2.18 110.429 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -130.51 73.02 1.51 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.945 -1.131 . . . . 2.45 107.945 166.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.441 ' CD2' HD23 ' A' ' 12' ' ' LEU . 3.2 m-30 -49.32 -25.6 2.53 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.812 1.645 . . . . 2.76 112.225 165.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.99 -20.12 32.94 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 120.884 -0.674 . . . . 3.52 112.02 176.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.4 -105.43 0.39 Allowed 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.104 0.952 . . . . 3.85 109.321 161.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.5 m -159.97 59.96 0.36 Allowed 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.983 -1.488 . . . . 4.87 106.983 -172.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -151.87 141.18 21.45 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.7 0.682 . . . . 4.75 111.719 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.07 107.08 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.294 1.438 . . . . 0.72 109.186 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.8 m -84.38 134.1 34.49 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.686 1.195 . . . . 0.81 109.73 173.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -122.74 139.15 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.199 1.8 . . . . 0.68 106.679 171.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.1 m -148.81 136.87 20.85 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 107.031 -1.47 . . . . 0.95 107.031 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.89 -94.62 0.15 Allowed Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 106.261 -2.736 . . . . 0.63 106.261 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -159.86 49.22 0.29 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.325 0.65 . . . . 2.43 110.381 169.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.6 173.07 12.37 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.503 -0.748 . . . . 0.59 112.022 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.1 m -127.7 164.73 21.45 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.709 1.603 . . . . 0.58 111.358 -174.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 tp -53.71 -28.71 16.72 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 CA-C-O 117.809 -1.091 . . . . 1.8 113.231 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -32.73 -50.92 0.28 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.391 1.076 . . . . 2.21 111.825 171.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -68.89 -41.44 78.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.385 0.612 . . . . 2.49 111.652 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 25' ' ' VAL . 38.0 t -67.44 -37.15 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.662 0.785 . . . . 0.38 110.111 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -57.41 -54.42 47.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.596 1.558 . . . . 3.15 107.944 173.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.63 -53.73 47.65 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 110.101 -0.333 . . . . 3.07 110.101 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.63 -47.95 63.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.132 0.491 . . . . 0.51 111.132 173.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.27 -18.44 4.89 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 126.336 1.922 . . . . 0.5 113.245 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.73 -24.52 0.58 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.468 1.634 . . . . 0.72 112.878 171.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -54.01 -34.33 59.59 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.893 1.224 . . . . 2.24 113.315 172.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -120.35 -19.73 7.51 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.195 1.398 . . . . 2.66 112.339 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 74.13 55.24 0.09 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.494 1.918 . . . . 1.02 110.729 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.95 166.09 23.98 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.261 -0.899 . . . . 1.39 111.082 -176.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.98 121.16 38.34 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.523 -1.288 . . . . 4.13 107.523 169.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.33 140.6 44.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 125.007 1.323 . . . . 0.66 108.029 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.12 131.74 23.99 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.356 1.062 . . . . 1.61 108.525 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.28 97.82 0.79 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.537 2.158 . . . . 0.76 108.829 170.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -49.19 -46.85 46.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.532 0.733 . . . . 3.35 111.028 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? 71.69 -65.89 0.33 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.758 1.623 . . . . 4.49 111.145 172.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -167.87 -54.03 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.168 1.387 . . . . 7.42 108.526 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.471 0 N-CA-C 105.09 -2.189 . . . . 8.59 105.09 179.206 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.5 pttt . . . . . 0 N--CA 1.444 -0.754 0 N-CA-C 105.946 -1.872 . . . . 3.81 105.946 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.5 m -151.9 154.76 36.75 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 105.888 -1.893 . . . . 0.88 105.888 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.25 137.99 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 O-C-N 124.428 1.08 . . . . 0.66 109.851 169.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -116.49 151.21 36.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.517 -1.661 . . . . 1.88 106.517 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 -87.86 131.94 34.38 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 107.67 -1.233 . . . . 5.55 107.67 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.87 147.7 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 119.677 1.126 . . . . 0.64 109.963 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . 32.5 t0 -141.21 151.76 44.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.007 -0.738 . . . . 2.84 109.007 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.68 -79.78 0.37 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.253 1.406 . . . . 1.92 110.941 174.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 12' ' ' LEU . 1.2 pp -73.38 150.93 41.42 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 122.348 -0.501 . . . . 2.87 110.629 -171.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 p -144.51 63.81 1.31 Allowed 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.762 0.825 . . . . 2.64 110.793 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.8 t -155.49 123.77 5.88 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.861 -0.525 . . . . 2.22 111.653 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m -48.43 -41.06 28.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.349 1.46 . . . . 2.12 112.222 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -61.27 -42.44 98.63 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.481 -0.762 . . . . 3.13 110.681 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.8 m -67.83 -40.6 83.75 Favored 'General case' 0 C--O 1.231 0.124 0 O-C-N 121.355 -0.841 . . . . 1.17 110.248 176.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.33 -46.22 72.84 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 122.2 -0.313 . . . . 0.8 110.326 171.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.91 -43.92 97.88 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.767 0.827 . . . . 0.94 110.987 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -54.19 -51.62 63.81 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.745 -0.597 . . . . 3.2 109.599 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.26 -60.51 3.3 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.293 0.637 . . . . 2.45 112.508 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -38.57 72.48 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.383 0.992 . . . . 2.91 110.57 -173.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -64.68 -46.38 82.67 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.643 0.377 . . . . 2.8 110.894 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.504 HD22 ' HB1' ' A' ' 57' ' ' ALA . 7.3 m-20 -52.44 -41.91 63.69 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 122.052 -0.405 . . . . 1.3 110.604 173.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.635 HG12 HG11 ' A' ' 31' ' ' VAL . 51.5 t -62.68 -55.12 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.971 -0.455 . . . . 0.69 110.106 174.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.7 mttt -48.47 -37.74 18.16 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.772 1.027 . . . . 1.56 113.772 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -54.0 -34.72 60.64 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.805 0.729 . . . . 3.3 112.717 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.587 HG22 ' H ' ' A' ' 30' ' ' GLY . 13.9 mt -70.0 129.72 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.66 -0.867 . . . . 1.27 108.66 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -71.06 -11.11 60.78 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.906 -1.121 . . . . 2.58 113.472 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.587 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -81.24 -21.95 61.68 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.873 0.749 . . . . 0.91 112.397 -177.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.635 HG11 HG12 ' A' ' 25' ' ' VAL . 9.7 p -111.65 152.67 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 O-C-N 121.365 -1.08 . . . . 0.96 109.143 -175.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.8 m -106.72 -56.51 2.18 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.208 1.403 . . . . 0.95 107.848 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -125.49 161.33 27.36 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.374 0.607 . . . . 2.36 112.323 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.16 139.91 20.78 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.729 -1.212 . . . . 0.82 107.729 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.0 mt -133.01 106.38 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 106.065 -1.828 . . . . 1.35 106.065 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.453 HG12 HG13 ' A' ' 43' ' ' ILE . 2.2 m -120.76 118.59 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 122.79 0.436 . . . . 2.04 109.937 -162.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 . . . . . 0 CA--C 1.528 0.106 0 O-C-N 122.425 -0.172 . . . . 2.44 110.778 -167.757 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.1 m . . . . . 0 CA--C 1.534 0.357 0 CA-C-O 120.48 0.181 . . . . 2.48 111.135 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -158.64 165.59 34.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.61 -0.681 . . . . 3.66 109.933 -158.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.463 HG21 HD13 ' A' ' 65' ' ' ILE . 11.1 tt -129.38 104.8 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 126.084 1.754 . . . . 2.81 108.171 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.7 m -84.81 139.5 31.88 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.673 -0.862 . . . . 0.73 108.673 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.2 t -134.35 138.63 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 104.556 -2.387 . . . . 1.04 104.556 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.3 m -147.91 133.8 19.09 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.111 -1.07 . . . . 0.93 108.111 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.79 -92.68 0.14 Allowed Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 107.398 -2.281 . . . . 0.71 107.398 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -165.88 51.97 0.09 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.996 1.718 . . . . 2.26 109.489 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.52 166.59 29.73 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 120.657 -1.277 . . . . 0.48 111.591 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.0 m -119.67 165.44 14.48 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.424 1.49 . . . . 0.58 111.155 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.433 HD11 HD12 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -46.88 -46.86 8.23 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 CA-C-O 117.214 -1.374 . . . . 2.69 110.725 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -29.87 -50.69 0.12 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.16 1.784 . . . . 2.55 114.052 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -65.02 -48.37 74.13 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 122.38 1.086 . . . . 2.51 110.827 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 25' ' ' VAL . 14.6 t -61.34 -32.79 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.058 1.743 . . . . 0.52 110.93 174.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -60.45 -53.75 53.81 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 126.696 1.998 . . . . 3.27 107.176 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.59 -56.44 13.53 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.434 -0.803 . . . . 3.15 109.571 176.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.504 ' HB1' HD22 ' A' ' 24' ' ' ASN . . . -48.21 -51.48 25.15 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.247 0.619 . . . . 0.5 110.81 175.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.68 -16.06 28.76 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 124.297 0.951 . . . . 0.37 113.197 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.65 -21.67 1.69 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.481 1.14 . . . . 0.48 112.293 169.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -54.07 -35.99 62.65 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.001 1.273 . . . . 1.85 112.705 173.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -121.29 -7.59 9.28 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.651 1.18 . . . . 2.45 112.528 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 71.85 53.86 0.2 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.515 1.526 . . . . 0.99 111.09 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.75 164.42 25.26 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.225 -0.922 . . . . 1.19 111.181 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.454 ' HD2' ' HB3' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -121.66 112.56 18.58 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.162 -1.792 . . . . 3.77 106.162 172.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.463 HD13 HG21 ' A' ' 43' ' ' ILE . 1.1 mt -113.58 143.51 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 106.735 -1.58 . . . . 0.66 106.735 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.9 mt -128.14 122.66 22.23 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 106.64 -1.615 . . . . 1.38 106.64 -173.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.53 111.76 2.19 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.665 1.577 . . . . 0.83 108.028 169.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 121.377 0.608 . . . . 4.4 110.71 169.529 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? . . . . . 0 C--O 1.233 0.216 0 N-CA-C 109.231 -0.655 . . . . 4.49 109.231 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.8 m -148.36 154.27 39.73 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 107.668 -1.234 . . . . 0.59 107.668 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 p -135.6 142.24 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 123.616 0.573 . . . . 0.39 110.438 169.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -127.52 147.15 50.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.602 1.161 . . . . 1.74 107.905 -169.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -89.0 128.5 35.71 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.372 -0.973 . . . . 3.81 108.372 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.29 149.23 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.095 -1.076 . . . . 0.6 108.095 169.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -143.47 148.95 36.85 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.423 -0.584 . . . . 2.62 109.423 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.51 -58.37 0.62 Allowed Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.146 0.879 . . . . 1.55 111.586 166.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.404 ' HB3' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -69.86 172.08 8.27 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.309 0.643 . . . . 2.51 112.157 -176.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.401 ' N ' HD22 ' A' ' 12' ' ' LEU . 11.2 t -163.8 77.63 0.39 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.692 0.397 . . . . 3.28 109.962 171.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.9 t -168.11 126.91 1.21 Allowed 'General case' 0 C--N 1.342 0.266 0 O-C-N 121.969 -0.457 . . . . 1.76 111.427 172.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.4 m -49.91 -42.09 47.44 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.475 1.11 . . . . 1.37 112.233 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -53.76 -40.92 66.62 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.648 -0.657 . . . . 3.4 111.451 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.44 -47.08 83.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.381 -0.6 . . . . 2.46 109.381 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.15 -42.81 77.56 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.802 0.441 . . . . 0.54 111.098 175.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.81 -49.39 73.08 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.401 0.62 . . . . 0.63 109.87 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -53.83 -48.41 69.94 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.415 -0.587 . . . . 4.22 109.415 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -53.94 -65.33 0.59 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.723 0.809 . . . . 2.83 111.899 176.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.94 -40.69 70.2 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.976 0.807 . . . . 2.87 110.828 -171.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -61.81 -48.87 78.67 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 110.201 -0.296 . . . . 3.43 110.201 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -57.36 -41.17 79.59 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.986 -0.446 . . . . 2.4 110.473 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.452 HG22 HG22 ' A' ' 54' ' ' VAL . 59.1 t -64.41 -46.02 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 O-C-N 121.809 -0.557 . . . . 0.49 110.782 175.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -57.06 -33.95 67.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.913 0.885 . . . . 1.7 112.054 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.25 -21.54 65.26 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.932 0.716 . . . . 2.65 112.932 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.5 mm -77.8 106.71 8.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 O-C-N 120.739 -1.226 . . . . 2.35 110.748 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -65.95 85.19 0.08 Allowed 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 125.71 1.604 . . . . 2.57 108.653 163.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.47 -40.37 0.08 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.459 -1.056 . . . . 0.99 110.459 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.9 p -97.14 156.65 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 108.347 -0.982 . . . . 0.85 108.347 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 55.0 m -105.4 -54.9 2.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.171 1.388 . . . . 0.65 107.69 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -126.29 134.9 51.01 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 109.552 -0.536 . . . . 2.42 109.552 170.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.11 126.27 40.82 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.972 -1.122 . . . . 0.52 107.972 170.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.0 mm -111.22 101.91 13.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.237 -1.394 . . . . 2.22 107.237 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.03 145.88 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 116.618 -0.265 . . . . 2.04 110.553 -175.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 107.429 -1.323 . . . . 2.04 107.429 173.031 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 111.942 0.349 . . . . 2.9 111.942 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.92 171.1 20.02 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.639 0.775 . . . . 4.4 110.063 -165.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.81 113.99 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 108.48 -0.934 . . . . 0.8 108.48 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 m -91.2 143.33 26.78 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 123.983 0.913 . . . . 0.44 109.976 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.18 133.75 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.842 2.057 . . . . 0.61 106.761 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.8 m -143.05 124.34 14.62 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 106.96 -1.496 . . . . 0.86 106.96 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.12 -93.07 0.11 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 118.663 -1.732 . . . . 0.63 109.172 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -166.66 53.76 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.454 1.102 . . . . 2.34 109.931 166.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.51 172.93 15.23 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.022 -1.048 . . . . 0.81 110.643 176.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.0 m -117.14 162.83 17.2 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.678 1.591 . . . . 0.69 111.154 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 tp -52.27 -32.17 15.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.719 0 CA-C-O 117.525 -1.226 . . . . 1.92 112.973 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -34.93 -47.22 0.34 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.387 1.075 . . . . 3.52 112.103 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -57.46 -51.66 68.55 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.405 1.098 . . . . 2.21 111.465 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.452 HG22 HG22 ' A' ' 25' ' ' VAL . 58.1 t -66.11 -42.18 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.681 1.592 . . . . 0.36 110.902 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -63.22 -43.77 97.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.84 0.856 . . . . 4.02 108.836 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -52.11 -54.88 25.03 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.813 -0.613 . . . . 3.01 109.62 171.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.41 -54.15 15.08 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.926 0.784 . . . . 0.42 110.162 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.96 -15.99 15.93 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 125.395 1.474 . . . . 0.33 114.442 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.0 -26.01 2.3 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.424 1.112 . . . . 0.64 111.534 167.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -51.03 -41.77 60.05 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.111 0.869 . . . . 2.23 112.857 173.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.35 -3.67 12.43 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.164 0.986 . . . . 4.3 111.216 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 73.85 49.83 0.12 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.846 1.659 . . . . 1.07 110.835 175.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 63' ' ' LEU . 4.5 mm? -74.47 166.81 22.89 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.641 -0.662 . . . . 1.34 111.311 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.62 122.5 33.27 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.652 -1.61 . . . . 4.23 106.652 171.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 mt -122.98 108.2 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.363 0.665 . . . . 1.17 110.079 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 91.7 mt -94.12 130.79 33.17 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.436 0.694 . . . . 1.17 109.315 -172.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.01 91.8 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.387 2.058 . . . . 0.64 109.008 168.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.252 0 C-N-CA 123.409 0.684 . . . . 4.42 109.987 168.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 109.306 -0.628 . . . . 5.13 109.306 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.5 m -149.08 146.25 27.63 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 106.212 -1.773 . . . . 0.81 106.212 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.15 140.16 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 124.226 0.954 . . . . 0.55 110.847 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -128.67 148.86 50.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.774 1.23 . . . . 2.07 107.92 -172.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -88.02 122.73 31.95 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.815 -0.809 . . . . 4.32 108.815 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 p -109.81 140.05 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 124.386 1.074 . . . . 0.5 108.332 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -138.82 157.59 45.79 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.878 -1.156 . . . . 2.74 107.878 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 120.97 -77.37 0.32 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.925 1.25 . . . . 1.66 110.614 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.452 ' C ' HD12 ' A' ' 12' ' ' LEU . 3.1 pp -76.3 177.63 7.11 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.549 0.69 . . . . 2.63 111.486 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.6 t -161.59 -43.91 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.994 0.918 . . . . 4.29 110.401 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.3 t -50.97 126.23 15.65 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.351 1.06 . . . . 1.9 113.301 -168.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 m -45.32 -44.64 11.73 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.237 1.815 . . . . 1.5 112.914 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -54.37 -48.12 71.85 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.63 0.729 . . . . 3.68 111.016 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.06 -43.18 88.17 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 123.474 0.71 . . . . 1.16 109.367 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.55 -49.31 70.64 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.335 0.254 . . . . 0.87 110.958 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.37 -52.95 63.45 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.523 1.129 . . . . 0.71 109.651 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -48.94 -49.5 39.99 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.888 -0.412 . . . . 2.7 109.888 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.8 -64.18 0.96 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 112.69 0.626 . . . . 2.47 112.69 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -55.82 -44.58 78.04 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.83 0.741 . . . . 3.03 109.552 -172.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -57.03 -53.02 62.82 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.874 -0.417 . . . . 4.47 109.874 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.743 HD22 ' HB1' ' A' ' 57' ' ' ALA . 4.8 m-20 -48.16 -48.65 34.24 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.303 -0.628 . . . . 1.52 109.303 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.436 HG22 HG22 ' A' ' 54' ' ' VAL . 34.6 t -60.99 -47.0 95.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 117.915 0.325 . . . . 0.42 110.789 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -36.52 63.87 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.017 0.527 . . . . 2.5 111.765 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -70.84 -9.91 58.53 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 119.109 0.868 . . . . 1.98 113.161 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.1 mm -83.72 128.91 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 120.539 1.518 . . . . 2.43 109.812 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.44 -28.83 61.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.412 1.485 . . . . 2.44 113.411 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.54 -16.03 64.8 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 123.983 0.801 . . . . 1.3 113.685 -174.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.8 p -118.8 153.47 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.928 1.291 . . . . 1.0 109.232 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 93.0 m -93.95 -51.1 5.02 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.723 -0.843 . . . . 0.62 108.723 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -135.47 160.23 39.13 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.057 0.456 . . . . 2.64 110.517 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -154.08 140.33 18.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.078 -1.082 . . . . 0.49 108.078 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.6 mt -127.59 118.98 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 105.73 -1.952 . . . . 1.28 105.73 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.736 HG12 HG12 ' A' ' 43' ' ' ILE . 5.5 m -105.56 133.76 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.767 -0.827 . . . . 1.98 108.767 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 m120 . . . . . 0 CA--C 1.523 -0.089 0 N-CA-C 108.286 -1.005 . . . . 2.62 108.286 167.528 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 m . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 108.435 -0.95 . . . . 2.64 108.435 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.52 174.82 14.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.911 0.778 . . . . 4.22 111.522 -174.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.736 HG12 HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -130.4 118.98 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.168 1.787 . . . . 0.76 107.764 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.8 m -97.03 138.11 35.07 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.61 1.164 . . . . 0.52 109.58 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.0 t -118.24 143.66 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 127.871 2.468 . . . . 0.73 105.823 171.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.1 m -146.32 88.25 1.78 Allowed 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 125.111 1.364 . . . . 1.01 107.547 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.37 -113.12 0.27 Allowed Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 108.638 -1.785 . . . . 0.89 108.638 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -155.94 48.45 0.5 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.932 -0.766 . . . . 2.99 108.932 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -155.61 177.68 11.11 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.792 -0.567 . . . . 1.28 110.234 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.4 m -114.27 169.81 8.75 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.235 1.414 . . . . 0.9 111.274 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.6 tp -53.92 -33.07 23.17 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 CA-C-O 117.685 -1.15 . . . . 1.81 111.728 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -35.37 -48.59 0.48 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.538 1.063 . . . . 2.68 112.48 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -61.13 -50.27 73.88 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.301 0.572 . . . . 2.22 112.287 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 HG22 ' A' ' 25' ' ' VAL . 58.6 t -58.34 -44.91 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 125.127 1.371 . . . . 0.5 110.536 177.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -67.27 -41.84 84.84 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.111 0.964 . . . . 3.53 110.112 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -54.42 -51.57 64.5 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.062 -0.718 . . . . 3.0 109.062 171.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.743 ' HB1' HD22 ' A' ' 24' ' ' ASN . . . -49.05 -48.36 44.01 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.005 -0.434 . . . . 0.44 110.785 170.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.93 -9.79 16.03 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.064 1.316 . . . . 0.36 114.795 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.58 -21.63 10.92 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.232 1.516 . . . . 0.68 112.122 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -56.69 -33.28 66.29 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.414 1.006 . . . . 2.08 112.854 172.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.06 -12.31 9.13 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.862 1.265 . . . . 2.51 112.683 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 72.26 62.29 0.13 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.571 1.148 . . . . 0.8 110.369 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.3 174.21 11.48 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.489 -0.757 . . . . 1.13 110.458 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -143.22 68.34 1.3 Allowed 'General case' 0 C--N 1.34 0.162 0 N-CA-C 106.935 -1.505 . . . . 4.82 106.935 -169.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.8 mt -84.82 107.18 15.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 113.922 -1.49 . . . . 0.96 110.138 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.4 mt -92.7 129.19 41.14 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 108.98 -0.748 . . . . 1.31 108.98 -172.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.07 100.9 0.66 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.397 2.065 . . . . 0.7 109.797 172.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 . . . . . 0 CA--C 1.533 0.308 0 C-N-CA 122.609 0.364 . . . . 3.31 111.293 169.328 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 107.31 -1.367 . . . . 4.5 107.31 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.0 m -151.55 156.12 39.87 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.315 -1.365 . . . . 0.93 107.315 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.01 139.81 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 O-C-N 124.593 1.183 . . . . 0.5 111.545 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.522 ' CD2' HD13 ' A' ' 51' ' ' ILE . 5.6 m-85 -127.43 143.22 51.24 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.713 1.605 . . . . 2.34 107.691 -163.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.33 140.73 31.41 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 118.876 0.762 . . . . 3.62 109.279 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.89 137.33 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 123.822 0.849 . . . . 0.71 109.106 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -140.77 152.11 44.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.03 1.332 . . . . 2.72 107.74 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.02 -56.68 0.73 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 125.225 1.393 . . . . 1.44 110.409 164.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.456 ' C ' HD22 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -61.72 157.71 17.21 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.103 0.561 . . . . 2.5 111.456 -178.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 t -161.55 73.56 0.44 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.319 -0.622 . . . . 2.81 109.319 174.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -169.39 134.05 1.43 Allowed 'General case' 0 C--N 1.338 0.099 0 O-C-N 121.62 -0.675 . . . . 2.43 110.734 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 m -59.84 -43.07 94.79 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.313 0.645 . . . . 1.72 111.147 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -58.44 -48.59 80.22 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.791 -0.568 . . . . 2.39 110.17 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.0 m -57.32 -48.05 79.98 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.625 -0.509 . . . . 1.12 109.625 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.46 -50.41 65.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.736 0.414 . . . . 1.08 111.007 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.31 -52.34 66.02 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.154 0.981 . . . . 0.72 109.64 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -54.93 -44.65 74.45 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 119.881 -0.727 . . . . 3.81 110.669 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.36 -63.24 1.21 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.12 0.568 . . . . 2.34 110.131 177.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.86 -40.01 87.17 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.835 0.35 . . . . 2.58 110.612 -171.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -49.52 72.92 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.896 0.878 . . . . 3.22 109.647 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -51.64 -48.44 63.34 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.14 0.576 . . . . 1.66 109.587 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.6 t -60.15 -48.38 88.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 O-C-N 122.179 -0.326 . . . . 0.53 110.628 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -55.04 -34.78 63.83 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.594 -0.691 . . . . 1.89 112.539 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -70.9 -8.79 55.39 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.47 0.915 . . . . 2.12 113.47 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.5 mm -70.86 140.19 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 120.282 1.401 . . . . 2.17 109.768 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -89.74 139.96 30.05 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 125.373 1.469 . . . . 2.73 109.172 171.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.34 -46.54 1.16 Allowed Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.327 1.442 . . . . 1.81 110.601 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.3 p -64.33 158.54 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 122.386 -0.479 . . . . 0.96 110.062 174.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.8 m -108.34 -60.2 1.76 Allowed 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 107.996 -1.113 . . . . 1.13 107.996 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -127.78 161.8 28.13 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.659 0.614 . . . . 2.21 112.659 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.65 141.58 21.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.431 -0.951 . . . . 0.68 108.431 166.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.8 mt -127.96 104.57 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 106.433 -1.692 . . . . 1.39 106.433 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.44 122.1 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.704 -1.221 . . . . 1.94 107.704 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 . . . . . 0 CA--C 1.52 -0.176 0 N-CA-C 105.9 -1.889 . . . . 2.58 105.9 175.374 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 119.356 -0.354 . . . . 3.32 111.582 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt -162.45 153.96 18.14 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.03 1.332 . . . . 4.08 111.269 -165.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.64 117.9 52.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.712 1.205 . . . . 0.79 109.23 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.4 m -91.3 141.17 29.07 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 124.599 1.16 . . . . 0.51 109.338 173.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 t -122.23 145.83 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.439 -1.689 . . . . 0.68 106.439 166.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.2 m -145.89 138.67 25.75 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.265 -1.383 . . . . 0.85 107.265 175.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.94 -91.98 0.18 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 108.224 -1.95 . . . . 0.74 108.224 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -170.75 58.34 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.276 1.83 . . . . 2.2 109.737 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.73 162.44 41.26 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.165 -0.96 . . . . 0.51 111.4 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 61.8 m -109.76 168.01 9.73 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.43 1.892 . . . . 0.94 110.09 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.522 HD13 ' CD2' ' A' ' 7' ' ' TYR . 7.7 tp -52.06 -35.53 18.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 CA-C-O 117.083 -1.437 . . . . 1.53 111.736 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -28.37 -52.67 0.09 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.53 1.532 . . . . 2.36 112.661 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -61.85 -46.01 91.32 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.789 0.804 . . . . 2.17 111.484 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.1 t -70.15 -37.45 71.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.157 1.383 . . . . 0.37 110.913 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -48.6 80.86 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.525 1.53 . . . . 3.3 108.452 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -51.07 -47.94 61.71 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.75 0.42 . . . . 3.93 110.752 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.64 -51.18 71.02 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.424 0.556 . . . . 0.77 110.771 173.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.84 -26.23 25.3 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 126.54 2.019 . . . . 0.51 112.308 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -44.31 -31.77 1.12 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.276 1.038 . . . . 0.54 112.469 170.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -53.72 -32.37 51.76 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.681 1.128 . . . . 2.13 113.63 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.49 0.56 6.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.177 1.391 . . . . 2.6 112.168 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 60.21 57.17 3.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.508 1.523 . . . . 1.54 111.896 177.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.83 160.65 20.16 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 121.46 -0.775 . . . . 1.34 112.118 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 72.43 0.82 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.998 -1.112 . . . . 3.65 107.998 -169.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -82.23 119.7 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.189 -0.671 . . . . 0.64 109.189 -175.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.9 mm -98.3 112.28 61.78 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 125.0 1.32 . . . . 1.48 108.7 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -73.44 83.14 1.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.017 1.811 . . . . 1.42 110.488 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 . . . . . 0 N--CA 1.447 -0.582 0 C-N-CA 125.522 1.529 . . . . 3.11 110.62 173.386 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 107.787 -1.19 . . . . 4.5 107.787 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.7 m -146.74 154.66 41.66 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.032 -1.47 . . . . 0.53 107.032 172.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.02 142.69 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 O-C-N 123.999 0.812 . . . . 0.54 110.151 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -127.67 140.45 52.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.732 -1.581 . . . . 1.86 106.732 -172.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.3 ttt-85 -84.62 126.34 33.26 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.735 -1.209 . . . . 5.16 107.735 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.448 ' CG2' HD21 ' A' ' 12' ' ' LEU . 1.7 p -111.39 146.4 16.41 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 107.356 -1.35 . . . . 0.51 107.356 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.02 171.96 14.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.335 0.397 . . . . 2.31 111.546 -176.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.26 56.77 21.77 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.379 -0.828 . . . . 2.26 112.418 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.448 HD21 ' CG2' ' A' ' 9' ' ' VAL . 2.5 pp -163.07 166.47 23.54 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.602 1.561 . . . . 2.72 107.854 174.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.3 p -174.76 66.11 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.091 0.557 . . . . 2.71 109.951 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.6 t -156.71 124.63 5.54 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.334 0.515 . . . . 2.18 111.436 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -58.29 -43.9 88.26 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.007 0.923 . . . . 1.37 111.727 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -57.42 -44.83 84.94 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.748 0.704 . . . . 2.5 110.533 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.6 m -61.27 -45.94 92.44 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.943 -0.391 . . . . 0.81 109.943 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.22 -47.02 72.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.717 0.407 . . . . 0.56 110.954 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.68 -51.3 69.0 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.533 1.133 . . . . 0.58 109.469 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -52.9 -45.17 67.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.883 -0.599 . . . . 2.91 109.603 174.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.417 ' CZ ' HD11 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -56.59 -63.39 1.21 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.184 -0.436 . . . . 2.58 110.846 176.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -60.51 -38.02 83.01 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.314 0.961 . . . . 2.35 111.527 -172.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.3 ttt85 -61.3 -49.62 76.28 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.122 -0.325 . . . . 3.62 110.122 175.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.457 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 77.6 m-20 -51.42 -50.58 59.41 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.266 -0.642 . . . . 1.36 109.266 174.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.654 HG22 HG22 ' A' ' 54' ' ' VAL . 39.4 t -56.83 -50.11 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 O-C-N 121.972 -0.455 . . . . 0.38 110.982 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -53.19 -34.69 58.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.449 1.099 . . . . 1.47 112.01 175.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -68.69 -16.55 63.86 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.178 0.899 . . . . 2.19 113.397 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.2 mt -77.28 111.21 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 120.036 1.289 . . . . 1.44 109.865 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -50.49 -31.39 15.22 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.187 2.195 . . . . 2.89 113.448 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.16 -25.05 74.68 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.286 0.946 . . . . 0.8 113.629 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -96.64 162.82 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 119.027 1.414 . . . . 0.84 110.723 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.1 m -110.43 -56.71 2.31 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.763 -1.199 . . . . 0.6 107.763 171.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -137.19 164.7 27.87 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.82 -0.437 . . . . 2.13 109.82 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.432 ' CB ' HG11 ' A' ' 25' ' ' VAL . . . -154.72 137.31 15.14 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.828 -1.175 . . . . 0.66 107.828 172.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.4 mm -112.6 101.55 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.035 -1.098 . . . . 1.8 108.035 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.69 120.87 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 108.681 -0.859 . . . . 2.52 108.681 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 107.901 -1.148 . . . . 2.17 107.901 171.599 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 CA--C 1.533 0.312 0 CA-C-O 119.789 -0.148 . . . . 2.88 110.676 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -161.51 164.68 29.46 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.986 0.914 . . . . 4.13 110.056 -164.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.66 112.4 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.097 1.359 . . . . 0.76 108.089 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.7 m -88.25 147.7 24.7 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 123.746 0.819 . . . . 0.56 109.735 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.9 t -132.61 137.29 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 127.586 2.355 . . . . 1.05 105.729 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.3 m -145.89 101.17 3.51 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.798 -1.186 . . . . 0.99 107.798 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 178.77 -102.38 0.17 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 118.11 -1.995 . . . . 0.48 110.023 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -163.03 44.8 0.12 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.44 1.496 . . . . 2.44 108.278 172.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.03 169.62 17.31 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.329 1.052 . . . . 0.71 109.965 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.0 m -131.44 169.95 15.34 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.672 1.189 . . . . 0.64 110.066 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 tp -61.19 -30.59 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-O 117.363 -1.303 . . . . 1.74 112.727 -174.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -37.32 -52.76 1.1 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.892 1.223 . . . . 2.75 111.928 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -59.47 -46.77 87.82 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.742 0.645 . . . . 3.8 112.742 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.654 HG22 HG22 ' A' ' 25' ' ' VAL . 34.8 t -63.06 -42.72 97.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 123.694 0.797 . . . . 0.44 110.206 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.85 -52.75 64.09 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 127.154 2.182 . . . . 3.07 108.729 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -51.19 -52.36 45.07 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.622 -0.51 . . . . 2.95 109.622 173.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.457 ' HB1' ' ND2' ' A' ' 24' ' ' ASN . . . -55.98 -41.43 74.8 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.803 -0.561 . . . . 0.59 110.721 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.0 -6.41 12.52 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.48 1.99 . . . . 0.45 113.867 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.37 -24.75 1.33 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.017 1.408 . . . . 0.69 112.071 171.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -54.52 -36.29 64.09 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.479 0.918 . . . . 2.09 113.479 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -121.92 -5.87 9.03 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.095 0.861 . . . . 2.35 113.088 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 68.55 58.0 0.42 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.24 1.016 . . . . 0.88 110.845 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.437 ' HG ' HD23 ' A' ' 12' ' ' LEU . 2.0 mm? -80.27 168.77 18.65 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.36 -0.838 . . . . 1.16 111.236 -176.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.92 68.25 1.51 Allowed 'General case' 0 C--N 1.343 0.322 0 CA-C-O 122.239 1.019 . . . . 4.23 110.061 -170.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.417 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 1.4 mt -81.82 139.61 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.49 -0.777 . . . . 0.53 110.288 -172.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.5 mt -129.25 133.42 25.13 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.224 1.009 . . . . 1.18 109.942 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.59 87.6 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.408 2.739 . . . . 0.89 111.592 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 N--CA 1.44 -0.973 0 C-N-CA 124.337 1.055 . . . . 3.18 109.268 169.776 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 108.155 -1.054 . . . . 3.5 108.155 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.0 m -150.55 140.59 22.03 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.077 -1.453 . . . . 0.94 107.077 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 p -127.47 140.92 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 124.195 0.934 . . . . 0.66 110.32 171.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -128.97 155.89 44.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.321 -1.363 . . . . 2.32 107.321 -174.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.0 ttt-85 -88.99 122.08 31.99 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.295 -0.859 . . . . 4.56 109.1 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.5 p -113.09 140.15 34.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 124.521 1.129 . . . . 0.77 108.033 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -153.28 164.81 37.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.853 -1.536 . . . . 3.47 106.853 -172.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.69 -54.6 0.54 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.467 1.032 . . . . 1.54 112.105 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.506 ' HB3' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -61.31 172.28 1.16 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.708 1.203 . . . . 2.67 113.142 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -168.44 67.62 0.07 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.723 -0.656 . . . . 2.93 111.498 170.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.1 t -160.03 133.69 7.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.817 1.19 . . . . 1.91 113.366 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 m -56.16 -49.88 72.73 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.342 1.457 . . . . 1.58 112.065 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -51.62 -45.14 63.14 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.661 0.744 . . . . 2.39 110.515 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.0 m -68.04 -37.9 81.87 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.001 -0.545 . . . . 1.04 110.567 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.42 -48.65 65.61 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.279 0.49 . . . . 0.79 110.605 170.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.48 -50.81 72.09 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.831 0.824 . . . . 0.74 109.193 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -53.67 -43.56 68.98 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.854 -0.612 . . . . 2.67 110.799 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.496 ' HZ ' HD11 ' A' ' 65' ' ' ILE . 1.3 t80 -65.77 -60.65 2.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.643 0.377 . . . . 2.51 111.199 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -56.55 -41.42 76.81 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 118.818 0.736 . . . . 2.9 110.614 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -60.01 -53.49 57.19 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 119.185 -0.436 . . . . 3.21 110.352 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.745 HD22 ' HB1' ' A' ' 57' ' ' ALA . 41.2 m-20 -50.59 -46.73 58.06 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 118.672 0.669 . . . . 1.32 110.015 178.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.9 t -59.77 -49.15 84.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 109.713 -0.477 . . . . 0.57 109.713 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -55.32 -36.36 66.15 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.547 -0.721 . . . . 1.58 112.643 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -72.35 -6.99 47.18 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.425 0.898 . . . . 1.89 113.425 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.3 141.92 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 120.46 1.482 . . . . 1.83 109.274 171.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -88.7 128.45 35.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.46 -1.311 . . . . 3.67 107.46 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.14 -39.26 2.95 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.264 0.935 . . . . 2.03 112.097 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 p -64.71 159.38 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 121.578 -0.954 . . . . 0.96 110.615 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.2 m -115.25 -61.86 1.68 Allowed 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.333 1.053 . . . . 1.07 108.208 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -122.44 154.21 38.08 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.288 0.367 . . . . 2.54 111.338 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.9 137.89 19.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.867 -0.52 . . . . 0.48 110.101 169.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.4 mt -128.59 91.02 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 106.766 -1.568 . . . . 1.57 106.766 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.99 103.39 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.742 -0.836 . . . . 2.57 108.742 -176.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 . . . . . 0 C--O 1.231 0.086 0 N-CA-C 106.316 -1.735 . . . . 1.86 106.316 174.893 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 119.855 -0.117 . . . . 2.58 111.19 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 169.77 24.04 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.459 0.704 . . . . 5.99 110.944 -172.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.401 HD13 ' C ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -129.33 117.35 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 124.588 1.155 . . . . 0.82 108.141 176.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.7 m -97.07 134.67 40.12 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 123.545 0.738 . . . . 0.44 109.571 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.34 145.33 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 126.305 1.842 . . . . 0.97 106.673 168.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.6 m -146.81 136.72 23.29 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 106.625 -1.62 . . . . 0.62 106.625 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.05 -90.23 0.17 Allowed Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 109.343 -1.503 . . . . 0.59 109.343 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -173.17 55.72 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.321 1.448 . . . . 2.54 110.178 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.35 160.14 43.92 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.692 -1.255 . . . . 0.57 110.79 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.9 m -111.57 167.01 10.66 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.713 1.605 . . . . 0.6 110.315 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.3 tp -56.43 -30.2 30.45 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 CA-C-O 117.763 -1.113 . . . . 1.75 113.191 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -33.06 -53.8 0.37 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.615 1.166 . . . . 2.44 112.224 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -63.52 -47.73 80.48 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.655 0.74 . . . . 2.38 111.685 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.34 -45.36 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.008 0.923 . . . . 0.38 110.078 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.87 -51.63 69.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.663 1.985 . . . . 2.66 109.108 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -53.56 -44.33 69.19 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.597 0.359 . . . . 3.07 110.477 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.745 ' HB1' HD22 ' A' ' 24' ' ' ASN . . . -58.03 -54.99 40.74 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.16 0.505 . . . . 0.44 110.47 169.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.96 -17.19 9.05 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 126.957 2.218 . . . . 0.39 114.088 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -38.86 -35.79 0.23 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.944 0.872 . . . . 0.7 111.921 162.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -54.54 -31.52 56.55 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.723 1.008 . . . . 1.98 113.723 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -122.35 4.24 9.7 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.954 1.301 . . . . 2.25 111.921 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 58.69 53.98 5.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.694 1.198 . . . . 1.18 110.629 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 12' ' ' LEU . 4.6 mm? -68.95 159.79 32.04 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.851 -0.531 . . . . 1.69 111.535 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.37 67.05 1.38 Allowed 'General case' 0 C--N 1.343 0.301 0 CA-C-O 121.42 0.628 . . . . 3.65 109.608 -172.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.496 HD11 ' HZ ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -81.56 140.28 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.069 -0.514 . . . . 0.68 109.888 -172.563 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 85.5 mt -127.66 132.35 24.29 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.164 0.986 . . . . 1.23 108.942 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.99 105.03 1.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.124 2.549 . . . . 0.88 110.033 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 123.674 0.79 . . . . 3.36 111.001 177.812 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.155 0 N-CA-C 110.811 -0.07 . . . . 4.27 110.811 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.9 m -155.35 162.12 40.9 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.592 -1.262 . . . . 0.95 107.592 174.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.54 148.94 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 O-C-N 123.453 0.471 . . . . 0.54 111.531 164.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -135.56 143.49 45.7 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.069 1.348 . . . . 1.95 107.954 -170.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -91.57 126.93 36.83 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.576 0.625 . . . . 4.59 110.132 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.32 154.43 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 C-N-CA 123.929 0.892 . . . . 0.76 109.213 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.422 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . 51.0 t0 -147.15 158.23 43.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.783 -0.821 . . . . 2.71 108.783 171.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.62 -56.82 0.68 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 125.16 1.362 . . . . 1.6 111.06 164.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.98 173.72 4.32 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.9 0.88 . . . . 2.4 112.483 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.3 p -162.82 63.01 0.2 Allowed 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.882 -0.511 . . . . 3.04 110.193 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.3 t -155.52 118.49 4.31 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.241 0.473 . . . . 1.87 111.709 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.1 t -52.87 -38.95 62.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.375 0.67 . . . . 2.24 111.354 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -56.23 -39.28 72.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.642 -0.661 . . . . 2.91 110.707 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.5 m -70.53 -39.9 73.78 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.786 -0.572 . . . . 0.79 110.373 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.05 -43.77 74.1 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.787 0.722 . . . . 0.66 110.764 171.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.74 -49.58 74.47 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.709 0.404 . . . . 0.62 110.344 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.4 tptt -49.76 -48.11 50.48 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.146 0.579 . . . . 3.1 109.668 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -56.08 -64.05 0.98 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.443 1.097 . . . . 2.72 111.148 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -56.33 -38.2 71.02 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.129 1.331 . . . . 2.64 111.85 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -63.61 -51.05 66.95 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.348 0.659 . . . . 2.82 111.38 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -53.96 -44.33 70.66 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.629 -0.669 . . . . 1.4 110.27 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 54' ' ' VAL . 89.8 t -61.54 -48.14 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 122.777 0.431 . . . . 0.41 110.274 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -54.01 -34.92 61.2 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.801 0.84 . . . . 1.58 112.825 175.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -62.31 -23.95 67.03 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.763 0.711 . . . . 3.04 112.355 174.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.425 HG22 ' H ' ' A' ' 30' ' ' GLY . 41.9 mt -70.81 131.69 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 O-C-N 120.963 -1.086 . . . . 1.33 108.777 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -75.75 -28.2 58.38 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.21 1.004 . . . . 3.01 112.722 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.425 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -68.74 -29.36 72.7 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.827 0.727 . . . . 0.86 113.013 -176.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 p -89.59 166.95 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 118.633 1.217 . . . . 0.63 109.356 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.0 m -124.02 -61.25 1.38 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.825 -1.176 . . . . 0.57 107.825 173.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -129.17 111.12 12.6 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.195 -0.668 . . . . 2.68 109.195 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.22 131.96 49.85 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.147 -1.057 . . . . 0.5 108.147 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.7 mm -109.54 97.91 6.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.035 -1.839 . . . . 1.72 106.035 176.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -97.9 136.29 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 109.241 -0.651 . . . . 2.21 109.241 -175.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 . . . . . 0 N--CA 1.456 -0.141 0 N-CA-C 108.736 -0.838 . . . . 2.66 108.736 171.398 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.0 m . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 109.871 -0.418 . . . . 2.85 109.871 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -157.91 178.12 10.58 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.515 -0.741 . . . . 3.83 110.93 -167.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.4 111.94 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 125.466 1.506 . . . . 0.75 108.318 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.0 m -90.17 141.78 28.36 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 123.675 0.79 . . . . 0.55 109.168 171.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 69.2 t -120.95 130.15 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 127.115 2.166 . . . . 0.81 105.249 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.7 m -133.78 142.26 47.82 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 106.781 -1.563 . . . . 0.78 106.781 163.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.93 -102.54 0.23 Allowed Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 104.18 -3.568 . . . . 0.53 104.18 175.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -160.05 45.67 0.23 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.581 0.752 . . . . 3.1 110.983 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.07 176.21 9.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.003 0.921 . . . . 0.51 111.12 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.4 m -126.03 166.64 16.6 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.934 1.694 . . . . 0.58 110.757 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.42 HD11 HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -49.52 -39.97 14.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-O 117.016 -1.469 . . . . 2.52 111.402 178.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -29.58 -53.5 0.14 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.419 1.488 . . . . 2.47 113.195 -177.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -66.03 -44.5 84.49 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.358 0.599 . . . . 2.21 112.282 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 25' ' ' VAL . 14.7 t -58.4 -36.62 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.517 1.127 . . . . 0.34 110.895 171.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.35 -55.45 33.42 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 107.988 -1.116 . . . . 2.77 107.988 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.1 tp60 -52.31 -44.86 65.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.466 1.106 . . . . 3.98 110.509 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.4 -55.46 34.76 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.625 0.77 . . . . 0.44 111.049 171.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.2 -15.84 39.12 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 125.636 1.588 . . . . 0.27 113.41 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.96 -25.25 0.19 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.167 -0.92 . . . . 0.54 112.699 165.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -51.38 -40.32 58.98 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.914 1.234 . . . . 1.88 112.901 172.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -111.04 -13.07 14.13 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.31 1.044 . . . . 2.92 111.81 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 76.32 49.01 0.07 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.367 1.467 . . . . 0.88 110.095 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 63' ' ' LEU . 4.4 mm? -67.32 159.83 28.47 Favored 'General case' 0 N--CA 1.462 0.142 0 O-C-N 121.648 -0.657 . . . . 1.35 111.804 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HD2' ' HB3' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -124.02 112.71 17.49 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 106.477 -1.675 . . . . 4.43 106.477 174.195 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.42 HD12 HD11 ' A' ' 51' ' ' ILE . 0.9 OUTLIER -117.56 130.86 71.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.528 -0.915 . . . . 0.67 108.528 -178.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 49.0 mm -108.4 126.9 28.54 Favored Pre-proline 0 N--CA 1.452 -0.345 0 C-N-CA 125.07 1.348 . . . . 1.56 108.593 -174.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.67 97.69 0.73 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.641 2.227 . . . . 0.64 109.08 171.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 . . . . . 0 CA--C 1.537 0.471 0 C-N-CA 120.17 -0.612 . . . . 3.66 110.092 173.087 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 pttp . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 109.974 -0.38 . . . . 3.24 109.974 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.2 m -148.28 150.07 32.99 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.367 -1.345 . . . . 0.52 107.367 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.82 140.18 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 O-C-N 123.901 0.751 . . . . 0.39 111.542 169.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -122.95 148.68 45.2 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.41 -1.7 . . . . 1.9 106.41 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.89 150.55 26.43 Favored 'General case' 0 N--CA 1.461 0.122 0 N-CA-C 108.31 -0.996 . . . . 6.62 108.31 173.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.67 146.78 23.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.478 0.711 . . . . 0.57 109.413 170.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.4 167.07 22.92 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.005 1.322 . . . . 2.42 107.923 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 120.44 -75.63 0.32 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.691 1.139 . . . . 1.65 111.156 173.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.474 HD22 ' HB3' ' A' ' 17' ' ' CYS . 1.6 pp -68.8 157.41 36.49 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-N 117.088 0.444 . . . . 2.67 109.855 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 p -146.83 62.15 1.2 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.29 0.636 . . . . 2.81 110.176 -176.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 t -160.03 123.08 3.48 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.715 0.635 . . . . 1.81 112.715 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.7 m -48.66 -45.0 38.2 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.672 1.189 . . . . 1.73 111.908 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -57.3 -36.65 71.33 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.755 -0.59 . . . . 3.18 111.24 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.474 ' HB3' HD22 ' A' ' 12' ' ' LEU . 20.5 m -70.15 -41.0 74.44 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 122.055 -0.403 . . . . 0.9 110.034 177.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.81 -47.74 73.66 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.01 0.368 . . . . 0.78 110.117 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.92 -52.34 65.88 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.756 0.822 . . . . 0.71 110.823 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -50.31 -52.3 37.89 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.105 0.962 . . . . 2.21 109.793 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -52.19 -62.1 1.85 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 118.571 -0.728 . . . . 2.71 111.571 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.55 -40.62 79.3 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.262 0.937 . . . . 2.66 110.975 -173.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.2 mtt180 -52.71 -56.01 18.57 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.774 0.716 . . . . 3.91 110.468 171.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -51.57 -43.38 62.42 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.355 0.597 . . . . 2.37 110.252 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.549 HG22 HG22 ' A' ' 54' ' ' VAL . 92.4 t -61.95 -50.08 81.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 C-N-CA 123.254 0.622 . . . . 0.48 111.141 175.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -57.75 -27.86 63.41 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.008 1.323 . . . . 1.92 112.318 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -68.36 -22.55 64.66 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.845 0.748 . . . . 2.21 112.825 171.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.7 mt -69.33 132.69 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.624 1.102 . . . . 1.36 108.13 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -74.32 -32.62 62.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.652 0.781 . . . . 2.76 112.446 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.15 -36.54 90.9 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.063 0.839 . . . . 0.91 112.435 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 p -86.31 159.1 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 O-C-N 121.115 -1.226 . . . . 0.63 109.937 -176.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -117.93 -57.34 2.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.858 1.263 . . . . 0.57 108.15 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -127.87 144.97 51.08 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.048 -0.661 . . . . 2.28 111.315 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.64 131.57 31.72 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.87 -0.789 . . . . 0.5 108.87 171.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mp -114.88 78.99 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 107.746 -1.205 . . . . 2.01 107.746 -173.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 m -84.08 136.51 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 115.636 -0.711 . . . . 2.14 110.821 -167.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 105.995 -1.854 . . . . 2.05 105.995 179.097 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 120.619 0.247 . . . . 2.48 111.271 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.59 172.51 18.43 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 112.831 0.678 . . . . 6.53 112.831 -161.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.31 112.43 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 106.776 -1.565 . . . . 0.71 106.776 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.8 m -92.78 135.94 33.67 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.221 -1.029 . . . . 0.53 108.221 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.53 142.31 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.237 1.815 . . . . 0.74 106.789 173.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.3 m -147.44 136.95 22.71 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 106.983 -1.488 . . . . 0.72 106.983 176.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.76 -94.75 0.16 Allowed Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 106.12 -2.792 . . . . 0.53 106.12 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -165.11 56.33 0.12 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.223 1.809 . . . . 2.5 108.984 173.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.09 170.6 15.64 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.072 -1.017 . . . . 0.65 110.945 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.2 m -129.62 160.66 32.62 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.387 1.475 . . . . 0.69 110.319 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 tp -53.41 -33.71 21.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 CA-C-O 117.299 -1.334 . . . . 1.71 113.059 -172.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -35.07 -48.15 0.41 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.826 1.194 . . . . 3.63 112.089 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -62.38 -49.74 74.33 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.169 0.985 . . . . 2.42 111.223 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.549 HG22 HG22 ' A' ' 25' ' ' VAL . 45.7 t -63.22 -38.52 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.884 1.274 . . . . 0.28 110.581 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -67.41 -46.64 72.61 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.833 1.653 . . . . 2.96 108.329 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -51.87 -52.6 48.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.798 0.439 . . . . 3.22 109.93 172.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.85 -51.31 52.63 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.508 0.595 . . . . 0.4 110.872 170.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.54 -13.9 18.9 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 125.373 1.464 . . . . 0.27 113.911 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.68 -25.92 1.36 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.751 1.275 . . . . 0.42 111.813 168.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -51.81 -31.43 27.33 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.478 1.036 . . . . 2.03 113.322 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -133.98 -6.25 2.74 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.802 1.038 . . . . 2.31 113.802 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 74.03 60.02 0.08 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.354 1.462 . . . . 0.82 111.106 173.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.98 161.86 25.23 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.701 -0.625 . . . . 1.36 110.466 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.67 72.31 1.33 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 107.508 -1.293 . . . . 4.47 107.508 -170.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 mt -82.24 135.49 24.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.2 -1.363 . . . . 0.51 109.247 -172.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 38.8 mm -124.89 127.41 25.12 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 123.629 0.771 . . . . 2.25 110.268 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.23 103.3 1.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.912 2.408 . . . . 0.65 110.108 174.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 N--CA 1.44 -0.94 0 C-N-CA 125.812 1.645 . . . . 4.82 110.5 170.985 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.178 0 N-CA-C 109.996 -0.372 . . . . 3.91 109.996 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.8 m -155.58 162.02 40.73 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.551 -0.907 . . . . 0.63 108.551 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.62 142.47 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 O-C-N 123.535 0.522 . . . . 0.46 110.962 165.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.466 ' CD1' HD13 ' A' ' 51' ' ' ILE . 35.1 m-85 -126.88 154.57 44.25 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.217 1.407 . . . . 1.93 108.665 -171.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -92.02 114.63 27.23 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 118.574 -0.726 . . . . 3.7 109.209 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 p -100.63 137.08 29.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.797 0.839 . . . . 0.47 109.025 174.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.64 156.4 46.86 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.322 -0.992 . . . . 2.4 108.322 171.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 133.2 -74.71 0.43 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.386 -1.485 . . . . 1.39 109.386 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.64 171.14 9.88 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.007 0.743 . . . . 2.61 113.007 -174.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.3 m -158.22 83.08 0.85 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.263 1.425 . . . . 3.84 109.649 175.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.4 t -158.25 137.6 11.75 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.055 0.843 . . . . 1.9 112.158 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.3 m -61.19 -47.05 87.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.03 0.932 . . . . 1.48 111.305 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -60.15 -40.35 89.54 Favored 'General case' 0 C--O 1.233 0.196 0 O-C-N 121.164 -0.96 . . . . 2.69 110.265 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.1 m -60.77 -44.72 96.4 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.019 -0.426 . . . . 0.9 109.999 173.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.78 -46.72 71.11 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.404 0.282 . . . . 0.72 110.493 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.14 -50.55 72.45 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.952 0.501 . . . . 0.69 109.915 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.22 -50.07 40.07 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.235 0.614 . . . . 2.16 109.996 174.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.554 ' O ' HG23 ' A' ' 25' ' ' VAL . 2.8 t80 -64.2 -57.58 9.08 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.081 0.552 . . . . 2.63 110.513 -173.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -59.05 -41.13 87.14 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.866 -0.733 . . . . 2.13 110.142 -176.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -61.87 -50.01 73.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.994 -0.527 . . . . 3.8 109.897 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -48.22 -50.58 28.89 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.614 -0.513 . . . . 1.62 109.614 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.563 HG22 HG22 ' A' ' 54' ' ' VAL . 18.7 t -57.74 -52.15 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 110.395 -0.224 . . . . 0.51 110.395 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -49.35 -39.74 32.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.503 1.121 . . . . 2.16 111.605 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -67.49 -19.96 65.4 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.872 0.693 . . . . 2.08 112.872 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.594 HG22 ' H ' ' A' ' 30' ' ' GLY . 19.9 mt -76.12 122.22 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 119.857 1.208 . . . . 1.35 109.552 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -66.52 -18.67 65.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.745 1.218 . . . . 2.67 113.648 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.594 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -70.45 -34.2 68.17 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 123.51 0.576 . . . . 0.9 111.978 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.512 HG11 HG12 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -92.92 -173.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 O-C-N 121.799 -0.824 . . . . 0.87 110.542 -172.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.0 m -132.93 -62.0 0.82 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.834 -1.172 . . . . 0.83 107.834 170.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -120.64 164.48 16.45 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.076 0.465 . . . . 4.14 111.982 175.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.462 ' CB ' HG11 ' A' ' 25' ' ' VAL . . . -158.25 136.56 10.9 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.987 -1.006 . . . . 0.5 109.898 168.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 35' ' ' ILE . 3.4 mp -119.78 101.36 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 O-C-N 124.686 1.241 . . . . 1.73 107.812 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.5 p -84.96 137.16 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.588 0.755 . . . . 2.33 109.792 175.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 . . . . . 0 N--CA 1.465 0.283 0 CA-C-N 118.838 0.745 . . . . 2.78 109.747 165.752 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 119.444 -0.312 . . . . 2.48 110.174 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -158.51 165.8 33.7 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.619 0.768 . . . . 3.49 111.103 -173.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.45 119.11 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.63 1.172 . . . . 0.77 109.848 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.7 m -94.13 145.79 24.44 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.558 1.143 . . . . 0.54 111.098 175.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 90.0 t -131.75 134.22 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 127.557 2.343 . . . . 1.0 105.871 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.1 m -145.71 75.46 1.43 Allowed 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 120.707 -1.245 . . . . 1.39 108.461 -173.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -157.92 -117.31 0.51 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 108.065 -2.014 . . . . 1.19 108.065 173.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.02 59.08 1.3 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.769 1.227 . . . . 4.31 108.185 177.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.73 162.02 41.07 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.686 -0.634 . . . . 0.5 110.063 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.9 m -110.92 161.43 15.85 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.343 1.457 . . . . 0.59 110.339 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.466 HD13 ' CD1' ' A' ' 7' ' ' TYR . 6.1 tp -51.21 -36.52 16.79 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 117.732 -1.128 . . . . 1.92 113.154 -175.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -35.52 -47.37 0.45 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.685 1.194 . . . . 3.38 113.393 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -67.49 -39.73 85.21 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.361 -0.837 . . . . 2.35 111.659 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.563 HG22 HG22 ' A' ' 25' ' ' VAL . 43.7 t -68.05 -44.01 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.202 1.001 . . . . 0.38 109.524 178.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -53.37 -48.65 68.4 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.107 2.163 . . . . 2.8 109.163 174.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -52.9 -52.22 58.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.637 0.775 . . . . 4.02 110.605 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.29 -49.23 70.1 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.098 0.863 . . . . 0.6 110.666 172.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.78 -13.6 4.54 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.131 1.348 . . . . 0.46 113.957 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.69 -32.75 1.06 Allowed 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.545 1.173 . . . . 0.72 111.565 165.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -49.18 -37.01 21.1 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.656 0.984 . . . . 1.9 113.656 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -125.43 12.09 8.08 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.217 1.007 . . . . 2.84 111.127 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 60.77 47.91 7.52 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.805 1.242 . . . . 1.15 110.467 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 mp -65.15 153.04 42.06 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.524 -0.307 . . . . 2.33 110.764 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.65 108.65 11.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.612 -1.996 . . . . 3.6 105.612 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.551 HD11 ' HZ ' ' A' ' 21' ' ' PHE . 1.5 mt -112.55 126.29 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.481 -0.933 . . . . 0.57 108.481 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 mp -104.56 131.16 22.11 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 108.133 -1.062 . . . . 1.3 108.133 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.33 105.02 0.81 Allowed 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.783 1.656 . . . . 0.78 107.875 165.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 121.288 0.566 . . . . 4.41 111.195 171.619 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 108.799 -0.815 . . . . 3.86 108.799 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.0 m -149.48 154.41 38.76 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 107.804 -1.184 . . . . 0.59 107.804 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.34 140.07 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 O-C-N 124.431 1.082 . . . . 0.49 109.905 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -129.41 136.93 50.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.23 -1.396 . . . . 1.9 107.23 -167.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -84.56 133.11 34.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 118.189 -0.91 . . . . 4.69 109.384 -174.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -120.54 145.53 26.8 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 C-N-CA 124.63 1.172 . . . . 0.66 109.842 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -139.42 150.76 45.63 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.899 -1.519 . . . . 2.4 106.899 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.76 -71.11 0.42 Allowed Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.471 1.034 . . . . 1.41 110.729 168.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.98 165.92 8.24 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.265 1.026 . . . . 2.32 112.106 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.2 p -161.62 64.91 0.26 Allowed 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.875 -0.516 . . . . 2.84 110.055 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.6 t -159.34 134.59 8.3 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 110.047 -0.353 . . . . 1.83 110.047 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.7 p -53.34 -48.13 68.75 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.12 0.968 . . . . 2.18 109.89 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -43.4 -51.11 6.67 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.302 1.041 . . . . 2.53 111.772 173.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.4 m -64.06 -45.63 87.94 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 109.988 -0.375 . . . . 0.8 109.988 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -46.97 73.22 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.567 0.222 . . . . 0.55 111.401 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.45 -48.98 78.65 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.326 1.05 . . . . 0.58 109.86 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -53.77 -48.19 69.99 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.724 -0.473 . . . . 4.23 109.724 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.76 -59.81 4.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.695 0.798 . . . . 2.37 111.573 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -56.88 -41.22 77.64 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 119.347 -0.941 . . . . 2.73 109.961 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -60.04 -48.43 81.76 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 119.275 -0.393 . . . . 3.22 110.165 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.661 HD22 ' HB1' ' A' ' 57' ' ' ALA . 34.6 m-20 -49.06 -51.77 29.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.072 0.397 . . . . 1.34 110.001 172.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 54' ' ' VAL . 45.2 t -59.11 -48.04 88.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 O-C-N 122.027 -0.421 . . . . 0.34 110.76 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -54.47 -37.06 64.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.739 1.215 . . . . 1.48 112.086 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -65.31 -18.54 65.39 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.895 0.77 . . . . 2.09 112.963 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.1 mt -76.88 115.92 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 119.79 1.177 . . . . 1.22 109.538 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -77.68 60.76 2.26 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.595 1.958 . . . . 3.92 110.097 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -154.15 -36.72 0.03 OUTLIER Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.205 1.859 . . . . 0.81 111.965 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.94 172.31 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 121.46 -1.024 . . . . 0.68 109.124 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.2 m -121.58 -60.71 1.59 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.682 1.193 . . . . 0.68 108.032 171.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -122.89 134.33 54.38 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 109.887 -0.412 . . . . 2.1 109.887 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.19 126.09 42.21 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.149 -1.056 . . . . 0.45 108.149 171.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.19 95.07 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 105.408 -2.071 . . . . 2.22 105.408 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -91.79 141.38 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 120.398 -0.521 . . . . 2.05 109.856 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 . . . . . 0 CA--C 1.529 0.161 0 N-CA-C 107.951 -1.129 . . . . 1.73 107.951 168.894 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.9 m . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 111.823 0.305 . . . . 2.73 111.823 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.457 ' NZ ' ' OE1' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -158.27 167.75 28.92 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.36 1.064 . . . . 4.01 109.98 -173.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.67 119.48 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 125.544 1.537 . . . . 0.82 108.386 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.1 m -96.83 144.76 26.49 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 118.313 0.506 . . . . 0.48 110.099 172.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.27 138.84 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 127.116 2.166 . . . . 0.75 106.87 174.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.4 m -145.47 134.47 22.61 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.536 -1.653 . . . . 0.69 106.536 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.55 -94.98 0.16 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 107.348 -2.301 . . . . 0.52 107.348 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -164.3 50.07 0.12 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.337 1.455 . . . . 2.57 109.349 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.14 173.71 11.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.897 0.879 . . . . 0.67 110.414 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.0 m -137.89 169.73 17.29 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.071 1.348 . . . . 0.9 111.039 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.468 ' O ' HD13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -50.46 -40.61 18.82 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 CA-C-O 117.222 -1.37 . . . . 2.65 110.694 -179.221 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -34.63 -49.8 0.43 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.681 1.582 . . . . 4.19 113.773 -176.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -68.77 -45.39 71.5 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.441 0.639 . . . . 2.19 112.035 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 25' ' ' VAL . 21.9 t -57.32 -33.84 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.271 1.028 . . . . 0.37 110.593 174.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -59.98 -57.29 13.48 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.667 1.587 . . . . 3.07 106.863 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -53.84 -47.34 71.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.868 -1.06 . . . . 3.26 110.01 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.661 ' HB1' HD22 ' A' ' 24' ' ' ASN . . . -51.62 -52.2 49.57 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.848 -0.532 . . . . 0.42 111.191 171.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.52 -9.7 26.17 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.64 1.114 . . . . 0.34 112.643 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.34 -23.68 3.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 119.151 1.476 . . . . 0.47 111.478 169.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -52.11 -32.11 33.78 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.277 0.944 . . . . 2.01 112.76 172.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -136.96 10.48 3.07 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.819 0.848 . . . . 2.49 112.682 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 57.33 65.75 1.3 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.855 1.262 . . . . 1.29 111.655 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.404 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.2 mm? -77.19 -166.53 0.73 Allowed 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.848 -0.533 . . . . 1.32 110.959 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.401 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -155.53 62.65 0.61 Allowed 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 120.49 -1.381 . . . . 4.63 107.5 -179.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.465 HD12 HD11 ' A' ' 51' ' ' ILE . 1.1 mt -79.86 137.8 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.359 -1.291 . . . . 0.61 109.299 -173.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.9 mt -127.19 136.28 28.65 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 124.194 0.997 . . . . 1.31 109.599 -174.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.18 83.67 0.35 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.979 2.453 . . . . 0.82 110.968 172.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.457 ' OE1' ' NZ ' ' A' ' 42' ' ' LYS . 5.1 tt0 . . . . . 0 CA--C 1.542 0.671 0 C-N-CA 126.526 1.931 . . . . 3.52 109.969 167.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 107.361 -1.348 . . . . 4.38 107.361 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.7 m -155.1 151.97 28.95 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.372 -1.344 . . . . 0.78 107.372 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -119.3 141.12 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 O-C-N 124.448 1.092 . . . . 0.68 110.535 162.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -122.32 152.86 39.67 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.914 1.685 . . . . 1.79 106.746 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -94.26 134.71 36.45 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.41 1.005 . . . . 3.87 110.704 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 p -112.58 135.85 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 O-C-N 124.322 1.014 . . . . 0.64 109.71 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -135.82 172.08 13.52 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.147 0.43 . . . . 2.98 110.593 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.41 -47.43 2.6 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.43 1.491 . . . . 1.62 112.129 176.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.49 167.28 2.66 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.475 0.71 . . . . 2.55 112.863 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.5 t -165.99 64.19 0.11 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.869 0.468 . . . . 2.91 111.125 172.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.8 t -156.85 134.68 10.94 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 120.949 -1.094 . . . . 2.05 110.582 171.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.411 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 91.4 m -68.18 -44.92 74.82 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 122.114 -0.367 . . . . 2.16 110.918 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -56.19 -40.52 74.11 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.141 -0.974 . . . . 2.74 110.803 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.0 m -55.82 -32.98 64.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.037 0.535 . . . . 0.82 111.364 174.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 15' ' ' THR . . . -60.46 -41.96 95.21 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 122.843 0.457 . . . . 0.52 109.839 176.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.37 -45.34 91.59 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.635 0.731 . . . . 0.52 109.078 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.2 tmtp? -52.1 -46.63 65.35 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.749 -0.659 . . . . 2.86 109.325 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.619 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -61.97 -58.21 8.75 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 119.007 -0.52 . . . . 2.58 112.325 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -54.27 -47.94 71.77 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.873 -0.788 . . . . 2.6 108.873 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 ttt-85 -63.03 -50.61 70.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.704 -0.48 . . . . 4.25 109.704 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.605 HD22 ' HB1' ' A' ' 57' ' ' ALA . 29.0 m-20 -49.34 -47.77 47.09 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 117.904 0.32 . . . . 1.39 110.265 175.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 21' ' ' PHE . 19.5 t -62.51 -49.4 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 122.088 -0.383 . . . . 0.5 110.102 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -50.95 -35.66 34.68 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.9 0.88 . . . . 2.27 112.162 173.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -70.36 -12.76 61.8 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.322 0.86 . . . . 2.87 113.322 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.679 HG22 ' H ' ' A' ' 30' ' ' GLY . 36.3 mt -78.54 131.51 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 120.199 1.363 . . . . 1.41 109.791 177.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -86.3 20.77 2.26 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.638 1.975 . . . . 3.55 112.494 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.679 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -122.62 -12.87 4.87 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.845 1.212 . . . . 1.13 112.54 -178.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -115.67 157.17 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 C-N-CA 125.332 1.453 . . . . 0.6 107.433 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.9 m -109.32 -60.08 1.81 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.708 1.203 . . . . 0.65 108.454 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -117.27 148.62 41.51 Favored 'General case' 0 N--CA 1.462 0.125 0 O-C-N 123.207 0.317 . . . . 2.94 110.589 175.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.416 ' CB ' HG11 ' A' ' 25' ' ' VAL . . . -150.58 129.68 12.68 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.71 -0.478 . . . . 0.58 109.71 172.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.3 mt -130.19 102.49 7.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 107.269 -1.382 . . . . 1.33 107.269 -174.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 p -88.94 144.73 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 122.938 0.495 . . . . 1.99 110.81 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 . . . . . 0 CA--C 1.536 0.418 0 C-N-CA 125.076 1.351 . . . . 1.98 108.465 176.735 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.441 -0.888 0 N-CA-C 106.148 -1.797 . . . . 5.46 106.148 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -153.63 140.29 18.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.678 -0.489 . . . . 5.63 109.678 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.89 114.78 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.263 1.025 . . . . 0.78 108.627 174.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.1 m -87.58 133.09 33.86 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 123.811 0.845 . . . . 0.55 109.034 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.4 t -121.91 140.52 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 126.657 1.983 . . . . 0.7 105.797 171.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.9 m -147.98 135.3 20.54 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.535 -1.283 . . . . 0.78 107.535 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.03 -96.46 0.16 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 106.509 -2.636 . . . . 0.56 106.509 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.4 49.24 0.26 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.611 1.164 . . . . 4.12 109.411 169.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.17 174.32 11.7 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.843 0.857 . . . . 0.73 111.131 177.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -125.05 170.57 11.04 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.926 1.691 . . . . 0.78 111.557 -174.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.4 tp -52.47 -37.61 24.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-O 117.513 -1.232 . . . . 1.77 112.269 -177.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -31.7 -52.47 0.24 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.019 1.328 . . . . 3.24 112.365 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -58.98 -50.75 72.89 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.584 1.183 . . . . 2.25 111.675 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.568 HG12 ' CZ ' ' A' ' 21' ' ' PHE . 65.1 t -61.89 -44.77 99.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.935 1.694 . . . . 0.48 110.433 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -63.29 -45.08 93.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.531 1.532 . . . . 3.55 109.495 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -51.58 -51.04 58.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.235 -0.654 . . . . 4.11 109.235 172.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.605 ' HB1' HD22 ' A' ' 24' ' ' ASN . . . -53.3 -48.97 67.92 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.912 -0.492 . . . . 0.38 110.682 173.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.02 -9.22 7.01 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.873 1.702 . . . . 0.31 113.96 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.53 -29.18 1.67 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.497 1.148 . . . . 0.47 111.49 166.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -51.69 -35.56 43.21 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.344 0.974 . . . . 1.95 113.555 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -121.61 4.73 10.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.41 1.084 . . . . 2.47 111.472 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 59.24 52.51 6.0 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.631 1.172 . . . . 1.07 110.054 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.22 158.03 29.91 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.575 -0.284 . . . . 2.18 110.481 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.75 119.2 25.24 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.747 -1.205 . . . . 3.95 107.747 167.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.0 mt -120.54 139.36 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.171 1.388 . . . . 0.49 107.97 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mp -128.28 133.31 25.01 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 108.358 -0.978 . . . . 1.39 108.358 -176.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.53 112.53 3.06 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.337 2.025 . . . . 0.84 108.87 170.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 . . . . . 0 CA--C 1.532 0.285 0 C-N-CA 123.657 0.783 . . . . 3.24 111.27 172.341 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 107.639 -1.245 . . . . 4.64 107.639 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.7 m -150.15 156.53 41.78 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.579 -1.267 . . . . 0.58 107.579 174.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 p -137.21 139.65 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 123.761 0.663 . . . . 0.42 110.326 168.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -125.18 145.84 49.78 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.011 1.325 . . . . 2.32 108.156 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.18 125.18 32.63 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 118.307 -0.854 . . . . 3.64 109.484 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 p -115.92 132.59 64.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 C-N-CA 123.34 0.656 . . . . 0.64 110.132 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -135.09 166.85 22.12 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.38 1.472 . . . . 3.09 108.661 -175.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.23 -50.84 0.98 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.908 1.242 . . . . 1.31 111.407 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.04 161.48 4.03 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.735 1.214 . . . . 3.25 113.417 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.1 p -172.45 51.03 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.746 0.647 . . . . 3.17 112.746 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -160.86 143.0 12.46 Favored 'General case' 0 C--N 1.346 0.426 0 O-C-N 120.76 -1.212 . . . . 2.0 113.656 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.8 m -63.32 -49.32 74.41 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.074 0.95 . . . . 1.82 111.661 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -55.05 -40.49 70.34 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.571 -0.706 . . . . 4.46 110.674 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.0 m -64.56 -43.26 94.49 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 122.136 -0.352 . . . . 0.95 110.771 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.99 -48.58 64.36 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.009 0.368 . . . . 0.96 110.173 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.53 -51.49 69.23 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.715 0.806 . . . . 0.86 110.332 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -49.9 -44.98 50.39 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.872 0.469 . . . . 2.55 109.978 175.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.414 ' HZ ' HD11 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -64.65 -58.49 6.16 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.22 -0.895 . . . . 2.51 111.536 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -51.98 -45.19 64.36 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.55 1.068 . . . . 3.53 108.91 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -61.61 -59.06 5.77 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.344 0.658 . . . . 5.54 111.082 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.475 ' HB3' ' HB1' ' A' ' 57' ' ' ALA . 6.3 m-20 -49.67 -48.11 49.68 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.016 -0.735 . . . . 1.61 109.016 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.403 HG22 HG13 ' A' ' 54' ' ' VAL . 90.5 t -60.76 -48.24 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 122.994 0.518 . . . . 0.76 110.546 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -56.07 -36.06 67.67 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.663 1.185 . . . . 2.45 111.992 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.14 -9.71 58.53 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.255 0.835 . . . . 2.38 113.255 175.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.1 mm -78.69 110.52 14.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 120.039 1.291 . . . . 2.19 110.587 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.61 85.7 0.07 Allowed 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.166 1.786 . . . . 3.44 108.584 165.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.38 -42.1 0.12 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 109.865 -1.294 . . . . 0.96 109.865 -177.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -97.92 151.29 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 108.642 -0.873 . . . . 0.97 108.642 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.3 m -106.28 -55.95 2.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.943 1.297 . . . . 0.6 108.09 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -121.44 125.44 46.9 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.948 -0.76 . . . . 3.36 108.948 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.82 136.89 47.85 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.292 -1.003 . . . . 0.63 108.292 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.8 mt -129.39 110.84 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.871 -1.159 . . . . 1.27 107.871 -176.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.6 p -95.24 111.48 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 118.413 0.551 . . . . 2.04 111.37 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 C--N 1.341 0.228 0 N-CA-C 106.953 -1.499 . . . . 2.19 106.953 167.266 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 110.258 -0.275 . . . . 2.61 110.258 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -157.79 155.73 30.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.812 -0.555 . . . . 3.37 110.731 -163.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.28 117.46 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 125.69 1.596 . . . . 0.81 108.367 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.3 m -89.18 144.63 25.97 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.727 0.811 . . . . 0.54 109.921 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.96 132.43 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 127.163 2.185 . . . . 0.73 106.617 175.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.9 m -143.27 132.41 23.11 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.996 -1.483 . . . . 0.88 106.996 173.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.9 -90.07 0.12 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.982 -1.647 . . . . 0.76 108.982 177.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -165.41 54.65 0.11 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.72 1.608 . . . . 2.88 109.208 167.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.88 174.68 10.36 Favored 'General case' 0 C--N 1.34 0.172 0 O-C-N 121.032 -1.042 . . . . 0.69 112.175 -176.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.1 m -134.61 166.35 23.11 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.454 1.501 . . . . 0.59 110.518 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.803 HD11 HD12 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -48.1 -44.5 12.12 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.877 0 CA-C-O 117.199 -1.381 . . . . 2.73 111.098 -178.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -31.7 -47.93 0.14 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.054 1.741 . . . . 2.79 114.113 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -66.73 -46.51 75.22 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.671 0.748 . . . . 2.76 111.32 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.403 HG13 HG22 ' A' ' 25' ' ' VAL . 25.1 t -62.1 -31.47 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.993 1.317 . . . . 0.43 111.161 172.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -60.24 -55.5 33.03 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.253 1.421 . . . . 3.19 107.274 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.06 -48.06 76.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.374 -0.83 . . . . 3.69 110.3 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.475 ' HB1' ' HB3' ' A' ' 24' ' ' ASN . . . -50.04 -51.1 44.95 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.414 0.552 . . . . 0.63 110.793 172.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.18 -10.7 29.07 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.112 -0.826 . . . . 0.28 113.533 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.04 -30.18 4.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.857 1.328 . . . . 0.59 112.24 172.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -57.57 -28.18 63.35 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.464 1.029 . . . . 2.22 113.213 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -128.38 -5.75 5.36 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.131 0.973 . . . . 3.09 112.471 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 63.22 61.39 1.08 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.715 1.206 . . . . 1.24 111.018 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 63' ' ' LEU . 2.0 mm? -82.19 169.37 16.68 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 121.891 -0.506 . . . . 1.02 110.495 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.05 70.8 1.42 Allowed 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.114 -1.069 . . . . 4.54 108.114 -170.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.803 HD12 HD11 ' A' ' 51' ' ' ILE . 2.0 mt -79.96 135.41 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 108.678 -0.86 . . . . 0.56 108.678 -173.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.26 135.62 23.2 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 124.37 1.068 . . . . 1.37 108.291 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.33 100.46 0.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 121.847 1.698 . . . . 0.97 109.324 170.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 108.687 -0.857 . . . . 3.96 108.687 172.33 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 105.659 -1.978 . . . . 4.96 105.659 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 88.9 m -153.5 156.07 37.42 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 106.301 -1.741 . . . . 0.69 106.301 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -132.69 145.99 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 O-C-N 123.992 0.807 . . . . 0.42 110.919 168.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -131.06 146.68 52.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.401 -1.703 . . . . 1.9 106.401 -172.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -85.17 128.15 34.55 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.816 -0.809 . . . . 5.15 108.816 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -112.31 135.26 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.91 -1.515 . . . . 0.49 106.91 174.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -142.59 154.74 44.69 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 104.964 -2.236 . . . . 3.05 104.964 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.52 -81.81 0.35 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.398 0.999 . . . . 1.6 110.999 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.557 HD23 HD21 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -81.31 163.06 23.19 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.304 0.552 . . . . 2.72 110.929 -174.278 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.545 ' N ' HD12 ' A' ' 12' ' ' LEU . 18.2 t -149.26 79.21 1.4 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.197 0.599 . . . . 3.67 110.721 177.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.3 t -160.53 146.65 15.18 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.087 0.858 . . . . 1.78 112.387 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -68.39 -46.35 70.26 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.391 1.476 . . . . 1.56 111.996 -177.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -55.02 -43.52 73.76 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.426 -0.796 . . . . 2.75 110.424 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.3 m -56.96 -45.25 82.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.624 -0.716 . . . . 0.97 110.512 173.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.413 ' HB1' HG13 ' A' ' 36' ' ' VAL . . . -56.12 -49.89 72.63 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 122.941 0.497 . . . . 0.92 110.268 176.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.07 -46.42 68.58 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.235 0.54 . . . . 0.8 110.267 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -61.52 -46.11 91.35 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.446 -0.343 . . . . 3.49 110.849 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.21 -64.81 0.72 Allowed 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.848 0.859 . . . . 2.79 110.706 175.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -39.63 83.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.981 0.81 . . . . 2.42 111.086 -172.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -53.04 62.76 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.139 0.576 . . . . 2.82 110.393 172.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.545 HD22 ' HB1' ' A' ' 57' ' ' ALA . 64.6 m-20 -53.33 -46.5 69.51 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.431 -0.581 . . . . 1.33 109.431 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.578 HG11 ' CB ' ' A' ' 34' ' ' ALA . 48.5 t -59.22 -51.25 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 122.678 0.391 . . . . 0.55 110.324 176.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.5 mttt -50.64 -38.43 46.18 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.036 0.935 . . . . 1.87 112.414 173.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.63 -12.53 54.08 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.488 0.921 . . . . 3.01 113.488 175.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 30' ' ' GLY . 19.2 mt -86.29 113.47 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 120.319 1.418 . . . . 1.36 110.1 178.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -53.4 -25.16 14.59 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.833 1.653 . . . . 3.36 114.006 176.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.496 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -71.67 -31.13 65.43 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.886 0.755 . . . . 0.8 112.466 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.54 HG11 HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -92.27 -172.99 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 121.278 -1.131 . . . . 0.8 109.99 -171.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.1 m -140.71 -57.97 0.52 Allowed 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 120.769 -1.207 . . . . 0.79 108.811 171.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -128.53 157.95 39.77 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 119.954 -0.698 . . . . 2.67 111.36 171.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.578 ' CB ' HG11 ' A' ' 25' ' ' VAL . . . -154.84 149.55 26.53 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.239 -0.652 . . . . 0.57 109.239 172.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.9 mt -130.32 131.07 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 107.047 -1.464 . . . . 1.61 107.047 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.413 HG13 ' HB1' ' A' ' 18' ' ' ALA . 2.8 p -118.61 110.04 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 124.389 1.076 . . . . 2.32 109.703 -175.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 107.619 -1.252 . . . . 2.12 107.619 171.73 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 112.493 0.553 . . . . 2.64 112.493 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -157.94 160.02 37.14 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.793 -0.567 . . . . 3.76 110.891 -158.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.26 115.7 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.145 -1.428 . . . . 0.81 107.145 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 79.6 m -90.84 141.76 28.48 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.322 1.449 . . . . 0.46 108.722 174.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.1 t -129.63 140.85 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 104.58 -2.378 . . . . 1.01 104.58 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.4 m -147.26 133.35 19.3 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 107.185 -1.413 . . . . 0.88 107.185 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.7 -96.26 0.16 Allowed Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 106.836 -2.505 . . . . 0.62 106.836 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -163.8 57.53 0.17 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.585 1.954 . . . . 3.31 108.475 172.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.71 168.12 25.32 Favored 'General case' 0 C--N 1.341 0.219 0 O-C-N 120.9 -1.125 . . . . 0.53 111.588 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -126.29 165.67 18.55 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.278 1.431 . . . . 1.05 111.696 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.7 tp -55.64 -28.93 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 117.352 -1.308 . . . . 1.85 113.321 -172.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -35.6 -51.03 0.63 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.78 1.173 . . . . 2.46 111.469 173.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -69.13 -41.46 77.34 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.289 0.566 . . . . 2.39 111.776 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.449 HG22 HG22 ' A' ' 25' ' ' VAL . 18.2 t -65.24 -38.42 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 O-C-N 121.624 -0.672 . . . . 0.36 110.22 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -61.38 -53.85 51.33 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 127.611 2.364 . . . . 3.35 107.97 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -49.03 -42.36 37.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.15 0.58 . . . . 3.8 111.135 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.545 ' HB1' HD22 ' A' ' 24' ' ' ASN . . . -67.77 -47.6 68.72 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.167 0.508 . . . . 0.49 110.849 174.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.27 -15.99 12.93 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 126.928 2.204 . . . . 0.31 113.117 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -40.5 -29.32 0.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.303 1.051 . . . . 0.43 112.465 163.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -50.23 -36.16 29.84 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.9 1.074 . . . . 1.85 113.9 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -126.16 -4.73 6.77 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.472 1.509 . . . . 2.39 112.47 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 73.03 57.46 0.11 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.092 1.357 . . . . 1.33 110.85 173.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.557 HD21 HD23 ' A' ' 12' ' ' LEU . 3.8 mm? -79.11 168.29 19.84 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.186 -0.946 . . . . 1.18 111.204 -175.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -135.09 64.55 1.59 Allowed 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.492 -1.299 . . . . 4.92 107.492 -171.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.74 130.78 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 113.501 -1.681 . . . . 0.6 109.098 -174.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.8 mt -122.62 131.13 24.41 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 108.388 -0.967 . . . . 1.04 108.388 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.41 106.88 1.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.203 1.935 . . . . 0.85 109.128 169.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 CA--C 1.536 0.405 0 C-N-CA 123.858 0.863 . . . . 3.41 109.881 172.617 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 108.005 -1.109 . . . . 4.53 108.005 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.2 m -153.35 159.03 42.37 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 106.422 -1.696 . . . . 0.65 106.422 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 p -136.66 148.33 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 O-C-N 124.111 0.882 . . . . 0.49 110.778 173.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -133.27 141.8 48.19 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 106.729 -1.582 . . . . 2.01 106.729 -171.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.1 mtt85 -83.14 137.26 34.14 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.455 1.025 . . . . 3.92 108.416 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 p -121.78 140.65 45.11 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 124.093 0.957 . . . . 0.52 110.112 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -140.33 155.03 46.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.998 -1.482 . . . . 2.86 106.998 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.17 -81.68 0.35 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.811 1.196 . . . . 1.42 110.598 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.5 ' C ' HD12 ' A' ' 12' ' ' LEU . 1.3 pp -75.64 161.23 29.29 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.957 0.379 . . . . 2.67 110.522 -175.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 t -153.52 90.78 1.43 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.315 -0.624 . . . . 3.7 109.315 170.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.9 t -165.36 127.83 2.13 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.4 0.68 . . . . 1.91 110.077 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 m -50.32 -45.38 54.76 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.258 1.023 . . . . 1.43 111.743 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -59.34 -39.78 84.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.891 -0.506 . . . . 2.68 111.227 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.419 ' HB3' HD22 ' A' ' 12' ' ' LEU . 9.4 m -65.95 -46.29 78.67 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.686 -0.487 . . . . 0.84 109.686 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.58 -49.07 71.24 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.742 0.246 . . . . 0.66 110.417 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.87 67.59 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.57 0.748 . . . . 0.74 110.556 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.0 tttp -57.17 -46.93 82.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.135 -0.484 . . . . 2.8 110.349 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -49.61 -63.29 1.15 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 118.643 -0.694 . . . . 2.69 111.108 171.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -57.97 -39.75 78.92 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 119.099 0.863 . . . . 2.61 111.321 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -58.11 -51.06 71.28 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.698 -0.482 . . . . 3.06 109.698 173.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -53.5 -43.14 68.04 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.11 0.414 . . . . 2.69 110.223 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 54' ' ' VAL . 47.1 t -60.68 -52.18 64.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 122.808 0.443 . . . . 0.36 111.28 174.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -53.84 -35.36 61.38 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.366 1.066 . . . . 1.86 111.515 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -72.53 10.26 0.87 Allowed 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 114.128 1.159 . . . . 2.75 114.128 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.0 mt -105.42 112.83 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.276 1.43 . . . . 1.23 110.714 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -52.59 -36.15 55.54 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 127.887 2.475 . . . . 3.62 113.758 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.2 -30.17 75.08 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.474 -0.785 . . . . 0.85 112.002 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.05 172.3 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 O-C-N 121.627 -0.925 . . . . 0.89 109.252 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.6 m -126.34 -59.83 1.29 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.466 -1.309 . . . . 0.66 107.466 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -122.58 164.2 18.59 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-O 121.351 0.596 . . . . 3.5 112.404 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.48 135.73 12.12 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.986 -0.746 . . . . 0.48 108.986 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.7 mm -118.82 102.39 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 105.389 -2.078 . . . . 2.11 105.389 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.51 118.93 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.651 -0.87 . . . . 2.01 108.651 -172.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 . . . . . 0 C--N 1.338 0.1 0 N-CA-C 108.857 -0.794 . . . . 2.3 108.857 -176.387 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 m . . . . . 0 CA--C 1.534 0.33 0 CA-C-O 120.648 0.261 . . . . 2.61 110.968 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.05 167.29 30.88 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.833 0.853 . . . . 3.92 109.885 -173.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.47 114.27 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 126.348 1.859 . . . . 0.89 107.541 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.1 m -91.55 136.26 33.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.37 -0.974 . . . . 0.44 108.37 171.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 t -119.96 147.93 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 126.584 1.954 . . . . 0.82 106.791 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.9 m -146.27 138.29 25.01 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.447 -1.316 . . . . 0.81 107.447 175.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.11 -91.84 0.15 Allowed Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 108.047 -2.021 . . . . 0.54 108.047 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -167.11 50.31 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.937 1.695 . . . . 2.31 109.196 173.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.12 178.05 8.87 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.968 -1.083 . . . . 0.49 110.821 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.2 m -138.21 171.37 14.5 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.21 1.404 . . . . 1.17 110.951 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -46.43 -47.41 6.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-O 116.68 -1.628 . . . . 2.74 110.875 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -33.18 -47.74 0.2 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 121.104 1.774 . . . . 2.96 114.155 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -70.16 -44.39 68.91 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.252 -0.905 . . . . 2.05 112.291 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 25' ' ' VAL . 13.7 t -58.47 -27.83 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.139 1.376 . . . . 0.37 111.547 169.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.29 -52.23 29.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.876 1.67 . . . . 2.99 106.747 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -54.15 -45.67 72.06 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.808 0.843 . . . . 3.9 110.403 174.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.8 -57.65 10.13 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.408 0.549 . . . . 0.45 110.658 169.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.11 -16.18 25.11 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 125.407 1.479 . . . . 0.31 113.713 -174.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -42.7 -29.47 0.3 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.18 -0.914 . . . . 0.49 112.544 166.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -52.97 -35.26 58.73 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.836 1.198 . . . . 1.9 113.411 175.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.8 -1.55 9.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.682 1.193 . . . . 2.48 112.264 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 65.06 55.6 1.11 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.732 1.213 . . . . 0.88 110.519 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.05 171.66 11.49 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.156 -0.965 . . . . 1.16 110.955 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -137.57 64.3 1.52 Allowed 'General case' 0 C--N 1.341 0.218 0 N-CA-C 107.731 -1.211 . . . . 4.79 107.731 -175.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mt -80.7 139.47 18.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 113.982 -1.463 . . . . 0.83 108.429 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.5 mt -128.0 133.25 24.93 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.436 1.094 . . . . 1.14 108.116 -174.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -64.52 109.0 1.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.323 2.016 . . . . 0.78 109.621 172.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 109.725 -0.472 . . . . 4.54 109.725 172.804 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.114 0.483 . . . . 3.79 109.77 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -150.25 148.4 28.84 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 105.838 -1.912 . . . . 0.65 105.838 170.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.67 147.64 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 124.204 0.94 . . . . 0.54 110.284 169.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -133.0 145.09 50.55 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.082 -1.451 . . . . 2.17 107.082 -173.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 50.8 mtm-85 -87.68 124.89 34.03 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 109.037 -0.727 . . . . 5.33 109.037 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 p -109.74 152.91 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.056 0 N-CA-C 108.638 -0.875 . . . . 0.55 108.638 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.418 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . 57.2 t0 -147.37 166.81 26.02 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.284 -1.376 . . . . 2.35 107.284 177.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.6 -68.34 0.28 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.236 0.922 . . . . 1.61 112.14 171.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 12' ' ' LEU . 1.3 pp -73.41 157.94 35.94 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 117.833 0.817 . . . . 2.68 110.347 -175.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.0 m -152.25 69.9 0.9 Allowed 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.92 0.488 . . . . 3.31 110.199 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.2 t -157.86 121.87 4.15 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.045 0.538 . . . . 1.82 110.775 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 m -47.18 -44.26 21.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.205 1.402 . . . . 1.39 111.947 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -53.52 -43.92 68.7 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.888 0.475 . . . . 3.02 110.787 178.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.443 ' HB3' HD22 ' A' ' 12' ' ' LEU . 4.1 m -70.43 -39.73 74.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.386 -0.34 . . . . 0.85 110.369 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.01 -44.64 78.86 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.681 0.673 . . . . 0.56 110.766 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.39 -49.12 72.85 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.345 0.658 . . . . 0.58 110.683 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -49.53 -49.38 46.27 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.494 0.717 . . . . 2.7 109.227 173.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -56.93 -63.43 1.21 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 118.449 -0.786 . . . . 2.77 111.646 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -40.17 74.76 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 119.173 -1.011 . . . . 2.47 110.671 -172.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -59.32 -51.71 68.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.216 0.207 . . . . 2.74 111.232 174.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.55 HD22 ' HB1' ' A' ' 57' ' ' ALA . 1.9 m120 -52.24 -45.77 65.46 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.76 -0.588 . . . . 1.61 110.702 175.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.0 t -65.51 -45.33 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.095 0.558 . . . . 0.55 110.399 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -54.03 -38.44 65.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.293 1.037 . . . . 2.04 110.867 173.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -70.33 -0.61 8.45 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.864 1.061 . . . . 2.99 113.864 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.9 mm -85.6 134.08 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 120.837 1.653 . . . . 2.11 110.287 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -74.74 124.7 27.25 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.839 1.656 . . . . 4.11 109.316 167.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.91 -39.86 1.95 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.578 1.085 . . . . 1.1 110.955 171.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.03 159.08 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 O-C-N 121.871 -0.782 . . . . 0.59 109.311 173.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.7 m -116.17 -55.68 2.38 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.871 1.668 . . . . 0.74 107.856 177.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -127.23 147.29 50.22 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.416 0.447 . . . . 2.89 110.554 170.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.79 140.53 40.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.719 -1.215 . . . . 0.51 107.719 166.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.6 mt -125.25 109.92 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 N-CA-C 106.451 -1.685 . . . . 1.42 106.451 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.78 129.96 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 123.106 0.253 . . . . 1.94 110.788 -171.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 107.034 -1.469 . . . . 1.92 107.034 169.191 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 111.659 0.244 . . . . 2.59 111.659 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.34 168.54 25.03 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.692 -0.63 . . . . 4.05 111.669 -163.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.08 113.99 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.773 -1.195 . . . . 0.77 107.773 -176.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.8 m -91.88 141.58 28.49 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.49 1.116 . . . . 0.48 109.066 174.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.8 t -129.34 138.38 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 104.744 -2.317 . . . . 0.84 104.744 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.2 m -147.61 132.46 18.03 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 106.391 -1.707 . . . . 0.67 106.391 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.87 -95.82 0.17 Allowed Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 106.651 -2.579 . . . . 0.57 106.651 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.63 63.59 0.11 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.086 1.754 . . . . 3.81 108.53 174.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.22 164.69 36.84 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.075 -1.016 . . . . 0.5 110.629 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.0 m -118.26 162.61 17.98 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 125.939 1.696 . . . . 0.68 110.65 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 tp -54.02 -31.84 21.83 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 CA-C-O 117.466 -1.254 . . . . 1.77 112.632 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -32.17 -48.57 0.17 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.89 1.276 . . . . 3.6 111.953 175.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -59.83 -52.5 65.18 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.92 0.867 . . . . 2.34 111.465 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.06 -42.41 96.52 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 C-N-CA 125.44 1.496 . . . . 0.44 110.699 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -61.99 -48.96 78.01 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.049 1.34 . . . . 2.93 108.644 178.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -56.12 -51.59 67.39 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.162 0.585 . . . . 3.31 110.35 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.55 ' HB1' HD22 ' A' ' 24' ' ' ASN . . . -48.51 -52.98 19.83 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.654 0.661 . . . . 0.37 110.835 168.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.46 -18.4 29.67 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 125.382 1.468 . . . . 0.31 113.414 -177.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.23 -22.77 1.11 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.543 1.171 . . . . 0.47 112.335 170.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -55.49 -32.11 62.58 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 120.167 1.348 . . . . 1.89 112.894 172.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.91 -25.21 6.83 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.127 1.371 . . . . 2.16 111.657 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 83.48 60.41 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.674 2.39 . . . . 0.74 111.363 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.16 165.72 22.16 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.119 -0.988 . . . . 1.32 111.73 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.418 ' HD2' ' HB3' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -121.04 111.72 17.82 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.966 -1.494 . . . . 4.9 106.966 175.073 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.08 127.6 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 108.845 -0.798 . . . . 0.51 108.845 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.9 mm -111.64 125.3 30.63 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.027 1.331 . . . . 1.42 108.796 -172.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.14 92.24 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.04 2.493 . . . . 0.7 110.032 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 121.531 0.681 . . . . 3.91 111.002 177.923 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.6 pttt . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 108.117 -1.068 . . . . 3.81 108.117 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.9 m -147.46 150.64 34.99 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 108.234 -1.025 . . . . 0.67 108.234 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -135.36 132.88 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 124.337 1.023 . . . . 0.71 111.114 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -115.57 153.65 30.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.772 1.629 . . . . 2.02 108.012 -169.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -92.89 112.72 24.78 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.484 -0.932 . . . . 4.1 108.484 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.9 p -96.18 144.03 11.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.572 1.149 . . . . 0.51 109.055 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -141.93 163.39 33.02 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.541 -0.541 . . . . 2.96 109.541 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.4 -70.26 0.24 Allowed Glycine 0 CA--C 1.528 0.906 0 C-N-CA 126.013 1.768 . . . . 1.55 111.024 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.94 173.3 8.99 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.388 0.884 . . . . 2.54 113.388 -170.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.1 p -167.06 82.63 0.23 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.846 0.859 . . . . 2.73 109.716 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.01 133.03 4.39 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.763 0.711 . . . . 2.03 112.422 176.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.4 m -54.59 -46.72 73.81 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.573 1.149 . . . . 1.5 111.71 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -59.42 -36.59 76.16 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.985 0.898 . . . . 3.21 111.142 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.9 m -69.79 -45.37 68.12 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 108.822 -0.807 . . . . 1.17 108.822 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.56 -43.85 68.82 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 122.759 0.424 . . . . 0.66 110.419 174.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.68 -55.21 37.83 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.471 0.708 . . . . 0.64 109.515 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -54.88 -41.09 70.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.53 -0.304 . . . . 2.88 111.037 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.522 ' CZ ' HG12 ' A' ' 54' ' ' VAL . 2.2 t80 -64.6 -60.16 3.45 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 119.403 -0.332 . . . . 2.44 111.096 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.31 -40.93 75.15 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 118.429 0.559 . . . . 2.52 109.781 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -57.97 -54.53 45.86 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.059 0.943 . . . . 2.76 109.352 175.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -49.67 -51.71 36.19 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.422 0.556 . . . . 1.95 109.851 176.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.581 HG22 HG22 ' A' ' 54' ' ' VAL . 32.5 t -55.5 -52.65 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 110.26 -0.274 . . . . 0.4 110.26 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -51.05 -39.24 55.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.194 1.398 . . . . 1.63 112.383 174.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -71.88 -14.17 61.87 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.057 0.762 . . . . 2.07 113.057 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.687 HG22 ' H ' ' A' ' 30' ' ' GLY . 17.0 mt -77.55 131.47 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 120.531 1.514 . . . . 1.33 108.761 171.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -77.22 -9.5 58.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.447 1.099 . . . . 2.44 113.75 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.687 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -78.91 -30.91 45.56 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.768 0.699 . . . . 0.81 112.09 -178.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.454 HG11 HG12 ' A' ' 25' ' ' VAL . 12.1 p -97.36 158.67 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 121.377 -1.072 . . . . 0.61 109.42 -178.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.0 m -106.08 -55.0 2.39 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.677 -1.231 . . . . 0.6 107.677 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -129.32 154.62 46.69 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.758 -0.46 . . . . 2.92 109.758 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.72 143.9 23.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.892 -0.781 . . . . 0.44 108.892 173.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.5 mt -127.5 105.77 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.313 -1.366 . . . . 1.48 107.313 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.57 125.95 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.507 -0.923 . . . . 2.56 108.507 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.0 m120 . . . . . 0 N--CA 1.465 0.296 0 CA-C-N 119.408 1.004 . . . . 2.79 109.94 169.32 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 m . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.898 -0.408 . . . . 2.55 109.898 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.77 167.85 28.38 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 122.948 0.499 . . . . 3.56 110.637 -170.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.52 120.39 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.632 1.173 . . . . 0.72 108.892 174.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.7 m -98.09 145.29 26.7 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.408 1.083 . . . . 0.54 111.177 177.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.75 140.55 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 127.563 2.345 . . . . 0.61 107.551 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.1 m -148.5 89.66 1.72 Allowed 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 124.971 1.309 . . . . 1.08 108.486 -177.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.89 -106.98 0.19 Allowed Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 108.51 -1.836 . . . . 0.72 108.51 175.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -151.92 62.77 0.85 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.706 1.202 . . . . 3.61 108.114 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.15 162.61 36.65 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.121 0.969 . . . . 0.67 110.071 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -119.5 162.14 19.39 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.884 1.673 . . . . 0.62 109.043 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.0 tp -52.67 -33.51 18.5 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 CA-C-O 117.231 -1.366 . . . . 1.64 112.012 -176.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.3 mm-40 -28.7 -53.41 0.11 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.67 1.588 . . . . 2.53 112.802 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -69.09 -41.87 76.92 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.574 0.702 . . . . 2.39 111.708 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.581 HG22 HG22 ' A' ' 25' ' ' VAL . 33.9 t -66.99 -38.04 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.278 1.031 . . . . 0.31 110.272 178.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -60.98 -49.76 76.14 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.229 1.812 . . . . 2.85 108.512 174.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -52.53 -51.62 58.73 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.83 0.452 . . . . 3.31 110.142 175.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.5 -48.61 62.85 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.627 0.649 . . . . 0.37 111.188 170.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.32 -9.64 6.42 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.918 -0.935 . . . . 0.35 114.036 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.91 -25.66 0.83 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 119.176 1.488 . . . . 0.53 112.682 170.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -53.73 -36.35 62.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.81 1.186 . . . . 2.0 113.235 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -121.0 -5.93 9.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.217 1.007 . . . . 2.61 112.894 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 67.46 50.57 0.92 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.75 1.22 . . . . 0.79 110.417 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -72.35 168.01 19.28 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.532 -0.73 . . . . 1.36 112.158 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.07 124.49 40.73 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.195 -1.78 . . . . 4.36 106.195 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.0 mt -130.85 134.49 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.708 1.203 . . . . 0.57 107.913 -175.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.6 mt -113.98 121.79 36.07 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.756 1.222 . . . . 1.47 108.169 -172.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -77.37 70.73 6.68 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 124.227 3.284 . . . . 1.41 109.5 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 . . . . . 0 N--CA 1.441 -0.913 0 C-N-CA 126.057 1.743 . . . . 6.96 112.913 -167.927 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 30.8 pttt . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 108.059 -1.089 . . . . 3.75 108.059 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.1 m -150.2 147.19 27.4 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 107.766 -1.198 . . . . 0.53 107.766 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -123.02 143.84 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 124.947 1.404 . . . . 0.38 110.318 171.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -129.8 153.42 48.26 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.023 -1.843 . . . . 1.9 106.023 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -95.42 147.95 22.98 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.583 0.629 . . . . 3.92 110.156 173.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.34 121.7 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 123.045 0.538 . . . . 0.97 110.684 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.04 -173.45 2.31 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.069 0.548 . . . . 2.81 111.449 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.43 -46.94 3.34 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.666 1.603 . . . . 1.34 113.427 170.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 pp -50.13 156.8 0.74 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.874 1.269 . . . . 3.3 113.495 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 t -167.55 51.21 0.06 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.88 0.472 . . . . 2.83 111.221 173.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.1 t -159.16 117.74 2.9 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 120.807 -1.183 . . . . 2.2 112.854 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 m -53.04 -41.96 65.26 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.191 0.996 . . . . 1.65 112.212 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -57.25 -39.74 76.2 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.67 0.747 . . . . 3.15 109.982 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.0 m -69.39 -43.83 72.7 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.866 -0.606 . . . . 0.92 109.947 175.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.28 -48.57 45.9 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.062 0.545 . . . . 0.63 110.84 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.27 -48.86 80.04 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.573 -0.739 . . . . 0.51 109.879 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -58.51 -38.42 77.66 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.022 -0.535 . . . . 3.34 110.532 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.525 ' O ' HG23 ' A' ' 25' ' ' VAL . 2.2 t80 -58.07 -60.52 3.62 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.45 0.7 . . . . 2.72 109.758 174.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -55.8 -45.04 78.35 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.278 0.49 . . . . 2.47 110.029 -175.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -64.06 -47.26 80.84 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.022 -0.535 . . . . 2.76 109.808 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -52.46 -46.39 66.47 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.918 -0.401 . . . . 1.33 109.918 173.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 21' ' ' PHE . 15.4 t -60.33 -50.16 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 118.314 0.507 . . . . 0.49 109.727 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -51.63 -34.83 39.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.899 0.88 . . . . 1.42 112.996 173.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -67.26 -22.81 65.65 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.875 0.761 . . . . 3.03 112.533 176.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.665 HG22 ' H ' ' A' ' 30' ' ' GLY . 25.1 mt -70.74 133.18 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.596 1.089 . . . . 1.5 109.213 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -77.66 -17.35 57.8 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.557 1.143 . . . . 2.94 113.093 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.665 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -83.48 -11.44 80.15 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.379 0.99 . . . . 1.03 113.768 -176.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.3 p -115.06 153.18 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 118.59 1.195 . . . . 0.66 108.949 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.8 m -103.1 -51.56 3.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.23 -1.026 . . . . 0.6 108.23 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -132.38 161.08 34.51 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.837 0.351 . . . . 2.1 110.278 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.77 138.05 16.6 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.874 -1.158 . . . . 0.42 107.874 174.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 22.0 mm -126.55 102.81 10.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 106.839 -1.541 . . . . 2.03 106.839 -177.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.2 p -98.42 144.38 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 122.507 0.323 . . . . 2.04 110.658 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.0 m120 . . . . . 0 C--O 1.235 0.295 0 N-CA-C 108.803 -0.814 . . . . 2.87 108.803 173.423 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.444 -0.725 0 N-CA-C 108.32 -0.993 . . . . 5.22 108.32 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -145.69 142.54 29.1 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.044 1.293 . . . . 5.24 112.407 -170.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.78 119.33 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.105 1.362 . . . . 0.74 110.151 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 m -98.56 139.96 33.5 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.941 1.296 . . . . 0.42 110.225 172.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.5 t -122.29 140.66 45.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 127.806 2.442 . . . . 0.74 105.576 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.5 m -147.22 85.72 1.61 Allowed 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.134 -0.979 . . . . 1.03 108.424 -173.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.88 -106.87 0.19 Allowed Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 109.43 -1.468 . . . . 0.67 109.43 176.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -152.21 54.87 0.81 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.733 0.813 . . . . 2.14 108.958 170.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.77 163.6 33.55 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.425 -0.797 . . . . 0.6 110.497 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.5 m -109.57 161.42 15.37 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.337 1.455 . . . . 0.85 110.136 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.0 tp -50.74 -31.63 9.96 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 CA-C-O 117.314 -1.327 . . . . 1.74 113.321 -178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -29.86 -50.04 0.11 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.07 1.348 . . . . 3.69 112.475 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -63.93 -45.49 89.02 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 122.025 0.917 . . . . 2.37 111.604 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.43 HG22 HG22 ' A' ' 25' ' ' VAL . 28.0 t -69.57 -30.73 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.507 1.123 . . . . 0.43 110.48 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -61.7 -50.06 73.97 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.046 -1.094 . . . . 3.19 108.046 172.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -51.97 -50.87 60.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.837 0.455 . . . . 3.1 110.617 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.14 -52.24 36.78 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.856 -0.527 . . . . 0.81 111.13 170.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.07 -22.31 35.09 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 126.002 1.763 . . . . 0.41 112.952 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.38 -31.49 4.08 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.733 1.266 . . . . 0.44 112.368 171.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.57 -36.32 55.72 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.314 0.961 . . . . 2.13 113.113 175.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -130.35 4.62 4.75 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.255 1.022 . . . . 3.08 112.122 -173.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 61.82 54.75 2.8 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.597 1.559 . . . . 0.86 112.884 171.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.412 ' H ' HD22 ' A' ' 63' ' ' LEU . 1.6 mm? -80.17 -176.96 5.84 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.344 -0.542 . . . . 1.11 110.801 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -144.87 87.72 1.86 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.328 -1.73 . . . . 4.3 106.328 -176.285 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 mt -89.0 132.31 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.858 1.263 . . . . 0.9 109.9 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.7 mp -129.17 136.54 29.32 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.539 1.136 . . . . 1.44 109.025 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -72.51 64.93 3.76 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.812 3.008 . . . . 1.03 110.847 174.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 . . . . . 0 N--CA 1.453 -0.297 0 C-N-CA 123.24 0.616 . . . . 6.4 109.928 170.992 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.8 pttt . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.226 0.536 . . . . 4.23 109.699 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.0 m -146.84 143.72 28.78 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.44 -0.948 . . . . 0.74 108.44 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -116.34 134.44 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 124.869 1.356 . . . . 0.69 110.505 168.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -116.13 163.26 16.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.791 1.636 . . . . 2.08 106.593 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -106.21 131.41 53.49 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 118.619 -0.705 . . . . 3.84 110.39 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 p -116.87 142.64 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.366 -0.976 . . . . 0.42 108.366 -174.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -142.93 166.64 24.09 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.756 0.707 . . . . 2.9 109.885 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.25 66.0 3.0 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.464 1.507 . . . . 3.12 112.379 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.578 HD13 ' H ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -129.16 167.96 16.84 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.774 1.63 . . . . 2.68 109.712 175.411 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 m -64.41 -82.66 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.302 0.482 . . . . 6.73 112.302 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -172.71 -167.52 0.44 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.372 -0.83 . . . . 4.39 109.911 -175.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.7 t -47.95 -36.72 12.98 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.417 1.487 . . . . 2.35 112.969 -176.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -52.49 -50.93 61.76 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.929 0.871 . . . . 3.68 110.385 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.5 m -71.89 -32.66 67.63 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.909 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.71 -46.86 74.26 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 118.581 0.628 . . . . 0.59 110.044 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -49.99 75.43 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.495 -0.775 . . . . 0.58 109.085 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -53.65 -41.86 67.22 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.415 -0.357 . . . . 2.33 110.686 175.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -63.76 -57.39 10.08 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.362 0.665 . . . . 2.82 110.549 179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -55.16 -45.3 75.71 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.61 0.641 . . . . 2.53 109.609 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -60.82 -52.15 66.29 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.407 0.683 . . . . 3.71 109.462 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -48.78 -49.87 36.71 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 123.335 0.654 . . . . 2.01 109.961 176.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.496 HG22 HG22 ' A' ' 54' ' ' VAL . 38.8 t -61.65 -50.76 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 120.392 -0.523 . . . . 0.43 109.938 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -50.31 -33.92 21.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.187 0.995 . . . . 1.52 113.113 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -69.91 -22.39 63.21 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.459 0.704 . . . . 2.74 112.614 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.61 HG22 ' H ' ' A' ' 30' ' ' GLY . 21.9 mt -76.97 138.95 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.674 1.124 . . . . 1.2 109.18 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -82.47 -21.12 35.7 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.33 1.052 . . . . 2.36 113.402 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.61 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -68.86 -31.11 72.52 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 123.845 0.736 . . . . 1.0 112.503 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 32' ' ' THR . 9.8 p -95.01 -178.95 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 124.846 1.258 . . . . 0.7 109.222 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.43 ' H ' HG22 ' A' ' 31' ' ' VAL . 82.9 m -141.83 -57.95 0.47 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.372 1.069 . . . . 0.98 109.062 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.79 148.91 35.72 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-O 121.169 0.509 . . . . 2.56 110.228 172.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.11 124.0 11.3 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.729 -1.211 . . . . 0.83 107.729 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.0 mt -128.49 98.95 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 107.653 -1.24 . . . . 1.33 107.653 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 p -96.4 138.22 22.24 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 C-N-CA 122.85 0.46 . . . . 2.17 110.541 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 . . . . . 0 C--O 1.232 0.176 0 N-CA-C 107.952 -1.129 . . . . 2.45 107.952 166.486 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.5 m . . . . . 0 N--CA 1.44 -0.926 0 N-CA-C 107.019 -1.475 . . . . 4.89 107.019 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -152.35 140.84 20.69 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.611 0.641 . . . . 4.77 111.547 -176.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.9 106.91 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.226 1.411 . . . . 0.72 109.18 -177.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.2 m -84.39 134.12 34.49 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.67 1.188 . . . . 0.79 109.718 174.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.02 138.94 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.294 1.838 . . . . 0.68 106.67 171.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.5 m -148.71 136.58 20.74 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.045 -1.465 . . . . 0.94 107.045 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.74 -94.38 0.15 Allowed Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 106.188 -2.765 . . . . 0.63 106.188 173.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -159.97 49.16 0.29 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.27 0.628 . . . . 2.37 110.383 169.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.6 172.91 12.56 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.516 -0.74 . . . . 0.59 112.035 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.8 m -127.29 164.93 20.67 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.785 1.634 . . . . 0.58 111.316 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 tp -53.75 -28.54 16.66 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-O 117.846 -1.073 . . . . 1.8 113.228 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -32.48 -51.09 0.26 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.542 1.137 . . . . 2.2 111.831 171.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -68.91 -41.76 77.77 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.416 0.627 . . . . 2.5 111.601 -177.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.496 HG22 HG22 ' A' ' 25' ' ' VAL . 37.1 t -67.1 -37.13 78.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 123.691 0.796 . . . . 0.38 110.224 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -57.32 -54.5 46.05 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.496 1.518 . . . . 3.16 108.05 173.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.82 -53.68 49.07 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 110.081 -0.34 . . . . 3.08 110.081 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.46 -47.96 62.94 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.159 0.504 . . . . 0.51 111.161 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.23 -18.34 4.74 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 126.348 1.927 . . . . 0.5 113.208 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.97 -24.26 0.58 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.555 1.678 . . . . 0.74 112.837 171.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -53.96 -34.39 59.6 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.88 1.218 . . . . 2.24 113.35 172.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -120.84 -19.38 7.33 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.316 1.446 . . . . 2.67 112.394 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 73.71 55.45 0.1 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.415 1.886 . . . . 1.04 110.856 -177.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.26 166.42 23.49 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.279 -0.888 . . . . 1.39 111.079 -176.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.51 120.06 34.77 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.568 -1.271 . . . . 4.16 107.568 169.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.45 140.28 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 125.001 1.321 . . . . 0.64 108.049 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.77 131.93 24.1 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.288 1.035 . . . . 1.59 108.602 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.08 97.35 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.567 2.178 . . . . 0.76 108.998 170.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 . . . . . 0 N--CA 1.451 -0.408 0 C-N-CA 123.758 0.823 . . . . 3.32 111.107 176.433 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.7 pttt . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 108.425 -0.954 . . . . 4.19 108.425 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.0 m -156.15 154.18 30.45 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 107.75 -1.204 . . . . 0.52 107.75 -173.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -129.36 143.15 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 124.499 1.125 . . . . 0.4 110.931 170.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -128.22 147.86 50.6 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.169 1.388 . . . . 1.83 107.574 -175.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -88.75 132.77 34.47 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.623 0.647 . . . . 6.03 109.392 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 p -109.62 148.95 12.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.9 1.28 . . . . 0.63 107.792 172.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.27 160.82 42.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.784 -0.821 . . . . 2.69 108.784 168.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.15 34.53 5.86 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.116 0.865 . . . . 1.99 113.785 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.96 171.5 20.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.362 1.081 . . . . 2.18 109.814 169.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.1 t -171.08 60.24 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.849 0.86 . . . . 3.53 110.404 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -142.58 121.69 12.93 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.503 0.592 . . . . 2.29 110.854 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m -51.57 -50.14 60.69 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.328 1.051 . . . . 1.28 111.321 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -54.11 -44.4 71.23 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.978 -0.451 . . . . 2.68 110.803 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.1 m -64.92 -46.67 80.68 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.942 -0.392 . . . . 0.82 109.942 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.87 74.73 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.918 0.487 . . . . 0.59 111.195 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.04 -49.18 66.03 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.587 0.755 . . . . 0.77 110.185 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -52.32 -47.84 65.77 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.642 -0.503 . . . . 2.64 109.642 173.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.17 -57.53 10.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.104 0.562 . . . . 2.28 110.93 174.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -56.63 -44.57 81.38 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.722 0.692 . . . . 2.39 110.089 -174.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -59.87 -53.86 52.97 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 108.834 -0.802 . . . . 5.57 108.834 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -44.94 -49.16 11.26 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.401 1.08 . . . . 1.76 110.342 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 54' ' ' VAL . 59.5 t -60.39 -52.21 64.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 110.298 -0.26 . . . . 0.38 110.298 175.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -53.18 -31.88 45.03 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.277 0.843 . . . . 1.37 113.277 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -70.33 -15.42 62.87 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.388 0.994 . . . . 2.28 113.094 175.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.5 mt -71.99 115.92 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-O 122.474 1.13 . . . . 1.31 109.445 178.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.08 95.12 0.16 Allowed 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.76 1.624 . . . . 2.61 108.941 171.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.84 -36.74 0.72 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.227 -0.749 . . . . 1.39 111.227 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.2 p -79.67 155.25 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 121.677 -0.896 . . . . 0.84 109.757 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.2 m -109.44 -58.55 2.02 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.529 1.132 . . . . 0.81 108.133 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -123.74 157.74 33.29 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.206 0.527 . . . . 2.94 111.343 173.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.43 134.99 20.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.97 -1.493 . . . . 0.55 106.97 167.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.8 mt -124.85 102.61 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 104.541 -2.392 . . . . 1.71 104.541 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.458 HG12 HG12 ' A' ' 43' ' ' ILE . 2.0 m -117.14 133.05 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 110.328 -0.249 . . . . 2.4 110.328 -167.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 . . . . . 0 C--O 1.227 -0.116 0 N-CA-C 109.358 -0.608 . . . . 2.88 109.358 176.755 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.0 m . . . . . 0 C--O 1.235 0.311 0 CA-C-O 118.338 -0.839 . . . . 2.51 109.479 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -156.32 165.91 34.97 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.961 0.8 . . . . 3.97 112.199 -170.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -128.2 115.89 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 126.663 1.985 . . . . 0.98 107.706 -178.401 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.9 m -97.1 137.45 36.14 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.974 0.909 . . . . 0.44 109.026 173.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.18 143.98 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 126.564 1.946 . . . . 0.79 106.325 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 m -146.1 130.74 17.9 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 106.669 -1.604 . . . . 0.64 106.669 178.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 147.23 -101.52 0.23 Allowed Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 105.888 -2.885 . . . . 0.53 105.888 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -163.57 56.94 0.17 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.719 1.608 . . . . 2.29 109.069 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.09 164.21 31.31 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.155 0.982 . . . . 0.9 109.16 173.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.3 m -131.26 163.38 27.92 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.662 1.185 . . . . 0.87 111.211 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.573 HD11 HD12 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -45.83 -48.73 4.86 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.859 0 CA-C-O 117.19 -1.386 . . . . 2.62 111.178 -174.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -30.97 -50.91 0.15 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.296 1.438 . . . . 2.85 113.318 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -66.15 -44.66 83.49 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 122.027 0.917 . . . . 3.5 110.67 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 25' ' ' VAL . 24.5 t -65.89 -33.37 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.815 1.246 . . . . 0.38 110.63 174.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.85 -55.35 36.02 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.951 -1.5 . . . . 4.0 106.951 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -51.55 -45.74 63.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.901 -1.045 . . . . 3.28 110.837 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.88 -53.95 52.12 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.706 0.685 . . . . 0.37 111.138 171.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.85 -20.51 19.36 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 125.179 1.371 . . . . 0.29 112.703 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.81 -22.48 0.31 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.418 1.109 . . . . 0.44 113.156 168.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -53.76 -31.66 49.41 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.223 1.374 . . . . 1.9 112.825 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -128.62 -10.85 5.02 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.463 1.505 . . . . 2.93 112.593 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 74.59 60.57 0.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.631 1.973 . . . . 0.89 111.507 172.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -84.35 -179.05 7.1 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.469 -0.769 . . . . 1.25 112.429 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.22 110.22 8.25 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 105.872 -1.899 . . . . 4.22 105.872 176.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.573 HD12 HD11 ' A' ' 51' ' ' ILE . 0.9 OUTLIER -117.12 135.65 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.908 -1.145 . . . . 0.56 107.908 -179.293 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.22 137.15 29.39 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.818 1.247 . . . . 1.1 108.967 -169.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.77 89.82 0.63 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.193 2.595 . . . . 1.12 111.184 174.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 . . . . . 0 CA--C 1.54 0.573 0 C-N-CA 126.579 1.951 . . . . 3.7 111.156 171.887 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.8 pttt . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 121.326 0.584 . . . . 4.22 109.697 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.1 m -147.11 143.65 28.45 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.471 -0.937 . . . . 0.74 108.471 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -116.37 134.64 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 O-C-N 124.899 1.374 . . . . 0.69 110.454 168.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -116.41 163.12 16.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.522 -1.659 . . . . 2.07 106.522 -177.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -106.55 131.06 54.15 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 118.644 -0.693 . . . . 3.84 110.323 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 p -117.12 142.63 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 108.354 -0.98 . . . . 0.43 108.354 -173.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -143.34 166.84 23.63 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.752 0.706 . . . . 2.91 109.648 176.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.73 64.77 3.81 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.421 1.486 . . . . 3.12 112.339 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.578 HD13 ' H ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -128.64 167.55 17.03 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.799 1.639 . . . . 2.69 109.748 175.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.4 m -64.88 -82.35 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.254 0.464 . . . . 6.71 112.254 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -172.46 -167.67 0.47 Allowed 'General case' 0 C--N 1.344 0.333 0 O-C-N 121.323 -0.861 . . . . 4.38 110.06 -175.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.0 t -48.28 -36.55 14.32 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.339 1.456 . . . . 2.35 113.021 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -52.63 -50.73 62.56 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.949 0.88 . . . . 3.65 110.349 176.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.7 m -71.81 -33.07 68.23 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.744 -0.662 . . . . 0.98 110.823 176.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.56 -47.1 73.64 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 118.46 0.573 . . . . 0.59 110.035 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.46 -50.09 74.97 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.571 -0.741 . . . . 0.59 109.072 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -53.53 -41.68 66.64 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.44 -0.345 . . . . 2.34 110.758 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -63.84 -57.22 10.53 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.478 0.711 . . . . 2.81 110.561 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -55.25 -45.16 76.06 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 118.61 0.641 . . . . 2.53 109.674 -177.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -60.7 -52.29 65.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.307 0.643 . . . . 3.7 109.378 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -48.75 -49.88 36.3 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.351 0.661 . . . . 2.0 109.908 176.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 54' ' ' VAL . 39.0 t -61.71 -50.88 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 120.499 -0.48 . . . . 0.42 109.912 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 55.4 mttt -50.61 -33.43 22.13 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.128 0.971 . . . . 1.52 113.214 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -69.97 -22.3 63.16 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.498 0.719 . . . . 2.71 112.582 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.6 HG22 ' H ' ' A' ' 30' ' ' GLY . 21.9 mt -77.25 139.29 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 119.64 1.109 . . . . 1.2 109.232 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -82.83 -21.1 34.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.283 1.033 . . . . 2.37 113.419 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.6 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -68.97 -31.23 72.36 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.9 0.762 . . . . 0.99 112.359 -178.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 ' H ' ' A' ' 32' ' ' THR . 9.8 p -94.41 -177.61 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.855 1.262 . . . . 0.72 109.104 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.452 ' H ' HG22 ' A' ' 31' ' ' VAL . 62.2 m -143.91 -57.47 0.39 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.04 -1.037 . . . . 1.0 109.092 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -113.97 149.25 35.58 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-O 121.236 0.541 . . . . 2.59 110.251 171.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.4 124.51 11.43 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.791 -1.188 . . . . 0.82 107.791 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.91 99.13 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 107.692 -1.225 . . . . 1.33 107.692 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 p -96.07 138.67 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 C-N-CA 122.807 0.443 . . . . 2.18 110.429 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 . . . . . 0 C--O 1.233 0.19 0 N-CA-C 107.945 -1.131 . . . . 2.45 107.945 166.016 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.5 m . . . . . 0 N--CA 1.442 -0.87 0 N-CA-C 106.983 -1.488 . . . . 4.87 106.983 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -151.87 141.18 21.45 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.7 0.682 . . . . 4.75 111.719 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.07 107.08 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.294 1.438 . . . . 0.72 109.186 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.8 m -84.38 134.1 34.49 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.686 1.195 . . . . 0.81 109.73 173.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -122.74 139.15 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.199 1.8 . . . . 0.68 106.679 171.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.1 m -148.81 136.87 20.85 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 107.031 -1.47 . . . . 0.95 107.031 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.89 -94.62 0.15 Allowed Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 106.261 -2.736 . . . . 0.63 106.261 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -159.86 49.22 0.29 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.325 0.65 . . . . 2.43 110.381 169.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.6 173.07 12.37 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.503 -0.748 . . . . 0.59 112.022 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.1 m -127.7 164.73 21.45 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.709 1.603 . . . . 0.58 111.358 -174.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 tp -53.71 -28.71 16.72 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 CA-C-O 117.809 -1.091 . . . . 1.8 113.231 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -32.73 -50.92 0.28 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.391 1.076 . . . . 2.21 111.825 171.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -68.89 -41.44 78.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.385 0.612 . . . . 2.49 111.652 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 25' ' ' VAL . 38.0 t -67.44 -37.15 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.662 0.785 . . . . 0.38 110.111 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -57.41 -54.42 47.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.596 1.558 . . . . 3.15 107.944 173.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.63 -53.73 47.65 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 110.101 -0.333 . . . . 3.07 110.101 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.63 -47.95 63.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.132 0.491 . . . . 0.51 111.132 173.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.27 -18.44 4.89 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 126.336 1.922 . . . . 0.5 113.245 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.73 -24.52 0.58 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.468 1.634 . . . . 0.72 112.878 171.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -54.01 -34.33 59.59 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.893 1.224 . . . . 2.24 113.315 172.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -120.35 -19.73 7.51 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.195 1.398 . . . . 2.66 112.339 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 74.13 55.24 0.09 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.494 1.918 . . . . 1.02 110.729 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.95 166.09 23.98 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.261 -0.899 . . . . 1.39 111.082 -176.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.98 121.16 38.34 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.523 -1.288 . . . . 4.13 107.523 169.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.33 140.6 44.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 125.007 1.323 . . . . 0.66 108.029 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.12 131.74 23.99 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.356 1.062 . . . . 1.61 108.525 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.28 97.82 0.79 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.537 2.158 . . . . 0.76 108.829 170.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 . . . . . 0 N--CA 1.45 -0.441 0 C-N-CA 123.532 0.733 . . . . 3.35 111.028 177.105 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mtt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 109.492 -0.559 . . . . 9.18 109.492 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.41 ' H ' ' CD ' ' A' ' 3' ' ' GLU . . . -173.7 -53.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.766 1.226 . . . . 6.65 109.1 -175.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.41 ' CD ' ' H ' ' A' ' 2' ' ' ALA . 1.1 mp0 49.03 44.84 22.91 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.447 1.499 . . . . 4.6 111.511 166.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -136.48 143.79 44.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 127.634 2.374 . . . . 3.81 105.946 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.5 m -151.9 154.76 36.75 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 105.888 -1.893 . . . . 0.88 105.888 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.25 137.99 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 O-C-N 124.428 1.08 . . . . 0.66 109.851 169.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -116.49 151.21 36.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.517 -1.661 . . . . 1.88 106.517 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 -87.86 131.94 34.38 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 107.67 -1.233 . . . . 5.55 107.67 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.505 HG21 ' CE1' ' A' ' 38' ' ' PHE . 7.5 p -125.87 147.7 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 119.677 1.126 . . . . 0.64 109.963 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . 32.5 t0 -141.21 151.76 44.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.007 -0.738 . . . . 2.84 109.007 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.68 -79.78 0.37 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.253 1.406 . . . . 1.92 110.941 174.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 12' ' ' LEU . 1.2 pp -73.38 150.93 41.42 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 122.348 -0.501 . . . . 2.87 110.629 -171.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 p -144.51 63.81 1.31 Allowed 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.762 0.825 . . . . 2.64 110.793 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.8 t -155.49 123.77 5.88 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.861 -0.525 . . . . 2.22 111.653 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m -48.43 -41.06 28.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.349 1.46 . . . . 2.12 112.222 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -61.27 -42.44 98.63 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.481 -0.762 . . . . 3.13 110.681 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.8 m -67.83 -40.6 83.75 Favored 'General case' 0 C--O 1.231 0.124 0 O-C-N 121.355 -0.841 . . . . 1.17 110.248 176.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.33 -46.22 72.84 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 122.2 -0.313 . . . . 0.8 110.326 171.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.91 -43.92 97.88 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.767 0.827 . . . . 0.94 110.987 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -54.19 -51.62 63.81 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.745 -0.597 . . . . 3.2 109.599 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.26 -60.51 3.3 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.293 0.637 . . . . 2.45 112.508 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -38.57 72.48 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.383 0.992 . . . . 2.91 110.57 -173.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -64.68 -46.38 82.67 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.643 0.377 . . . . 2.8 110.894 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.504 HD22 ' HB1' ' A' ' 57' ' ' ALA . 7.3 m-20 -52.44 -41.91 63.69 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 122.052 -0.405 . . . . 1.3 110.604 173.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.635 HG12 HG11 ' A' ' 31' ' ' VAL . 51.5 t -62.68 -55.12 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.971 -0.455 . . . . 0.69 110.106 174.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.7 mttt -48.47 -37.74 18.16 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.772 1.027 . . . . 1.56 113.772 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -54.0 -34.72 60.64 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.805 0.729 . . . . 3.3 112.717 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.587 HG22 ' H ' ' A' ' 30' ' ' GLY . 13.9 mt -70.0 129.72 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.66 -0.867 . . . . 1.27 108.66 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -71.06 -11.11 60.78 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.906 -1.121 . . . . 2.58 113.472 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.587 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -81.24 -21.95 61.68 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.873 0.749 . . . . 0.91 112.397 -177.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.635 HG11 HG12 ' A' ' 25' ' ' VAL . 9.7 p -111.65 152.67 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 O-C-N 121.365 -1.08 . . . . 0.96 109.143 -175.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.8 m -106.72 -56.51 2.18 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.208 1.403 . . . . 0.95 107.848 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -125.49 161.33 27.36 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.374 0.607 . . . . 2.36 112.323 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.16 139.91 20.78 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.729 -1.212 . . . . 0.82 107.729 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.0 mt -133.01 106.38 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 106.065 -1.828 . . . . 1.35 106.065 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.453 HG12 HG13 ' A' ' 43' ' ' ILE . 2.2 m -120.76 118.59 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 122.79 0.436 . . . . 2.04 109.937 -162.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -99.13 -49.34 4.53 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 122.425 -0.172 . . . . 2.44 110.778 -167.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.505 ' CE1' HG21 ' A' ' 9' ' ' VAL . 88.9 m-85 58.46 -162.77 0.22 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.443 0.697 . . . . 2.59 112.094 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.12 -69.91 2.65 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 110.084 -1.206 . . . . 3.06 110.084 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.2 61.57 0.1 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.312 -1.736 . . . . 2.25 106.312 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.1 m -155.06 -125.03 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 O-C-N 122.052 -0.405 . . . . 2.48 111.135 -171.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -158.64 165.59 34.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.61 -0.681 . . . . 3.66 109.933 -158.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.463 HG21 HD13 ' A' ' 65' ' ' ILE . 11.1 tt -129.38 104.8 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 126.084 1.754 . . . . 2.81 108.171 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.7 m -84.81 139.5 31.88 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.673 -0.862 . . . . 0.73 108.673 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.2 t -134.35 138.63 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 104.556 -2.387 . . . . 1.04 104.556 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.3 m -147.91 133.8 19.09 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.111 -1.07 . . . . 0.93 108.111 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.79 -92.68 0.14 Allowed Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 107.398 -2.281 . . . . 0.71 107.398 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -165.88 51.97 0.09 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.996 1.718 . . . . 2.26 109.489 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.52 166.59 29.73 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 120.657 -1.277 . . . . 0.48 111.591 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.0 m -119.67 165.44 14.48 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.424 1.49 . . . . 0.58 111.155 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.433 HD11 HD12 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -46.88 -46.86 8.23 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 CA-C-O 117.214 -1.374 . . . . 2.69 110.725 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -29.87 -50.69 0.12 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.16 1.784 . . . . 2.55 114.052 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -65.02 -48.37 74.13 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 122.38 1.086 . . . . 2.51 110.827 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 25' ' ' VAL . 14.6 t -61.34 -32.79 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.058 1.743 . . . . 0.52 110.93 174.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -60.45 -53.75 53.81 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 126.696 1.998 . . . . 3.27 107.176 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.59 -56.44 13.53 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.434 -0.803 . . . . 3.15 109.571 176.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.504 ' HB1' HD22 ' A' ' 24' ' ' ASN . . . -48.21 -51.48 25.15 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.247 0.619 . . . . 0.5 110.81 175.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.68 -16.06 28.76 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 124.297 0.951 . . . . 0.37 113.197 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.65 -21.67 1.69 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.481 1.14 . . . . 0.48 112.293 169.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -54.07 -35.99 62.65 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.001 1.273 . . . . 1.85 112.705 173.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -121.29 -7.59 9.28 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.651 1.18 . . . . 2.45 112.528 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 71.85 53.86 0.2 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.515 1.526 . . . . 0.99 111.09 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.75 164.42 25.26 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.225 -0.922 . . . . 1.19 111.181 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.454 ' HD2' ' HB3' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -121.66 112.56 18.58 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.162 -1.792 . . . . 3.77 106.162 172.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.463 HD13 HG21 ' A' ' 43' ' ' ILE . 1.1 mt -113.58 143.51 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 106.735 -1.58 . . . . 0.66 106.735 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.9 mt -128.14 122.66 22.23 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 106.64 -1.615 . . . . 1.38 106.64 -173.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.53 111.76 2.19 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.665 1.577 . . . . 0.83 108.028 169.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -54.27 147.11 13.91 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.377 0.608 . . . . 4.4 110.71 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.9 tptp -152.46 136.77 16.65 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.321 -1.733 . . . . 4.25 106.321 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -140.04 98.02 3.36 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.081 -1.822 . . . . 7.84 106.081 164.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.37 0 C-N-CA 129.078 2.951 . . . . 9.51 104.652 -179.294 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.6 mtt . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 109.286 -0.635 . . . . 9.07 109.286 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.02 160.96 40.48 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.153 -1.425 . . . . 5.98 107.153 174.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -142.77 37.39 1.45 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.256 1.023 . . . . 6.67 110.908 -168.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -126.13 135.48 51.73 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.787 1.635 . . . . 4.49 109.231 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.8 m -148.36 154.27 39.73 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 107.668 -1.234 . . . . 0.59 107.668 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 p -135.6 142.24 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 123.616 0.573 . . . . 0.39 110.438 169.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -127.52 147.15 50.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.602 1.161 . . . . 1.74 107.905 -169.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -89.0 128.5 35.71 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.372 -0.973 . . . . 3.81 108.372 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.437 HG21 ' CD2' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -105.29 149.23 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.095 -1.076 . . . . 0.6 108.095 169.02 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -143.47 148.95 36.85 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.423 -0.584 . . . . 2.62 109.423 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.51 -58.37 0.62 Allowed Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.146 0.879 . . . . 1.55 111.586 166.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.404 ' HB3' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -69.86 172.08 8.27 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.309 0.643 . . . . 2.51 112.157 -176.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.401 ' N ' HD22 ' A' ' 12' ' ' LEU . 11.2 t -163.8 77.63 0.39 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.692 0.397 . . . . 3.28 109.962 171.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.9 t -168.11 126.91 1.21 Allowed 'General case' 0 C--N 1.342 0.266 0 O-C-N 121.969 -0.457 . . . . 1.76 111.427 172.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.4 m -49.91 -42.09 47.44 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.475 1.11 . . . . 1.37 112.233 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -53.76 -40.92 66.62 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.648 -0.657 . . . . 3.4 111.451 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.44 -47.08 83.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.381 -0.6 . . . . 2.46 109.381 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.15 -42.81 77.56 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.802 0.441 . . . . 0.54 111.098 175.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.81 -49.39 73.08 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.401 0.62 . . . . 0.63 109.87 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -53.83 -48.41 69.94 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.415 -0.587 . . . . 4.22 109.415 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -53.94 -65.33 0.59 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.723 0.809 . . . . 2.83 111.899 176.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.94 -40.69 70.2 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.976 0.807 . . . . 2.87 110.828 -171.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -61.81 -48.87 78.67 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 110.201 -0.296 . . . . 3.43 110.201 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -57.36 -41.17 79.59 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.986 -0.446 . . . . 2.4 110.473 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.452 HG22 HG22 ' A' ' 54' ' ' VAL . 59.1 t -64.41 -46.02 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 O-C-N 121.809 -0.557 . . . . 0.49 110.782 175.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -57.06 -33.95 67.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.913 0.885 . . . . 1.7 112.054 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.25 -21.54 65.26 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.932 0.716 . . . . 2.65 112.932 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.5 mm -77.8 106.71 8.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 O-C-N 120.739 -1.226 . . . . 2.35 110.748 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -65.95 85.19 0.08 Allowed 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 125.71 1.604 . . . . 2.57 108.653 163.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.47 -40.37 0.08 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.459 -1.056 . . . . 0.99 110.459 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.9 p -97.14 156.65 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 108.347 -0.982 . . . . 0.85 108.347 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 55.0 m -105.4 -54.9 2.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.171 1.388 . . . . 0.65 107.69 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -126.29 134.9 51.01 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 109.552 -0.536 . . . . 2.42 109.552 170.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.11 126.27 40.82 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.972 -1.122 . . . . 0.52 107.972 170.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.0 mm -111.22 101.91 13.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.237 -1.394 . . . . 2.22 107.237 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.03 145.88 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 116.618 -0.265 . . . . 2.04 110.553 -175.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -140.2 51.89 1.68 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.429 -1.323 . . . . 2.04 107.429 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.437 ' CD2' HG21 ' A' ' 9' ' ' VAL . 66.0 m-85 -60.36 123.2 16.57 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.566 0.746 . . . . 3.14 109.186 174.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.19 -60.47 0.38 Allowed Glycine 0 C--O 1.225 -0.455 0 N-CA-C 109.061 -1.616 . . . . 2.76 109.061 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.4 56.04 0.18 Allowed 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.874 -1.158 . . . . 2.12 107.874 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.63 -113.51 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.913 -0.492 . . . . 2.9 111.942 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.92 171.1 20.02 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.639 0.775 . . . . 4.4 110.063 -165.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.81 113.99 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 108.48 -0.934 . . . . 0.8 108.48 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 m -91.2 143.33 26.78 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 123.983 0.913 . . . . 0.44 109.976 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.18 133.75 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.842 2.057 . . . . 0.61 106.761 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.8 m -143.05 124.34 14.62 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 106.96 -1.496 . . . . 0.86 106.96 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.12 -93.07 0.11 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 118.663 -1.732 . . . . 0.63 109.172 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -166.66 53.76 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.454 1.102 . . . . 2.34 109.931 166.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.51 172.93 15.23 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.022 -1.048 . . . . 0.81 110.643 176.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.0 m -117.14 162.83 17.2 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.678 1.591 . . . . 0.69 111.154 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 tp -52.27 -32.17 15.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.719 0 CA-C-O 117.525 -1.226 . . . . 1.92 112.973 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -34.93 -47.22 0.34 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.387 1.075 . . . . 3.52 112.103 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -57.46 -51.66 68.55 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.405 1.098 . . . . 2.21 111.465 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.452 HG22 HG22 ' A' ' 25' ' ' VAL . 58.1 t -66.11 -42.18 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.681 1.592 . . . . 0.36 110.902 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -63.22 -43.77 97.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.84 0.856 . . . . 4.02 108.836 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -52.11 -54.88 25.03 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.813 -0.613 . . . . 3.01 109.62 171.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.41 -54.15 15.08 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.926 0.784 . . . . 0.42 110.162 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.96 -15.99 15.93 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 125.395 1.474 . . . . 0.33 114.442 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.0 -26.01 2.3 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.424 1.112 . . . . 0.64 111.534 167.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -51.03 -41.77 60.05 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.111 0.869 . . . . 2.23 112.857 173.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.35 -3.67 12.43 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.164 0.986 . . . . 4.3 111.216 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 73.85 49.83 0.12 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.846 1.659 . . . . 1.07 110.835 175.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 63' ' ' LEU . 4.5 mm? -74.47 166.81 22.89 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.641 -0.662 . . . . 1.34 111.311 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.62 122.5 33.27 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.652 -1.61 . . . . 4.23 106.652 171.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 mt -122.98 108.2 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.363 0.665 . . . . 1.17 110.079 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 91.7 mt -94.12 130.79 33.17 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.436 0.694 . . . . 1.17 109.315 -172.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.01 91.8 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.387 2.058 . . . . 0.64 109.008 168.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.48 154.11 1.39 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.409 0.684 . . . . 4.42 109.987 168.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.86 130.8 16.2 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.877 -0.786 . . . . 6.98 108.877 -176.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -59.19 146.68 38.17 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.529 0.68 . . . . 7.8 110.892 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 N-CA-C 105.773 -1.936 . . . . 9.4 105.773 -176.951 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 mtt . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 107.735 -1.209 . . . . 8.96 107.735 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.97 155.92 3.19 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.536 -1.653 . . . . 5.08 106.536 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -160.35 170.79 20.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.247 1.419 . . . . 4.79 108.461 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.41 160.65 20.56 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.306 -0.628 . . . . 5.13 109.306 171.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.5 m -149.08 146.25 27.63 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 106.212 -1.773 . . . . 0.81 106.212 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.15 140.16 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 124.226 0.954 . . . . 0.55 110.847 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -128.67 148.86 50.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.774 1.23 . . . . 2.07 107.92 -172.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -88.02 122.73 31.95 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.815 -0.809 . . . . 4.32 108.815 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 p -109.81 140.05 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 124.386 1.074 . . . . 0.5 108.332 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -138.82 157.59 45.79 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.878 -1.156 . . . . 2.74 107.878 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 120.97 -77.37 0.32 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.925 1.25 . . . . 1.66 110.614 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.452 ' C ' HD12 ' A' ' 12' ' ' LEU . 3.1 pp -76.3 177.63 7.11 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.549 0.69 . . . . 2.63 111.486 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.6 t -161.59 -43.91 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.994 0.918 . . . . 4.29 110.401 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.3 t -50.97 126.23 15.65 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.351 1.06 . . . . 1.9 113.301 -168.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 m -45.32 -44.64 11.73 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.237 1.815 . . . . 1.5 112.914 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -54.37 -48.12 71.85 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.63 0.729 . . . . 3.68 111.016 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.06 -43.18 88.17 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 123.474 0.71 . . . . 1.16 109.367 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.55 -49.31 70.64 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.335 0.254 . . . . 0.87 110.958 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.37 -52.95 63.45 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.523 1.129 . . . . 0.71 109.651 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -48.94 -49.5 39.99 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.888 -0.412 . . . . 2.7 109.888 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.8 -64.18 0.96 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 112.69 0.626 . . . . 2.47 112.69 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -55.82 -44.58 78.04 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.83 0.741 . . . . 3.03 109.552 -172.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -57.03 -53.02 62.82 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.874 -0.417 . . . . 4.47 109.874 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.743 HD22 ' HB1' ' A' ' 57' ' ' ALA . 4.8 m-20 -48.16 -48.65 34.24 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.303 -0.628 . . . . 1.52 109.303 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.436 HG22 HG22 ' A' ' 54' ' ' VAL . 34.6 t -60.99 -47.0 95.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 117.915 0.325 . . . . 0.42 110.789 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -36.52 63.87 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.017 0.527 . . . . 2.5 111.765 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -70.84 -9.91 58.53 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 119.109 0.868 . . . . 1.98 113.161 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.1 mm -83.72 128.91 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 120.539 1.518 . . . . 2.43 109.812 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.44 -28.83 61.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.412 1.485 . . . . 2.44 113.411 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.54 -16.03 64.8 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 123.983 0.801 . . . . 1.3 113.685 -174.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.8 p -118.8 153.47 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.928 1.291 . . . . 1.0 109.232 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 93.0 m -93.95 -51.1 5.02 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.723 -0.843 . . . . 0.62 108.723 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -135.47 160.23 39.13 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.057 0.456 . . . . 2.64 110.517 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -154.08 140.33 18.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.078 -1.082 . . . . 0.49 108.078 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.6 mt -127.59 118.98 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 105.73 -1.952 . . . . 1.28 105.73 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.736 HG12 HG12 ' A' ' 43' ' ' ILE . 5.5 m -105.56 133.76 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.767 -0.827 . . . . 1.98 108.767 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -90.89 -59.05 2.27 Favored 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 108.286 -1.005 . . . . 2.62 108.286 167.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 56.97 -168.77 0.11 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.03 0.932 . . . . 2.75 111.15 -165.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.92 38.01 94.72 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.537 -0.625 . . . . 2.65 111.537 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 76.84 69.23 0.06 Allowed 'General case' 0 C--N 1.338 0.094 0 C-N-CA 126.735 2.014 . . . . 2.26 109.152 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 m -157.42 -120.48 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.387 1.075 . . . . 2.64 108.435 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.52 174.82 14.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.911 0.778 . . . . 4.22 111.522 -174.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.736 HG12 HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -130.4 118.98 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.168 1.787 . . . . 0.76 107.764 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.8 m -97.03 138.11 35.07 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.61 1.164 . . . . 0.52 109.58 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.0 t -118.24 143.66 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 127.871 2.468 . . . . 0.73 105.823 171.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.1 m -146.32 88.25 1.78 Allowed 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 125.111 1.364 . . . . 1.01 107.547 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.37 -113.12 0.27 Allowed Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 108.638 -1.785 . . . . 0.89 108.638 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -155.94 48.45 0.5 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.932 -0.766 . . . . 2.99 108.932 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -155.61 177.68 11.11 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.792 -0.567 . . . . 1.28 110.234 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.4 m -114.27 169.81 8.75 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.235 1.414 . . . . 0.9 111.274 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.6 tp -53.92 -33.07 23.17 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 CA-C-O 117.685 -1.15 . . . . 1.81 111.728 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -35.37 -48.59 0.48 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.538 1.063 . . . . 2.68 112.48 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -61.13 -50.27 73.88 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.301 0.572 . . . . 2.22 112.287 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 HG22 ' A' ' 25' ' ' VAL . 58.6 t -58.34 -44.91 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 125.127 1.371 . . . . 0.5 110.536 177.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -67.27 -41.84 84.84 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.111 0.964 . . . . 3.53 110.112 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -54.42 -51.57 64.5 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.062 -0.718 . . . . 3.0 109.062 171.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.743 ' HB1' HD22 ' A' ' 24' ' ' ASN . . . -49.05 -48.36 44.01 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.005 -0.434 . . . . 0.44 110.785 170.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.93 -9.79 16.03 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.064 1.316 . . . . 0.36 114.795 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.58 -21.63 10.92 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.232 1.516 . . . . 0.68 112.122 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -56.69 -33.28 66.29 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.414 1.006 . . . . 2.08 112.854 172.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.06 -12.31 9.13 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.862 1.265 . . . . 2.51 112.683 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 72.26 62.29 0.13 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.571 1.148 . . . . 0.8 110.369 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.3 174.21 11.48 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.489 -0.757 . . . . 1.13 110.458 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -143.22 68.34 1.3 Allowed 'General case' 0 C--N 1.34 0.162 0 N-CA-C 106.935 -1.505 . . . . 4.82 106.935 -169.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.8 mt -84.82 107.18 15.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 113.922 -1.49 . . . . 0.96 110.138 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.4 mt -92.7 129.19 41.14 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 108.98 -0.748 . . . . 1.31 108.98 -172.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.07 100.9 0.66 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.397 2.065 . . . . 0.7 109.797 172.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -46.87 -49.97 19.4 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.609 0.364 . . . . 3.31 111.293 169.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.83 83.17 0.16 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.684 0.794 . . . . 4.62 109.455 175.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 82.23 -175.69 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.691 2.396 . . . . 7.73 108.943 -169.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.26 0 CA-C-O 115.816 -2.04 . . . . 9.34 105.991 -174.371 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.0 mtt . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 117.565 -1.207 . . . . 9.62 110.295 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -34.47 -68.13 0.12 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.104 1.362 . . . . 5.39 112.675 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.45 141.78 9.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.859 -1.163 . . . . 6.44 107.859 163.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.37 119.0 3.35 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.997 2.119 . . . . 4.5 107.31 174.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.0 m -151.55 156.12 39.87 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.315 -1.365 . . . . 0.93 107.315 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.01 139.81 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 O-C-N 124.593 1.183 . . . . 0.5 111.545 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.522 ' CD2' HD13 ' A' ' 51' ' ' ILE . 5.6 m-85 -127.43 143.22 51.24 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.713 1.605 . . . . 2.34 107.691 -163.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.33 140.73 31.41 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 118.876 0.762 . . . . 3.62 109.279 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.89 137.33 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 123.822 0.849 . . . . 0.71 109.106 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -140.77 152.11 44.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.03 1.332 . . . . 2.72 107.74 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.02 -56.68 0.73 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 125.225 1.393 . . . . 1.44 110.409 164.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.469 HD21 ' HB3' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -61.72 157.71 17.21 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.103 0.561 . . . . 2.5 111.456 -178.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 t -161.55 73.56 0.44 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.319 -0.622 . . . . 2.81 109.319 174.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -169.39 134.05 1.43 Allowed 'General case' 0 C--N 1.338 0.099 0 O-C-N 121.62 -0.675 . . . . 2.43 110.734 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 m -59.84 -43.07 94.79 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.313 0.645 . . . . 1.72 111.147 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -58.44 -48.59 80.22 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.791 -0.568 . . . . 2.39 110.17 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.0 m -57.32 -48.05 79.98 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.625 -0.509 . . . . 1.12 109.625 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.46 -50.41 65.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.736 0.414 . . . . 1.08 111.007 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.31 -52.34 66.02 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.154 0.981 . . . . 0.72 109.64 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -54.93 -44.65 74.45 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 119.881 -0.727 . . . . 3.81 110.669 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.36 -63.24 1.21 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.12 0.568 . . . . 2.34 110.131 177.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.86 -40.01 87.17 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.835 0.35 . . . . 2.58 110.612 -171.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -49.52 72.92 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.896 0.878 . . . . 3.22 109.647 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -51.64 -48.44 63.34 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.14 0.576 . . . . 1.66 109.587 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.6 t -60.15 -48.38 88.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 O-C-N 122.179 -0.326 . . . . 0.53 110.628 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -55.04 -34.78 63.83 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.594 -0.691 . . . . 1.89 112.539 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -70.9 -8.79 55.39 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.47 0.915 . . . . 2.12 113.47 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.5 mm -70.86 140.19 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 120.282 1.401 . . . . 2.17 109.768 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -89.74 139.96 30.05 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 125.373 1.469 . . . . 2.73 109.172 171.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.34 -46.54 1.16 Allowed Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.327 1.442 . . . . 1.81 110.601 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.3 p -64.33 158.54 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 122.386 -0.479 . . . . 0.96 110.062 174.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.8 m -108.34 -60.2 1.76 Allowed 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 107.996 -1.113 . . . . 1.13 107.996 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -127.78 161.8 28.13 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.659 0.614 . . . . 2.21 112.659 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.65 141.58 21.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.431 -0.951 . . . . 0.68 108.431 166.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.8 mt -127.96 104.57 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 106.433 -1.692 . . . . 1.39 106.433 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.44 122.1 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.704 -1.221 . . . . 1.94 107.704 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -122.11 102.63 8.27 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 105.9 -1.889 . . . . 2.58 105.9 175.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.469 ' HB3' HD21 ' A' ' 12' ' ' LEU . 26.8 m-85 -100.51 -161.47 0.87 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.092 0.557 . . . . 2.8 110.992 -174.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.02 -61.47 4.34 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.825 -1.31 . . . . 2.4 109.825 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.35 61.9 0.22 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.961 0.905 . . . . 2.63 108.701 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.4 m -155.58 -129.21 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.836 -0.54 . . . . 3.32 111.582 -175.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt -162.45 153.96 18.14 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.03 1.332 . . . . 4.08 111.269 -165.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.64 117.9 52.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.712 1.205 . . . . 0.79 109.23 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.4 m -91.3 141.17 29.07 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 124.599 1.16 . . . . 0.51 109.338 173.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 t -122.23 145.83 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.439 -1.689 . . . . 0.68 106.439 166.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.2 m -145.89 138.67 25.75 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.265 -1.383 . . . . 0.85 107.265 175.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.94 -91.98 0.18 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 108.224 -1.95 . . . . 0.74 108.224 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -170.75 58.34 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.276 1.83 . . . . 2.2 109.737 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.73 162.44 41.26 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.165 -0.96 . . . . 0.51 111.4 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 61.8 m -109.76 168.01 9.73 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.43 1.892 . . . . 0.94 110.09 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.522 HD13 ' CD2' ' A' ' 7' ' ' TYR . 7.7 tp -52.06 -35.53 18.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 CA-C-O 117.083 -1.437 . . . . 1.53 111.736 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -28.37 -52.67 0.09 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.53 1.532 . . . . 2.36 112.661 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -61.85 -46.01 91.32 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.789 0.804 . . . . 2.17 111.484 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.1 t -70.15 -37.45 71.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.157 1.383 . . . . 0.37 110.913 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -48.6 80.86 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.525 1.53 . . . . 3.3 108.452 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -51.07 -47.94 61.71 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.75 0.42 . . . . 3.93 110.752 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.64 -51.18 71.02 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.424 0.556 . . . . 0.77 110.771 173.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.84 -26.23 25.3 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 126.54 2.019 . . . . 0.51 112.308 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -44.31 -31.77 1.12 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.276 1.038 . . . . 0.54 112.469 170.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -53.72 -32.37 51.76 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.681 1.128 . . . . 2.13 113.63 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.49 0.56 6.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.177 1.391 . . . . 2.6 112.168 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 60.21 57.17 3.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.508 1.523 . . . . 1.54 111.896 177.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.83 160.65 20.16 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 121.46 -0.775 . . . . 1.34 112.118 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 72.43 0.82 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.998 -1.112 . . . . 3.65 107.998 -169.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -82.23 119.7 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.189 -0.671 . . . . 0.64 109.189 -175.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.9 mm -98.3 112.28 61.78 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 125.0 1.32 . . . . 1.48 108.7 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -73.44 83.14 1.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.017 1.811 . . . . 1.42 110.488 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -48.09 133.41 15.06 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.522 1.529 . . . . 3.11 110.62 173.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? 76.74 70.89 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.038 1.335 . . . . 6.15 111.384 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.58 124.32 46.09 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.808 1.643 . . . . 13.34 106.992 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.152 0 C-N-CA 126.801 2.041 . . . . 11.8 107.583 -177.723 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 109.657 -0.497 . . . . 10.61 109.657 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.95 152.36 11.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.266 -1.753 . . . . 6.1 106.266 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -86.18 50.78 2.05 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.667 1.187 . . . . 4.71 110.248 -163.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.69 134.8 54.51 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.544 1.937 . . . . 4.5 107.787 174.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.7 m -146.74 154.66 41.66 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.032 -1.47 . . . . 0.53 107.032 172.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.02 142.69 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 O-C-N 123.999 0.812 . . . . 0.54 110.151 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -127.67 140.45 52.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.732 -1.581 . . . . 1.86 106.732 -172.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.3 ttt-85 -84.62 126.34 33.26 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.735 -1.209 . . . . 5.16 107.735 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.448 ' CG2' HD21 ' A' ' 12' ' ' LEU . 1.7 p -111.39 146.4 16.41 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 107.356 -1.35 . . . . 0.51 107.356 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.02 171.96 14.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.335 0.397 . . . . 2.31 111.546 -176.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.26 56.77 21.77 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.379 -0.828 . . . . 2.26 112.418 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.64 HD22 ' CE2' ' A' ' 38' ' ' PHE . 2.5 pp -163.07 166.47 23.54 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.602 1.561 . . . . 2.72 107.854 174.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.3 p -174.76 66.11 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.091 0.557 . . . . 2.71 109.951 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.6 t -156.71 124.63 5.54 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.334 0.515 . . . . 2.18 111.436 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -58.29 -43.9 88.26 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.007 0.923 . . . . 1.37 111.727 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -57.42 -44.83 84.94 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.748 0.704 . . . . 2.5 110.533 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.6 m -61.27 -45.94 92.44 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.943 -0.391 . . . . 0.81 109.943 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.22 -47.02 72.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.717 0.407 . . . . 0.56 110.954 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.68 -51.3 69.0 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.533 1.133 . . . . 0.58 109.469 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -52.9 -45.17 67.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.883 -0.599 . . . . 2.91 109.603 174.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.417 ' CZ ' HD11 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -56.59 -63.39 1.21 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.184 -0.436 . . . . 2.58 110.846 176.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -60.51 -38.02 83.01 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.314 0.961 . . . . 2.35 111.527 -172.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.3 ttt85 -61.3 -49.62 76.28 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.122 -0.325 . . . . 3.62 110.122 175.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.457 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 77.6 m-20 -51.42 -50.58 59.41 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.266 -0.642 . . . . 1.36 109.266 174.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.654 HG22 HG22 ' A' ' 54' ' ' VAL . 39.4 t -56.83 -50.11 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 O-C-N 121.972 -0.455 . . . . 0.38 110.982 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -53.19 -34.69 58.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.449 1.099 . . . . 1.47 112.01 175.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -68.69 -16.55 63.86 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.178 0.899 . . . . 2.19 113.397 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.2 mt -77.28 111.21 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 120.036 1.289 . . . . 1.44 109.865 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -50.49 -31.39 15.22 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.187 2.195 . . . . 2.89 113.448 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.16 -25.05 74.68 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.286 0.946 . . . . 0.8 113.629 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -96.64 162.82 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 119.027 1.414 . . . . 0.84 110.723 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.1 m -110.43 -56.71 2.31 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.763 -1.199 . . . . 0.6 107.763 171.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -137.19 164.7 27.87 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.82 -0.437 . . . . 2.13 109.82 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.432 ' CB ' HG11 ' A' ' 25' ' ' VAL . . . -154.72 137.31 15.14 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.828 -1.175 . . . . 0.66 107.828 172.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.4 mm -112.6 101.55 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.035 -1.098 . . . . 1.8 108.035 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.69 120.87 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 108.681 -0.859 . . . . 2.52 108.681 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -117.09 97.22 5.82 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.901 -1.148 . . . . 2.17 107.901 171.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.64 ' CE2' HD22 ' A' ' 12' ' ' LEU . 2.7 m-30 -82.15 -166.49 1.26 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.362 1.465 . . . . 3.37 110.93 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.64 -65.44 4.11 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.174 -1.57 . . . . 2.34 109.174 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -171.97 72.53 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.11 0.964 . . . . 1.94 108.41 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.3 m -156.74 -121.65 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 O-C-N 122.002 -0.436 . . . . 2.88 110.676 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -161.51 164.68 29.46 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.986 0.914 . . . . 4.13 110.056 -164.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.66 112.4 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.097 1.359 . . . . 0.76 108.089 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.7 m -88.25 147.7 24.7 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 123.746 0.819 . . . . 0.56 109.735 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.9 t -132.61 137.29 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 127.586 2.355 . . . . 1.05 105.729 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.3 m -145.89 101.17 3.51 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.798 -1.186 . . . . 0.99 107.798 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 178.77 -102.38 0.17 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 118.11 -1.995 . . . . 0.48 110.023 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -163.03 44.8 0.12 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.44 1.496 . . . . 2.44 108.278 172.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.03 169.62 17.31 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.329 1.052 . . . . 0.71 109.965 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.0 m -131.44 169.95 15.34 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.672 1.189 . . . . 0.64 110.066 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 tp -61.19 -30.59 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-O 117.363 -1.303 . . . . 1.74 112.727 -174.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -37.32 -52.76 1.1 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.892 1.223 . . . . 2.75 111.928 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -59.47 -46.77 87.82 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.742 0.645 . . . . 3.8 112.742 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.654 HG22 HG22 ' A' ' 25' ' ' VAL . 34.8 t -63.06 -42.72 97.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 123.694 0.797 . . . . 0.44 110.206 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.85 -52.75 64.09 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 127.154 2.182 . . . . 3.07 108.729 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -51.19 -52.36 45.07 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.622 -0.51 . . . . 2.95 109.622 173.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.457 ' HB1' ' ND2' ' A' ' 24' ' ' ASN . . . -55.98 -41.43 74.8 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.803 -0.561 . . . . 0.59 110.721 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.0 -6.41 12.52 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.48 1.99 . . . . 0.45 113.867 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.37 -24.75 1.33 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.017 1.408 . . . . 0.69 112.071 171.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -54.52 -36.29 64.09 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.479 0.918 . . . . 2.09 113.479 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -121.92 -5.87 9.03 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.095 0.861 . . . . 2.35 113.088 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 68.55 58.0 0.42 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.24 1.016 . . . . 0.88 110.845 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.437 ' HG ' HD23 ' A' ' 12' ' ' LEU . 2.0 mm? -80.27 168.77 18.65 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.36 -0.838 . . . . 1.16 111.236 -176.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.92 68.25 1.51 Allowed 'General case' 0 C--N 1.343 0.322 0 CA-C-O 122.239 1.019 . . . . 4.23 110.061 -170.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.417 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 1.4 mt -81.82 139.61 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.49 -0.777 . . . . 0.53 110.288 -172.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.5 mt -129.25 133.42 25.13 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.224 1.009 . . . . 1.18 109.942 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.59 87.6 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.408 2.739 . . . . 0.89 111.592 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -66.58 92.56 0.21 Allowed 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.337 1.055 . . . . 3.18 109.268 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -63.26 158.58 19.81 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.82 0.448 . . . . 5.75 110.325 165.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -116.5 132.74 56.6 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.898 1.679 . . . . 9.12 106.657 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.821 1.248 . . . . 8.16 111.102 -172.255 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 108.303 -0.999 . . . . 9.17 108.303 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.05 65.28 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.194 0.597 . . . . 6.43 110.009 -175.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -81.3 55.32 2.53 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.608 0.718 . . . . 4.62 111.625 -170.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.52 141.28 37.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.857 2.063 . . . . 3.5 108.155 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.0 m -150.55 140.59 22.03 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.077 -1.453 . . . . 0.94 107.077 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 p -127.47 140.92 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 124.195 0.934 . . . . 0.66 110.32 171.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -128.97 155.89 44.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.321 -1.363 . . . . 2.32 107.321 -174.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.0 ttt-85 -88.99 122.08 31.99 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.295 -0.859 . . . . 4.56 109.1 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.5 p -113.09 140.15 34.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 124.521 1.129 . . . . 0.77 108.033 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -153.28 164.81 37.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.853 -1.536 . . . . 3.47 106.853 -172.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.69 -54.6 0.54 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.467 1.032 . . . . 1.54 112.105 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.506 ' HB3' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -61.31 172.28 1.16 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.708 1.203 . . . . 2.67 113.142 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -168.44 67.62 0.07 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.723 -0.656 . . . . 2.93 111.498 170.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.1 t -160.03 133.69 7.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.817 1.19 . . . . 1.91 113.366 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 m -56.16 -49.88 72.73 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.342 1.457 . . . . 1.58 112.065 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -51.62 -45.14 63.14 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.661 0.744 . . . . 2.39 110.515 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.0 m -68.04 -37.9 81.87 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.001 -0.545 . . . . 1.04 110.567 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.421 ' HA ' ' CD2' ' A' ' 38' ' ' PHE . . . -52.42 -48.65 65.61 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.279 0.49 . . . . 0.79 110.605 170.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.48 -50.81 72.09 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.831 0.824 . . . . 0.74 109.193 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -53.67 -43.56 68.98 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.854 -0.612 . . . . 2.67 110.799 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.496 ' HZ ' HD11 ' A' ' 65' ' ' ILE . 1.3 t80 -65.77 -60.65 2.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.643 0.377 . . . . 2.51 111.199 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -56.55 -41.42 76.81 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 118.818 0.736 . . . . 2.9 110.614 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -60.01 -53.49 57.19 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 119.185 -0.436 . . . . 3.21 110.352 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.745 HD22 ' HB1' ' A' ' 57' ' ' ALA . 41.2 m-20 -50.59 -46.73 58.06 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 118.672 0.669 . . . . 1.32 110.015 178.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.9 t -59.77 -49.15 84.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 109.713 -0.477 . . . . 0.57 109.713 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -55.32 -36.36 66.15 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.547 -0.721 . . . . 1.58 112.643 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -72.35 -6.99 47.18 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.425 0.898 . . . . 1.89 113.425 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.3 141.92 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 120.46 1.482 . . . . 1.83 109.274 171.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -88.7 128.45 35.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.46 -1.311 . . . . 3.67 107.46 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.14 -39.26 2.95 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.264 0.935 . . . . 2.03 112.097 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 p -64.71 159.38 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 121.578 -0.954 . . . . 0.96 110.615 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.2 m -115.25 -61.86 1.68 Allowed 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.333 1.053 . . . . 1.07 108.208 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -122.44 154.21 38.08 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.288 0.367 . . . . 2.54 111.338 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.9 137.89 19.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.867 -0.52 . . . . 0.48 110.101 169.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.4 mt -128.59 91.02 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 106.766 -1.568 . . . . 1.57 106.766 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.99 103.39 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.742 -0.836 . . . . 2.57 108.742 -176.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -84.59 65.88 9.24 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 106.316 -1.735 . . . . 1.86 106.316 174.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 18' ' ' ALA . 0.3 OUTLIER -70.59 132.68 45.84 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.844 -0.799 . . . . 3.07 108.844 -177.263 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.16 -65.69 0.39 Allowed Glycine 0 C--O 1.226 -0.396 0 N-CA-C 107.853 -2.099 . . . . 2.84 107.853 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -175.64 69.36 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 125.081 1.352 . . . . 2.13 107.712 178.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.2 m -156.02 -103.95 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 O-C-N 121.767 -0.583 . . . . 2.58 111.19 -175.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 169.77 24.04 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.459 0.704 . . . . 5.99 110.944 -172.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.401 HD13 ' C ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -129.33 117.35 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 124.588 1.155 . . . . 0.82 108.141 176.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.7 m -97.07 134.67 40.12 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 123.545 0.738 . . . . 0.44 109.571 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.34 145.33 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 126.305 1.842 . . . . 0.97 106.673 168.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.6 m -146.81 136.72 23.29 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 106.625 -1.62 . . . . 0.62 106.625 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.05 -90.23 0.17 Allowed Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 109.343 -1.503 . . . . 0.59 109.343 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -173.17 55.72 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.321 1.448 . . . . 2.54 110.178 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.35 160.14 43.92 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.692 -1.255 . . . . 0.57 110.79 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.9 m -111.57 167.01 10.66 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.713 1.605 . . . . 0.6 110.315 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.3 tp -56.43 -30.2 30.45 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 CA-C-O 117.763 -1.113 . . . . 1.75 113.191 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -33.06 -53.8 0.37 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.615 1.166 . . . . 2.44 112.224 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -63.52 -47.73 80.48 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.655 0.74 . . . . 2.38 111.685 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.34 -45.36 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.008 0.923 . . . . 0.38 110.078 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.87 -51.63 69.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.663 1.985 . . . . 2.66 109.108 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -53.56 -44.33 69.19 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.597 0.359 . . . . 3.07 110.477 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.745 ' HB1' HD22 ' A' ' 24' ' ' ASN . . . -58.03 -54.99 40.74 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.16 0.505 . . . . 0.44 110.47 169.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.96 -17.19 9.05 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 126.957 2.218 . . . . 0.39 114.088 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -38.86 -35.79 0.23 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.944 0.872 . . . . 0.7 111.921 162.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -54.54 -31.52 56.55 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.723 1.008 . . . . 1.98 113.723 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -122.35 4.24 9.7 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.954 1.301 . . . . 2.25 111.921 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 58.69 53.98 5.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.694 1.198 . . . . 1.18 110.629 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 12' ' ' LEU . 4.6 mm? -68.95 159.79 32.04 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.851 -0.531 . . . . 1.69 111.535 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.37 67.05 1.38 Allowed 'General case' 0 C--N 1.343 0.301 0 CA-C-O 121.42 0.628 . . . . 3.65 109.608 -172.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.496 HD11 ' HZ ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -81.56 140.28 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.069 -0.514 . . . . 0.68 109.888 -172.563 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 85.5 mt -127.66 132.35 24.29 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.164 0.986 . . . . 1.23 108.942 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.99 105.03 1.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.124 2.549 . . . . 0.88 110.033 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -58.58 -42.84 88.95 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.674 0.79 . . . . 3.36 111.001 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -147.18 169.25 19.72 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 105.273 -2.121 . . . . 6.26 105.273 168.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 27.38 89.16 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 128.235 2.614 . . . . 9.97 114.65 173.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.291 0 CA-C-O 117.186 -1.388 . . . . 14.96 112.35 178.848 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 109.081 -0.711 . . . . 15.07 109.081 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.93 -166.67 0.44 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.174 1.39 . . . . 7.91 107.305 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -146.45 -158.15 0.88 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.732 1.213 . . . . 4.77 108.08 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.61 153.21 22.54 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.199 0.599 . . . . 4.27 110.811 175.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.9 m -155.35 162.12 40.9 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.592 -1.262 . . . . 0.95 107.592 174.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.54 148.94 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 O-C-N 123.453 0.471 . . . . 0.54 111.531 164.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -135.56 143.49 45.7 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.069 1.348 . . . . 1.95 107.954 -170.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -91.57 126.93 36.83 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.576 0.625 . . . . 4.59 110.132 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.32 154.43 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 C-N-CA 123.929 0.892 . . . . 0.76 109.213 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.422 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . 51.0 t0 -147.15 158.23 43.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.783 -0.821 . . . . 2.71 108.783 171.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.62 -56.82 0.68 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 125.16 1.362 . . . . 1.6 111.06 164.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.98 173.72 4.32 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.9 0.88 . . . . 2.4 112.483 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.3 p -162.82 63.01 0.2 Allowed 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.882 -0.511 . . . . 3.04 110.193 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.3 t -155.52 118.49 4.31 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.241 0.473 . . . . 1.87 111.709 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.1 t -52.87 -38.95 62.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.375 0.67 . . . . 2.24 111.354 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -56.23 -39.28 72.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.642 -0.661 . . . . 2.91 110.707 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.5 m -70.53 -39.9 73.78 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.786 -0.572 . . . . 0.79 110.373 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.05 -43.77 74.1 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.787 0.722 . . . . 0.66 110.764 171.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.74 -49.58 74.47 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.709 0.404 . . . . 0.62 110.344 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.4 tptt -49.76 -48.11 50.48 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.146 0.579 . . . . 3.1 109.668 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -56.08 -64.05 0.98 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.443 1.097 . . . . 2.72 111.148 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -56.33 -38.2 71.02 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.129 1.331 . . . . 2.64 111.85 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -63.61 -51.05 66.95 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.348 0.659 . . . . 2.82 111.38 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -53.96 -44.33 70.66 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.629 -0.669 . . . . 1.4 110.27 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 54' ' ' VAL . 89.8 t -61.54 -48.14 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 122.777 0.431 . . . . 0.41 110.274 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -54.01 -34.92 61.2 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.801 0.84 . . . . 1.58 112.825 175.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -62.31 -23.95 67.03 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.763 0.711 . . . . 3.04 112.355 174.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.425 HG22 ' H ' ' A' ' 30' ' ' GLY . 41.9 mt -70.81 131.69 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 O-C-N 120.963 -1.086 . . . . 1.33 108.777 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -75.75 -28.2 58.38 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.21 1.004 . . . . 3.01 112.722 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.425 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -68.74 -29.36 72.7 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.827 0.727 . . . . 0.86 113.013 -176.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 p -89.59 166.95 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 118.633 1.217 . . . . 0.63 109.356 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.0 m -124.02 -61.25 1.38 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.825 -1.176 . . . . 0.57 107.825 173.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -129.17 111.12 12.6 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.195 -0.668 . . . . 2.68 109.195 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.22 131.96 49.85 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.147 -1.057 . . . . 0.5 108.147 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.7 mm -109.54 97.91 6.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.035 -1.839 . . . . 1.72 106.035 176.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -97.9 136.29 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 109.241 -0.651 . . . . 2.21 109.241 -175.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -111.41 -51.0 2.89 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.736 -0.838 . . . . 2.66 108.736 171.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 55.99 -161.98 0.17 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 110.316 -0.253 . . . . 2.76 110.316 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.08 -71.31 1.73 Allowed Glycine 0 C--N 1.339 0.746 0 O-C-N 121.184 -0.948 . . . . 2.89 111.037 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.78 55.79 0.31 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.303 -1.369 . . . . 2.12 107.303 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.0 m -155.75 -120.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.696 0.798 . . . . 2.85 109.871 -173.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -157.91 178.12 10.58 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.515 -0.741 . . . . 3.83 110.93 -167.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.4 111.94 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 125.466 1.506 . . . . 0.75 108.318 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.0 m -90.17 141.78 28.36 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 123.675 0.79 . . . . 0.55 109.168 171.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 69.2 t -120.95 130.15 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 127.115 2.166 . . . . 0.81 105.249 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.7 m -133.78 142.26 47.82 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 106.781 -1.563 . . . . 0.78 106.781 163.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.93 -102.54 0.23 Allowed Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 104.18 -3.568 . . . . 0.53 104.18 175.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -160.05 45.67 0.23 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.581 0.752 . . . . 3.1 110.983 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.07 176.21 9.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.003 0.921 . . . . 0.51 111.12 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.4 m -126.03 166.64 16.6 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.934 1.694 . . . . 0.58 110.757 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.42 HD11 HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -49.52 -39.97 14.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-O 117.016 -1.469 . . . . 2.52 111.402 178.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -29.58 -53.5 0.14 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.419 1.488 . . . . 2.47 113.195 -177.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -66.03 -44.5 84.49 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.358 0.599 . . . . 2.21 112.282 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 25' ' ' VAL . 14.7 t -58.4 -36.62 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.517 1.127 . . . . 0.34 110.895 171.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.35 -55.45 33.42 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 107.988 -1.116 . . . . 2.77 107.988 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.1 tp60 -52.31 -44.86 65.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.466 1.106 . . . . 3.98 110.509 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.4 -55.46 34.76 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.625 0.77 . . . . 0.44 111.049 171.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.2 -15.84 39.12 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 125.636 1.588 . . . . 0.27 113.41 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.96 -25.25 0.19 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.167 -0.92 . . . . 0.54 112.699 165.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -51.38 -40.32 58.98 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.914 1.234 . . . . 1.88 112.901 172.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -111.04 -13.07 14.13 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.31 1.044 . . . . 2.92 111.81 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 76.32 49.01 0.07 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.367 1.467 . . . . 0.88 110.095 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 63' ' ' LEU . 4.4 mm? -67.32 159.83 28.47 Favored 'General case' 0 N--CA 1.462 0.142 0 O-C-N 121.648 -0.657 . . . . 1.35 111.804 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HD2' ' HB3' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -124.02 112.71 17.49 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 106.477 -1.675 . . . . 4.43 106.477 174.195 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.42 HD12 HD11 ' A' ' 51' ' ' ILE . 0.9 OUTLIER -117.56 130.86 71.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.528 -0.915 . . . . 0.67 108.528 -178.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 49.0 mm -108.4 126.9 28.54 Favored Pre-proline 0 N--CA 1.452 -0.345 0 C-N-CA 125.07 1.348 . . . . 1.56 108.593 -174.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.67 97.69 0.73 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.641 2.227 . . . . 0.64 109.08 171.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -60.73 145.95 47.67 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 120.17 -0.612 . . . . 3.66 110.092 173.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.57 171.71 18.47 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 105.96 -1.867 . . . . 5.81 105.96 -170.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -154.54 -69.5 0.13 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.038 -1.467 . . . . 7.59 107.038 -170.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 N-CA-C 106.793 -1.558 . . . . 8.41 106.793 145.949 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 109.064 -0.717 . . . . 9.25 109.064 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.34 160.95 17.8 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.911 0.708 . . . . 6.45 112.911 -174.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.48 46.06 1.81 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.376 2.27 . . . . 6.61 109.508 -165.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -126.15 148.88 49.31 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.804 1.241 . . . . 3.24 109.974 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.2 m -148.28 150.07 32.99 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.367 -1.345 . . . . 0.52 107.367 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.82 140.18 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 O-C-N 123.901 0.751 . . . . 0.39 111.542 169.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -122.95 148.68 45.2 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.41 -1.7 . . . . 1.9 106.41 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.89 150.55 26.43 Favored 'General case' 0 N--CA 1.461 0.122 0 N-CA-C 108.31 -0.996 . . . . 6.62 108.31 173.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.67 146.78 23.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.478 0.711 . . . . 0.57 109.413 170.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.4 167.07 22.92 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.005 1.322 . . . . 2.42 107.923 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 120.44 -75.63 0.32 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.691 1.139 . . . . 1.65 111.156 173.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.474 HD22 ' HB3' ' A' ' 17' ' ' CYS . 1.6 pp -68.8 157.41 36.49 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-N 117.088 0.444 . . . . 2.67 109.855 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 p -146.83 62.15 1.2 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.29 0.636 . . . . 2.81 110.176 -176.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 t -160.03 123.08 3.48 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.715 0.635 . . . . 1.81 112.715 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.7 m -48.66 -45.0 38.2 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.672 1.189 . . . . 1.73 111.908 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -57.3 -36.65 71.33 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.755 -0.59 . . . . 3.18 111.24 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.474 ' HB3' HD22 ' A' ' 12' ' ' LEU . 20.5 m -70.15 -41.0 74.44 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 122.055 -0.403 . . . . 0.9 110.034 177.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.81 -47.74 73.66 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.01 0.368 . . . . 0.78 110.117 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.92 -52.34 65.88 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.756 0.822 . . . . 0.71 110.823 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -50.31 -52.3 37.89 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.105 0.962 . . . . 2.21 109.793 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -52.19 -62.1 1.85 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 118.571 -0.728 . . . . 2.71 111.571 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.55 -40.62 79.3 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.262 0.937 . . . . 2.66 110.975 -173.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.2 mtt180 -52.71 -56.01 18.57 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.774 0.716 . . . . 3.91 110.468 171.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -51.57 -43.38 62.42 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.355 0.597 . . . . 2.37 110.252 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.549 HG22 HG22 ' A' ' 54' ' ' VAL . 92.4 t -61.95 -50.08 81.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 C-N-CA 123.254 0.622 . . . . 0.48 111.141 175.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -57.75 -27.86 63.41 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.008 1.323 . . . . 1.92 112.318 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -68.36 -22.55 64.66 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.845 0.748 . . . . 2.21 112.825 171.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.7 mt -69.33 132.69 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.624 1.102 . . . . 1.36 108.13 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -74.32 -32.62 62.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.652 0.781 . . . . 2.76 112.446 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.15 -36.54 90.9 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.063 0.839 . . . . 0.91 112.435 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 p -86.31 159.1 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 O-C-N 121.115 -1.226 . . . . 0.63 109.937 -176.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -117.93 -57.34 2.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.858 1.263 . . . . 0.57 108.15 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -127.87 144.97 51.08 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.048 -0.661 . . . . 2.28 111.315 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.64 131.57 31.72 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.87 -0.789 . . . . 0.5 108.87 171.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mp -114.88 78.99 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 107.746 -1.205 . . . . 2.01 107.746 -173.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 m -84.08 136.51 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 115.636 -0.711 . . . . 2.14 110.821 -167.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -133.71 58.13 1.78 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.995 -1.854 . . . . 2.05 105.995 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -66.8 137.07 56.35 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.185 -1.043 . . . . 3.08 108.185 171.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.63 -54.59 0.47 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.589 -1.404 . . . . 3.0 109.589 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -175.72 53.39 0.01 OUTLIER 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.733 1.613 . . . . 2.16 107.136 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 m -157.31 -106.94 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.833 -0.542 . . . . 2.48 111.271 -173.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.59 172.51 18.43 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 112.831 0.678 . . . . 6.53 112.831 -161.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.31 112.43 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 106.776 -1.565 . . . . 0.71 106.776 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.8 m -92.78 135.94 33.67 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.221 -1.029 . . . . 0.53 108.221 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.53 142.31 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.237 1.815 . . . . 0.74 106.789 173.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.3 m -147.44 136.95 22.71 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 106.983 -1.488 . . . . 0.72 106.983 176.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.76 -94.75 0.16 Allowed Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 106.12 -2.792 . . . . 0.53 106.12 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -165.11 56.33 0.12 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.223 1.809 . . . . 2.5 108.984 173.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.09 170.6 15.64 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.072 -1.017 . . . . 0.65 110.945 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.2 m -129.62 160.66 32.62 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.387 1.475 . . . . 0.69 110.319 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 tp -53.41 -33.71 21.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 CA-C-O 117.299 -1.334 . . . . 1.71 113.059 -172.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -35.07 -48.15 0.41 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.826 1.194 . . . . 3.63 112.089 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -62.38 -49.74 74.33 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.169 0.985 . . . . 2.42 111.223 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.549 HG22 HG22 ' A' ' 25' ' ' VAL . 45.7 t -63.22 -38.52 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.884 1.274 . . . . 0.28 110.581 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -67.41 -46.64 72.61 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.833 1.653 . . . . 2.96 108.329 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -51.87 -52.6 48.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.798 0.439 . . . . 3.22 109.93 172.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.85 -51.31 52.63 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.508 0.595 . . . . 0.4 110.872 170.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.54 -13.9 18.9 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 125.373 1.464 . . . . 0.27 113.911 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.68 -25.92 1.36 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.751 1.275 . . . . 0.42 111.813 168.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -51.81 -31.43 27.33 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.478 1.036 . . . . 2.03 113.322 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -133.98 -6.25 2.74 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.802 1.038 . . . . 2.31 113.802 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 74.03 60.02 0.08 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.354 1.462 . . . . 0.82 111.106 173.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.98 161.86 25.23 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.701 -0.625 . . . . 1.36 110.466 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.67 72.31 1.33 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 107.508 -1.293 . . . . 4.47 107.508 -170.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 mt -82.24 135.49 24.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.2 -1.363 . . . . 0.51 109.247 -172.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 38.8 mm -124.89 127.41 25.12 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 123.629 0.771 . . . . 2.25 110.268 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.23 103.3 1.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.912 2.408 . . . . 0.65 110.108 174.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -55.49 -55.52 30.84 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.812 1.645 . . . . 4.82 110.5 170.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -72.77 113.06 9.39 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.169 -0.678 . . . . 7.33 109.169 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -115.12 -55.09 2.5 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.476 1.511 . . . . 11.37 108.19 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 N-CA-C 106.218 -1.771 . . . . 9.04 106.218 168.276 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ttt . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 108.416 -0.957 . . . . 10.61 108.416 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.77 59.17 3.31 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.819 0.848 . . . . 6.27 110.666 -170.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -141.62 177.38 8.19 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.565 1.546 . . . . 5.26 109.531 -173.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.44 158.06 24.71 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.447 1.099 . . . . 3.91 109.996 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.8 m -155.58 162.02 40.73 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.551 -0.907 . . . . 0.63 108.551 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.62 142.47 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 O-C-N 123.535 0.522 . . . . 0.46 110.962 165.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.466 ' CD1' HD13 ' A' ' 51' ' ' ILE . 35.1 m-85 -126.88 154.57 44.25 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.217 1.407 . . . . 1.93 108.665 -171.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -92.02 114.63 27.23 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 118.574 -0.726 . . . . 3.7 109.209 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 p -100.63 137.08 29.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.797 0.839 . . . . 0.47 109.025 174.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.64 156.4 46.86 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.322 -0.992 . . . . 2.4 108.322 171.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 133.2 -74.71 0.43 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.386 -1.485 . . . . 1.39 109.386 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.413 HD21 ' CE2' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -89.64 171.14 9.88 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.007 0.743 . . . . 2.61 113.007 -174.429 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.3 m -158.22 83.08 0.85 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.263 1.425 . . . . 3.84 109.649 175.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.4 t -158.25 137.6 11.75 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.055 0.843 . . . . 1.9 112.158 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.3 m -61.19 -47.05 87.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.03 0.932 . . . . 1.48 111.305 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -60.15 -40.35 89.54 Favored 'General case' 0 C--O 1.233 0.196 0 O-C-N 121.164 -0.96 . . . . 2.69 110.265 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.1 m -60.77 -44.72 96.4 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.019 -0.426 . . . . 0.9 109.999 173.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.78 -46.72 71.11 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.404 0.282 . . . . 0.72 110.493 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.14 -50.55 72.45 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.952 0.501 . . . . 0.69 109.915 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.22 -50.07 40.07 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.235 0.614 . . . . 2.16 109.996 174.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.554 ' O ' HG23 ' A' ' 25' ' ' VAL . 2.8 t80 -64.2 -57.58 9.08 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.081 0.552 . . . . 2.63 110.513 -173.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -59.05 -41.13 87.14 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.866 -0.733 . . . . 2.13 110.142 -176.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -61.87 -50.01 73.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.994 -0.527 . . . . 3.8 109.897 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -48.22 -50.58 28.89 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.614 -0.513 . . . . 1.62 109.614 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.563 HG22 HG22 ' A' ' 54' ' ' VAL . 18.7 t -57.74 -52.15 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 110.395 -0.224 . . . . 0.51 110.395 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -49.35 -39.74 32.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.503 1.121 . . . . 2.16 111.605 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -67.49 -19.96 65.4 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.872 0.693 . . . . 2.08 112.872 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.594 HG22 ' H ' ' A' ' 30' ' ' GLY . 19.9 mt -76.12 122.22 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 119.857 1.208 . . . . 1.35 109.552 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -66.52 -18.67 65.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.745 1.218 . . . . 2.67 113.648 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.594 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -70.45 -34.2 68.17 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 123.51 0.576 . . . . 0.9 111.978 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.512 HG11 HG12 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -92.92 -173.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 O-C-N 121.799 -0.824 . . . . 0.87 110.542 -172.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.0 m -132.93 -62.0 0.82 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.834 -1.172 . . . . 0.83 107.834 170.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -120.64 164.48 16.45 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.076 0.465 . . . . 4.14 111.982 175.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.462 ' CB ' HG11 ' A' ' 25' ' ' VAL . . . -158.25 136.56 10.9 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.987 -1.006 . . . . 0.5 109.898 168.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 35' ' ' ILE . 3.4 mp -119.78 101.36 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 O-C-N 124.686 1.241 . . . . 1.73 107.812 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.5 p -84.96 137.16 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.588 0.755 . . . . 2.33 109.792 175.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -89.0 -59.77 2.14 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.838 0.745 . . . . 2.78 109.747 165.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.413 ' CE2' HD21 ' A' ' 12' ' ' LEU . 10.6 m-30 58.56 -177.37 0.08 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.076 0.95 . . . . 2.66 110.73 -162.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.18 36.41 79.72 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.162 -0.775 . . . . 2.32 111.162 -174.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 69.75 74.09 0.23 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.632 1.573 . . . . 2.81 108.455 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.3 m -155.2 -114.11 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.87 -0.604 . . . . 2.48 110.174 -172.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -158.51 165.8 33.7 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.619 0.768 . . . . 3.49 111.103 -173.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.45 119.11 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.63 1.172 . . . . 0.77 109.848 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.7 m -94.13 145.79 24.44 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.558 1.143 . . . . 0.54 111.098 175.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 90.0 t -131.75 134.22 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 127.557 2.343 . . . . 1.0 105.871 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.1 m -145.71 75.46 1.43 Allowed 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 120.707 -1.245 . . . . 1.39 108.461 -173.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -157.92 -117.31 0.51 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 108.065 -2.014 . . . . 1.19 108.065 173.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.02 59.08 1.3 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.769 1.227 . . . . 4.31 108.185 177.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.73 162.02 41.07 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.686 -0.634 . . . . 0.5 110.063 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.9 m -110.92 161.43 15.85 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.343 1.457 . . . . 0.59 110.339 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.466 HD13 ' CD1' ' A' ' 7' ' ' TYR . 6.1 tp -51.21 -36.52 16.79 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 117.732 -1.128 . . . . 1.92 113.154 -175.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -35.52 -47.37 0.45 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.685 1.194 . . . . 3.38 113.393 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -67.49 -39.73 85.21 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.361 -0.837 . . . . 2.35 111.659 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.563 HG22 HG22 ' A' ' 25' ' ' VAL . 43.7 t -68.05 -44.01 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.202 1.001 . . . . 0.38 109.524 178.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -53.37 -48.65 68.4 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.107 2.163 . . . . 2.8 109.163 174.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -52.9 -52.22 58.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.637 0.775 . . . . 4.02 110.605 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.29 -49.23 70.1 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.098 0.863 . . . . 0.6 110.666 172.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.78 -13.6 4.54 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.131 1.348 . . . . 0.46 113.957 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -43.69 -32.75 1.06 Allowed 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.545 1.173 . . . . 0.72 111.565 165.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -49.18 -37.01 21.1 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.656 0.984 . . . . 1.9 113.656 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -125.43 12.09 8.08 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.217 1.007 . . . . 2.84 111.127 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 60.77 47.91 7.52 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.805 1.242 . . . . 1.15 110.467 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 mp -65.15 153.04 42.06 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.524 -0.307 . . . . 2.33 110.764 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.65 108.65 11.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.612 -1.996 . . . . 3.6 105.612 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.551 HD11 ' HZ ' ' A' ' 21' ' ' PHE . 1.5 mt -112.55 126.29 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.481 -0.933 . . . . 0.57 108.481 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.1 mp -104.56 131.16 22.11 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 108.133 -1.062 . . . . 1.3 108.133 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.33 105.02 0.81 Allowed 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.783 1.656 . . . . 0.78 107.875 165.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -52.74 157.74 1.53 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.288 0.566 . . . . 4.41 111.195 171.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.4 tptt -71.65 148.8 46.17 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.161 -0.616 . . . . 6.1 110.114 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.56 79.62 0.27 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.938 0.895 . . . . 9.01 110.459 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.202 0 C-N-CA 126.875 2.07 . . . . 8.08 111.463 -179.324 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 ttt . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 106.346 -1.724 . . . . 12.5 106.346 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.23 153.93 42.86 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.417 1.008 . . . . 5.83 110.562 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -71.17 106.59 3.83 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.642 -0.873 . . . . 5.88 108.642 177.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 136.32 40.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.798 1.239 . . . . 3.86 108.799 175.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.0 m -149.48 154.41 38.76 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 107.804 -1.184 . . . . 0.59 107.804 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.34 140.07 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 O-C-N 124.431 1.082 . . . . 0.49 109.905 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -129.41 136.93 50.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.23 -1.396 . . . . 1.9 107.23 -167.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -84.56 133.11 34.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 118.189 -0.91 . . . . 4.69 109.384 -174.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -120.54 145.53 26.8 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 C-N-CA 124.63 1.172 . . . . 0.66 109.842 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -139.42 150.76 45.63 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.899 -1.519 . . . . 2.4 106.899 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.76 -71.11 0.42 Allowed Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.471 1.034 . . . . 1.41 110.729 168.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.615 HD21 ' HB3' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -63.98 165.92 8.24 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.265 1.026 . . . . 2.32 112.106 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.2 p -161.62 64.91 0.26 Allowed 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.875 -0.516 . . . . 2.84 110.055 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.6 t -159.34 134.59 8.3 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 110.047 -0.353 . . . . 1.83 110.047 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.7 p -53.34 -48.13 68.75 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.12 0.968 . . . . 2.18 109.89 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -43.4 -51.11 6.67 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.302 1.041 . . . . 2.53 111.772 173.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.4 m -64.06 -45.63 87.94 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 109.988 -0.375 . . . . 0.8 109.988 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -46.97 73.22 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.567 0.222 . . . . 0.55 111.401 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.45 -48.98 78.65 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.326 1.05 . . . . 0.58 109.86 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -53.77 -48.19 69.99 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.724 -0.473 . . . . 4.23 109.724 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.76 -59.81 4.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.695 0.798 . . . . 2.37 111.573 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -56.88 -41.22 77.64 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 119.347 -0.941 . . . . 2.73 109.961 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -60.04 -48.43 81.76 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 119.275 -0.393 . . . . 3.22 110.165 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.661 HD22 ' HB1' ' A' ' 57' ' ' ALA . 34.6 m-20 -49.06 -51.77 29.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.072 0.397 . . . . 1.34 110.001 172.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 54' ' ' VAL . 45.2 t -59.11 -48.04 88.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 O-C-N 122.027 -0.421 . . . . 0.34 110.76 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -54.47 -37.06 64.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.739 1.215 . . . . 1.48 112.086 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -65.31 -18.54 65.39 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.895 0.77 . . . . 2.09 112.963 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.1 mt -76.88 115.92 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 119.79 1.177 . . . . 1.22 109.538 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -77.68 60.76 2.26 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.595 1.958 . . . . 3.92 110.097 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -154.15 -36.72 0.03 OUTLIER Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.205 1.859 . . . . 0.81 111.965 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.94 172.31 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 121.46 -1.024 . . . . 0.68 109.124 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.2 m -121.58 -60.71 1.59 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.682 1.193 . . . . 0.68 108.032 171.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -122.89 134.33 54.38 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 109.887 -0.412 . . . . 2.1 109.887 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.19 126.09 42.21 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.149 -1.056 . . . . 0.45 108.149 171.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.19 95.07 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 105.408 -2.071 . . . . 2.22 105.408 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -91.79 141.38 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 120.398 -0.521 . . . . 2.05 109.856 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -127.5 46.23 2.58 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.951 -1.129 . . . . 1.73 107.951 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.615 ' HB3' HD21 ' A' ' 12' ' ' LEU . 53.7 m-85 -54.06 122.94 11.22 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.12 0.568 . . . . 3.19 109.5 173.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.69 -55.9 0.43 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.401 -1.48 . . . . 2.61 109.401 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.98 34.66 0.1 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.73 0.412 . . . . 2.14 111.467 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.9 m -146.63 -111.38 0.09 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.562 0.345 . . . . 2.73 111.823 -170.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.457 ' NZ ' ' OE1' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -158.27 167.75 28.92 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.36 1.064 . . . . 4.01 109.98 -173.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.67 119.48 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 125.544 1.537 . . . . 0.82 108.386 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.1 m -96.83 144.76 26.49 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 118.313 0.506 . . . . 0.48 110.099 172.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.27 138.84 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 127.116 2.166 . . . . 0.75 106.87 174.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.4 m -145.47 134.47 22.61 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.536 -1.653 . . . . 0.69 106.536 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.55 -94.98 0.16 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 107.348 -2.301 . . . . 0.52 107.348 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -164.3 50.07 0.12 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.337 1.455 . . . . 2.57 109.349 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.14 173.71 11.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.897 0.879 . . . . 0.67 110.414 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.0 m -137.89 169.73 17.29 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.071 1.348 . . . . 0.9 111.039 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.468 ' O ' HD13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -50.46 -40.61 18.82 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 CA-C-O 117.222 -1.37 . . . . 2.65 110.694 -179.221 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -34.63 -49.8 0.43 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.681 1.582 . . . . 4.19 113.773 -176.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -68.77 -45.39 71.5 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.441 0.639 . . . . 2.19 112.035 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 25' ' ' VAL . 21.9 t -57.32 -33.84 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.271 1.028 . . . . 0.37 110.593 174.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -59.98 -57.29 13.48 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.667 1.587 . . . . 3.07 106.863 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -53.84 -47.34 71.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.868 -1.06 . . . . 3.26 110.01 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.661 ' HB1' HD22 ' A' ' 24' ' ' ASN . . . -51.62 -52.2 49.57 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.848 -0.532 . . . . 0.42 111.191 171.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.52 -9.7 26.17 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.64 1.114 . . . . 0.34 112.643 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.34 -23.68 3.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 119.151 1.476 . . . . 0.47 111.478 169.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -52.11 -32.11 33.78 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.277 0.944 . . . . 2.01 112.76 172.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -136.96 10.48 3.07 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.819 0.848 . . . . 2.49 112.682 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 57.33 65.75 1.3 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.855 1.262 . . . . 1.29 111.655 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.404 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.2 mm? -77.19 -166.53 0.73 Allowed 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.848 -0.533 . . . . 1.32 110.959 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.401 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -155.53 62.65 0.61 Allowed 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 120.49 -1.381 . . . . 4.63 107.5 -179.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.465 HD12 HD11 ' A' ' 51' ' ' ILE . 1.1 mt -79.86 137.8 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.359 -1.291 . . . . 0.61 109.299 -173.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.9 mt -127.19 136.28 28.65 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 124.194 0.997 . . . . 1.31 109.599 -174.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.18 83.67 0.35 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.979 2.453 . . . . 0.82 110.968 172.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.457 ' OE1' ' NZ ' ' A' ' 42' ' ' LYS . 5.1 tt0 -40.63 120.21 1.23 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.526 1.931 . . . . 3.52 109.969 167.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -111.53 -55.88 2.45 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.52 0.728 . . . . 4.49 110.253 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -136.78 151.91 49.72 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 104.876 -2.268 . . . . 8.67 104.876 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.204 0 CA-C-O 116.125 -1.893 . . . . 11.31 107.724 -170.222 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 tpt . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 108.104 -1.072 . . . . 8.14 108.104 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.72 25.48 9.75 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.999 0.92 . . . . 5.22 112.76 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.79 91.48 0.14 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.132 0.973 . . . . 5.24 110.626 176.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.36 134.33 46.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.091 1.756 . . . . 4.38 107.361 164.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.7 m -155.1 151.97 28.95 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.372 -1.344 . . . . 0.78 107.372 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -119.3 141.12 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 O-C-N 124.448 1.092 . . . . 0.68 110.535 162.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -122.32 152.86 39.67 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.914 1.685 . . . . 1.79 106.746 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -94.26 134.71 36.45 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.41 1.005 . . . . 3.87 110.704 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 p -112.58 135.85 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 O-C-N 124.322 1.014 . . . . 0.64 109.71 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -135.82 172.08 13.52 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.147 0.43 . . . . 2.98 110.593 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.41 -47.43 2.6 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.43 1.491 . . . . 1.62 112.129 176.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.513 HD22 ' CE2' ' A' ' 38' ' ' PHE . 4.3 pp -60.49 167.28 2.66 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.475 0.71 . . . . 2.55 112.863 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.5 t -165.99 64.19 0.11 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.869 0.468 . . . . 2.91 111.125 172.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.8 t -156.85 134.68 10.94 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 120.949 -1.094 . . . . 2.05 110.582 171.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.411 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 91.4 m -68.18 -44.92 74.82 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 122.114 -0.367 . . . . 2.16 110.918 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -56.19 -40.52 74.11 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.141 -0.974 . . . . 2.74 110.803 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.0 m -55.82 -32.98 64.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.037 0.535 . . . . 0.82 111.364 174.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 15' ' ' THR . . . -60.46 -41.96 95.21 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 122.843 0.457 . . . . 0.52 109.839 176.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.37 -45.34 91.59 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.635 0.731 . . . . 0.52 109.078 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.2 tmtp? -52.1 -46.63 65.35 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.749 -0.659 . . . . 2.86 109.325 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.619 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -61.97 -58.21 8.75 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 119.007 -0.52 . . . . 2.58 112.325 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -54.27 -47.94 71.77 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.873 -0.788 . . . . 2.6 108.873 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 ttt-85 -63.03 -50.61 70.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.704 -0.48 . . . . 4.25 109.704 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.605 HD22 ' HB1' ' A' ' 57' ' ' ALA . 29.0 m-20 -49.34 -47.77 47.09 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 117.904 0.32 . . . . 1.39 110.265 175.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 21' ' ' PHE . 19.5 t -62.51 -49.4 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 122.088 -0.383 . . . . 0.5 110.102 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -50.95 -35.66 34.68 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.9 0.88 . . . . 2.27 112.162 173.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -70.36 -12.76 61.8 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.322 0.86 . . . . 2.87 113.322 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.679 HG22 ' H ' ' A' ' 30' ' ' GLY . 36.3 mt -78.54 131.51 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 120.199 1.363 . . . . 1.41 109.791 177.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -86.3 20.77 2.26 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.638 1.975 . . . . 3.55 112.494 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.679 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -122.62 -12.87 4.87 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.845 1.212 . . . . 1.13 112.54 -178.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -115.67 157.17 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 C-N-CA 125.332 1.453 . . . . 0.6 107.433 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.9 m -109.32 -60.08 1.81 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.708 1.203 . . . . 0.65 108.454 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -117.27 148.62 41.51 Favored 'General case' 0 N--CA 1.462 0.125 0 O-C-N 123.207 0.317 . . . . 2.94 110.589 175.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.416 ' CB ' HG11 ' A' ' 25' ' ' VAL . . . -150.58 129.68 12.68 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.71 -0.478 . . . . 0.58 109.71 172.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.3 mt -130.19 102.49 7.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 107.269 -1.382 . . . . 1.33 107.269 -174.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 p -88.94 144.73 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 122.938 0.495 . . . . 1.99 110.81 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -134.66 64.03 1.61 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.076 1.351 . . . . 1.98 108.465 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.513 ' CE2' HD22 ' A' ' 12' ' ' LEU . 8.1 m-30 -54.69 -21.93 12.29 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 124.404 1.082 . . . . 2.88 112.486 171.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.27 -19.16 38.51 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 120.318 -0.944 . . . . 3.39 111.686 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.47 -106.37 0.33 Allowed 'General case' 0 C--N 1.344 0.337 0 CA-C-N 118.25 1.025 . . . . 3.44 108.677 159.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.1 m -157.25 68.58 0.54 Allowed 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.148 -1.797 . . . . 5.46 106.148 -173.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -153.63 140.29 18.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.678 -0.489 . . . . 5.63 109.678 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.89 114.78 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.263 1.025 . . . . 0.78 108.627 174.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.1 m -87.58 133.09 33.86 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 123.811 0.845 . . . . 0.55 109.034 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.4 t -121.91 140.52 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 126.657 1.983 . . . . 0.7 105.797 171.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.9 m -147.98 135.3 20.54 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.535 -1.283 . . . . 0.78 107.535 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.03 -96.46 0.16 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 106.509 -2.636 . . . . 0.56 106.509 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.4 49.24 0.26 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.611 1.164 . . . . 4.12 109.411 169.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.17 174.32 11.7 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.843 0.857 . . . . 0.73 111.131 177.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -125.05 170.57 11.04 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.926 1.691 . . . . 0.78 111.557 -174.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.4 tp -52.47 -37.61 24.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-O 117.513 -1.232 . . . . 1.77 112.269 -177.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -31.7 -52.47 0.24 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.019 1.328 . . . . 3.24 112.365 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -58.98 -50.75 72.89 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.584 1.183 . . . . 2.25 111.675 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.568 HG12 ' CZ ' ' A' ' 21' ' ' PHE . 65.1 t -61.89 -44.77 99.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.935 1.694 . . . . 0.48 110.433 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -63.29 -45.08 93.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.531 1.532 . . . . 3.55 109.495 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -51.58 -51.04 58.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.235 -0.654 . . . . 4.11 109.235 172.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.605 ' HB1' HD22 ' A' ' 24' ' ' ASN . . . -53.3 -48.97 67.92 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.912 -0.492 . . . . 0.38 110.682 173.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.02 -9.22 7.01 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.873 1.702 . . . . 0.31 113.96 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.53 -29.18 1.67 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.497 1.148 . . . . 0.47 111.49 166.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -51.69 -35.56 43.21 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.344 0.974 . . . . 1.95 113.555 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -121.61 4.73 10.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.41 1.084 . . . . 2.47 111.472 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 59.24 52.51 6.0 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.631 1.172 . . . . 1.07 110.054 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.22 158.03 29.91 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.575 -0.284 . . . . 2.18 110.481 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.75 119.2 25.24 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.747 -1.205 . . . . 3.95 107.747 167.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.0 mt -120.54 139.36 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.171 1.388 . . . . 0.49 107.97 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mp -128.28 133.31 25.01 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 108.358 -0.978 . . . . 1.39 108.358 -176.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.53 112.53 3.06 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.337 2.025 . . . . 0.84 108.87 170.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -45.82 -47.6 15.82 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.657 0.783 . . . . 3.24 111.27 172.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.0 tttm 61.86 50.0 4.48 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.243 1.017 . . . . 5.17 110.745 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -74.91 68.64 1.8 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.109 0.964 . . . . 7.22 110.024 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.286 0 CA-C-O 116.624 -1.655 . . . . 8.41 107.916 176.662 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 107.035 -1.468 . . . . 10.9 107.035 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.27 -144.54 0.18 Allowed 'General case' 0 CA--C 1.541 0.602 0 O-C-N 124.785 1.303 . . . . 5.16 111.316 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 18.44 62.09 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 129.251 3.02 . . . . 4.98 114.893 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.35 133.6 31.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.739 2.016 . . . . 4.64 107.639 175.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.7 m -150.15 156.53 41.78 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.579 -1.267 . . . . 0.58 107.579 174.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 p -137.21 139.65 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 123.761 0.663 . . . . 0.42 110.326 168.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -125.18 145.84 49.78 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.011 1.325 . . . . 2.32 108.156 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.18 125.18 32.63 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 118.307 -0.854 . . . . 3.64 109.484 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 p -115.92 132.59 64.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 C-N-CA 123.34 0.656 . . . . 0.64 110.132 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -135.09 166.85 22.12 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.38 1.472 . . . . 3.09 108.661 -175.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.23 -50.84 0.98 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.908 1.242 . . . . 1.31 111.407 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.04 161.48 4.03 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.735 1.214 . . . . 3.25 113.417 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.1 p -172.45 51.03 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.746 0.647 . . . . 3.17 112.746 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -160.86 143.0 12.46 Favored 'General case' 0 C--N 1.346 0.426 0 O-C-N 120.76 -1.212 . . . . 2.0 113.656 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.8 m -63.32 -49.32 74.41 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.074 0.95 . . . . 1.82 111.661 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -55.05 -40.49 70.34 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.571 -0.706 . . . . 4.46 110.674 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.0 m -64.56 -43.26 94.49 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 122.136 -0.352 . . . . 0.95 110.771 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.99 -48.58 64.36 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.009 0.368 . . . . 0.96 110.173 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.53 -51.49 69.23 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.715 0.806 . . . . 0.86 110.332 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -49.9 -44.98 50.39 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.872 0.469 . . . . 2.55 109.978 175.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.414 ' HZ ' HD11 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -64.65 -58.49 6.16 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.22 -0.895 . . . . 2.51 111.536 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -51.98 -45.19 64.36 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.55 1.068 . . . . 3.53 108.91 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -61.61 -59.06 5.77 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.344 0.658 . . . . 5.54 111.082 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.475 ' HB3' ' HB1' ' A' ' 57' ' ' ALA . 6.3 m-20 -49.67 -48.11 49.68 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.016 -0.735 . . . . 1.61 109.016 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.403 HG22 HG13 ' A' ' 54' ' ' VAL . 90.5 t -60.76 -48.24 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 122.994 0.518 . . . . 0.76 110.546 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -56.07 -36.06 67.67 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.663 1.185 . . . . 2.45 111.992 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.14 -9.71 58.53 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.255 0.835 . . . . 2.38 113.255 175.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.1 mm -78.69 110.52 14.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 120.039 1.291 . . . . 2.19 110.587 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.61 85.7 0.07 Allowed 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.166 1.786 . . . . 3.44 108.584 165.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.38 -42.1 0.12 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 109.865 -1.294 . . . . 0.96 109.865 -177.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -97.92 151.29 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 108.642 -0.873 . . . . 0.97 108.642 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.3 m -106.28 -55.95 2.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.943 1.297 . . . . 0.6 108.09 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -121.44 125.44 46.9 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.948 -0.76 . . . . 3.36 108.948 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.82 136.89 47.85 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.292 -1.003 . . . . 0.63 108.292 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.8 mt -129.39 110.84 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.871 -1.159 . . . . 1.27 107.871 -176.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.6 p -95.24 111.48 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 118.413 0.551 . . . . 2.04 111.37 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -83.55 71.59 10.33 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 106.953 -1.499 . . . . 2.19 106.953 167.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.64 67.14 2.72 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.785 0.802 . . . . 2.95 109.286 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -161.46 52.38 0.33 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.356 -1.498 . . . . 3.15 109.356 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 68.6 63.35 0.34 Allowed 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 125.491 1.516 . . . . 2.04 108.766 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m -157.09 -113.69 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.46 -0.791 . . . . 2.61 110.258 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -157.79 155.73 30.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.812 -0.555 . . . . 3.37 110.731 -163.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.28 117.46 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 125.69 1.596 . . . . 0.81 108.367 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.3 m -89.18 144.63 25.97 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.727 0.811 . . . . 0.54 109.921 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.96 132.43 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 127.163 2.185 . . . . 0.73 106.617 175.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.9 m -143.27 132.41 23.11 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.996 -1.483 . . . . 0.88 106.996 173.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.9 -90.07 0.12 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.982 -1.647 . . . . 0.76 108.982 177.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -165.41 54.65 0.11 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.72 1.608 . . . . 2.88 109.208 167.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.88 174.68 10.36 Favored 'General case' 0 C--N 1.34 0.172 0 O-C-N 121.032 -1.042 . . . . 0.69 112.175 -176.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.1 m -134.61 166.35 23.11 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.454 1.501 . . . . 0.59 110.518 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.803 HD11 HD12 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -48.1 -44.5 12.12 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.877 0 CA-C-O 117.199 -1.381 . . . . 2.73 111.098 -178.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -31.7 -47.93 0.14 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.054 1.741 . . . . 2.79 114.113 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -66.73 -46.51 75.22 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.671 0.748 . . . . 2.76 111.32 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.403 HG13 HG22 ' A' ' 25' ' ' VAL . 25.1 t -62.1 -31.47 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.993 1.317 . . . . 0.43 111.161 172.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -60.24 -55.5 33.03 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.253 1.421 . . . . 3.19 107.274 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.06 -48.06 76.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.374 -0.83 . . . . 3.69 110.3 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.475 ' HB1' ' HB3' ' A' ' 24' ' ' ASN . . . -50.04 -51.1 44.95 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.414 0.552 . . . . 0.63 110.793 172.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.18 -10.7 29.07 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.112 -0.826 . . . . 0.28 113.533 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.04 -30.18 4.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.857 1.328 . . . . 0.59 112.24 172.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -57.57 -28.18 63.35 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.464 1.029 . . . . 2.22 113.213 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -128.38 -5.75 5.36 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.131 0.973 . . . . 3.09 112.471 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 63.22 61.39 1.08 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.715 1.206 . . . . 1.24 111.018 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 63' ' ' LEU . 2.0 mm? -82.19 169.37 16.68 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 121.891 -0.506 . . . . 1.02 110.495 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.05 70.8 1.42 Allowed 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.114 -1.069 . . . . 4.54 108.114 -170.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.803 HD12 HD11 ' A' ' 51' ' ' ILE . 2.0 mt -79.96 135.41 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 108.678 -0.86 . . . . 0.56 108.678 -173.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.26 135.62 23.2 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 124.37 1.068 . . . . 1.37 108.291 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.33 100.46 0.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 121.847 1.698 . . . . 0.97 109.324 170.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -56.26 138.65 50.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.687 -0.857 . . . . 3.96 108.687 172.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -61.98 147.1 48.11 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.682 -0.488 . . . . 5.08 109.682 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -48.39 144.77 3.82 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.739 0.816 . . . . 7.63 110.992 171.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.431 0 N-CA-C 104.904 -2.258 . . . . 10.95 104.904 176.403 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 108.179 -1.045 . . . . 8.11 108.179 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.74 121.68 10.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.571 -1.27 . . . . 6.12 107.571 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -86.41 112.06 21.12 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.158 1.783 . . . . 5.65 109.945 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.413 ' H ' ' HE3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -122.37 147.2 46.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.659 -1.978 . . . . 4.96 105.659 166.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 88.9 m -153.5 156.07 37.42 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 106.301 -1.741 . . . . 0.69 106.301 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -132.69 145.99 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 O-C-N 123.992 0.807 . . . . 0.42 110.919 168.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -131.06 146.68 52.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.401 -1.703 . . . . 1.9 106.401 -172.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -85.17 128.15 34.55 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.816 -0.809 . . . . 5.15 108.816 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -112.31 135.26 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.91 -1.515 . . . . 0.49 106.91 174.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -142.59 154.74 44.69 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 104.964 -2.236 . . . . 3.05 104.964 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.52 -81.81 0.35 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.398 0.999 . . . . 1.6 110.999 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.574 HD21 ' CZ ' ' A' ' 38' ' ' PHE . 0.5 OUTLIER -81.31 163.06 23.19 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.304 0.552 . . . . 2.72 110.929 -174.278 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.545 ' N ' HD12 ' A' ' 12' ' ' LEU . 18.2 t -149.26 79.21 1.4 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.197 0.599 . . . . 3.67 110.721 177.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.3 t -160.53 146.65 15.18 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.087 0.858 . . . . 1.78 112.387 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -68.39 -46.35 70.26 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.391 1.476 . . . . 1.56 111.996 -177.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -55.02 -43.52 73.76 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.426 -0.796 . . . . 2.75 110.424 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.3 m -56.96 -45.25 82.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.624 -0.716 . . . . 0.97 110.512 173.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.413 ' HB1' HG13 ' A' ' 36' ' ' VAL . . . -56.12 -49.89 72.63 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 122.941 0.497 . . . . 0.92 110.268 176.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.07 -46.42 68.58 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.235 0.54 . . . . 0.8 110.267 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -61.52 -46.11 91.35 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.446 -0.343 . . . . 3.49 110.849 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.21 -64.81 0.72 Allowed 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.848 0.859 . . . . 2.79 110.706 175.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -39.63 83.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.981 0.81 . . . . 2.42 111.086 -172.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -53.04 62.76 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.139 0.576 . . . . 2.82 110.393 172.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.545 HD22 ' HB1' ' A' ' 57' ' ' ALA . 64.6 m-20 -53.33 -46.5 69.51 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.431 -0.581 . . . . 1.33 109.431 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.578 HG11 ' CB ' ' A' ' 34' ' ' ALA . 48.5 t -59.22 -51.25 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 122.678 0.391 . . . . 0.55 110.324 176.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.5 mttt -50.64 -38.43 46.18 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.036 0.935 . . . . 1.87 112.414 173.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.63 -12.53 54.08 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.488 0.921 . . . . 3.01 113.488 175.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 30' ' ' GLY . 19.2 mt -86.29 113.47 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 120.319 1.418 . . . . 1.36 110.1 178.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -53.4 -25.16 14.59 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.833 1.653 . . . . 3.36 114.006 176.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.496 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -71.67 -31.13 65.43 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.886 0.755 . . . . 0.8 112.466 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.54 HG11 HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -92.27 -172.99 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 121.278 -1.131 . . . . 0.8 109.99 -171.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.1 m -140.71 -57.97 0.52 Allowed 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 120.769 -1.207 . . . . 0.79 108.811 171.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -128.53 157.95 39.77 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 119.954 -0.698 . . . . 2.67 111.36 171.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.578 ' CB ' HG11 ' A' ' 25' ' ' VAL . . . -154.84 149.55 26.53 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.239 -0.652 . . . . 0.57 109.239 172.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.9 mt -130.32 131.07 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 107.047 -1.464 . . . . 1.61 107.047 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.413 HG13 ' HB1' ' A' ' 18' ' ' ALA . 2.8 p -118.61 110.04 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 124.389 1.076 . . . . 2.32 109.703 -175.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -101.21 78.0 1.86 Allowed 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.619 -1.252 . . . . 2.12 107.619 171.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.574 ' CZ ' HD21 ' A' ' 12' ' ' LEU . 18.6 m-85 -67.97 169.36 10.1 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 121.063 0.459 . . . . 2.71 110.431 169.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.27 -71.4 0.22 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 107.137 -2.385 . . . . 2.72 107.137 -173.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -170.59 67.26 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.234 1.013 . . . . 2.18 108.61 176.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 m -152.51 -113.06 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.493 0.553 . . . . 2.64 112.493 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -157.94 160.02 37.14 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.793 -0.567 . . . . 3.76 110.891 -158.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.26 115.7 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.145 -1.428 . . . . 0.81 107.145 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 79.6 m -90.84 141.76 28.48 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.322 1.449 . . . . 0.46 108.722 174.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.1 t -129.63 140.85 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 104.58 -2.378 . . . . 1.01 104.58 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.4 m -147.26 133.35 19.3 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 107.185 -1.413 . . . . 0.88 107.185 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.7 -96.26 0.16 Allowed Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 106.836 -2.505 . . . . 0.62 106.836 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -163.8 57.53 0.17 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.585 1.954 . . . . 3.31 108.475 172.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.71 168.12 25.32 Favored 'General case' 0 C--N 1.341 0.219 0 O-C-N 120.9 -1.125 . . . . 0.53 111.588 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -126.29 165.67 18.55 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.278 1.431 . . . . 1.05 111.696 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.7 tp -55.64 -28.93 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 117.352 -1.308 . . . . 1.85 113.321 -172.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -35.6 -51.03 0.63 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.78 1.173 . . . . 2.46 111.469 173.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -69.13 -41.46 77.34 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.289 0.566 . . . . 2.39 111.776 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.449 HG22 HG22 ' A' ' 25' ' ' VAL . 18.2 t -65.24 -38.42 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 O-C-N 121.624 -0.672 . . . . 0.36 110.22 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -61.38 -53.85 51.33 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 127.611 2.364 . . . . 3.35 107.97 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -49.03 -42.36 37.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.15 0.58 . . . . 3.8 111.135 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.545 ' HB1' HD22 ' A' ' 24' ' ' ASN . . . -67.77 -47.6 68.72 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.167 0.508 . . . . 0.49 110.849 174.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.27 -15.99 12.93 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 126.928 2.204 . . . . 0.31 113.117 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -40.5 -29.32 0.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.303 1.051 . . . . 0.43 112.465 163.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -50.23 -36.16 29.84 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.9 1.074 . . . . 1.85 113.9 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -126.16 -4.73 6.77 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.472 1.509 . . . . 2.39 112.47 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 73.03 57.46 0.11 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.092 1.357 . . . . 1.33 110.85 173.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.557 HD21 HD23 ' A' ' 12' ' ' LEU . 3.8 mm? -79.11 168.29 19.84 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.186 -0.946 . . . . 1.18 111.204 -175.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -135.09 64.55 1.59 Allowed 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.492 -1.299 . . . . 4.92 107.492 -171.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.74 130.78 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 113.501 -1.681 . . . . 0.6 109.098 -174.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.8 mt -122.62 131.13 24.41 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 108.388 -0.967 . . . . 1.04 108.388 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.41 106.88 1.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.203 1.935 . . . . 0.85 109.128 169.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -48.53 -51.33 28.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.858 0.863 . . . . 3.41 109.881 172.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.7 tttm 61.2 -174.66 0.13 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.777 1.231 . . . . 5.32 110.961 -174.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -167.65 154.13 7.92 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.346 -1.724 . . . . 8.21 106.346 -176.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 C-N-CA 124.867 1.267 . . . . 8.83 111.197 -171.69 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.2 mtt . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 105.985 -1.858 . . . . 8.84 105.985 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.79 121.69 21.04 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 119.023 0.828 . . . . 6.32 109.27 -174.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -71.82 74.14 0.85 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.079 0.952 . . . . 5.2 110.971 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.75 144.26 51.0 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.078 1.351 . . . . 4.53 108.005 164.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.2 m -153.35 159.03 42.37 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 106.422 -1.696 . . . . 0.65 106.422 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 p -136.66 148.33 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 O-C-N 124.111 0.882 . . . . 0.49 110.778 173.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -133.27 141.8 48.19 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 106.729 -1.582 . . . . 2.01 106.729 -171.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.1 mtt85 -83.14 137.26 34.14 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.455 1.025 . . . . 3.92 108.416 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.484 HG21 ' CE2' ' A' ' 38' ' ' PHE . 2.7 p -121.78 140.65 45.11 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 124.093 0.957 . . . . 0.52 110.112 178.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -140.33 155.03 46.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.998 -1.482 . . . . 2.86 106.998 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.17 -81.68 0.35 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.811 1.196 . . . . 1.42 110.598 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.5 ' C ' HD12 ' A' ' 12' ' ' LEU . 1.3 pp -75.64 161.23 29.29 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.957 0.379 . . . . 2.67 110.522 -175.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 t -153.52 90.78 1.43 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.315 -0.624 . . . . 3.7 109.315 170.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.9 t -165.36 127.83 2.13 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.4 0.68 . . . . 1.91 110.077 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 m -50.32 -45.38 54.76 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.258 1.023 . . . . 1.43 111.743 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -59.34 -39.78 84.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.891 -0.506 . . . . 2.68 111.227 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.419 ' HB3' HD22 ' A' ' 12' ' ' LEU . 9.4 m -65.95 -46.29 78.67 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.686 -0.487 . . . . 0.84 109.686 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.58 -49.07 71.24 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.742 0.246 . . . . 0.66 110.417 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.87 67.59 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.57 0.748 . . . . 0.74 110.556 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.0 tttp -57.17 -46.93 82.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.135 -0.484 . . . . 2.8 110.349 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -49.61 -63.29 1.15 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 118.643 -0.694 . . . . 2.69 111.108 171.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -57.97 -39.75 78.92 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 119.099 0.863 . . . . 2.61 111.321 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -58.11 -51.06 71.28 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.698 -0.482 . . . . 3.06 109.698 173.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -53.5 -43.14 68.04 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.11 0.414 . . . . 2.69 110.223 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 54' ' ' VAL . 47.1 t -60.68 -52.18 64.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 122.808 0.443 . . . . 0.36 111.28 174.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -53.84 -35.36 61.38 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.366 1.066 . . . . 1.86 111.515 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -72.53 10.26 0.87 Allowed 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 114.128 1.159 . . . . 2.75 114.128 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.0 mt -105.42 112.83 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.276 1.43 . . . . 1.23 110.714 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -52.59 -36.15 55.54 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 127.887 2.475 . . . . 3.62 113.758 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.2 -30.17 75.08 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.474 -0.785 . . . . 0.85 112.002 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.05 172.3 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 O-C-N 121.627 -0.925 . . . . 0.89 109.252 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.6 m -126.34 -59.83 1.29 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.466 -1.309 . . . . 0.66 107.466 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -122.58 164.2 18.59 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-O 121.351 0.596 . . . . 3.5 112.404 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.48 135.73 12.12 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.986 -0.746 . . . . 0.48 108.986 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.7 mm -118.82 102.39 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 105.389 -2.078 . . . . 2.11 105.389 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.51 118.93 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.651 -0.87 . . . . 2.01 108.651 -172.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -93.14 -49.35 6.03 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 108.857 -0.794 . . . . 2.3 108.857 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.484 ' CE2' HG21 ' A' ' 9' ' ' VAL . 12.0 m-85 60.18 -168.37 0.16 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.883 0.473 . . . . 3.09 111.771 176.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.32 -66.86 3.4 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.711 -0.956 . . . . 2.78 110.711 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.44 47.85 0.13 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.36 1.064 . . . . 2.01 108.765 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 m -143.72 -125.33 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.917 0.487 . . . . 2.61 110.968 -163.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.05 167.29 30.88 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.833 0.853 . . . . 3.92 109.885 -173.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.47 114.27 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 126.348 1.859 . . . . 0.89 107.541 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.1 m -91.55 136.26 33.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.37 -0.974 . . . . 0.44 108.37 171.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 t -119.96 147.93 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 126.584 1.954 . . . . 0.82 106.791 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.9 m -146.27 138.29 25.01 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.447 -1.316 . . . . 0.81 107.447 175.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.11 -91.84 0.15 Allowed Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 108.047 -2.021 . . . . 0.54 108.047 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -167.11 50.31 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.937 1.695 . . . . 2.31 109.196 173.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.12 178.05 8.87 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.968 -1.083 . . . . 0.49 110.821 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.2 m -138.21 171.37 14.5 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.21 1.404 . . . . 1.17 110.951 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -46.43 -47.41 6.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-O 116.68 -1.628 . . . . 2.74 110.875 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -33.18 -47.74 0.2 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 121.104 1.774 . . . . 2.96 114.155 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -70.16 -44.39 68.91 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.252 -0.905 . . . . 2.05 112.291 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 25' ' ' VAL . 13.7 t -58.47 -27.83 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.139 1.376 . . . . 0.37 111.547 169.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.29 -52.23 29.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.876 1.67 . . . . 2.99 106.747 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -54.15 -45.67 72.06 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.808 0.843 . . . . 3.9 110.403 174.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.8 -57.65 10.13 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.408 0.549 . . . . 0.45 110.658 169.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.11 -16.18 25.11 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 125.407 1.479 . . . . 0.31 113.713 -174.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -42.7 -29.47 0.3 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.18 -0.914 . . . . 0.49 112.544 166.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -52.97 -35.26 58.73 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.836 1.198 . . . . 1.9 113.411 175.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.8 -1.55 9.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.682 1.193 . . . . 2.48 112.264 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 65.06 55.6 1.11 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.732 1.213 . . . . 0.88 110.519 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.05 171.66 11.49 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.156 -0.965 . . . . 1.16 110.955 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -137.57 64.3 1.52 Allowed 'General case' 0 C--N 1.341 0.218 0 N-CA-C 107.731 -1.211 . . . . 4.79 107.731 -175.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mt -80.7 139.47 18.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 113.982 -1.463 . . . . 0.83 108.429 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.5 mt -128.0 133.25 24.93 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.436 1.094 . . . . 1.14 108.116 -174.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -64.52 109.0 1.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.323 2.016 . . . . 0.78 109.621 172.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -61.66 138.59 58.32 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.725 -0.472 . . . . 4.54 109.725 172.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -130.1 125.46 35.19 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.548 -1.649 . . . . 4.73 106.548 -177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -157.92 138.2 12.63 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.263 -2.125 . . . . 8.23 105.263 -177.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.254 0 C-N-CA 126.822 2.049 . . . . 9.19 105.529 -175.846 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mtt . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 106.712 -1.588 . . . . 11.13 106.712 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 178.98 127.88 0.07 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.339 1.856 . . . . 5.34 106.534 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.14 -178.95 1.05 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.328 2.251 . . . . 6.22 105.211 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.99 165.8 19.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.696 0.798 . . . . 3.79 109.77 170.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -150.25 148.4 28.84 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 105.838 -1.912 . . . . 0.65 105.838 170.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.67 147.64 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 124.204 0.94 . . . . 0.54 110.284 169.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -133.0 145.09 50.55 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.082 -1.451 . . . . 2.17 107.082 -173.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 50.8 mtm-85 -87.68 124.89 34.03 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 109.037 -0.727 . . . . 5.33 109.037 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.461 HG21 ' CE2' ' A' ' 38' ' ' PHE . 2.4 p -109.74 152.91 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.056 0 N-CA-C 108.638 -0.875 . . . . 0.55 108.638 172.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.418 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . 57.2 t0 -147.37 166.81 26.02 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.284 -1.376 . . . . 2.35 107.284 177.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.6 -68.34 0.28 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.236 0.922 . . . . 1.61 112.14 171.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 12' ' ' LEU . 1.3 pp -73.41 157.94 35.94 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 117.833 0.817 . . . . 2.68 110.347 -175.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.0 m -152.25 69.9 0.9 Allowed 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.92 0.488 . . . . 3.31 110.199 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.2 t -157.86 121.87 4.15 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.045 0.538 . . . . 1.82 110.775 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 m -47.18 -44.26 21.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.205 1.402 . . . . 1.39 111.947 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -53.52 -43.92 68.7 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.888 0.475 . . . . 3.02 110.787 178.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.443 ' HB3' HD22 ' A' ' 12' ' ' LEU . 4.1 m -70.43 -39.73 74.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.386 -0.34 . . . . 0.85 110.369 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.01 -44.64 78.86 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.681 0.673 . . . . 0.56 110.766 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.39 -49.12 72.85 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.345 0.658 . . . . 0.58 110.683 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -49.53 -49.38 46.27 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.494 0.717 . . . . 2.7 109.227 173.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -56.93 -63.43 1.21 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 118.449 -0.786 . . . . 2.77 111.646 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -40.17 74.76 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 119.173 -1.011 . . . . 2.47 110.671 -172.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -59.32 -51.71 68.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.216 0.207 . . . . 2.74 111.232 174.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.55 HD22 ' HB1' ' A' ' 57' ' ' ALA . 1.9 m120 -52.24 -45.77 65.46 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.76 -0.588 . . . . 1.61 110.702 175.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.0 t -65.51 -45.33 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.095 0.558 . . . . 0.55 110.399 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -54.03 -38.44 65.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.293 1.037 . . . . 2.04 110.867 173.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -70.33 -0.61 8.45 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.864 1.061 . . . . 2.99 113.864 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.9 mm -85.6 134.08 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 120.837 1.653 . . . . 2.11 110.287 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -74.74 124.7 27.25 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.839 1.656 . . . . 4.11 109.316 167.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.91 -39.86 1.95 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.578 1.085 . . . . 1.1 110.955 171.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.03 159.08 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 O-C-N 121.871 -0.782 . . . . 0.59 109.311 173.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.7 m -116.17 -55.68 2.38 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.871 1.668 . . . . 0.74 107.856 177.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -127.23 147.29 50.22 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.416 0.447 . . . . 2.89 110.554 170.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.79 140.53 40.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.719 -1.215 . . . . 0.51 107.719 166.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.6 mt -125.25 109.92 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 N-CA-C 106.451 -1.685 . . . . 1.42 106.451 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.78 129.96 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 123.106 0.253 . . . . 1.94 110.788 -171.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -120.7 57.53 0.97 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.034 -1.469 . . . . 1.92 107.034 169.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.461 ' CE2' HG21 ' A' ' 9' ' ' VAL . 72.6 m-85 -62.91 135.66 57.43 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 108.432 -0.951 . . . . 3.4 108.432 170.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.25 -56.75 0.5 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 109.214 -1.555 . . . . 2.84 109.214 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -171.78 53.98 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.68 1.192 . . . . 2.04 108.404 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.4 m -156.78 -112.77 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.898 -0.501 . . . . 2.59 111.659 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.34 168.54 25.03 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.692 -0.63 . . . . 4.05 111.669 -163.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.08 113.99 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.773 -1.195 . . . . 0.77 107.773 -176.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.8 m -91.88 141.58 28.49 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.49 1.116 . . . . 0.48 109.066 174.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.8 t -129.34 138.38 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 104.744 -2.317 . . . . 0.84 104.744 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.2 m -147.61 132.46 18.03 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 106.391 -1.707 . . . . 0.67 106.391 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.87 -95.82 0.17 Allowed Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 106.651 -2.579 . . . . 0.57 106.651 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.63 63.59 0.11 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.086 1.754 . . . . 3.81 108.53 174.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.22 164.69 36.84 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.075 -1.016 . . . . 0.5 110.629 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.0 m -118.26 162.61 17.98 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 125.939 1.696 . . . . 0.68 110.65 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 tp -54.02 -31.84 21.83 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 CA-C-O 117.466 -1.254 . . . . 1.77 112.632 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -32.17 -48.57 0.17 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.89 1.276 . . . . 3.6 111.953 175.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -59.83 -52.5 65.18 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.92 0.867 . . . . 2.34 111.465 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.06 -42.41 96.52 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 C-N-CA 125.44 1.496 . . . . 0.44 110.699 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -61.99 -48.96 78.01 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.049 1.34 . . . . 2.93 108.644 178.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -56.12 -51.59 67.39 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.162 0.585 . . . . 3.31 110.35 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.55 ' HB1' HD22 ' A' ' 24' ' ' ASN . . . -48.51 -52.98 19.83 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.654 0.661 . . . . 0.37 110.835 168.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.46 -18.4 29.67 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 125.382 1.468 . . . . 0.31 113.414 -177.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.23 -22.77 1.11 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.543 1.171 . . . . 0.47 112.335 170.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -55.49 -32.11 62.58 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 120.167 1.348 . . . . 1.89 112.894 172.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.91 -25.21 6.83 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.127 1.371 . . . . 2.16 111.657 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 83.48 60.41 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.674 2.39 . . . . 0.74 111.363 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.16 165.72 22.16 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.119 -0.988 . . . . 1.32 111.73 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.418 ' HD2' ' HB3' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -121.04 111.72 17.82 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.966 -1.494 . . . . 4.9 106.966 175.073 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.08 127.6 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 108.845 -0.798 . . . . 0.51 108.845 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.9 mm -111.64 125.3 30.63 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.027 1.331 . . . . 1.42 108.796 -172.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.14 92.24 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.04 2.493 . . . . 0.7 110.032 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -61.28 116.2 4.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.531 0.681 . . . . 3.91 111.002 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -95.0 80.47 3.64 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.6 -1.259 . . . . 5.1 107.6 170.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -61.39 128.24 35.37 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.086 -1.079 . . . . 8.86 108.086 173.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.362 0 N-CA-C 105.765 -1.939 . . . . 8.56 105.765 -169.381 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.1 mtm . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 106.507 -1.664 . . . . 7.97 106.507 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.01 -63.55 0.64 Allowed 'General case' 0 C--O 1.227 -0.083 0 O-C-N 124.482 1.114 . . . . 5.4 108.573 -175.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 62.32 -140.25 0.43 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.218 1.007 . . . . 6.61 111.295 173.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -123.76 148.67 46.43 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.073 1.749 . . . . 3.81 108.117 -178.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.9 m -147.46 150.64 34.99 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 108.234 -1.025 . . . . 0.67 108.234 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -135.36 132.88 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 124.337 1.023 . . . . 0.71 111.114 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -115.57 153.65 30.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.772 1.629 . . . . 2.02 108.012 -169.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -92.89 112.72 24.78 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.484 -0.932 . . . . 4.1 108.484 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.9 p -96.18 144.03 11.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.572 1.149 . . . . 0.51 109.055 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -141.93 163.39 33.02 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.541 -0.541 . . . . 2.96 109.541 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.4 -70.26 0.24 Allowed Glycine 0 CA--C 1.528 0.906 0 C-N-CA 126.013 1.768 . . . . 1.55 111.024 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.94 173.3 8.99 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.388 0.884 . . . . 2.54 113.388 -170.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.1 p -167.06 82.63 0.23 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.846 0.859 . . . . 2.73 109.716 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.01 133.03 4.39 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.763 0.711 . . . . 2.03 112.422 176.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.4 m -54.59 -46.72 73.81 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.573 1.149 . . . . 1.5 111.71 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -59.42 -36.59 76.16 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.985 0.898 . . . . 3.21 111.142 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.9 m -69.79 -45.37 68.12 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 108.822 -0.807 . . . . 1.17 108.822 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.56 -43.85 68.82 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 122.759 0.424 . . . . 0.66 110.419 174.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.68 -55.21 37.83 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.471 0.708 . . . . 0.64 109.515 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -54.88 -41.09 70.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.53 -0.304 . . . . 2.88 111.037 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.522 ' CZ ' HG12 ' A' ' 54' ' ' VAL . 2.2 t80 -64.6 -60.16 3.45 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 119.403 -0.332 . . . . 2.44 111.096 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.31 -40.93 75.15 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 118.429 0.559 . . . . 2.52 109.781 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -57.97 -54.53 45.86 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.059 0.943 . . . . 2.76 109.352 175.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -49.67 -51.71 36.19 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.422 0.556 . . . . 1.95 109.851 176.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.581 HG22 HG22 ' A' ' 54' ' ' VAL . 32.5 t -55.5 -52.65 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 110.26 -0.274 . . . . 0.4 110.26 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -51.05 -39.24 55.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.194 1.398 . . . . 1.63 112.383 174.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -71.88 -14.17 61.87 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.057 0.762 . . . . 2.07 113.057 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.687 HG22 ' H ' ' A' ' 30' ' ' GLY . 17.0 mt -77.55 131.47 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 120.531 1.514 . . . . 1.33 108.761 171.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -77.22 -9.5 58.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.447 1.099 . . . . 2.44 113.75 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.687 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -78.91 -30.91 45.56 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.768 0.699 . . . . 0.81 112.09 -178.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.454 HG11 HG12 ' A' ' 25' ' ' VAL . 12.1 p -97.36 158.67 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 121.377 -1.072 . . . . 0.61 109.42 -178.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.0 m -106.08 -55.0 2.39 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.677 -1.231 . . . . 0.6 107.677 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -129.32 154.62 46.69 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.758 -0.46 . . . . 2.92 109.758 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.72 143.9 23.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.892 -0.781 . . . . 0.44 108.892 173.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.5 mt -127.5 105.77 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.313 -1.366 . . . . 1.48 107.313 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.57 125.95 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.507 -0.923 . . . . 2.56 108.507 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -86.44 -57.74 2.88 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.408 1.004 . . . . 2.79 109.94 169.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 57.81 -171.91 0.1 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.273 0.629 . . . . 2.6 109.87 -162.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.28 35.79 88.52 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 121.62 -0.675 . . . . 2.49 111.48 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 69.88 72.26 0.23 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.548 1.539 . . . . 2.42 108.472 177.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 m -155.24 -109.3 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.445 -0.798 . . . . 2.55 109.898 -176.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.77 167.85 28.38 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 122.948 0.499 . . . . 3.56 110.637 -170.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.52 120.39 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.632 1.173 . . . . 0.72 108.892 174.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.7 m -98.09 145.29 26.7 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.408 1.083 . . . . 0.54 111.177 177.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.75 140.55 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 127.563 2.345 . . . . 0.61 107.551 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.1 m -148.5 89.66 1.72 Allowed 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 124.971 1.309 . . . . 1.08 108.486 -177.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.89 -106.98 0.19 Allowed Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 108.51 -1.836 . . . . 0.72 108.51 175.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -151.92 62.77 0.85 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.706 1.202 . . . . 3.61 108.114 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.15 162.61 36.65 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.121 0.969 . . . . 0.67 110.071 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -119.5 162.14 19.39 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.884 1.673 . . . . 0.62 109.043 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.0 tp -52.67 -33.51 18.5 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 CA-C-O 117.231 -1.366 . . . . 1.64 112.012 -176.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.3 mm-40 -28.7 -53.41 0.11 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.67 1.588 . . . . 2.53 112.802 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -69.09 -41.87 76.92 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.574 0.702 . . . . 2.39 111.708 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.581 HG22 HG22 ' A' ' 25' ' ' VAL . 33.9 t -66.99 -38.04 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.278 1.031 . . . . 0.31 110.272 178.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -60.98 -49.76 76.14 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.229 1.812 . . . . 2.85 108.512 174.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -52.53 -51.62 58.73 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.83 0.452 . . . . 3.31 110.142 175.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.5 -48.61 62.85 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.627 0.649 . . . . 0.37 111.188 170.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.32 -9.64 6.42 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.918 -0.935 . . . . 0.35 114.036 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.91 -25.66 0.83 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 119.176 1.488 . . . . 0.53 112.682 170.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -53.73 -36.35 62.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.81 1.186 . . . . 2.0 113.235 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -121.0 -5.93 9.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.217 1.007 . . . . 2.61 112.894 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 67.46 50.57 0.92 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.75 1.22 . . . . 0.79 110.417 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -72.35 168.01 19.28 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.532 -0.73 . . . . 1.36 112.158 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.07 124.49 40.73 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.195 -1.78 . . . . 4.36 106.195 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.0 mt -130.85 134.49 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.708 1.203 . . . . 0.57 107.913 -175.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.6 mt -113.98 121.79 36.07 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.756 1.222 . . . . 1.47 108.169 -172.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -77.37 70.73 6.68 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 124.227 3.284 . . . . 1.41 109.5 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 46.92 -167.91 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.057 1.743 . . . . 6.96 112.913 -167.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? 62.58 122.06 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.053 1.341 . . . . 9.11 112.368 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -51.82 134.9 30.62 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.453 -0.943 . . . . 10.54 108.453 164.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.148 0 CA-C-O 116.813 -1.565 . . . . 14.22 109.464 -175.681 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 mtt . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 106.901 -1.518 . . . . 9.51 106.901 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.1 -72.08 0.02 OUTLIER 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 125.03 1.332 . . . . 5.89 107.584 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 59.03 -151.16 0.43 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.17 0.988 . . . . 5.23 110.384 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -99.1 156.35 16.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.059 -1.089 . . . . 3.75 108.059 168.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.1 m -150.2 147.19 27.4 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 107.766 -1.198 . . . . 0.53 107.766 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -123.02 143.84 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 124.947 1.404 . . . . 0.38 110.318 171.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -129.8 153.42 48.26 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.023 -1.843 . . . . 1.9 106.023 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -95.42 147.95 22.98 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.583 0.629 . . . . 3.92 110.156 173.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.34 121.7 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 123.045 0.538 . . . . 0.97 110.684 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.04 -173.45 2.31 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.069 0.548 . . . . 2.81 111.449 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.43 -46.94 3.34 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.666 1.603 . . . . 1.34 113.427 170.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.476 HD22 ' CD1' ' A' ' 38' ' ' PHE . 3.2 pp -50.13 156.8 0.74 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.874 1.269 . . . . 3.3 113.495 178.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 t -167.55 51.21 0.06 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.88 0.472 . . . . 2.83 111.221 173.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.1 t -159.16 117.74 2.9 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 120.807 -1.183 . . . . 2.2 112.854 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 m -53.04 -41.96 65.26 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.191 0.996 . . . . 1.65 112.212 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -57.25 -39.74 76.2 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.67 0.747 . . . . 3.15 109.982 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.0 m -69.39 -43.83 72.7 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.866 -0.606 . . . . 0.92 109.947 175.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.462 ' HB2' ' CG ' ' A' ' 38' ' ' PHE . . . -49.28 -48.57 45.9 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.062 0.545 . . . . 0.63 110.84 176.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.27 -48.86 80.04 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.573 -0.739 . . . . 0.51 109.879 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -58.51 -38.42 77.66 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.022 -0.535 . . . . 3.34 110.532 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.525 ' O ' HG23 ' A' ' 25' ' ' VAL . 2.2 t80 -58.07 -60.52 3.62 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.45 0.7 . . . . 2.72 109.758 174.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -55.8 -45.04 78.35 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.278 0.49 . . . . 2.47 110.029 -175.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -64.06 -47.26 80.84 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.022 -0.535 . . . . 2.76 109.808 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -52.46 -46.39 66.47 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.918 -0.401 . . . . 1.33 109.918 173.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 21' ' ' PHE . 15.4 t -60.33 -50.16 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 118.314 0.507 . . . . 0.49 109.727 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -51.63 -34.83 39.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.899 0.88 . . . . 1.42 112.996 173.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -67.26 -22.81 65.65 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.875 0.761 . . . . 3.03 112.533 176.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.665 HG22 ' H ' ' A' ' 30' ' ' GLY . 25.1 mt -70.74 133.18 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.596 1.089 . . . . 1.5 109.213 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -77.66 -17.35 57.8 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.557 1.143 . . . . 2.94 113.093 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.665 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -83.48 -11.44 80.15 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.379 0.99 . . . . 1.03 113.768 -176.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.3 p -115.06 153.18 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 118.59 1.195 . . . . 0.66 108.949 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.8 m -103.1 -51.56 3.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.23 -1.026 . . . . 0.6 108.23 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -132.38 161.08 34.51 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.837 0.351 . . . . 2.1 110.278 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.77 138.05 16.6 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.874 -1.158 . . . . 0.42 107.874 174.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 22.0 mm -126.55 102.81 10.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 106.839 -1.541 . . . . 2.03 106.839 -177.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.2 p -98.42 144.38 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 122.507 0.323 . . . . 2.04 110.658 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -137.17 71.91 1.41 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.803 -0.814 . . . . 2.87 108.803 173.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.476 ' CD1' HD22 ' A' ' 12' ' ' LEU . 2.7 m-30 -44.68 -31.13 1.07 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.528 1.531 . . . . 3.35 111.876 167.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.49 -22.22 23.26 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.035 -0.87 . . . . 3.31 112.768 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.6 -103.3 0.41 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.408 1.104 . . . . 3.48 108.678 161.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.3 m -159.66 51.89 0.35 Allowed 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.32 -0.993 . . . . 5.22 108.32 -175.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -145.69 142.54 29.1 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.044 1.293 . . . . 5.24 112.407 -170.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.78 119.33 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.105 1.362 . . . . 0.74 110.151 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 m -98.56 139.96 33.5 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.941 1.296 . . . . 0.42 110.225 172.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.5 t -122.29 140.66 45.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 127.806 2.442 . . . . 0.74 105.576 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.5 m -147.22 85.72 1.61 Allowed 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 121.134 -0.979 . . . . 1.03 108.424 -173.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.88 -106.87 0.19 Allowed Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 109.43 -1.468 . . . . 0.67 109.43 176.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -152.21 54.87 0.81 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.733 0.813 . . . . 2.14 108.958 170.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.77 163.6 33.55 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.425 -0.797 . . . . 0.6 110.497 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.5 m -109.57 161.42 15.37 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.337 1.455 . . . . 0.85 110.136 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.0 tp -50.74 -31.63 9.96 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 CA-C-O 117.314 -1.327 . . . . 1.74 113.321 -178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -29.86 -50.04 0.11 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.07 1.348 . . . . 3.69 112.475 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -63.93 -45.49 89.02 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 122.025 0.917 . . . . 2.37 111.604 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.43 HG22 HG22 ' A' ' 25' ' ' VAL . 28.0 t -69.57 -30.73 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.507 1.123 . . . . 0.43 110.48 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -61.7 -50.06 73.97 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.046 -1.094 . . . . 3.19 108.046 172.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -51.97 -50.87 60.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.837 0.455 . . . . 3.1 110.617 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.14 -52.24 36.78 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.856 -0.527 . . . . 0.81 111.13 170.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.07 -22.31 35.09 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 126.002 1.763 . . . . 0.41 112.952 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -47.38 -31.49 4.08 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.733 1.266 . . . . 0.44 112.368 171.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.57 -36.32 55.72 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.314 0.961 . . . . 2.13 113.113 175.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -130.35 4.62 4.75 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.255 1.022 . . . . 3.08 112.122 -173.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 61.82 54.75 2.8 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.597 1.559 . . . . 0.86 112.884 171.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.412 ' H ' HD22 ' A' ' 63' ' ' LEU . 1.6 mm? -80.17 -176.96 5.84 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.344 -0.542 . . . . 1.11 110.801 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -144.87 87.72 1.86 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.328 -1.73 . . . . 4.3 106.328 -176.285 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 mt -89.0 132.31 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.858 1.263 . . . . 0.9 109.9 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.7 mp -129.17 136.54 29.32 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.539 1.136 . . . . 1.44 109.025 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -72.51 64.93 3.76 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.812 3.008 . . . . 1.03 110.847 174.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -60.47 145.52 48.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.24 0.616 . . . . 6.4 109.928 170.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -152.79 159.72 43.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.912 -1.144 . . . . 7.04 107.912 176.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -148.98 -68.33 0.22 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 105.976 -1.861 . . . . 9.68 105.976 -175.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.288 0 N-CA-C 105.932 -1.877 . . . . 9.81 105.932 146.721 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 106.185 -1.783 . . . . 9.8 106.185 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 30.33 65.75 0.14 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.46 1.904 . . . . 7.08 113.233 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -58.31 178.71 0.09 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 122.6 1.191 . . . . 4.99 111.828 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -75.51 144.24 42.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.987 -1.006 . . . . 4.23 109.699 -169.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.0 m -146.84 143.72 28.78 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.44 -0.948 . . . . 0.74 108.44 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -116.34 134.44 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 124.869 1.356 . . . . 0.69 110.505 168.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -116.13 163.26 16.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.791 1.636 . . . . 2.08 106.593 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -106.21 131.41 53.49 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 118.619 -0.705 . . . . 3.84 110.39 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 p -116.87 142.64 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.366 -0.976 . . . . 0.42 108.366 -174.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -142.93 166.64 24.09 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.756 0.707 . . . . 2.9 109.885 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.25 66.0 3.0 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.464 1.507 . . . . 3.12 112.379 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.578 HD13 ' H ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -129.16 167.96 16.84 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.774 1.63 . . . . 2.68 109.712 175.411 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 m -64.41 -82.66 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.302 0.482 . . . . 6.73 112.302 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -172.71 -167.52 0.44 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.372 -0.83 . . . . 4.39 109.911 -175.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.7 t -47.95 -36.72 12.98 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.417 1.487 . . . . 2.35 112.969 -176.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -52.49 -50.93 61.76 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.929 0.871 . . . . 3.68 110.385 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.5 m -71.89 -32.66 67.63 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.909 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.71 -46.86 74.26 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 118.581 0.628 . . . . 0.59 110.044 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -49.99 75.43 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.495 -0.775 . . . . 0.58 109.085 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -53.65 -41.86 67.22 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.415 -0.357 . . . . 2.33 110.686 175.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -63.76 -57.39 10.08 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.362 0.665 . . . . 2.82 110.549 179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -55.16 -45.3 75.71 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.61 0.641 . . . . 2.53 109.609 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -60.82 -52.15 66.29 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.407 0.683 . . . . 3.71 109.462 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -48.78 -49.87 36.71 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 123.335 0.654 . . . . 2.01 109.961 176.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.496 HG22 HG22 ' A' ' 54' ' ' VAL . 38.8 t -61.65 -50.76 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 120.392 -0.523 . . . . 0.43 109.938 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -50.31 -33.92 21.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.187 0.995 . . . . 1.52 113.113 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -69.91 -22.39 63.21 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.459 0.704 . . . . 2.74 112.614 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.61 HG22 ' H ' ' A' ' 30' ' ' GLY . 21.9 mt -76.97 138.95 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.674 1.124 . . . . 1.2 109.18 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -82.47 -21.12 35.7 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.33 1.052 . . . . 2.36 113.402 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.61 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -68.86 -31.11 72.52 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 123.845 0.736 . . . . 1.0 112.503 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 32' ' ' THR . 9.8 p -95.01 -178.95 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 124.846 1.258 . . . . 0.7 109.222 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.43 ' H ' HG22 ' A' ' 31' ' ' VAL . 82.9 m -141.83 -57.95 0.47 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.372 1.069 . . . . 0.98 109.062 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.79 148.91 35.72 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-O 121.169 0.509 . . . . 2.56 110.228 172.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.11 124.0 11.3 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.729 -1.211 . . . . 0.83 107.729 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.0 mt -128.49 98.95 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 107.653 -1.24 . . . . 1.33 107.653 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 p -96.4 138.22 22.24 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 C-N-CA 122.85 0.46 . . . . 2.17 110.541 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -130.06 73.08 1.51 Allowed 'General case' 0 C--O 1.232 0.176 0 N-CA-C 107.952 -1.129 . . . . 2.45 107.952 166.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.439 ' CD2' HD23 ' A' ' 12' ' ' LEU . 3.3 m-30 -49.48 -25.02 2.32 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 125.794 1.638 . . . . 2.76 112.251 165.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.14 -20.1 33.99 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 120.814 -0.708 . . . . 3.52 111.988 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.75 -105.99 0.38 Allowed 'General case' 0 C--N 1.344 0.331 0 CA-C-N 118.155 0.977 . . . . 3.83 109.223 161.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.5 m -159.47 60.51 0.39 Allowed 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.019 -1.475 . . . . 4.89 107.019 -172.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -152.35 140.84 20.69 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.611 0.641 . . . . 4.77 111.547 -176.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.9 106.91 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.226 1.411 . . . . 0.72 109.18 -177.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.2 m -84.39 134.12 34.49 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.67 1.188 . . . . 0.79 109.718 174.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.02 138.94 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.294 1.838 . . . . 0.68 106.67 171.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.5 m -148.71 136.58 20.74 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.045 -1.465 . . . . 0.94 107.045 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.74 -94.38 0.15 Allowed Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 106.188 -2.765 . . . . 0.63 106.188 173.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -159.97 49.16 0.29 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.27 0.628 . . . . 2.37 110.383 169.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.6 172.91 12.56 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.516 -0.74 . . . . 0.59 112.035 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.8 m -127.29 164.93 20.67 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.785 1.634 . . . . 0.58 111.316 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 tp -53.75 -28.54 16.66 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-O 117.846 -1.073 . . . . 1.8 113.228 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -32.48 -51.09 0.26 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.542 1.137 . . . . 2.2 111.831 171.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -68.91 -41.76 77.77 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.416 0.627 . . . . 2.5 111.601 -177.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.496 HG22 HG22 ' A' ' 25' ' ' VAL . 37.1 t -67.1 -37.13 78.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 123.691 0.796 . . . . 0.38 110.224 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -57.32 -54.5 46.05 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.496 1.518 . . . . 3.16 108.05 173.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.82 -53.68 49.07 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 110.081 -0.34 . . . . 3.08 110.081 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.46 -47.96 62.94 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.159 0.504 . . . . 0.51 111.161 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.23 -18.34 4.74 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 126.348 1.927 . . . . 0.5 113.208 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.97 -24.26 0.58 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.555 1.678 . . . . 0.74 112.837 171.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -53.96 -34.39 59.6 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.88 1.218 . . . . 2.24 113.35 172.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -120.84 -19.38 7.33 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.316 1.446 . . . . 2.67 112.394 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 73.71 55.45 0.1 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.415 1.886 . . . . 1.04 110.856 -177.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.26 166.42 23.49 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.279 -0.888 . . . . 1.39 111.079 -176.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.51 120.06 34.77 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.568 -1.271 . . . . 4.16 107.568 169.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.45 140.28 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 125.001 1.321 . . . . 0.64 108.049 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.77 131.93 24.1 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.288 1.035 . . . . 1.59 108.602 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.08 97.35 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.567 2.178 . . . . 0.76 108.998 170.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -47.85 -47.91 31.32 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.758 0.823 . . . . 3.32 111.107 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? 71.55 -65.58 0.34 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.848 1.659 . . . . 4.51 111.157 173.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -168.24 -53.55 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.051 1.34 . . . . 7.42 108.68 173.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.409 0 N-CA-C 105.107 -2.183 . . . . 8.6 105.107 179.639 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.0 mtt . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 107.299 -1.371 . . . . 13.66 107.299 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.45 -99.35 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 105.542 -2.022 . . . . 5.88 105.542 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -116.89 150.29 38.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.251 0.932 . . . . 7.38 109.086 166.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -155.35 133.35 11.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.251 1.02 . . . . 4.19 108.425 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.0 m -156.15 154.18 30.45 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 107.75 -1.204 . . . . 0.52 107.75 -173.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -129.36 143.15 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 124.499 1.125 . . . . 0.4 110.931 170.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -128.22 147.86 50.6 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.169 1.388 . . . . 1.83 107.574 -175.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -88.75 132.77 34.47 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.623 0.647 . . . . 6.03 109.392 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 p -109.62 148.95 12.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.9 1.28 . . . . 0.63 107.792 172.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.27 160.82 42.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.784 -0.821 . . . . 2.69 108.784 168.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.15 34.53 5.86 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.116 0.865 . . . . 1.99 113.785 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.96 171.5 20.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.362 1.081 . . . . 2.18 109.814 169.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.1 t -171.08 60.24 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.849 0.86 . . . . 3.53 110.404 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -142.58 121.69 12.93 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.503 0.592 . . . . 2.29 110.854 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m -51.57 -50.14 60.69 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.328 1.051 . . . . 1.28 111.321 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -54.11 -44.4 71.23 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.978 -0.451 . . . . 2.68 110.803 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.1 m -64.92 -46.67 80.68 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.942 -0.392 . . . . 0.82 109.942 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.87 74.73 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.918 0.487 . . . . 0.59 111.195 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.04 -49.18 66.03 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.587 0.755 . . . . 0.77 110.185 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -52.32 -47.84 65.77 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.642 -0.503 . . . . 2.64 109.642 173.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.17 -57.53 10.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.104 0.562 . . . . 2.28 110.93 174.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -56.63 -44.57 81.38 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.722 0.692 . . . . 2.39 110.089 -174.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -59.87 -53.86 52.97 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 108.834 -0.802 . . . . 5.57 108.834 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -44.94 -49.16 11.26 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.401 1.08 . . . . 1.76 110.342 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 54' ' ' VAL . 59.5 t -60.39 -52.21 64.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 110.298 -0.26 . . . . 0.38 110.298 175.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -53.18 -31.88 45.03 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.277 0.843 . . . . 1.37 113.277 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -70.33 -15.42 62.87 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.388 0.994 . . . . 2.28 113.094 175.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.5 mt -71.99 115.92 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-O 122.474 1.13 . . . . 1.31 109.445 178.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.08 95.12 0.16 Allowed 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.76 1.624 . . . . 2.61 108.941 171.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.84 -36.74 0.72 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.227 -0.749 . . . . 1.39 111.227 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.2 p -79.67 155.25 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 121.677 -0.896 . . . . 0.84 109.757 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.2 m -109.44 -58.55 2.02 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.529 1.132 . . . . 0.81 108.133 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -123.74 157.74 33.29 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.206 0.527 . . . . 2.94 111.343 173.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.43 134.99 20.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.97 -1.493 . . . . 0.55 106.97 167.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.8 mt -124.85 102.61 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 104.541 -2.392 . . . . 1.71 104.541 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.458 HG12 HG12 ' A' ' 43' ' ' ILE . 2.0 m -117.14 133.05 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 110.328 -0.249 . . . . 2.4 110.328 -167.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -92.06 -53.37 4.28 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.358 -0.608 . . . . 2.88 109.358 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 47.1 58.81 4.48 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.226 1.011 . . . . 3.17 112.165 -176.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.04 71.48 0.11 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.503 -1.439 . . . . 2.56 109.503 173.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 62.7 51.11 3.19 Favored 'General case' 0 C--O 1.228 -0.061 0 C-N-CA 124.904 1.282 . . . . 2.28 108.856 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.0 m -155.53 -121.44 0.03 OUTLIER 'General case' 0 C--O 1.235 0.311 0 CA-C-O 118.338 -0.839 . . . . 2.51 109.479 -172.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -156.32 165.91 34.97 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.961 0.8 . . . . 3.97 112.199 -170.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -128.2 115.89 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 126.663 1.985 . . . . 0.98 107.706 -178.401 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.9 m -97.1 137.45 36.14 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.974 0.909 . . . . 0.44 109.026 173.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.18 143.98 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 126.564 1.946 . . . . 0.79 106.325 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 m -146.1 130.74 17.9 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 106.669 -1.604 . . . . 0.64 106.669 178.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 147.23 -101.52 0.23 Allowed Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 105.888 -2.885 . . . . 0.53 105.888 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -163.57 56.94 0.17 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.719 1.608 . . . . 2.29 109.069 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.09 164.21 31.31 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.155 0.982 . . . . 0.9 109.16 173.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.3 m -131.26 163.38 27.92 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.662 1.185 . . . . 0.87 111.211 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.573 HD11 HD12 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -45.83 -48.73 4.86 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.859 0 CA-C-O 117.19 -1.386 . . . . 2.62 111.178 -174.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -30.97 -50.91 0.15 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.296 1.438 . . . . 2.85 113.318 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -66.15 -44.66 83.49 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 122.027 0.917 . . . . 3.5 110.67 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 25' ' ' VAL . 24.5 t -65.89 -33.37 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.815 1.246 . . . . 0.38 110.63 174.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.85 -55.35 36.02 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.951 -1.5 . . . . 4.0 106.951 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -51.55 -45.74 63.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.901 -1.045 . . . . 3.28 110.837 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.88 -53.95 52.12 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.706 0.685 . . . . 0.37 111.138 171.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.85 -20.51 19.36 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 125.179 1.371 . . . . 0.29 112.703 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.81 -22.48 0.31 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.418 1.109 . . . . 0.44 113.156 168.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -53.76 -31.66 49.41 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.223 1.374 . . . . 1.9 112.825 171.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -128.62 -10.85 5.02 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.463 1.505 . . . . 2.93 112.593 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 74.59 60.57 0.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.631 1.973 . . . . 0.89 111.507 172.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -84.35 -179.05 7.1 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.469 -0.769 . . . . 1.25 112.429 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.22 110.22 8.25 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 105.872 -1.899 . . . . 4.22 105.872 176.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.573 HD12 HD11 ' A' ' 51' ' ' ILE . 0.9 OUTLIER -117.12 135.65 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.908 -1.145 . . . . 0.56 107.908 -179.293 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.22 137.15 29.39 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.818 1.247 . . . . 1.1 108.967 -169.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.77 89.82 0.63 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.193 2.595 . . . . 1.12 111.184 174.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -56.97 84.48 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.579 1.951 . . . . 3.7 111.156 171.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -152.87 102.68 2.7 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.418 0.687 . . . . 4.64 109.302 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 56.27 71.43 0.56 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.271 1.428 . . . . 7.69 111.28 174.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 N-CA-C 105.374 -2.084 . . . . 10.72 105.374 176.46 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 106.227 -1.768 . . . . 9.79 106.227 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 29.51 65.95 0.12 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.495 1.918 . . . . 7.1 113.349 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -58.91 179.12 0.09 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 122.548 1.166 . . . . 4.96 111.792 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -75.66 144.35 41.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.096 -0.956 . . . . 4.22 109.697 -169.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.1 m -147.11 143.65 28.45 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.471 -0.937 . . . . 0.74 108.471 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -116.37 134.64 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 O-C-N 124.899 1.374 . . . . 0.69 110.454 168.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -116.41 163.12 16.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.522 -1.659 . . . . 2.07 106.522 -177.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -106.55 131.06 54.15 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 118.644 -0.693 . . . . 3.84 110.323 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 p -117.12 142.63 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 108.354 -0.98 . . . . 0.43 108.354 -173.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -143.34 166.84 23.63 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.752 0.706 . . . . 2.91 109.648 176.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.73 64.77 3.81 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.421 1.486 . . . . 3.12 112.339 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.578 HD13 ' H ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -128.64 167.55 17.03 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.799 1.639 . . . . 2.69 109.748 175.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.4 m -64.88 -82.35 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.254 0.464 . . . . 6.71 112.254 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -172.46 -167.67 0.47 Allowed 'General case' 0 C--N 1.344 0.333 0 O-C-N 121.323 -0.861 . . . . 4.38 110.06 -175.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.0 t -48.28 -36.55 14.32 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.339 1.456 . . . . 2.35 113.021 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -52.63 -50.73 62.56 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.949 0.88 . . . . 3.65 110.349 176.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.7 m -71.81 -33.07 68.23 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.744 -0.662 . . . . 0.98 110.823 176.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.56 -47.1 73.64 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 118.46 0.573 . . . . 0.59 110.035 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.46 -50.09 74.97 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.571 -0.741 . . . . 0.59 109.072 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -53.53 -41.68 66.64 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.44 -0.345 . . . . 2.34 110.758 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -63.84 -57.22 10.53 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.478 0.711 . . . . 2.81 110.561 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -55.25 -45.16 76.06 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 118.61 0.641 . . . . 2.53 109.674 -177.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -60.7 -52.29 65.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.307 0.643 . . . . 3.7 109.378 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -48.75 -49.88 36.3 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.351 0.661 . . . . 2.0 109.908 176.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 54' ' ' VAL . 39.0 t -61.71 -50.88 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 120.499 -0.48 . . . . 0.42 109.912 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 55.4 mttt -50.61 -33.43 22.13 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.128 0.971 . . . . 1.52 113.214 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -69.97 -22.3 63.16 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.498 0.719 . . . . 2.71 112.582 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.6 HG22 ' H ' ' A' ' 30' ' ' GLY . 21.9 mt -77.25 139.29 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 119.64 1.109 . . . . 1.2 109.232 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -82.83 -21.1 34.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.283 1.033 . . . . 2.37 113.419 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.6 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -68.97 -31.23 72.36 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.9 0.762 . . . . 0.99 112.359 -178.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 ' H ' ' A' ' 32' ' ' THR . 9.8 p -94.41 -177.61 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.855 1.262 . . . . 0.72 109.104 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.452 ' H ' HG22 ' A' ' 31' ' ' VAL . 62.2 m -143.91 -57.47 0.39 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.04 -1.037 . . . . 1.0 109.092 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -113.97 149.25 35.58 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-O 121.236 0.541 . . . . 2.59 110.251 171.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.4 124.51 11.43 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.791 -1.188 . . . . 0.82 107.791 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.91 99.13 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 107.692 -1.225 . . . . 1.33 107.692 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 p -96.07 138.67 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 C-N-CA 122.807 0.443 . . . . 2.18 110.429 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -130.51 73.02 1.51 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.945 -1.131 . . . . 2.45 107.945 166.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.441 ' CD2' HD23 ' A' ' 12' ' ' LEU . 3.2 m-30 -49.32 -25.6 2.53 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.812 1.645 . . . . 2.76 112.225 165.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.99 -20.12 32.94 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 120.884 -0.674 . . . . 3.52 112.02 176.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.4 -105.43 0.39 Allowed 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.104 0.952 . . . . 3.85 109.321 161.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.5 m -159.97 59.96 0.36 Allowed 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.983 -1.488 . . . . 4.87 106.983 -172.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -151.87 141.18 21.45 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.7 0.682 . . . . 4.75 111.719 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.07 107.08 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.294 1.438 . . . . 0.72 109.186 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.8 m -84.38 134.1 34.49 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.686 1.195 . . . . 0.81 109.73 173.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -122.74 139.15 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.199 1.8 . . . . 0.68 106.679 171.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.1 m -148.81 136.87 20.85 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 107.031 -1.47 . . . . 0.95 107.031 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.89 -94.62 0.15 Allowed Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 106.261 -2.736 . . . . 0.63 106.261 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -159.86 49.22 0.29 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.325 0.65 . . . . 2.43 110.381 169.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.6 173.07 12.37 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.503 -0.748 . . . . 0.59 112.022 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.1 m -127.7 164.73 21.45 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.709 1.603 . . . . 0.58 111.358 -174.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 tp -53.71 -28.71 16.72 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 CA-C-O 117.809 -1.091 . . . . 1.8 113.231 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -32.73 -50.92 0.28 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.391 1.076 . . . . 2.21 111.825 171.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -68.89 -41.44 78.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.385 0.612 . . . . 2.49 111.652 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 25' ' ' VAL . 38.0 t -67.44 -37.15 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.662 0.785 . . . . 0.38 110.111 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -57.41 -54.42 47.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.596 1.558 . . . . 3.15 107.944 173.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.63 -53.73 47.65 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 110.101 -0.333 . . . . 3.07 110.101 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.63 -47.95 63.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.132 0.491 . . . . 0.51 111.132 173.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.27 -18.44 4.89 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 126.336 1.922 . . . . 0.5 113.245 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.73 -24.52 0.58 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.468 1.634 . . . . 0.72 112.878 171.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -54.01 -34.33 59.59 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.893 1.224 . . . . 2.24 113.315 172.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -120.35 -19.73 7.51 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.195 1.398 . . . . 2.66 112.339 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 74.13 55.24 0.09 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.494 1.918 . . . . 1.02 110.729 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.95 166.09 23.98 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.261 -0.899 . . . . 1.39 111.082 -176.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.98 121.16 38.34 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.523 -1.288 . . . . 4.13 107.523 169.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.33 140.6 44.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 125.007 1.323 . . . . 0.66 108.029 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.12 131.74 23.99 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.356 1.062 . . . . 1.61 108.525 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.28 97.82 0.79 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.537 2.158 . . . . 0.76 108.829 170.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -49.19 -46.85 46.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.532 0.733 . . . . 3.35 111.028 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? 71.69 -65.89 0.33 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.758 1.623 . . . . 4.49 111.145 172.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -167.87 -54.03 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.168 1.387 . . . . 7.42 108.526 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.471 0 N-CA-C 105.09 -2.189 . . . . 8.59 105.09 179.206 . . . . . . . . 0 0 . 1 stop_ save_